<SEC-DOCUMENT>0001615774-16-007154.txt : 20160913
<SEC-HEADER>0001615774-16-007154.hdr.sgml : 20160913
<ACCEPTANCE-DATETIME>20160913173116
ACCESSION NUMBER:		0001615774-16-007154
CONFORMED SUBMISSION TYPE:	S-1
PUBLIC DOCUMENT COUNT:		58
FILED AS OF DATE:		20160913
DATE AS OF CHANGE:		20160913

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			American BriVision (Holding) Corp
		CENTRAL INDEX KEY:			0001173313
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-INDUSTRIAL MACHINERY & EQUIPMENT [5084]
		IRS NUMBER:				260014658
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		S-1
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-213618
		FILM NUMBER:		161883579

	BUSINESS ADDRESS:	
		STREET 1:		11 SAWYERS PEAK DRIVE
		CITY:			GOSHEN
		STATE:			NY
		ZIP:			10924
		BUSINESS PHONE:		845-551-8728

	MAIL ADDRESS:	
		STREET 1:		11 SAWYERS PEAK DRIVE
		CITY:			GOSHEN
		STATE:			NY
		ZIP:			10924

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	METU BRANDS, INC.
		DATE OF NAME CHANGE:	20150908

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ECOLOGY COATINGS, INC.
		DATE OF NAME CHANGE:	20080821

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Ecology Coatings, Inc.
		DATE OF NAME CHANGE:	20070711
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1
<SEQUENCE>1
<FILENAME>s104086_s1.htm
<DESCRIPTION>S-1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Registration No.&nbsp;&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECURITIES AND
EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Washington, D.C.
20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>FORM S-1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OF 1933</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>AMERICAN BRIVISION
(HOLDING) CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>(Exact name of
Registrant as specified in its charter)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nevada</B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 32%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5084
    </B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 32%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<B>26-0014658</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(State or Other
    Jurisdiction of</I></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Incorporation or Organization)</I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Primary Standard
    Industrial</I></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Classification Code Number)</I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(I.R.S. Employer
    Identification</I></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Number)</I></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>11 Sawyers Peak
Drive, Goshen, NY, 10924</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(845) 291-1291</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Address, including
zip code, and telephone number,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">including area code,
of Registrant&rsquo;s principal executive offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><I>Copies to:</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Louis E. Taubman,
Esq.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Hunter Taubman
Fischer &amp; Li, LLC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>1450 Broadway,
Floor 26</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>New York, NY 10018</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Approximate date of commencement of proposed sale to the
public:</B> From time to time after this Registration Statement becomes effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under
the Securities Act of 1933, check the following box.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Wingdings">x</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the
following box and list the Securities Act registration statement number of the earlier effective registration statement for the
same offering.&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list
the Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list
the Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.&nbsp;&nbsp;&nbsp;See definitions of &ldquo;large
accelerated filer&rdquo;, &ldquo;accelerated filer&rdquo; and &ldquo;smaller reporting company&rdquo; in Rule 12b-2 of the Exchange
Act.&nbsp;&nbsp;(Check one):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 49.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large accelerated
    filer</FONT></TD>
    <TD NOWRAP STYLE="width: 10%"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD NOWRAP STYLE="width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated filer
    </FONT></TD>
    <TD NOWRAP STYLE="width: 10%"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD NOWRAP><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Non-accelerated filer</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(Do not check if a smaller reporting company)</P></TD>
    <TD NOWRAP><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD NOWRAP><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller reporting company </FONT></TD>
    <TD NOWRAP><FONT STYLE="font-family: Wingdings; font-size: 10pt">x</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CALCULATION OF
REGISTRATION FEE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Title of each class of securities
    to be <BR>
    registered</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Amount to <BR>
    be <BR>
    Registered <BR>
    (1)</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Proposed<BR>
    maximum <BR>
    offering <BR>
    price per<BR>
    share(2)</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Proposed <BR>
    maximum <BR>
    aggregate <BR>
    offering price</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Amount of <BR>
    registration <BR>
    fee</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 48%; text-align: left">Common stock, par value $.001 per share offered by certain selling stockholders</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">32,409,505</TD><TD STYLE="width: 1%; text-align: left">(3)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">2.00</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">64,819,010</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">6,528</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt">Total</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">32,409,505</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">64,819,010</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">6,528</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="width: 95%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
    to Rule 416 of the Securities Act of 1933, also registered hereby are such additional and indeterminable number of shares
    as may be issuable due to adjustments for changes resulting from stock dividends, stock splits and similar changes.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="width: 95%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended,
    based on the average of the high and low sales price of the common stock on the OTCQB Market on August 24, 2016.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="width: 95%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The 32,409,505
    shares of common stock are being registered for resale by certain selling stockholders named in this registration statement,
    which shares were issued by the registrant in the Share Exchange, as defined below.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>The registrant hereby amends this
registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a
further amendment which specifically states that this registration statement shall thereafter become effective in accordance with
Section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date as the Securities
and Exchange Commission, acting pursuant to Section 8(a) may determine.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="color: Red"><B>The
information in this prospectus is not complete and may be changed.&nbsp;&nbsp;We may not sell these securities until the registration
statement filed with the Securities and Exchange Commission (&ldquo;SEC&rdquo;) is effective.&nbsp;&nbsp;This prospectus is not
an offer to sell these securities and is not soliciting an offer to buy these securities in any state where the offer or sale
is not permitted.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; text-indent: 0.5in"><FONT STYLE="color: Red">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 47%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>Preliminary
    Prospectus</B></FONT></TD>
    <TD STYLE="width: 53%; font-size: 10pt; text-align: right; text-indent: 0.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>Subject
    to Completion, dated September 13, 2016</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>American BriVision
(Holding) Corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">32,409,505 Shares
of Common Stock</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.55in">This prospectus relates to the resale
of up to 32,409,505 shares of common stock of American BriVision (Holding) Corporation, a Nevada corporation (the &ldquo;Company&rdquo;),
$0.001 par value (the &ldquo;Common Stock&rdquo;).&nbsp;The selling stockholders named herein may sell common stock from time
to time in the principal market on which the stock is traded at the prevailing market price, at prices related to such prevailing
market price, in negotiated transactions or a combination of such methods of sale. We will not receive any proceeds from the sales
by the selling stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.55in">Our common stock is quoted on the OTC
Markets under the symbol ABVC. Prior to January 14, 2016, our common stock was quoted under the symbol MTOO. Prior to December
15, 2015, our common stock was quoted under the symbol ECOC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.55in">The selling stockholders, and any broker-dealer
executing sell orders on behalf of the selling stockholders, may be deemed to be &ldquo;underwriters&rdquo; within the meaning
of the Securities Act of 1933, as amended.&nbsp;&nbsp;Commissions received by any broker-dealer may be deemed underwriting commissions
under the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>THIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK.&nbsp;&nbsp;YOU
SHOULD PURCHASE SHARES ONLY IF YOU CAN AFFORD A COMPLETE LOSS OF YOUR INVESTMENT.&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE
SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED THESE SECURITIES, OR DETERMINED IF THIS PROSPECTUS IS TRUTHFUL OR COMPLETE.
ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The date of this prospectus is September
13&#9;, 2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 84%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><A HREF="#s1_001">PART I. INFORMATION REQUIRED IN PROSPECTUS</A></B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 10%; text-align: center">1</TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#s1_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">About This Prospectus </FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">1</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#s1_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prospectus Summary</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">2</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#s1_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk Factors</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">5</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#s1_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cautionary Note Regarding Forward-Looking Statements</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">19</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#s1_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use of Proceeds</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">19</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#s1_007"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Determination of Offering Price</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">19</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#s1_008"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management&rsquo;s Discussion and Analysis</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">20</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#s1_009"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">29</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#s1_010"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">34</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#s1_011"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Compensation</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">36</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#s1_012"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain Relationship and Related Transactions</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">38</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#s1_013"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Ownership of Certain Beneficial Owners and Management </FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">39</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#s1_014"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling Stockholders</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">41</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#s1_015"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plan of Distribution</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">45</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market for Common Equity and Related Stockholder Matters</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#s1_017">Legal Matters</A> </FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">48</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#s1_018">Experts</A></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">48</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#s1_016"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market For Our Common Stock, Dividends And Related Stockholder Information</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">47</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporation of Certain Information by Reference</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#s1_019">Disclosure of Commission Position on Indemnification for Securities Act Liabilities</A></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">48</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 84%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#s1_020">PART II. INFORMATION NOT REQUIRED IN PROSPECTUS</A></B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 10%; text-align: center">II-1</TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#s1_021"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Expenses of Issuances and Distribution</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">II-1</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#s1_022"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnification of Directors and Officers</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">II-1</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#s1_023"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recent Sales of Unregistered Securities</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">II-2</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#s1_024"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits and Financial Statement Schedule</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">II-3</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#s1_025"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Undertakings</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">II-3</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="s1_001"></A>PART 1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="s1_002"></A>ABOUT THIS PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0">We have not authorized any person to give
you any supplemental information or to make any representations for us. You should not rely upon any information about us that
is not contained in this prospectus or in one of our public reports filed with the Securities and Exchange Commission (&ldquo;SEC&rdquo;)
and incorporated into this prospectus. Information contained in this prospectus or in our public reports may become stale. You
should not assume that the information contained in this prospectus, any prospectus supplement or the documents incorporated by
reference are accurate as of any date other than their respective dates, regardless of the time of delivery of this prospectus
or of any sale of the shares. Our business, financial condition, results of operations and prospects may have changed since those
dates. The selling stockholders are offering to sell, and seeking offers to buy, shares of our common stock only in jurisdictions
where offers and sales are permitted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In this prospectus the &ldquo;Company,&rdquo; &ldquo;we,&rdquo;
&ldquo;us,&rdquo; and &ldquo;our&rdquo; refer to American Brivision (Holding) Corporation, a Nevada corporation and its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">All dealers that effect transactions in these securities, whether
or not participating in this offering, may be required to deliver a prospectus.&nbsp;&nbsp;This is in addition to the dealers&rsquo;
obligation to deliver a prospectus when acting as underwriters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="s1_003"></A>PROSPECTUS SUMMARY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This summary highlights selected information appearing elsewhere
in this prospectus. While this summary highlights what we consider to be the most important information about us, you should carefully
read this prospectus and the registration statement of which this prospectus is a part in their entirety before investing in our
common stock, and our financial statements and related notes beginning on page F-1 and F-4, respectively. Unless the context requires
otherwise, the words the &ldquo;Company,&rdquo; &ldquo;American BriVision&rdquo; &ldquo;we,&rdquo; &ldquo;us&rdquo; or &ldquo;our&rdquo;
are references to the combined business of American BriVision (Holding) Corporation and its consolidated subsidiaries.&nbsp;&nbsp;References
to &ldquo;Brivision&rdquo; are references to our wholly-owned subsidiary. References to &ldquo;China&rdquo; or &ldquo;PRC&rdquo;
are references to the People&rsquo;s Republic of China.&nbsp;&nbsp;References to &ldquo;RMB&rdquo; are to Renminbi, the legal
currency of China, and all references to &ldquo;$&rdquo; and dollar are to the U.S. dollar, the legal currency of the United States.
All market and industry data provided in this prospectus represents information that&nbsp;is generally available to the public
and was not prepared for us for a fee. We did not fund nor were&nbsp;we otherwise affiliated with these sources and we are not
attempting to incorporate the information on external web sites into this prospectus. We are only providing textual reference
of the information of market and industry data and the web addresses provided in this prospectus are not intended to be hyperlinks
and we do not assure that those external web sites will remain active and current.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Our Company</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Currently, we are a holding company operating through our wholly
owned subsidiary, American BriVision Corporation, a Delaware corporation, or BriVision. BriVision was incorporated in 2015 in
the State of Delaware. It is a biotechnology company focused on the development of new drugs and innovative medical devices to
fulfill unmet medical needs. The business model of the Company is to integrate research achievements from world-famous institutions,
conduct clinical trials of translational medicine for Proof of Concept (POC), out-license to international pharmaceutical companies,
and exploit global markets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We currently have sole licensing rights to the drug and therapeutic
use for five compounds developed by BioLite, Inc. (&ldquo;BioLite&rdquo;). BioLite is a botanical new drug developer incorporated
under the laws of Taiwan in 2006. On December 29, 2015,&nbsp;BriVision entered into a Collaborative Agreement (the &ldquo;Collaborative
Agreement&rdquo;) with BioLite. Our CEO and sole director, Eugene Jiang, is a director of BioLite and therefore BioLite is considered
a related party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>History and Background</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the consummation of the share exchange transaction described below, we were a public reporting company with nominal operations.&nbsp;&nbsp;
Ecology Coatings Inc. incorporated on March 12, 1990 in California (&ldquo;Ecology-CA&rdquo;).&nbsp; OCIS Corp (&ldquo;OCIS&rdquo;)was
incorporated in Nevada on February&nbsp;6, 2002 as and was a public reporting company.. (&ldquo;OCIS&rdquo;).&nbsp;&nbsp;OCIS
completed a merger with Ecology-CA on July&nbsp;26, 2007 (the &ldquo;Merger&rdquo;). In the Merger, OCIS changed its name from
OCIS Corporation to Ecology Coatings, Inc.&nbsp;&nbsp;The Company filed for Chapter 7 bankruptcy protection on May 15, 2013 and
subsequently the corporate shell emerged as its only unencumbered asset on September 19, 2014 using &quot;fresh start&quot; accounting
under section 852-10-45-17 as of date of sale corporate shell to reflect intangible assets sale through section 363. Any business
description below and all reporting results of the operating results reported in this filing for the fiscal year ending September
30, 2015 are post &quot;fresh start&quot; activity and not comparable to prior results. Post-bankruptcy, the Company operated
a web site for the sale of women's apparel. On November 14, 2014, a majority of the stockholders of the Company by unanimous written
consent in lieu of a special meeting of stockholders, unanimously approved an amendment to the Articles of Incorporation to change
the name of the Company to Metu Brands, Inc. . The Amendment the Articles of Incorporation was filed with the State of Nevada
on April 28, 2015. The name change was subsequently approved by the Financial Industry Regulatory Authority (&ldquo;FINRA&rdquo;)
on August 13, 2015. In conjunction with the name change, the Company&rsquo;s ticker symbol will be changed to &ldquo;MTOO&rdquo;.
On December 18, 2015, a Stock Purchase Agreement (&ldquo;Stock Purchase Agreement&rdquo;) was entered into by and among Euro-Asia
Investment &amp; Finance Corp. Limited, a company incorporated under the laws of Hong Kong Special Administrative Region of China
(&ldquo;Euro-Asia&rdquo; or &ldquo;Buyers&rsquo; Representative&rdquo;), &nbsp;seven other buyers listed in Schedule A attached
thereto (together with Euro-Asia, collectively, &ldquo;Buyers&rdquo;), Shulamit Lazar (&ldquo;Lazar&rdquo;), eleven other sellers
listed in Schedule B attached thereto (together with Lazar, collectively, &ldquo;Sellers&rdquo;),. Pursuant to the Stock Purchase
Agreement, for a total consideration of $395,000, the Buyers acquired from the Sellers a total of 65,420,000 shares of the Company&rsquo;s
common stock, $0.001 par value per share (the &ldquo;Common Stock&rdquo;) which represented approximately 99.98% of the Company&rsquo;s
65,431,144 shares of issued and outstanding Common Stock at that time.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 21, 2015, the majority holder of the issued and outstanding shares of common stock of the Company approved the change
of the Company&rsquo;s name from Metu Brands, Inc. to American BriVision (Holding) Corporation (the &ldquo;Name Change&rdquo;),
and the increase of its authorized shares of Common Stock from 90,000,000 to 350,000,000, and authorized shares of preferred stock
from 10,000,000 to 20,000,000, par value $0.001 per share (the &ldquo;Increase of Authorized Stock&rdquo;). A Certificate of Amendment
(the &ldquo;Amendment&rdquo;) to Articles of Incorporation effectuating the Name Change and Increase of Authorized Stock was filed
and became effective as of January 4, 2016. As a result of the Name Change, our trading symbol is changed from &ldquo;MTOO&rdquo;
to &ldquo;ABVC&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Reverse Merger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On February 8, 2016, a Share Exchange Agreement (&ldquo;Share
Exchange Agreement&rdquo;) was entered into by and among&nbsp;the&nbsp;Company, BriVision, Euro-Asia , being the owners of record
of 52,336,000 shares of common stock of the Company, and the owners of record of all of the issued share capital of BriVision
(the&nbsp;&ldquo;BriVision Stock&rdquo;). Pursuant to the Share Exchange Agreement, upon surrender by the BriVision Shareholders
and the cancellation by BriVision of the certificates evidencing the BriVision Stock as registered in the name of each BriVisionShareholder,
and pursuant to the registration of the Company in the register of members maintained by BriVision as the new holder of the BriVision
Stock and the issuance of the certificates evidencing the aforementioned registration of the BriVision Stock in the name of the
Company, the Company issued 52,936,583 shares (the&nbsp;&ldquo;Acquisition Stock&rdquo;) (subject to adjustment for fractionalized
shares) of the Company&rsquo;s common stock to the BriVision Shareholders (or their designees), and cancelled 51,945,225 shares
of the Company&rsquo;s common stock owned by Euro-Asia (such shares were retired to treasury). The Acquisition Stock collectively
represents 79.70% of the issued and outstanding common stock of the Company immediately after the closing of the transaction contemplated
in the Share Exchange Agreement (&ldquo;Share Agreement&rdquo;)..&nbsp;&nbsp;As a result of Share Exchange, BriVision became the
Company&rsquo;s wholly owned subsidiary &nbsp;&nbsp;There were no warrants, options or other equity instruments issued in connection
with the Share Exchange .</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Following the Share Exchange, we have abandoned our prior business
plan and we are now using&nbsp;BriVision&rsquo;s&nbsp;historical businesses and proposed businesses, which focus on the development
of new drugs and innovative medical devices to fulfill unmet medical needs.&nbsp;&nbsp;The business model of the Company is to
integrate research achievements from world-renown institutions, conduct clinical trials of translational medicine for Proof of
Concept (&ldquo;POC&rdquo;), out-license to international pharmaceutical companies, and exploit global markets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward Stock Split</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On March 21, 2016, the Board of Directors of the Company approved
an amendment to Articles of Incorporation to effect a forward split at a ratio of 1 to 3:141 and increase the number of our authorized
shares of common stock, par value $0.001 per share, to 360,000,000, . The amendment to Articles of Incorporation was approved
by the majority of the shareholders of the Company and became effective on April 8, 2016..</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Merger and Name Change</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ecology Coatings, Inc. (&ldquo;Ecology-CA&rdquo;) was originally
incorporated in California on March 12, 1990.&nbsp;&nbsp;OCIS Corp. (&ldquo;OCIS&rdquo;) was incorporated in Nevada on February&nbsp;6,
2002.&nbsp;&nbsp;OCIS completed a merger with Ecology-CA on July&nbsp;27, 2007 (the &ldquo;Merger&rdquo;).&nbsp;&nbsp;In the Merger,
OCIS issued approximately 6,106,137 shares of common stock to the Ecology-CA stockholders.&nbsp;&nbsp;In this transaction, OCIS
changed its name from OCIS Corporation to Ecology Coatings, Inc. and our ticker symbol on the OTC Bulletin Board association changed
to &ldquo;ECOC.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On November 14, 2014, Ecology-CA changed its name to Metu Brands,
Inc., which the Financial Industry Regulatory Authority (&ldquo;FINRA&rdquo;) approved on August 13, 2015. In conjunction with
the name change, Ecology-CA&rsquo;s ticker symbol will be changed to &ldquo;MTOO&rdquo;. On January 14, 2016, Metu Brands, Inc.
changed its name to American BriVision (Holing) Corporation and its OTCQB ticker symbol changed from &ldquo;MTOO&rdquo; to &ldquo;ABVC&rdquo;,
which was approved by FINRA and took effect as of January 14, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Principal Executive Office</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our principal executive offices are located at 11 Sawyers Peak
Drive, Goshen, NY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>The Offering</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 38%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock being offered
    by Selling Stockholders</FONT></TD>
    <TD STYLE="width: 62%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Up to 32,409,505 shares.
    </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock outstanding prior to the Offering</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">213,303,222 shares as of September 13,
    2016</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock outstanding after the Offering</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">213,303,222 shares</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use of Proceeds</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We will not receive any proceeds from the sale
    of shares by the Selling Stockholders</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading Symbol</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk Factors</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The securities offered by this prospectus are
    speculative and involve a high degree of risk and investors purchasing securities should not purchase the securities unless
    they can afford the loss of their entire investment.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><A NAME="s1_004"></A><B> RISK FACTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">You should carefully consider the risks described below as
well as other information provided to you in this document, including information in the section of this document entitled &ldquo;Forward
Looking Statements&rdquo;. If any of the following risks actually occur, our business, financial condition or results of operations
could be materially adversely affected, the value of our common stock could decline, and you may lose all or part of your investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risks Relating to Our Business</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We are a pre-revenue biopharmaceutical company and are
thus subject to the risks associated with new businesses in that industry.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We acquired the sole licensing rights to develop and commercialize
for drug and therapeutic use of five compounds and have only recently begun to pursue this new business opportunity. As such,
we are a clinical stage biopharmaceutical company with no history of revenue-generating operations, and our only assets consist
of the intellectual property and related assets licensed to us by BioLite. Therefore, we are, and expect for the foreseeable future
to be, subject to all the risks and uncertainties inherent in a new business, in particular new businesses engaged in the development
of pharmaceuticals. We still must establish and implement many important functions necessary to operate a business, including
the clinical development of the five compounds, establishing our managerial and administrative structure and implementing financial
systems and controls.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Accordingly, you should consider our prospects in light of
the costs, uncertainties, delays and difficulties frequently encountered by companies in their pre-revenue generating stages,
particularly those in the pharmaceutical field. Potential investors should carefully consider the risks and uncertainties that
a new company with no operating history will face. In particular, potential investors should consider that there is a significant
risk that we will not be able to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;implement or execute our current
business plan, or create a business plan that is sound;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;maintain our anticipated management
team;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;raise sufficient funds in the
capital markets or otherwise to effectuate our business plan;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;determine that the processes
and technologies that we have developed are commercially viable; and/or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;attract, enter into or maintain
contracts with, potential commercial partners such as licensors of technology and suppliers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If we cannot execute any one of the foregoing, our business
may fail, in which case you may lose the entire amount of your investment in our Company. To date, we are still setting up our
pipeline products. We cannot assure that any of our efforts will be successful or result in the development or timely launch of
additional products, or ultimately produce any material revenue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, as a pre-revenue biopharmaceutical company, we
expect to encounter unforeseen expenses, difficulties, complications, delays and other known and unknown factors. We will need
to transition at some point from a company with a research and development focus to a company capable of supporting commercial
activities. We may not be able to reach such point of transition or make such a transition, which would have a material adverse
effect on our company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>If we fail to raise additional capital, our ability to
implement our business model and strategy could be compromised.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have limited capital resources and operations. To date,
our operations have been&nbsp;funded&nbsp;partial&nbsp;from the proceeds from financings or loans from shareholders or our management.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If we do not raise $5,000,000&nbsp;by&nbsp;December 31, 2016&nbsp;,
we will likely be unable to carry out our business. We may not be able to obtain additional financing on terms acceptable to us,
or at all. Even if we obtain financing for our near term operations and product development, we may require additional capital
beyond the near term. If we are unable to raise capital when needed, our business, financial condition and results of operations
would be materially adversely affected, and we could be forced to reduce or discontinue our operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We are highly dependent on our license agreement with
BioLite, and the loss of this license would materially impair our business plan and viability.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have secured sole rights to develop and commercialize five
products from BioLite in the North America, and these five products are currently our only product candidates. As such, our Collaboration
Agreement with BioLite is critical to our business. In the event that our Collaboration Agreement with BioLite is terminated,
we would lose the ability to develop and commercialize the five products, and our business prospects would be materially damaged,
which could lead to the loss of your investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We have no experience as a company in obtaining regulatory
approval for, or commercializing, any product candidate.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As a company, we have never obtained regulatory approval for,
or commercialized, any product candidate. It is possible that the FDA may refuse to accept our planned New Drug Application (or
NDA) for any of the five products for substantive review, or may conclude after review of our data that our application is insufficient
to obtain regulatory approval of The five products or any future product candidates. If the FDA does not accept or approve our
planned NDA for our product candidates, it may require that we conduct additional clinical, preclinical or manufacturing validation
studies, which may be costly, and submit that data before it will reconsider our applications. Depending on the extent of these
or any other FDA required studies, approval of any NDA or application that we submit may be significantly delayed, possibly for
several years, or may require us to expend more resources than we have available. Any delay in obtaining, or an inability to obtain,
regulatory approvals would prevent us from commercializing The five products, generating revenues and achieving and sustaining
profitability. It is also possible that additional studies, if performed and completed, may not be considered sufficient by the
FDA to approve any NDA we submit. If any of these outcomes occur, we may be forced to abandon our planned NDA for The five products,
which would materially adversely affect our business and could potentially cause us to cease operations. We face similar risks
for any approval in a foreign jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Dependence on Key Existing and Future Personnel.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our success will depend, to a large degree, upon the efforts
and abilities of our officers and key employees. The loss of the services of one or more of our key employees could have a material
adverse effect on our operations. In addition, as our business model is implemented, we will need to recruit and retain additional
management and key employees in virtually all phases of our operations. Key employees will require a strong background in our
industry. We cannot assure that we will be able to successfully attract and retain key personnel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our growth is dependent on our ability to successfully
develop, acquire or license new drugs.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our growth is supported by continuous investment in time, resources
and capital to identify and develop new products or new formulations for the market via&nbsp;geographic expansion and market penetration.
If we are unable to either develop new products on our own or acquire licenses for new products from third parties, our ability
to grow revenues and market share will be adversely affected.&nbsp;In addition, we may not be able to recover our investment in
the development of new drugs and medical devices, given that projects may be interrupted, unsuccessful, not as profitable as initially
contemplated or we may not be able to obtain necessary financing for such development. Similarly, there is no assurance that we
can successfully secure such rights from third parties on an economically feasible basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We may not be able to secure financing needed for future
operating needs on acceptable terms, or on any terms at all.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">From time to time, we may seek additional financing to provide
the capital required to expand our production facilities, R&amp;D initiatives and/or working capital, as well as to repay outstanding
loans if cash flow from operations is insufficient to do so.&nbsp;We cannot predict with certainty the timing or amount of any
such capital requirements.&nbsp;If such financing is not available on satisfactory terms, we may be unable to expand our business
or to develop new business at the rate desired.&nbsp;If we are able to incur debt, we may be subject to certain restrictions imposed
by the terms of the debt and the repayment of such debt may limit our cash flow and growth.&nbsp;If we are unable to incur debt,
we may be forced to issue additional equity, which could have a dilutive effect on our current stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Expansion of our business may put pressure on our management
and the operational infrastructure which could impede our ability to meet an increased demand for our products</I></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our business plan is to develop new drug (product) and finish
Phase II clinical trial (after finish phase II clinical trial and if the result is good, this is co called prove of concept (POC)),
then ABVC would engage with the world leading Pharmaceuticals by out licensing the new drug for the next stage development. The
advantages are</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD>to diversify the risk involved with leading pharmaceuticals</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD>Quick return on investment (ROI) &amp; Improve cash flow</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.</TD><TD>Sustainable income</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Growth in our business may place a significant strain on our
personnel, management, financial systems and other resources.&nbsp;The evolution of our business also presents numerous risks
and challenges that include continued acceptance of our products, sales and market share expansion, costs for expansion, technological
evolvement and industrial dynamics.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If we are successful in obtaining rapid market growth of our
products, we will be required to deliver large volumes of quality products and services on a timely basis at a reasonable cost
to the customers.&nbsp;Meeting any such increased demands will require us to expand our manufacturing facilities, to increase
our ability to purchase raw materials, to expand our work force, to expand our quality control capabilities and to increase the
scale upon which we provide our products and services.&nbsp;&nbsp;Such demands would require more capital and working capital
than we currently have available and we may be unable to meet the needs of our customers, which could adversely affect our relationship
with our customers and reduce our revenues.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our growth strategy includes the pursuit of acquisitions,
and new product development, which could have a materially adverse effect on our business, financial condition, results of operations
and growth prospects.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our business strategy includes growth through strategic acquisitions,
&nbsp;and the development of new products, medical devices and technologies, which will involve significant capital expenditure
and risks.&nbsp;Innovative pharmaceutical development involves R&amp;D costs, but it may achieve no tangible results and instead
may adversely affect our future profitability.&nbsp;In addition, any acquisition or combination that we consummate will likely
involve, among other things, the payment of cash, the incurrence of contingent liabilities and the amortization of expenses related
to goodwill and other intangible assets, and transaction costs, which may adversely affect our business, financial condition,
results of operations and growth prospects.&nbsp;Our ability to integrate and organize any new businesses and/or products, whether
internally developed or obtained by acquisition or combination, will likely require significant expansion of our operations.&nbsp;There
is no assurance that we will be able to obtain the necessary resources for such expansion, and the failure to do so could have
a materially adverse effect on our business, financial condition, results of operations and growth prospects.&nbsp;&nbsp;In addition,
future acquisitions or combinations by the company involve risks of, among other things, entering markets or segments in which
we have no or limited prior experience, the potential loss of key employees or difficulty, delay or failure in the integration
of the operations of any such new business with our current business and operating and financial difficulties of any new or newly
combined operations, any of which could have a materially adverse effect on our business, financial condition, results of operations
and growth prospects.&nbsp;&nbsp;Moreover, there can be no assurance that the anticipated benefits of any internally developed
new business segment or business combination will be realized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our current products have certain side effects.&nbsp;&nbsp;If
the side effects associated with our current or future products are not identified prior to their marketing and sale, we may be
required to withdraw such products from the market, perform lengthy additional clinical trials or change the labeling of our products,
any of which could adversely impact our growth.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our current products have certain side effects.&nbsp;&nbsp;If
significant side effects of our medicines are identified after they are marketed and sold:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1)</TD><TD>regulatory authorities may withdraw or modify their approvals
                                         of such medicines;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2)</TD><TD>we may be required to reformulate these medicines, change
                                         the ways in which they are marketed, conduct additional clinical trials, change the labeling
                                         of these medicines or implement changes to obtain new approvals for our manufacturing
                                         facilities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3)</TD><TD>we may have to recall these medicines from the market and
                                         may not be able to re-launch them;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">4)</TD><TD>we may experience a significant decline in sales of the affected
                                         products;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">5)</TD><TD>our reputation may suffer; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">6)</TD><TD>We may become a target of lawsuits.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The occurrence of any of these events would harm our sales
of these medicines and substantially increase the costs and expenses of marketing these medicines, which in turn could cause our
revenues and net income to decline.&nbsp;In addition, the reputation and sales of our medicines could be adversely affected due
to the severe side effects discovered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We may be subject to product liability claims in the
future.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We face an inherent business risk of exposure to product liability
claims in the event that the uses of our products are alleged to have caused adverse side effects.&nbsp;Side effects or marketing
or manufacturing problems pertaining to any of our products could result in product liability claims or adverse publicity.&nbsp;These
risks will exist for those products in clinical development and with respect to those products that receive regulatory approval
for commercial sale.&nbsp;&nbsp;Furthermore, although we have not historically experienced any problems associated with claims
by users of our products, we do not currently maintain product liability insurance and&nbsp;there could be no assurance that we
are able to acquire product liability insurance with terms that are commercially feasible.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Product liability lawsuits against us could divert our
resources, cause us to incur substantial liabilities and limit commercialization of any products that we may develop.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We face an inherent risk of product liability claims as a result
of the clinical testing of our products and commercially selling any products that we may develop. For example, we may be sued
if any product we develop allegedly causes injury or is found to be otherwise unsuitable during clinical testing, manufacturing,
marketing or sale. Any such product liability claims may include allegations of defects in manufacturing, defects in design, a
failure to warn of dangers inherent in the product, negligence, strict liability or a breach of warranties. Claims could also
be asserted under state consumer protection acts. If we cannot successfully defend ourselves against product liability claims,
we may incur substantial liabilities or be required to limit commercialization of our product candidate. Regardless of the merits
or eventual outcome, liability claims may result in:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">decreased
                                         demand for our product candidate or products that we may develop;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">injury
                                         to our reputation and significant negative media attention;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">withdrawal
                                         of clinical trial participants;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">significant
                                         costs to defend resulting litigation;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">substantial
                                         monetary awards to trial participants or patients;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">loss
                                         of revenue;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">reduced
                                         resources of our management to pursue our business strategy; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">the
                                         inability to commercialize any products that we may develop.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We currently do not maintain general liability insurance; and
even if we have a general liability insurance in the future this insurance may not fully cover potential liabilities that we may
incur. The cost of any product liability litigation or other proceeding, even if resolved in our favor, could be substantial.
We would need to increase our insurance coverage if and when we begin selling any product candidate that receives marketing approval.
In addition, insurance coverage is becoming increasingly expensive. If we are unable to obtain or maintain sufficient insurance
coverage at an acceptable cost or to otherwise protect against potential product liability claims, it could prevent or inhibit
the development and commercial production and sale of our product candidate, which could adversely affect our business, financial
condition, results of operations and prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>If we are unable to keep up with rapid technological
changes in our field or compete effectively, we will be unable to operate profitably.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are engaged in a rapidly changing field. Other products
that will compete directly with the products that we are seeking to develop and market currently exist or are being developed.
Competition from fully integrated pharmaceutical companies and more established biotechnology companies is intense and is expected
to increase. Most of these companies have significantly greater financial resources and expertise in discovery and development,
manufacturing, preclinical and clinical testing, obtaining regulatory approvals and marketing than us. Smaller companies may also
prove to be significant competitors, particularly through collaborative arrangements with large pharmaceutical and established
biopharmaceutical or biotechnology companies. Many of these competitors have significant products that have been approved or are
in development and operate large, well-funded discovery and development programs. Academic institutions, governmental agencies
and other public and private research organizations also conduct research, seek patent protection and establish collaborative
arrangements for therapeutic products and clinical development and marketing. These companies and institutions compete with us
in recruiting and retaining highly qualified scientific and management personnel. In addition to the above factors, we will face
competition based on product efficacy and safety, the timing and scope of regulatory approvals, availability of supply, marketing
and sales capability, reimbursement coverage, price and patent position. There is no assurance that our competitors will not develop
more effective or more affordable products, or achieve earlier patent protection or product commercialization, than our own.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Other companies may succeed in developing products earlier
than ourselves, obtaining FDA approvals for such products more rapidly than we will, or in developing products that are more effective
than products we propose to develop. While we will seek to expand our technological capabilities in order to remain competitive,
there can be no assurance that research and development by others will not render our technology or products obsolete or non-competitive
or result in treatments or cures superior to any therapy we develop, or that any therapy we develop will be preferred to any existing
or newly developed technologies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We have conducted, and may in the future conduct, clinical
trials for certain of our product candidate at sites outside the United States, and the FDA may not accept data from trials conducted
in such locations.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have conducted and may in the future choose to conduct one
or more of our clinical trials outside the United States. Although the FDA may accept data from clinical trials conducted outside
the United States, acceptance of this data is subject to certain conditions imposed by the FDA. For example, the clinical trial
must be well designed and conducted and performed by qualified investigators in accordance with ethical principles. The trial
population must also adequately represent the U.S. population, and the data must be applicable to the U.S. population and U.S.
medical practice in ways that the FDA deems clinically meaningful. Generally, the patient population for any clinical trials conducted
outside of the United States must be representative of the population for whom we intend to seek approval in the United States.
In addition, while these clinical trials are subject to the applicable local laws, FDA acceptance of the data will be dependent
upon its determination that the trials also complied with all applicable U.S. laws and regulations. There can be no assurance
that the FDA will accept data from trials conducted outside of the United States. If the FDA does not accept the data from any
of our clinical trials that we determine to conduct outside the United States, it would likely result in the need for additional
trials, which would be costly and time-consuming and delay or permanently halt our development of the product candidate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, the conduct of clinical trials outside the United
States could have a significant impact on us. Risks inherent in conducting international clinical trials include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">foreign regulatory requirements that could restrict
    or limit our ability to conduct our clinical trials;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 74.25pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">administrative burdens of conducting clinical
    trials under multiple foreign regulatory schema;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 74.25pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">foreign exchange fluctuations; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 74.25pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">diminished protection of intellectual property
    in some countries.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>If clinical trials of our product candidates fail to
demonstrate safety and efficacy to the satisfaction of the FDA and comparable non-U.S. regulators, we may incur additional costs
or experience delays in completing, or ultimately be unable to complete the development and commercialization of our product candidate.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are not permitted to commercialize market, promote or sell
any product candidate in the United States without obtaining marketing approval from the FDA. Comparable non-U.S. regulatory authorities
impose similar restrictions. We may never receive such approvals. We must complete extensive preclinical development and clinical
trials to demonstrate the safety and efficacy of our product candidate in humans before we will be able to obtain these approvals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Clinical testing is expensive, difficult to design and implement,
can take many years to complete and is inherently uncertain as to outcome. Any inability to successfully complete preclinical
and clinical development could result in additional costs to us and impair our ability to generate revenues from product sales,
regulatory and commercialization milestones and royalties. In addition, if (1) we are required to conduct additional clinical
trials or other testing of our product candidate beyond the trials and testing that we contemplate, (2) we are unable to successfully
complete clinical trials of our product candidate or other testing, (3) the results of these trials or tests are unfavorable,
uncertain or are only modestly favorable, or (4) there are unacceptable safety concerns associated with our product candidate,
we, in addition to incurring additional costs, may:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">be
                                         delayed in obtaining marketing approval for our product candidates;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">not
                                         obtain marketing approval at all;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">obtain
                                         approval for indications or patient populations that are not as broad as we intended
                                         or desired;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">obtain
                                         approval with labeling that includes significant use or distribution restrictions or
                                         significant safety warnings, including boxed warnings;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">be
                                         subject to additional post-marketing testing or other requirements; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">be
                                         required to remove the product from the market after obtaining marketing approval.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Even if our product candidate receives marketing approval,
it may fail to achieve the degree of market acceptance by physicians, patients, third party payors and others in the medical community
necessary for commercial success and the market opportunity for the product candidate may be smaller than we estimate.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have never commercialized a product. Even if our products
are approved by the appropriate regulatory authorities for marketing and sale, they may nonetheless fail to gain sufficient market
acceptance by physicians, patients, third party payors and others in the medical community. For example, physicians are often
reluctant to switch their patients from existing therapies even when new and potentially more effective or convenient treatments
enter the market. Further, patients often acclimate to the therapy that they are currently taking and do not want to switch unless
their physicians recommend switching products or they are required to switch therapies due to lack of reimbursement for existing
therapies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Efforts to educate the medical community and third party payors(???)
on the benefits of our product candidate may require significant resources and may not be successful. If our product candidates
are approved but do not achieve an adequate level of market acceptance, we may not generate significant revenues and we may not
become profitable. The degree of market acceptance of our products, if approved for commercial sale, will depend on a number of
factors, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the efficacy and safety of the products;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the potential advantages of the products compared
    to alternative treatments;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the prevalence and severity of any side effects;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the clinical indications for which the products
    are approved;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether the products are designated under physician
    treatment guidelines as a first-line therapy or as a second- or third-line therapy;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">limitations or warnings, including distribution
    or use restrictions, contained in the product approved labeling;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to offer the products for sale at
    competitive prices;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to establish and maintain pricing
    sufficient to realize a meaningful return on our investment;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the products&rsquo;&nbsp;convenience and ease
    of administration compared to alternative treatments;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the willingness of the target patient population
    to try, and of physicians to prescribe, the products;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the strength of sales, marketing and distribution
    support;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the approval of other new products for the same
    indications;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes in the standard of care for the targeted
    indications for the products;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the timing of market introduction of our approved
    products as well as competitive products and other therapies;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 74.25pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">availability and amount of reimbursement from
    government payors, managed care plans and other third party payors;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 74.25pt">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">adverse publicity about the products or favorable
    publicity about competitive products; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 74.25pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential product liability claims.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The potential market opportunities for our products are difficult
to estimate precisely. Our estimates of the potential market opportunities are predicated on many assumptions, including industry
knowledge and publications, third party research reports and other surveys. While we believe that our internal assumptions are
reasonable, these assumptions involve the exercise of significant judgment on the part of our management, are inherently uncertain
and the reasonableness of these assumptions has not been assessed by an independent source. If any of the assumptions proves to
be inaccurate, the actual markets for our products could be smaller than our estimates of the potential market opportunities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We rely on a limited number of suppliers and the loss
of any of our suppliers, or delays or problems in the supply of materials used in our products, could materially and adversely
affect our operations and growth</I></B><B><I>.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We generally rely on a limited number of suppliers for most
of the primary materials used in our products.&nbsp;&nbsp;Our suppliers may not be able to supply the necessary materials without
interruption and we may not have adequate remedies for such failure, which could result in a shortage of our products.&nbsp;&nbsp;If
one of our suppliers fails or refuses to supply us for any reason, it could take time and expense to obtain a new supplier.&nbsp;&nbsp;In
addition, our failure to maintain existing relationships with our suppliers or to establish new relationships in the future could
negatively affect our ability to obtain the materials used in our products in a timely manner.&nbsp;&nbsp;The search for new suppliers
could potentially delay the manufacture of our products, resulting in shortages in the marketplace and may cause us to incur additional
expense.&nbsp;&nbsp;Failure to comply with applicable legal requirements subjects our suppliers to possible legal or regulatory
action, including shutdown, which may adversely affect their ability to supply us with the materials we need for our products.&nbsp;&nbsp;Any
delay in supplying, or failure to supply, materials for our products by any of our suppliers could result in our inability to
meet the commercial demand for our products, and could adversely affect our business, financial condition, results of operations
and growth prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We may seek to enter into collaborations with third parties
for the development and commercialization of our product candidate. If we fail to enter into such collaborations, or such collaborations
are not successful, we may not be able to capitalize on the market potential of our product candidate.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may seek third-party collaborators for development and commercialization
of our products. Our likely collaborators for any marketing, distribution, development, licensing or broader collaboration arrangements
include large and mid-size pharmaceutical companies, regional and national pharmaceutical companies, non-profit organizations,
government agencies, and biotechnology companies. Our ability to generate revenues from these arrangements will depend on our
collaborators&rsquo;&nbsp;abilities to successfully perform the functions assigned to them in these arrangements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Collaborations involving our products will pose, the following
risks to us:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">collaborators may have significant
    discretion in determining the efforts and resources that they will apply to these collaborations;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">collaborators may not pursue development and
    commercialization of our product candidate or may elect not to continue or renew development or commercialization programs
    based on preclinical or clinical trial results, changes in the collaborators&rsquo;&nbsp;strategic focus or available funding,
    or external factors such as an acquisition that diverts resources or creates competing priorities;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">collaborators may delay clinical
    trials, provide insufficient funding for a clinical trial program, stop a clinical trial or abandon a product candidate, repeat
    or conduct new clinical trials or require a new formulation of a product candidate for clinical testing;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">collaborators could independently develop, or
    develop with third parties, products that compete directly or indirectly with our product candidate if the collaborators believe
    that competitive products are more likely to be successfully developed or can be commercialized under terms that are more
    economically attractive than ours;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">collaborators with marketing and distribution
    rights to one or more products may not commit sufficient resources to the marketing and distribution of such product or products;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">collaborators may not properly maintain or defend
    our intellectual property rights or may use our proprietary information in such a way as to invite litigation that could jeopardize
    or invalidate our intellectual property or proprietary information or expose us to potential litigation;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">collaborators may infringe the intellectual
    property rights of third parties, which may expose us to litigation and potential liability;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">disputes may arise between the collaborators
    and us that result in the delay or termination of the research, development or commercialization of our product candidate
    or that result in costly litigation or arbitration that diverts management attention and resources; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">collaborations may be terminated and, if terminated,
    may result in a need for additional capital to pursue further development or commercialization of the applicable product candidates.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Collaboration agreements may not lead to development or commercialization
of our product candidate in the most efficient manner or at all. If a collaborator of ours were to be involved in a business combination,
the continued pursuit and emphasis on our product development or commercialization program could be delayed, diminished or terminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We are dependent on obtaining certain patents and protecting
our proprietary rights.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our success will depend, in part, on our ability to obtain
patents, maintain trade secret protection and operate without infringing on the proprietary rights of third parties or having
third parties circumvent our rights. We are licensing in patented technologies for our products. The patent positions of biotechnology,
biopharmaceutical and pharmaceutical companies can be highly uncertain and involve complex legal and factual questions. Thus,
there can be no assurance that any of our patent applications will result in the issuance of patents, that we will develop additional
proprietary products that are patentable, that any patents issued to us or those that already have been issued will provide us
with any competitive advantages or will not be challenged by any third parties, that the patents of others will not impede our
ability to do business or that third parties will not be able to circumvent our patents. Furthermore, there can be no assurance
that others will not independently develop similar products, duplicate any of our products not under patent protection, or, if
patents are issued to us, design around the patented products we developed or will develop.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may be required to obtain licenses from third parties to
avoid infringing patents or other proprietary rights. No assurance can be given that any licenses required under any such patents
or proprietary rights would be made available, if at all, on terms we find acceptable. If we do not obtain such licenses, we could
encounter delays in the introduction of products or could find that the development, manufacture or sale of products requiring
such licenses could be prohibited.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A number of pharmaceutical, biopharmaceutical and biotechnology
companies and research and academic institutions have developed technologies, filed patent applications or received patents on
various technologies that may be related to or affect our business. Some of these technologies, applications or patents may conflict
with our technologies or patent applications. Such conflict could limit the scope of the patents, if any, that we may be able
to obtain or result in the denial of our patent applications. In addition, if patents that cover our activities are issued to
other companies, there can be no assurance that we would be able to obtain licenses to these patents at a reasonable cost or be
able to develop or obtain alternative technology. If we do not obtain such licenses, we could encounter delays in the introduction
of products, or could find that the development, manufacture or sale of products requiring such licenses could be prohibited.
In addition, we could incur substantial costs in defending ourselves in suits brought against us on patents it might infringe
or in filing suits against others to have such patents declared invalid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We are subject to various government regulations.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The manufacture and sale of human therapeutic and diagnostic
products in the U.S. and foreign jurisdictions are governed by a variety of statutes and regulations. These laws require approval
of manufacturing facilities, controlled research and testing of products and government review and approval of a submission containing
manufacturing, preclinical and clinical data in order to obtain marketing approval based on establishing the safety and efficacy
of the product for each use sought, including adherence to current PIC/S GMP during production and storage, and control of marketing
activities, including advertising and labeling.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The product we are currently developing will require significant
development, preclinical and clinical testing and investment of substantial funds prior to its commercialization. The process
of obtaining required approvals can be costly and time-consuming, and there can be no assurance that future products will be successfully
developed and will prove to be safe and effective in clinical trials or receive applicable regulatory approvals. Markets other
than the U.S. have similar restrictions. Potential investors and shareholders should be aware of the risks, problems, delays,
expenses and difficulties which we may encounter in view of the extensive regulatory environment which controls our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our existing indebtedness</I></B>&nbsp;<B><I> may adversely
affect our ability to obtain additional funds and may increase our vulnerability to economic or business downturns. </I></B>We
are subject to a number of risks associated with our indebtedness, including: 1) we must dedicate a portion of our cash flows
from operations to pay debt service costs, and therefore we have less funds available for operations and other purposes; 2) it
may be more difficult and expensive to obtain additional funds through financings, if available at all; 3) we are more vulnerable
to economic downturns and fluctuations in interest rates, less able to withstand competitive pressures and less flexible in reacting
to changes in our industry and general economic conditions; and 4) if we default under any of our existing credit facilities or
if our creditors demand payment of a portion or all of our indebtedness, we may not have sufficient funds to make such payments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We face substantial competition from other pharmaceutical
and biotechnology companies and our operating results may suffer if we fail to compete effectively.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The development and commercialization of new drug products
is highly competitive. We expect that we will face significant competition from major pharmaceutical companies, specialty pharmaceutical
companies and biotechnology companies worldwide with respect to our products that we may seek to develop or commercialize in the
future. Our competitors may succeed in developing, acquiring or licensing technologies and drug products that are more effective,
have fewer or more tolerable side effects or are less costly than any product candidates that we are currently developing or that
we may develop, which could render our product candidates obsolete and noncompetitive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our commercial opportunity could be reduced or eliminated if
our competitors develop and commercialize products that are safer, more effective, have fewer or less severe side effects, are
more convenient or are less expensive than any products that we may develop. Our competitors also may obtain FDA or other marketing
approval for their products before we are able to obtain approval for ours, which could result in our competitors establishing
a strong market position before we are able to enter the market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Many of our existing and potential future competitors have
significantly greater financial resources and expertise in research and development, manufacturing, preclinical testing, conducting
clinical trials, obtaining marketing approvals and marketing approved products than we do. Mergers and acquisitions in the pharmaceutical
and biotechnology industries may result in even more resources being concentrated among a smaller number of our competitors. Smaller
or early stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large
and established companies. These competitors also compete with us in recruiting and retaining qualified scientific and management
personnel and establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies
complementary to, or necessary for, our programs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>If we are unable to establish appropriate internal financial
reporting controls and procedures, it could cause us to fail to meet our reporting obligations, result in the restatement of our
financial statements, harm our operating results, subject us to regulatory scrutiny and sanction, cause investors to lose confidence
in our reported financial information and have a negative effect on the market price for shares of our Common Stock.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt">Effective internal controls are necessary
for us to provide reliable financial reports and effectively prevent fraud. We maintain a system of internal control over financial
reporting, which is defined as a process designed by, or under the supervision of, our principal executive officer and principal
financial officer, or persons performing similar functions, and effected by our board of directors, management and other personnel,
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for
external purposes in accordance with generally accepted accounting principles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As a public company, we will have significant additional requirements
for enhanced financial reporting and internal controls.&nbsp;&nbsp;We will be required to document and test our internal control
procedures in order to satisfy the requirements of Section 404 of the Sarbanes-Oxley Act of 2002, which requires annual management
assessments of the effectiveness of our internal controls over financial reporting. The process of designing and implementing
effective internal controls is a continuous effort that requires us to anticipate and react to changes in our business and the
economic and regulatory environments and to expend significant resources to maintain a system of internal controls that is adequate
to satisfy our reporting obligations as a public company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We cannot assure you that we will not, in the future, identify
areas requiring improvement in our internal control over financial reporting.&nbsp;&nbsp;We cannot assure you that the measures
we will take to remediate any areas in need of improvement will be successful or that we will implement and maintain adequate
controls over our financial processes and reporting in the future as we continue our growth.&nbsp;&nbsp;If we are unable to establish
appropriate internal financial reporting controls and procedures, it could cause us to fail to meet our reporting obligations,
result in the restatement of our financial statements, harm our operating results, subject us to regulatory scrutiny and sanction,
cause investors to lose confidence in our reported financial information and have a negative effect on the market price for shares
of our Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risks Relating to Our Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Insiders have substantial control over us, and they could
delay or prevent a change in our corporate control even if our other stockholders wanted it to occur.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt">Our executive officers, directors, and
principal stockholders own, in the aggregate, approximately 70.86% of our outstanding Common Stock.&nbsp;As a result of their
stockholdings, these stockholders are able to assert substantial control over matters requiring stockholder approval, including
the election of directors and approval of significant corporate transactions.&nbsp;This could delay or prevent an outside party
from acquiring or merging with us even if our other stockholders wanted it to occur.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>The market price of our Common Stock may be volatile</I>&nbsp;and&nbsp;<I>there
may not be sufficient liquidity in the market for our securities in order for investors to sell their securities.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The market price of our Common Stock has been and will likely
continue to be highly volatile, as is the stock market in general. Factors that may materially affect the market price of our
Common Stock are beyond our control, these factors may materially adversely affect the market price of our Common Stock, regardless
of our performance.&nbsp;&nbsp;In addition, the public stock markets have experienced extreme price and trading volume volatility.&nbsp;These
broad market fluctuations may influence the market price of our Common Stock. There is currently only a limited public market
for our Common Stock, which is listed on the OTCQB Market, and there can be no assurance that a trading market will develop further
or be maintained in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our articles of incorporation allow for our board to
create new series of preferred stock without further approval by our stockholders, which could adversely affect the rights of
the holders of our common stock. </I></B>Our Board of Directors has the authority to fix and determine the relative rights and
preferences of preferred stock without stockholder approval. As a result, our Board of Directors could authorize the issuance
of a series of preferred stock that would grant to holders the preferred right to our assets upon liquidation, the right to receive
dividend payments before dividends are distributed to the holders of common stock and the right to the redemption of the shares,
together with a premium, prior to the redemption of our common stock. In addition, our Board of Directors could authorize the
issuance of a series of preferred stock that has greater voting power than our common stock or that is convertible into our common
stock, which could decrease the relative voting power of our common stock or result in dilution to our existing stockholders.
Although we have no present intention to issue any additional shares of preferred stock or to create any additional series of
preferred stock, we may issue such shares in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="s1_005"></A>CAUTIONARY NOTE REGARDING FORWARD-LOOKING
STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This report contains forward-looking statements and information
that are based on the beliefs of our management as well as assumptions made by and information currently available to us.&nbsp;&nbsp;Such
statements should not be unduly relied upon.&nbsp;&nbsp;When used in this report, forward-looking statements include, but are
not limited to, the words &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;estimate,&rdquo; &ldquo;expect,&rdquo; &ldquo;intend,&rdquo;
&ldquo;plan&rdquo; and similar expressions, as well as statements regarding new and existing products, technologies and opportunities,
statements regarding market and industry segment growth and demand and acceptance of new and existing products, any projections
of sales, earnings, revenue, margins or other financial items, any statements of the plans, strategies and objectives of management
for future operations, any statements regarding future economic conditions or performance, uncertainties related to conducting
business in China, any statements of belief or intention, and any statements or assumptions underlying any of the foregoing.&nbsp;&nbsp;These
statements reflect our current view concerning future events and are subject to risks, uncertainties and assumptions.&nbsp;&nbsp;There
are important factors that could cause actual results to vary materially from those described in this report as anticipated, estimated
or expected, including, but not limited to:&nbsp;competition in the industry in which we operate and the impact of such competition
on pricing, revenues and margins, volatility in the securities market due to the general economic downturn; Securities and Exchange
Commission (the &ldquo;SEC&rdquo;) regulations which affect trading in the securities of &ldquo;penny stocks,&rdquo; and other
risks and uncertainties.&nbsp;&nbsp;Except as required by law, we assume no obligation to update any forward-looking statements
publicly, or to update the reasons actual results could differ materially from those anticipated in any forward- looking statements,
even if new information becomes available in the future.&nbsp;&nbsp;Depending on the market for our stock and other conditional
tests, a specific safe harbor under the Private Securities Litigation Reform Act of 1995 may be available.&nbsp;&nbsp;Notwithstanding
the above, Section 27A of the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;) and Section 21E of the Securities
Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;) expressly state that the safe harbor for forward-looking statements
does not apply to companies that issue penny stock.&nbsp;&nbsp;Because we may from time to time be considered to be an issuer
of penny stock, the safe harbor for forward-looking statements may not apply to us at certain times.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="s1_006"></A>USE OF PROCEEDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We will not receive any proceeds from the sale of shares by
the selling stockholders named in this prospectus. All proceeds from the sale of the common stock will be paid directly to the
selling stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="s1_007"></A>DETERMINATION OF OFFERING PRICE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The selling stockholders may sell these shares in the over-the-counter
market or otherwise, at market prices prevailing at the time of sale, at prices related to the prevailing market price, or at
negotiated prices. We will not receive any proceeds from the sale of shares by the selling stockholders.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="s1_008"></A>MANAGEMENT DISCUSSION AND ANALYSIS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>The following discussion provides information which management
believes is relevant to an assessment and understanding of our results of operations and financial condition. The discussion should
be read along with our audited condensed consolidated financial statements and notes for the fiscal years ended September 30,
2015 and 2014 and the three months ended March 31, 2016 and 2015. The following discussion and analysis contains forward-looking
statements based upon current expectations that involve risks and uncertainties, such as our plans, objectives, expectations and
intentions. Our actual results may differ significantly from the results, expectations and plans discussed in these forward-looking
statements. We use words such as &ldquo;anticipate,&rdquo; &ldquo;estimate,&rdquo; &ldquo;plan,&rdquo; &ldquo;project,&rdquo;
&ldquo;continuing,&rdquo; &ldquo;ongoing,&rdquo; &ldquo;expect,&rdquo; &ldquo;believe,&rdquo; &ldquo;intend,&rdquo; &ldquo;may,&rdquo;
&ldquo;will,&rdquo; &ldquo;should,&rdquo; &ldquo;could,&rdquo; and similar expressions to identify forward-looking statements.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>See &ldquo;Cautionary Note Concerning Forward-Looking Statements.&rdquo;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Introduction</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Currently, we are a holding company operating
through our wholly owned subsidiary, American BriVision Corporation, a Delaware corporation (&ldquo;BriVision&rdquo;). BriVision
was incorporated in 2015 in the State of Delaware. It is a biotechnology company focused on the development of new drugs and innovative
medical devices to fulfill unmet medical needs.&nbsp;&nbsp;Following the Share Exchange (as described herein below), we have abandoned
our prior business plan and we are now pursuing BriVision&rsquo;s historical businesses and proposed businesses, which focus on
the development of new drugs and innovative medical devices to fulfill unmet medical needs.&nbsp;&nbsp;The business model of the
Company is to integrate research achievements from world-famous institutions, conduct clinical trials of translational medicine
for Proof of Concept (&ldquo;POC&rdquo;), out-license to international pharmaceutical companies, and exploit global markets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Overview</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Prior to the Share Exchange, we were&nbsp;a company&nbsp;operating
a web site for the sale of women's apparel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have had limited operations and have been issued a &quot;going
concern&quot; opinion by our auditor, based upon our reliance on the sale of our common stock as the sole source of funds for
our future operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On February 8, 2016, a Share Exchange Agreement
(&ldquo;Share Exchange Agreement&rdquo;) was entered into by and among American BriVision (Holding)
Corporation(the&nbsp;&ldquo;Company&rdquo;),&nbsp;American BriVision&nbsp;Corporation, a Delaware
Corporation&nbsp;(&ldquo;BriVision&rdquo;), Euro-Asia Investment &amp; Finance Corp. Limited, a company incorporated
under the laws of Hong Kong Special Administrative Region of Taiwan (&ldquo;Euro-Asia&rdquo;), being the owners of record of
52,336,000 common shares of the Company, and the persons listed in&nbsp;Exhibit A&nbsp;thereof
(the&nbsp;&ldquo;BriVision Shareholders&rdquo;), being the owners of record of all of the issued share capital of BriVision
(the&nbsp;&ldquo;BriVision Stock&rdquo;). Pursuant to the Share Exchange Agreement, upon surrender by the BriVision
Shareholders and the cancellation by BriVision of the certificates evidencing the BriVision Stock as registered in the name
of each BriVision Shareholder, and pursuant to the registration of the Company in the register of members maintained by
BriVision as the new holder of the BriVision Stock and the issuance of the certificates evidencing the aforementioned
registration of the BriVision Stock in the name of the Company, the Company would issue 52,936,583 shares
(the&nbsp;&ldquo;Acquisition Stock&rdquo;) (subject to adjustment for fractionalized shares as set forth below) of the
Company&rsquo;s common stock to the BriVision Shareholders (or their designees), and 51,945,225 shares of the
Company&rsquo;s common stock owned by Euro-Asia should be cancelled and retired to treasury. The Acquisition Stock
collectively should represent 79.70% of the issued and outstanding common stock of the Company immediately after the Closing,
in exchange for the BriVision Stock, representing 100% of the issued share capital of BriVision.&nbsp;&nbsp;As a result of
the exchange of the BriVision Stock for the Acquisition Stock (the&nbsp;&ldquo;Share Exchange&rdquo;), BriVision became a
wholly owned subsidiary (the&nbsp;&ldquo;Subsidiary&rdquo;) of the Company and there was a change of control of the Company
following the closing.&nbsp;&nbsp;There were no warrants, options or other equity instruments issued in connection with the
share exchange agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As a result of the consummation of the Share Exchange,&nbsp;BriVision&nbsp;is
now our wholly-owned subsidiary and its shareholders own approximately&nbsp;79.70% of our issued and outstanding common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">All references to the&nbsp;&ldquo;Combined Company&rdquo;&nbsp;refer
to&nbsp;American&nbsp;BriVision&nbsp;(Holding) Corporation&nbsp;and its wholly owned subsidiary,&nbsp;American&nbsp;BriVision&nbsp;Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Accounting Treatment of the Merger</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For financial reporting purposes, the
Share Exchange represents a &ldquo;reverse merger&rdquo; rather than a business combination and BriVision is deemed to be the
accounting acquirer in the transaction. The Share Exchange is being accounted for as a reverse-merger and recapitalization. BriVision
is the acquirer for financial reporting purposes and the Company is the acquired company. Consequently, the assets and liabilities
and the operations that will be reflected in the historical financial statements prior to the Share Exchange will be those of
BriVision and will be recorded at the historical cost basis of BriVision, and the consolidated financial statements after completion
of the Share Exchange will include the assets and liabilities of the Company and BriVision, and the historical operations of BriVision
and operations of the combined entities (American Brivision (Holding) Corporation and its wholly owned subsidiary Brivision) from
the closing date of the Share Exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For more information about the Share Exchange,
please refer to the current report on Form 8-K we filed on February 12, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Following the Share Exchange, we have abandoned our prior business
plan and we are now pursuing BriVision&rsquo;s historical businesses and proposed businesses.&nbsp;BriVision is a biotechnology
company focused on the development of new drugs to fulfill unmet medical needs.&nbsp;&nbsp;The business model of the Company is
to integrate research achievements from world-famous institutions (such as Memorial Sloan Kettering Cancer Center (&ldquo;MSKCC&rdquo;)
and MD Anderson Cancer Center), conduct clinical trials for Proof of Concept (&ldquo;POC&rdquo;), out-license to international
pharmaceutical companies, and exploit global markets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We currently have five products&nbsp;that are licensed to us:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Symbol">&middot;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABV- 1501&nbsp;Triple Negative Breast Cancer
- Combination therapy for Triple Negative Breast Cancer (TNBC)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Symbol">&middot;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABV-1502 &nbsp;Solid Tumor with Anti-PD1 - Combination
therapy for solid tumors</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Symbol">&middot;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABV-1503 &nbsp;Chronic Lymphocytic Leukemia -
Combination therapy for Chronic Lymphocytic Leukemia</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Symbol">&middot;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABV-1504 Major Depressive Disorder - Major Depressive
Disorder (MDD)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Symbol">&middot;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABV-1505 Attention Deficit Hyperactivity Disorder
- Attention Deficit Hyperactivity Disorder</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Those 5 drugs all are ready to go into phase II clinical study.
ABV-1504 already starts phase II clinical study in Taiwan and we expect it will start in the States this year. &nbsp;ABV-1505
got IND (Investigational New Drug Application) by US FDA on January 2016. &nbsp;ABV-1501 Phase II IND will be filed on February
2016. &nbsp;ABV-1502 and ABV-1503are preparing IDE package now.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Recent Developments</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Forward Stock Split</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 21, 2016, our Board approved
an amendment to Articles of Incorporation to effect a forward split at a ratio of 1 to 3:141 and increase the number of our authorized
shares of common stock, par value $0.001 per share, to 360,000,000, which went effective on April 8, 2016. The amendment to Articles
of Incorporation was approved by the majority of the shareholders of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Plans of Operation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">BriVision will select potential drug candidates
(including but not limited to botanical drugs) from different research institutes, start to develop it from pre-clinical stage
(including all CMC process and animal study) to clinical study stage. When the phase II clinical trial is finished and the efficacy
is approved, we will have reached the &ldquo;proof of concept&rdquo; stage. We plan to out license our drugs to big pharmaceutical
companies, coordinate with them to develop and enhance the drugs and exploit global markets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On December 29, 2015,&nbsp;BriVision entered into a Collaborative
Agreement (the &ldquo;Collaborative Agreement&rdquo;) with BioLite. Pursuant to the Collaborative Agreement, BioLite granted sole
licensing rights to BriVision of drug and therapeutic use of five products: BLI-1005 CNS-Major Depressive Disorder; BLI-1008 CNS-Attention
Deficit Hyperactivity Disorder; BLI-1401-1 Anti-Tumor Combination Therapy-Solid Tumor with Anti-PD-1; BLI-1401-2 Anti-Tumor Combination
Therapy-Triple Negative Breast Cancer; and BLI-1501 Hematology-Chronic Lymphocytic Leukemia, in USA and Canada. Under the Collaborative
Agreement, BriVision should pay a total of $100,000,000 in cash or stock of BriVision with equivalent value, according to the
following schedule:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Symbol">&middot;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upfront&nbsp;payment shall upon the signing of
this Collaborative Agreement: 3.5% of total payment. After receiving upfront payment from&nbsp;BriVision,&nbsp;BioLite&nbsp;has
to deliver all data to BriVision&nbsp;in one week.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Symbol">&middot;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon&nbsp;the first IND submission,&nbsp;BriVision&nbsp;shall
pay, but no later than December 15, 2016: 6.5% of total payment. After receiving second payment from&nbsp;BriVision,&nbsp;BioLite&nbsp;has
to deliver IND package to&nbsp;BriVision&nbsp;in one week.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Symbol">&middot;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at&nbsp;the completion of first phase II clinical
trial,&nbsp;BriVision&nbsp;shall pay, but no later than September&nbsp;15, 2017: 15% of total payment. After receiving third payment
from&nbsp;BriVision, BioLite&nbsp;has to deliver phase II clinical study report to&nbsp;BriVision&nbsp;in three months.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Symbol">&middot;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon&nbsp;the phase III IND submission,&nbsp;BriVision&nbsp;shall
pay, but no later than December 15, 2018: 20% of total payment. After receiving forth payment from&nbsp;BriVision,&nbsp;BioLite&nbsp;has
to deliver IND package to&nbsp;BriVision&nbsp;in one week.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Symbol">&middot;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at&nbsp;the completion of phase III,&nbsp;BriVision&nbsp;shall
pay, but no later than September 15, 2019:25% of total payment. After receiving fifth payment from&nbsp;BriVision,&nbsp;BioLite&nbsp;has
to deliver phase III clinical study report to&nbsp;BriVision&nbsp;in three months</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Symbol">&middot;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon&nbsp;the NDA submission,&nbsp;BriVision&nbsp;shall
pay, but no later than December 15, 2020, BriVision&nbsp;shall pay: 30% of total payment. After receiving sixth payment from&nbsp;BriVision,
BioLite&nbsp;has to deliver NDA package to&nbsp;BriVision&nbsp;in one week</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 6 , 2016, we and Biolite amended
the payment terms under the Collaborative Agreement by entering into a Milestone Payment Agreement, pursuant to which we paid
$2,600,000 in cash and $900,000 in newly issued shares of our common stock, at the price of $1.60 per share, for an aggregate
number of 562,500 shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Revenue Generation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Most of our licensed products are still
under development and trial stage. Therefore, no revenue is expected in near term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Research and Development</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the first nine months for the period
ended June 30, 2016, we have spent approximately&nbsp;$0&nbsp;on&nbsp;research and development.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Critical Accounting Policies and
Estimates</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe that the following accounting
policies are the most critical to aid you in fully understanding and evaluating this &ldquo;Management&rsquo;s Discussion and
Analysis of Financial Condition and Results of Operation.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Basis of Presentation</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying audited financial statements
and related notes have been prepared in accordance with generally accepted accounting principles in the United States of America
(U.S. GAAP). This basis of accounting involves the application of accrual accounting and consequently, revenues and gains are
recognized when earned, and expenses and losses are recognized when incurred. The Company&rsquo;s financial statements are expressed
in U.S. dollars.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Forward Stock split</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On March 21, 2016, the Board of Directors of the Company approved
an amendment to Articles of Incorporation to effect a forward split at a ratio of 1 to 3:141 and increase the number of our authorized
shares of common stock, par value $0.001 per share, to 360,000,000, which was effective on April 8, 2016. The majority of the
shareholders of the Company approved the amendment to Articles of Incorporation. See Note 4 for more details.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Use of Estimates</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of consolidated financial
statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts
of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements
and the amount of revenues and expenses during the reporting periods. Actual results could differ materially from those results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.5pt">&nbsp;</P>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Fair Value Measurements</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company applies the provisions of
ASC Subtopic 820-10,&nbsp;&ldquo;Fair Value Measurements&rdquo;,&nbsp;for fair value measurements of financial assets and financial
liabilities and for fair value measurements of nonfinancial items that are recognized or disclosed at fair value in the financial
statements.&nbsp;&nbsp;ASC 820 also establishes a framework for measuring fair value and expands disclosures about fair value
measurements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fair value is defined as the price that
would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the
measurement date.&nbsp;&nbsp;When determining the fair value measurements for assets and liabilities required or permitted to
be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and it considers
assumptions that market participants would use when pricing the asset or liability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASC 820 establishes a fair value hierarchy
that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair
value. ASC 820 establishes three levels of inputs to measure fair value. The hierarchy gives the highest priority to unadjusted
quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements
involving significant unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.7pt; text-align: justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.7pt; text-align: justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs
that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial
instruments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.7pt; text-align: justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Level 3 inputs to the valuation methodology are unobservable and significant to the fair value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.7pt; text-align: justify; text-indent: 27.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There were no assets or liabilities measured
at fair value on a recurring basis subject to the disclosure requirements of ASC 820 as of&nbsp;June 30, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Cash and Cash Equivalents</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company considers highly liquid investments
with maturities of three months or less, when purchased, to be cash equivalents. As of June 30, 2016 and September 30, 2015, the
Company&rsquo;s cash and cash equivalents amounted $84,904 and $994,830, respectively. All&nbsp;of the Company&rsquo;s cash deposit
is held in a financial institution located in PRC where there is currently regulation mandated on obligatory insurance of bank
accounts. The Company believes this financial institution is of high credit quality.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Income Taxes</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for income taxes
using the asset and liability approach which allows the recognition and measurement of deferred tax assets to be based upon the
likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided
for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting
purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred tax assets if it is more-likely-than-not
that these items will expire before the Company is able to realize their benefits, or that future deductibility is uncertain.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.5pt">&nbsp;</P>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under ASC 740, a tax position is recognized
as a benefit only if it is &ldquo;more likely than not&rdquo; that the tax position would be sustained in a tax examination, with
a tax examination being presumed to occur. The evaluation of a tax position is a two-step process. The first step is to determine
whether it is more-likely-than-not that a tax position will be sustained upon examination, including the resolution of any related
appeals or litigations based on the technical merits of that position. The second step is to measure a tax position that meets
the more-likely-than-not threshold to determine the amount of benefit to be recognized in the financial statements. A tax position
is measured at the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement.
Tax positions that previously failed to meet the more-likely-than-not recognition threshold should be recognized in the first
subsequent period in which the threshold is satisfied. Previously recognized tax positions that no longer meet the more-likely-than-not
criteria should be de-recognized in the first subsequent financial reporting period in which the threshold is no longer satisfied.
Penalties and interest incurred related to underpayment of income tax are classified as income tax expense in the year incurred.
No significant penalty or interest relating to income taxes has been incurred during the period from July 21, 2015 (inception)
to June 30, 2016. GAAP also provides guidance on de-recognition, classification, interest and penalties, accounting in interim
periods, disclosures and transition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2016 and September 30,
2015, the Company&rsquo;s income tax expense amounted $836 and $0, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Recent Accounting Pronouncements</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From time to time, new accounting standards
issued by the Financial Accounting Standards Board (&ldquo;FASB&rdquo;) or other standard setting bodies that are adopted by the
Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued
standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.
The recent accounting standards are not expected to have a material impact on the consolidated financial statements upon adoption.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Off-Balance Sheet Arrangements</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We do not have any off-balance sheet arrangements
that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition,
revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources that is material to investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Limited Operating History; Need for
Additional Capital</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There is no historical financial information
about us upon which to base an evaluation of our performance.&nbsp;&nbsp;As of the date of this filing, we have not generated
any revenues from operations. We cannot guarantee we will be successful in our business operations.&nbsp;&nbsp;Our business is
subject to risks inherent in the establishment of a new business enterprise, including limited capital resources, possible delays
in the launching of our games and market or wider economic downturns. We do not believe we have sufficient funds to operate our
business for the next 12 months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.5pt">&nbsp;</P>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have no assurance that future financing
will be available to us on acceptable terms, or at all.&nbsp;&nbsp;If financing is not available on satisfactory terms, we may
be unable to continue, develop or expand our operations.&nbsp;&nbsp;Equity financing could result in additional dilution to existing
shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we are unable to raise additional capital
to maintain our operations in the future, we may be unable to carry out our full business plan or we may be forced to cease operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following discussion and analysis
should be read in conjunction with the audited financial statements of&nbsp;BriVision&nbsp;for the period ended September 30,
2015 and accompanying notes that appear in our Annual Report on Form 8-K, as filed with the Securities and Exchange Commission
on November 27, 2015 and the financial statements included in this Report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Results of Operation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our financial statements have been prepared
assuming that we will continue as a going concern and, accordingly, do not include adjustments relating to the recoverability
and realization of assets and classification of liabilities that might be necessary should we be unable to continue in operation.
We expect we will require additional capital to meet our long term operating requirements. We expect to raise additional capital
through, among other things, the sale of equity or debt securities, but we cannot guarantee that we will be able to achieve the
same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Results of Operations &mdash; Three
Months Ended June 30, 2016 Compared to The Period from July 21, 2015 (Inception) to September 2015.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
presents, for the three months indicated, our consolidated statements of operations information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Three&nbsp;months&nbsp;ended<BR> June 30, 2016</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">For&nbsp;the&nbsp;period&nbsp;<BR> From&nbsp;July&nbsp;21,&nbsp;2015<BR> (inception)&nbsp;to&nbsp;<BR> September&nbsp;30,&nbsp;2015</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">REVENUE</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 1pt">COST OF REVENUE</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">GROSS LOSS</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">OPERATING EXPENSES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 70%; text-align: left">Selling, general and administrative expenses</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">289,098</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">315,602</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total Operating Expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">289,098</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">315,602</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">NET LOSS FROM OPERATIONS</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(289,098</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(315,602</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">OTHER (EXPENSES) INCOME, NET</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Bank interest income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">361</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Gain on exchange differences</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">89</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Interest Expense</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(3,753</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total Other (Expenses) Income</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(3,303</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">NET LOSS BEFORE TAXES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(292,401</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(315,602</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Income tax expense</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(836</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">NET LOSS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(293,237</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(315,602</TD><TD STYLE="text-align: left">)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 13.2pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 13.2pt"><B><I>Revenues.&nbsp;&nbsp;</I></B>&nbsp;We
generated zero and zero in revenues and zero and zero in cost of sales for the three months ended June 30, 2016 and the period
from July 21, 2015 (inception) to September 30, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 13.2pt"><B><I>Operating Expenses.&nbsp;&nbsp;</I></B>&nbsp;Our
operating expenses were $289,098 in the three months ended June 30, 2016 as compared to $315,602 for the period from July 21,
2015 (inception) to September 30, 2015. The decrease of $26,504 in the current period is the result of fewer professional fees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 13.2pt"><B><I>Interest Expense.&nbsp;</I></B>The
interest expense were $3,753 in the three months ended June 30, 2016 as compared to $0 for the period from July 21, 2015 (inception)
to September 30, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 13.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 13.2pt"><B><I>Net Loss.&nbsp;&nbsp;&nbsp;</I></B>&nbsp;The
net loss was $293,237 for the three months ended June 30, 2016 compared to a loss of $315,602 for the period from July 21, 2015
(inception) to September 30, 2015. The result of decrease of net loss in current period was due to the decreased professional
fees incurred during the nine months ended June 30, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Results of Operations &mdash; Nine
Months Ended June 30, 2016 Compared to The Period from July 21, 2015 (Inception) to September 2015.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
presents, for the three months indicated, our consolidated statements of operations information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Nine&nbsp;months&nbsp;ended<BR> June 30,&nbsp;2016</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">For&nbsp;the&nbsp;period&nbsp;<BR> From&nbsp;July&nbsp;21,&nbsp;2015<BR> (inception)&nbsp;to&nbsp;<BR> September&nbsp;30,&nbsp;2015</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">REVENUE</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 70%; font-weight: bold; padding-bottom: 1pt">COST OF REVENUE</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; border-bottom: Black 1pt solid; text-align: right">32</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">GROSS LOSS</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(32</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">OPERATING EXPENSES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Selling, general and administrative expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">349,486</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">315,602</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total Operating Expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">349,486</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">315,602</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">NET LOSS FROM OPERATIONS</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(349,518</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(315,602</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">OTHER (EXPENSES) INCOME, NET</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Interest income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">361</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Gain on exchange differences</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">141</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Interest expense</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(3,753</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total Other (Expenses) Income</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(3,251</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">NET LOSS BEFORE TAXES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(352,769</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(315,602</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Income tax expense</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">836</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">NET LOSS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(353,605</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(315,602</TD><TD STYLE="text-align: left">)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 13.2pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 13.2pt"><B><I>Revenues.&nbsp;&nbsp;</I></B>&nbsp;We
generated zero and zero in revenues and $32 and zero in cost of sales for the nine months ended June 30, 2016 and the period from
July 21, 2015 (inception) to September 30, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 13.2pt"><B><I>Operating Expenses.&nbsp;&nbsp;</I></B>&nbsp;Our
operating expenses were $349,486 in the nine months ended June 30, 2016 as compared to $315,602 for the period from July 21, 2015
(inception) to September 30, 2015. The decrease of $33,884 in the current period is the result of fewer professional fees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 13.2pt"><B><I>Interest Expense.</I></B>&nbsp;The
interest expense were $361 in the nine months ended June 30, 2016 as compared to $0 for the period from July 21, 2015 (inception)
to September 30, 2015</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 13.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 13.2pt"><B><I>Net Loss.&nbsp;&nbsp;&nbsp;</I></B>&nbsp;The
net loss was $353,605 for the nine months ended June 30, 2016 compared to a loss of $315,602 for the period from July 21, 2015
(inception) to September 30, 2015. The result of decrease of net loss in current period was due to the decreased professional
fees incurred during the nine months ended June 30, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Liquidity and Capital Resources</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Working Capital</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">As of&nbsp;June 30, 2016<BR> ($)</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">As of September 30,2015<BR> ($)</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 70%; text-align: left">Current Assets</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">3,584,904</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">998,645</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Current Liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,061,446</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">369,103</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Working Capital (deficit)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,523,458</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">629,542</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Cash Flows</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Cash Flow from Operating Activities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the nine months ended June 30,
2016 and the period from July 21, 2015 (inception) to September 30, 2015, the net cash used in and generated from operating activities
were $3,857,447 and $45,871 respectively. There was increase in prepayment and accounts payable during the nine months ended June
30, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Cash Flow from Investing Activities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the nine months ended June 30,
2016 and the period from July 21, 2015 (inception) to September 30, 2015, there were no net cash used in or generated from investing
activities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Cash Flow from Financing Activities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the nine months ended June 30,
2016 and the period from July 21, 2015 (inception) to September 30, 2015, the net cash generated from financing activities were
$2,947,521 and $948,959 respectively. A short-term loan raised during the nine months ended June 30, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Critical Accounting Policy and Estimates</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe that the following accounting
policies are the most critical to aid you in fully understanding and evaluating this &ldquo;Management&rsquo;s Discussion and
Analysis of Financial Condition and Results of Operation.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Off-Balance Sheet Arrangements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We do not have any off-balance sheet arrangements
that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition,
revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources that is material to investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="s1_009"></A>BUSINESS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Industry</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Biotechnology industry provides breakthrough products and technologies
to combat debilitating and rare diseases, reduce our environmental footprint, feed the hungry,&nbsp;use&nbsp;less and cleaner
energy, and have safer, cleaner and more efficient industrial manufacturing process.<BR>
<BR>
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The biotechnology industry is an extremely
important sector in the developed world's economies&nbsp;and human health. Biotechnology&nbsp;companies&nbsp;need to spend large
research budgets&nbsp;during the R&amp;D period. &nbsp;Usually it will take 12-16 years to develop a new drug and a new medical
device. &nbsp;Not only is a small biotechnology company&rsquo;s R&amp;D budget smaller than a large, well-known biotechnology
company or&nbsp;an&nbsp;international company, but the larger companies are typically more attractive to researchers or employers
and maintains better R&amp;D resources. However,&nbsp;at this early stage, we are developing our products, which are licensed&nbsp;from
a related party which&nbsp;substantially reduces our R&amp;D cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Business Overview</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are a clinical stage biopharmaceutical company focused on
utilizing our licensed technology to (i) enhance the development of pre-existing pharmaceutical products for the treatment of
various cancer indications and other diseases, (ii) prospectively identify patients that may respond to such pharmaceutical products
and (iii) commercialize such pharmaceutical products for license in various markets. Our business strategy is to integrate research
achievements from medical research institutions (such as Memorial Sloan Kettering Cancer Center (&ldquo;MSKCC&rdquo;) and MD Anderson
Cancer Center), conduct clinical trials of translational medicine for Proof of Concept (&ldquo;POC&rdquo;), out-license to pharmaceutical
companies. We currently have no revenue generated from our principal operations in clinical product development through research
and development efforts. Currently, our only operation is the research and development of five compound licensed to us by BioLite
Inc. (&ldquo;BioLite&rdquo;), a company formed in Taiwan who is one of our principal shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Collaboration Agreement with BioLite</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On December 29, 2015, we entered into a Collaborative Agreement
with BioLite pursuant to which BioLite granted us sole licensing rights for drug and therapeutic use of five compounds they developed:
BLI-1005 CNS-Major Depressive Disorder; BLI-1008 CNS-Attention Deficit Hyperactivity Disorder; BLI-1401-1 Anti-Tumor Combination
Therapy-Solid Tumor with Anti-PD-1; BLI-1401-2 Anti-Tumor Combination Therapy-Triple Negative Breast Cancer; and BLI-1501 Hematology-Chronic
Lymphocytic Leukemia, in USA and Canada. Our CEO and director, Eugene Jiang, is also a director of Biolite.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the Collaborative Agreement, an upfront payment
of $3,500,000 (the &ldquo;Milestone Payment&rdquo;), which is 3.5% of total payments due under the Collaborative Agreement, was
to be paid by us upon signing of the Collaboration Agreement. On May 6, 2016, we and Biolite amended the payment terms under the
Collaborative Agreement by entering into a Milestone Payment Agreement, pursuant to which we paid $2,600,000 in cash and $900,000
in newly issued shares of our common stock, at the price of $1.60 per share, for an aggregate number of 562,500 shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Our&nbsp;Licensed Compound</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have renamed the five compounds for our purpose and below
a brief description of each of the five compounds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">I.</TD><TD>ABV- 1501 &nbsp;Triple Negative Breast Cancer - Combination
                                         therapy for Triple Negative Breast Cancer (TNBC)</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Maitake
                                         mushroom extract Phase I clinical trial was preformed by MSKCC and safety was approved.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">ABV-1501
                                         US FDA Phase II IND cross reference with MSKCC Maitake and Phase II Investigational New
                                         Drug (IND) was approved in March 2016.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">We
                                         are currently negotiating with MSKCC for Phase II clinical study. If MSKCC agreed with
                                         our terms, we anticipate to start phase II clinical trial during 2017 Q1and finish the
                                         phase II clinical trial by 2018 Q3.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">We
                                         plan to apply for Institutional review board (IRB reviewing during 2016 Q4</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-indent: -0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">II.</TD><TD>ABV-1502 &nbsp;Solid Tumor with Anti-PD1 - Combination therapy
                                         for solid tumors with Anti-PD-1</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">This
                                         is a kind of anti-tumor Combination therapy of Maitake mushroom extract with standard
                                         therapy and anti- PD1 drug for solid tumor.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Maitake
                                         mushroom extract Phase I clinical trial was preformed by MSKCC and safety was approved.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Currently,
                                         we are cooperating with MD Anderson Cancer Center and one of top cancer center in the
                                         U.S. to develop Phase II clinical trial IND package</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">III.</TD><TD>ABV-1503 &nbsp;Chronic Lymphocytic Leukemia - Combination
                                         therapy for Chronic Lymphocytic Leukemia (CLL)</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Phase
                                         II study of Epigallocatechin gallate (EGCG) for CLL.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">We
                                         are cooperating with MSKCC to prepare clinical trial agreement.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">IV.</TD><TD>ABV-1504 &nbsp;Major Depressive Disorder - Major Depressive
                                         Disorder (MDD)</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">This
                                         is Polygala extract for Major Depressive Disorder</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">BioLite
                                         performed Phase I clinical trial and the safety was proved.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">BioLite
                                         has obtained US FDA Phase II Part One/Part Two IND approval and the Phase II Part One
                                         was completed with good result.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">BioLite
                                         plans to start Phase II Part Two at 2016 Q3 and currently working with five Taiwan medical
                                         sites and Stanford University to prepare clinical trial agreement</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">V.</TD><TD>ABV-1505 &nbsp;Attention Deficit Hyperactivity Disorder - Attention
                                         Deficit Hyperactivity Disorder</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">This
                                         is Polygala extract for Attention Deficit Hyperactivity Disorder.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Same
                                         Active Pharmaceutical Ingredients (API) with ABV-1504. Safety was approved.&nbsp;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">BioLite
                                         has obtained U.S. FDA Phase II IND approval and is currently negotiating with top medical
                                         site for Phase II clinical trial.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">BioLite
                                         intends to submit for IRB approval during 2016 Q4</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">BioLite
                                         plans to start Phase II clinical trial during 2017 Q1 and complete by 2018 Q3.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Market Opportunity and Growth Strategy/Business Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ABVC will focus on the development of new drugs and innovative
medical devices to fulfill unmet medical needs. The business model of ABVC is to integrate research achievements from world-renown
medical research institutions (Such as MSKCC and MD Anderson Cancer Center), conduct clinical trials of translational medicine
for POC (Proof of Concept), out-license to international pharmaceutical companies, and tap into global market opportunities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our business plan is to conduct Phase II clinical trial for
the above licensed compound (or potential medical device) in North America (US or Canada) and if we obtain satisfactory results
in the Phase II clinical trial for POC, we will out-license the compound to big international pharmaceutical companies for further
development.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The competitive advantages of our business model are:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">1. Once we complete POC, we will co-develop
our product with leading big international pharmaceuticals and in turn, receive more funding for our research and development.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">2. Our business model allows us to obtain
return on investment (ROI) in a shorter period of time, and thus improve our cash flow circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">3. We will have sustainable income to develop
our company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Currently, we are in the process of developing five products,
but we will continue to search for the appropriate products including potential medical device for in-licensing to our company
for further development and generate more revenue for our company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Intellectual Property</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We currently do not own any patent or trademark.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Employees</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of&nbsp;the date of the prospectus, we
have&nbsp;seven&nbsp;full-time employees&nbsp;and&nbsp;one&nbsp;consultant. None of our employees are represented by a labor
organization and we consider our relationship with our employees to be good.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Our Facilities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 95%">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 27%; border-bottom: Black 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Address</B></FONT></TD>
    <TD NOWRAP STYLE="width: 1%; text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 15%; border-bottom: Black 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Size</B></FONT></TD>
    <TD NOWRAP STYLE="width: 1%; text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 25%; border-bottom: Black 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Leased/Owned/Granted</B></FONT></TD>
    <TD NOWRAP STYLE="width: 1%; text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 17%; border-bottom: Black 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Function</B></FONT></TD>
    <TD NOWRAP STYLE="width: 1%; text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 12%; border-bottom: Black 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Monthly</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rent</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Building 27, 238 North City Road II, Xitun District,
        Taizhong City</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Taiwan</P></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,772 sq. feet</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leased</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate office</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>$0.00</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11 Sawyers Peak Drive, Goshen, NY 10924</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000sq. feet</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leased</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate office</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>$0.00</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Government Regulation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Regulation by governmental authorities in the U.S. and other
countries is a significant factor in development, manufacture and marketing of our proposed pharmaceutical products and in our
ongoing research and product development activities. The nature and extent to which such regulation applies to us will vary depending
on the nature of any products that may be developed by us. We anticipate that many, if not all, of our proposed products will
require regulatory approval by governmental agencies prior to commercialization. Our products are subject to rigorous pre-clinical
test and clinical trial and other approval procedures of the FDA, and similar regulatory authorities in European and other countries.
Various governmental statutes and regulations also govern or influence clinical trial, Chemistry, Manufacture and Control (CMC)
related to such products and their marketing. The process of obtaining these approvals and the subsequent compliance with appropriate
statutes and regulations require the expenditure of substantial time and money, and there can be no guarantee that approvals will
be granted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>FDA Approval Process</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Prior to commencement of clinical studies involving humans,
pre-clinical testing of new pharmaceutical products is generally conducted on animals in the laboratory to evaluate the potential
efficacy and safety of the product candidate. The results of these studies are submitted to the FDA as a part of an Investigational
New Drug (&ldquo;IND&rdquo;) application, which must become effective before clinical testing in humans can begin. Typically,
human clinical evaluation involves a time-consuming and costly three-phase process. In Phase I, clinical trials are conducted
with a small number of people to establish safety pattern of drug distribution and metabolism within the body. In Phase II, clinical
trials are conducted with groups of patients afflicted with a specific disease in order to determine preliminary efficacy, possible
dosages and expanded evidence of safety. In some cases, an initial trial is conducted in diseased patients to assess both preliminary
efficacy and preliminary safety and patterns of drug metabolism and distribution, in which case it is referred to as a Phase I/II
trial. In Phase III, large-scale, multi-center, comparative trials are conducted with patients afflicted with a target disease
in order to provide enough data to demonstrate the efficacy and safety required by the FDA. The FDA closely monitors the progress
of each of the three phases of clinical testing; and may, at its discretion, re-evaluate, alter, suspend or terminate the testing
based upon the data which have been accumulated to that point and its assessment of the risk/benefit ratio to the patient. Monitoring
of all aspects of the study to minimize risks is a continuing process. All adverse events must be reported to the FDA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The results of the pre-clinical and clinical testing on a non-biologic
drug and certain diagnostic drugs are submitted to the FDA in the form of a New Drug Application (&ldquo;NDA&rdquo;) for approval
prior to commencement of commercial sales. In the case of vaccines or gene and cell therapies, the results of clinical trials
are submitted as a Biologics License Application (&ldquo;BLA&rdquo;). In responding to a NDA or BLA, the FDA may grant marketing
approval, request additional information or refuse to approve if the FDA determines that the application does not satisfy its
regulatory approval criteria. There can be no assurance that approvals will be granted on a timely basis, if at all, for any of
our proposed products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>European and Other Regulatory Approval</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Whether or not FDA approval has been obtained, approval of
a product by comparable regulatory authorities in Europe and other countries will likely be necessary prior to commencement of
marketing the product in such countries. The regulatory authorities in each country may impose their own requirements and may
refuse to grant an approval, or may require additional data before granting it, even though the relevant product has been approved
by the FDA or another authority. As with the FDA, the regulatory authorities in the European Union (&ldquo;EU&rdquo;), Australia
and other developed countries have lengthy approval processes for pharmaceutical products. The process for gaining approval in
particular countries varies, but generally follows a similar sequence to that described for FDA approval. In Europe, the European
Committee for Proprietary Medicinal Products provides a mechanism for EU-member states to exchange information on all aspects
of product licensing. The EU has established a European agency for the evaluation of medical products, with both a centralized
community procedure and a decentralized procedure, the latter being based on the principle of licensing within one member country
followed by mutual recognition by the other member countries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are also subject to various U.S. federal, state, local and
international laws, regulations and recommendations relating to the treatment of oocyte donors, the manufacturing environment
under which human cells for therapy are derived, safe working conditions, laboratory and manufacturing practices and the use and
disposal of hazardous or potentially hazardous substances, including radioactive compounds and infectious disease agents, used
in connection with our research work. We cannot accurately predict the extent of government regulation which might result from
future legislation or administrative action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Legal Proceedings</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company filed for Chapter 7 bankruptcy protection on May
15, 2013 and subsequently the corporate shell emerged as its only unencumbered asset on September 19, 2014 using &quot;fresh start&quot;
accounting under section 852-10-45-17 as of date of sale corporate shell to reflect intangible assets sale through section 363
of the US bankruptcy code. &nbsp;Any business description below and all reporting results of the operating results reported in
this filing for the fiscal year ending September 30, 2015 and 2014 are post &quot;fresh start&quot; activity and not comparable
to prior results. Post bankruptcy&nbsp;the company has been operating a web site for the sale of women's apparel.&nbsp;Other than
disclosed herein, we&nbsp;are currently not a party to any material legal or administrative proceedings and are not aware of any
pending legal or administrative proceedings against us. We may from time to time become a party to various legal or administrative
proceedings arising in the ordinary course of our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="s1_010"></A>MANAGEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table sets forth the name,
age, and position of our sole officer and director as of the date of this prospectus. Executive officers are elected annually
by our Board of Directors. Each executive officer holds his office until he resigns, is removed by the Board, or his successor
is elected and qualified. Directors are elected annually by our stockholders at the annual meeting. Each director holds his office
until his successor is elected and qualified or his earlier resignation or removal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The officers of our company are appointed by the board of directors
and hold office until their death, resignation or removal from office. The directors and executive officers, their ages, positions
held, and duration as such, are as set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="width: 28%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD NOWRAP STYLE="width: 2%; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 52%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Position
    Held</B></FONT></TD>
    <TD NOWRAP STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 15%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Age</B></FONT></TD>
    <TD NOWRAP STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eugene Jiang</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Executive Officer,</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Financial Officer, Chairman, Director, President,</P></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;29</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kira Huang</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer, Secretary, Treasurer</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>46</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Eugene Jiang&nbsp;&ndash;&nbsp;Chief Executive Officer,
Chief Financial Officer, Chairman, Director, President,</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr. Eugene Jiang, age 29, has served as the CEO/Director of&nbsp;American&nbsp;BriVision&nbsp;Corporation
which started business since July 2015 through present. From June 2015 until present, Mr. Jiang also serves as Director for&nbsp;BioLite&nbsp;Incorporation.
He also serves as&nbsp;CEO for&nbsp;Genepro&nbsp;Investment Company since March 2010.&nbsp;Mr&nbsp;Jiang obtained an EMBA degree
from The University of&nbsp;Texas&nbsp;in Arrington in 2009. And in 2008, Mr. Jiang received a bachelor&rsquo;s degree in Physical
Education from Fu Jen Catholic University.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Kira Huang-Chief&nbsp;Financial&nbsp;Officer, Secretary,
Treasurer</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Kira Huang, has served as Chief Financial Officer&nbsp;of&nbsp;American&nbsp;BriVisionCorporation&nbsp;since
November2015. She served as Finance Manager in&nbsp;Coface&nbsp;credit insurance company from 2010 to 2014, and as country controlling
of Moody&rsquo;s Taiwan&nbsp;Corporation&nbsp;from 2008 to 2010. She holds&nbsp;an accounting bachelor degree from Eastern Michigan
University and also is a certified public accountant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Significant Employees</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following are employees who are not executive officers,
but who are expected to make significant contributions to our business:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>(Frank)Chih-Chung&nbsp;Liu-&nbsp;Chief Scientific&nbsp;Officer
of&nbsp;American&nbsp;BriVision&nbsp;Corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr. Frank Liu, age&nbsp;52,&nbsp;has served as the&nbsp;Chief
Scientific Officer since our inception. From 2010-2014, he was an associate researcher/cross strait medical affair project manager,
Division of Resource Development, Center for Drug Evaluation, Taiwan. From&nbsp;April&nbsp;2014&nbsp;until&nbsp;present. Mr. Liu
also&nbsp;serves as&nbsp;Director of&nbsp;Research and Development&nbsp;for&nbsp;BioFirst Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">He received his&nbsp;Bachelor of Medical Science&nbsp;degree
from&nbsp;Medical College, Jinan University,&nbsp;China.&nbsp;Major in Clinical Medicine&nbsp;and he got&nbsp;both of&nbsp;his&nbsp;Master
of Science&nbsp;degree from&nbsp;California University of Pennsylvania,&nbsp;Pennsylvania&nbsp; U.S.A.&nbsp;major in Biology&nbsp;and
his&nbsp;Bachelor of Science degree from&nbsp;&nbsp;Geneva College,&nbsp;Pennsylvania U.S.A.&nbsp;Major&nbsp;in Biology, Minor
in Chemistry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Section 16(a) Beneficial Ownership
Reporting Compliance</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section&nbsp;16(a) of the Exchange Act
and the rules thereunder require our officers and directors, and persons that own more than 10% of a registered class of our equity
securities, to file reports of ownership and changes in ownership with the Securities and Exchange Commission and to furnish us
with copies. Based solely on our review of the copies of the Section&nbsp;16(a) forms received by us, or written representations
from certain reporting persons, we believe that none of our officers, directors, and greater than 10% beneficial owners filed
on a timely basis reports required by Section&nbsp;16(a) of the Exchange Act prior to the Share Exchange on November&nbsp;30,
2012 during the fiscal year ended December&nbsp;31, 2012. After the Share Exchange, we believe that none of our officers, directors,
and greater than 10% beneficial owners failed to file on a timely basis reports required by Section&nbsp;16(a) of the Exchange
Act during the fiscal year ended September 30, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Code of Ethics</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our board of directors has adopted a Policy Statement on Business
Ethics and Conflicts of Interest (&ldquo;Code of Ethics&rdquo;) applicable to all employees, including the Company&rsquo;s chief
executive officer and chief financial officer. A copy of the Code of Ethics and Business Conduct is available on the Company&rsquo;s
website&nbsp; http://content.stockpr.com/onehorizongroup/media/250c1db923f658aca6cc69dfc35c7f89.pdf</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Board Leadership Structure and the Board&rsquo;s Role in
Risk Oversight.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Board of Directors is led by the Chairman who is also the
Chief Executive Officer. Although our sole officer is also our sole director, the Board believes that the most effective leadership
structure at this time is not to separate the roles of Chairman and Chief Executive Officer. A combined structure provides the
Company with a single leader who represents the company to our stockholders, regulators, business partners and other stakeholders,
among other reasons set forth below. Should the Board conclude otherwise, the Board will separate the roles and appoint an independent
director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This structure creates efficiency in the preparation of the
meeting agendas and related Board materials as the Company&rsquo;s Chief Executive Officer works directly with those individuals
preparing the necessary Board materials and is more connected to the overall daily operations of the Company. Agendas are also
prepared with the permitted input of the full Board of Directors allowing for any concerns or risks of any individual director
to be discussed as deemed appropriate. The Board believes that the Company has benefited from this structure, and Dr. Jiang's
continuation in the combined role of the Chairman and Chief Executive Officer is in the best interest of the stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company believes that the combined structure is necessary
and allows for efficient and effective oversight, given the Company&rsquo;s relatively small size, its corporate strategy and
focus</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Board of Directors does not have a specific role in risk
oversight of the Company. The Chairman, President and Chief Executive Officer and other executive officers and employees of the
Company provide the Board of Directors with information regarding the Company&rsquo;s risks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Director Independence</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Presently, we are not required to comply
with the director independence requirements of any securities exchange since we are listed on OTC markets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="s1_011"></A>EXECUTIVE COMPENSATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following tables set forth, for each of the last two completed
fiscal years of the Company, the total compensation awarded to, earned by or paid to any person who was a principal executive
officer during the preceding fiscal year and every other highest compensated executive officers earning more than $100,000 during
the last fiscal year (together, the&nbsp;&ldquo;Named Executive Officers&rdquo;). The tables set forth below reflect the compensation
of the Named Executive Officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Summary Compensation Table</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Name&nbsp;and</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Principal</B><BR>
                                         <B>Position</B></FONT></P></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Year</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Salary<BR>
    ($)</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Bonus<BR>
    ($)</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Stock</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Awards</B><BR>
                                         <B>($)</B></FONT></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Option</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Awards&nbsp;($)</B></FONT></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Non-Equity</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Incentive
                                         Plan</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Compensation</B><BR>
                                         <B>($)</B></FONT></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Change
                                         in</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Pension</B><BR>
                                         <B>Value</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>and</B><BR>
                                         <B>Nonqualified</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Deferred</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Compensation</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Earnings&nbsp;($)</B></FONT></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>All
                                         Other</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Compensation</B><BR>
                                         <B>($)</B></FONT></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Total<BR>
    ($)</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD NOWRAP STYLE="text-align: left; width: 11%"><FONT STYLE="font-size: 8pt">Shulamit Lazar (1)</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 8%; text-align: center"><FONT STYLE="font-size: 8pt">2015</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-size: 8pt">60,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-size: 8pt">60,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">2014</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;Eugene Jiang (2)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">2015</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">2014</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">Kira Huang (3)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">2016</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nil</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(1) Ms. Lazar was the Company&rsquo;s
sole executive officer until December 18, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(2) Mr. Jiang was elected the Company&rsquo;s
sole executive officer since December 18, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(3) The company entered into an employment
contract with Kira Huang on February 1, 2016 according to which Ms. Huang was employed as Chief Financial Officer. Pursuant to
the employment agreement, the company agrees to compensate Ms. Huang salary of $4,500 per month subject to normal statutory deduction
and annual review.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Narrative Disclosure to Summary Compensation Table</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Other than set out below, there are no arrangements or plans
in which we provide pension, retirement or similar benefits for directors or executive officers. Our directors and executive officers
may receive share options at the discretion of our board of directors in the future. We do not have any material bonus or profit
sharing plans pursuant to which cash or non-cash compensation is or may be paid to our directors or executive officers, except
that share options may be granted at the discretion of our board of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Stock Option Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Currently,&nbsp;we do not have a stock option plan&nbsp;in
favor of any director, officer, consultant or employee of our company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Grants of Plan-Based Awards</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There were no grants of plan-based awards during the year ended&nbsp;September
30, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Outstanding Equity Awards at Fiscal Year End</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our former Chief Executive Officer,&nbsp;Shulamit&nbsp;Lazar,
received compensation of 30,000,000 shares valued at $30,000 during the year ended September 30, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Option Exercises and Stock Vested</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During our fiscal year ended&nbsp;September 30, 2015&nbsp;there
were no options exercised by our named officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Compensation of Directors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We do not have any agreements for compensating our directors
for their services in their capacity as directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Pension, Retirement or Similar Benefit Plans</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There are no arrangements or plans in which we provide pension,
retirement or similar benefits for directors or executive officers. We have no material bonus or profit sharing plans pursuant
to which cash or non-cash compensation is or may be paid to our directors or executive officers, except that stock options may
be granted at the discretion of the board of directors or a committee thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Employment Contracts</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We&nbsp;currently do not&nbsp;have employment contracts with&nbsp;our
employees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Brivision has employment contracts with its&nbsp;CFO Kira Huang,
who is also our CFO.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Employment contract with the CFO&nbsp;of&nbsp; BriVision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">BriVision&nbsp; entered into an employment contract with Kira
Huang on February 1, 2016 according to which, among other terms, &nbsp;Ms. Huang is required to, as Chief Financial Officer, &nbsp;perform
duties and undertake the responsibilities&nbsp;in a professional manner including reporting the&nbsp;financials related matters
to&nbsp;American&nbsp;BriVision&rsquo;s&nbsp;Board of Directors; developing the financial planning and oversee tax reporting activities;
monitoring and submitting all required reports to SEC on timely basis, planning and overseeing annual budgets and other duties
as may arise from time to time and as may be assigned to her. And pursuant to the employment agreement,&nbsp;American&nbsp;BriVision&nbsp;agrees&nbsp;to
compensate Mrs. Huang salary&nbsp;of $4,500 per month subject to normal statutory deduction and annual review. Additional bonus
or stock options will be determined by&nbsp;its&nbsp;Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="s1_012"></A>CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS,
AND DIRECTOR INDEPENDENCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the fiscal year ended September 30, 2015, we had an
unsecured demand note payable due of $9,000 to&nbsp;Shulamit&nbsp;Lazar, our sole officer and director for funds advanced the
Company through the bankruptcy process. This is unsecured with a zero percent interest rate and is payable on demand. The note
was cancelled as of December 2, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On December 29, 2015,&nbsp;<B> </B>BriVision entered into a
Collaborative Agreement (the&nbsp;&ldquo;Collaborative Agreement&rdquo;) with&nbsp;BioLite, of which the Company&rsquo;s sole
officer and director, Eugene Jiang, is a director. Pursuant to the Collaborative Agreement,&nbsp;BioLite&nbsp;shall grant sole
licensing rights to&nbsp;BriVision&nbsp;of drug and therapeutic use of five products for 10 years: BLI-1005 CNS-Major Depressive
Disorder; BLI-1008 CNS-Attention Deficit Hyperactivity Disorder; BLI-1401-1 Anti-Tumor Combination Therapy-Solid Tumor with Anti-PD-1;
BLI-1401-2 Anti-Tumor Combination Therapy-Triple Negative Breast Cancer; and BLI-1501 Hematology-Chronic Lymphocytic Leukemia,
in USA and Canada. Under the&nbsp;Collaborative Agreement,&nbsp;BriVision&nbsp;shall pay a total of $100,000,000 in cash or stock
of&nbsp;BriVision&nbsp;with equivalent value, according to the following schedule:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Symbol">&middot;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upfront&nbsp;payment shall upon the signing of
this Collaborative Agreement: 3.5% of total payment. After receiving upfront payment from&nbsp;BriVision,&nbsp;BioLite&nbsp;has
to deliver all data to BriVision&nbsp;in one week.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Symbol">&middot;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon&nbsp;the first IND submission,&nbsp;BriVision&nbsp;shall
pay, but no later than December 15, 2016: 6.5% of total payment. After receiving second payment from&nbsp;BriVision,&nbsp;BioLite&nbsp;has
to deliver IND package to&nbsp;BriVision&nbsp;in one week.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Symbol">&middot;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at&nbsp;the completion of first phase II clinical
trial,&nbsp;BriVision&nbsp;shall pay, but no later than September&nbsp;15, 2017: 15% of total payment. After receiving third payment
from&nbsp;BriVision,BioLite&nbsp;has to deliver phase II clinical study report to&nbsp;BriVision&nbsp;in three months.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Symbol">&middot;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon&nbsp;the phase III IND submission,&nbsp;BriVision&nbsp;shall
pay, but no later than December 15, 2018: 20% of total payment. After receiving forth payment from&nbsp;BriVision,&nbsp;BioLite&nbsp;has
to deliver IND package to&nbsp;BriVision&nbsp;in one week.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Symbol">&middot;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at&nbsp;the completion of phase III,&nbsp;BriVision&nbsp;shall
pay, but no later than September 15, 2019: 25% of total payment. After receiving fifth payment from&nbsp;BriVision,&nbsp;BioLite&nbsp;has
to deliver phase III clinical study report to&nbsp;BriVision&nbsp;in three months</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Symbol">&middot;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon&nbsp;the NDA submission,&nbsp;BriVision&nbsp;shall
pay, but no later than December 15, 2020,BriVision&nbsp;shall pay: 30% of total payment. After receiving sixth payment from&nbsp;BriVision,BioLite&nbsp;has
to deliver NDA package to&nbsp;BriVision&nbsp;in one week</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On May 6 , 2016, we and Biolite amended the payment terms under
the Collaborative Agreement by entering into a Milestone Payment Agreement, pursuant to which we paid $2,600,000 in cash and $900,000
in newly issued shares of our common stock, at the price of $1.60 per share, for an aggregate number of 562,500 shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of March 31, 2016 and September 30, 2015, the amount due
to a related party, BioLite was $0 and $22,517, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of March 31, 2016 and September 30, 2015, the amount due
to shareholder, YuanGene Corporation, was $5,723 and $46,586, respectively; Mr. Jiang maintains voting control over the shares
of the Company&rsquo;s common stock that YuanGene Corporation owns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Promoters and Certain Control Persons</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">None of our management or other control
persons were &ldquo;promoters&rdquo; (within the meaning of Rule&nbsp;405 under the Securities Act), and none of such persons
took the initiative in the formation of our business or received any of our debt or equity securities or any of the proceeds from
the sale of such securities in exchange for the contribution of property or services, during the last five years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><A NAME="s1_013"></A><B>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL
OWNERS AND MANAGEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table sets forth certain information regarding
beneficial ownership of our common stock as of&nbsp;August 10, 2016 (i) each person (or group of affiliated persons)
who is known by us to own more than five percent (5%) of the outstanding shares of our common stock, (ii) each director, executive
officer and director nominee, and (iii) all of our directors, executive officers and director nominees as a group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Beneficial ownership is determined in accordance with SEC rules
and generally includes voting or investment power with respect to securities. For purposes of this table, a person or group of
persons is deemed to have&nbsp;&ldquo;beneficial ownership&rdquo;&nbsp;of any shares of common stock that such person has the
right to acquire within 60 days of the date of the respective table. For purposes of computing the percentage of outstanding shares
of our common stock held by each person or group of persons named above, any shares that such person or persons has the right
to acquire within 60 days of the date of the respective table is deemed to be outstanding for such person, but is not deemed to
be outstanding for the purpose of computing the percentage ownership of any other person. The inclusion herein of any shares listed
as beneficially owned does not constitute an admission of beneficial ownership.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Unless otherwise noted, the business address of each beneficial
owner listed is&nbsp;11 Sawyers Peak Drive,&nbsp;Goshen, NY 10924. Except as otherwise indicated, the persons listed below have
sole voting and investment power with respect to all shares of our common stock owned by them, except to the extent that power
may be shared with a spouse.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of&nbsp;September 13,&nbsp;2016, we
had&nbsp;213,303,222.&nbsp;shares of common stock issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; border-bottom: Black 1pt solid">Name of Beneficial Owner</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Amount and<BR> Nature of<BR> Beneficial<BR> Ownership</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Percent</B><BR> <B>of</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Class</B></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left">Eugene Jiang, Chairman and CEO (1)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 15%; text-align: right">147,842,856</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 15%; text-align: right">70</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Kira Huang</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">31,410</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD NOWRAP STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less than 1</FONT></TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">All officers and directors as a group ( persons)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD NOWRAP STYLE="text-align: right">147,874,266</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">71</TD><TD STYLE="text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(1)&nbsp;These shares are owned by YuanGene&nbsp;Corporation,
a corporation incorporated in&nbsp;Samoa.&nbsp; Eugene Jiang is the sole director of YuanGene Corporation and therefore will be
deemed as the beneficial owner of the shares held by YuanGene Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Changes in Control</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As a result of the Share Exchange,&nbsp;BriVision&nbsp;became
our wholly owned subsidiary and the former shareholders of&nbsp;BriVision&nbsp;collectively own approximately&nbsp;79.70% of the
shares of the Company outstanding post-exchange common stock. As a result, such persons now collectively control the Company&rsquo;s
shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Equity Compensation Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We do not have in effect any compensation plans under which
our equity securities are authorized for issuance and we do not have any outstanding stock options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>DESCRIPTION OF SECURITIES TO BE REGISTERED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Authorized Capital Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company&rsquo;s authorized capital stock consists of&nbsp;360,000,000shares
of common stock,&nbsp;$0.001 par value per share and&nbsp;20,000,000 shares of preferred stock&nbsp;$0.001 par value per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of September 13, 2016,&nbsp; 213,303,222 shares
of our Common Stock are issued and outstanding. Holders of Common Stock are entitled to cast one vote for each share on all
matters submitted to a vote of shareholders, including the election of directors. The holders of Common Stock are entitled to
receive ratably such dividends, if any, as may be declared by the Board out of funds legally available therefore. Such
holders do not have any preemptive or other rights to subscribe for additional shares. All holders of Common Stock are
entitled to share ratably in any assets for distribution to shareholders upon the liquidation, dissolution or winding up of
the Company. There are no conversion, redemption or sinking fund provisions applicable to the Common Stock. All outstanding
shares of Common Stock are fully paid and nonassessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Registration Rights</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -1.5pt">There are no outstanding stockholders&rsquo;
agreements, voting trusts or arrangements, registration rights agreements, rights of first refusal or other contracts pertaining
to the capital stock of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Transfer Agent</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The transfer agent and registrar for our common stock&nbsp;is:&nbsp;Olde&nbsp;Monmouth
Stock Transfer, Inc.; Address: 200 Memorial Pkwy, Atlantic Highlands, NJ 07716;&nbsp;Phone:&nbsp;(732) 872-2727;&nbsp;website:www.oldemonmouth.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="s1_014"></A>SELLING STOCKHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This prospectus relates to the offering and sale, from time
to time, of up to 32,409,505 shares of our common stock held by the stock holders named in the table below. We are registering
the shares to permit the Selling Stockholders and their pledgees, donees, transferees and other successors-in-interest that receive
their shares from a Selling Stockholder as a gift, partnership distribution or other non-sale related transfer after the date
of this prospectus to resell the shares when and as they deem appropriate in the manner described in the &ldquo;Plan of Distribution.&rdquo;&nbsp;&nbsp;As
of the date of September 13, 2016, there were 213,303,222 shares of Common Stock issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table sets forth:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the name of the Selling Stockholders,</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number of shares of our
    Common Stock that the Selling Stockholders beneficially owned prior to the offering for resale of the shares under this prospectus,</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the maximum number of shares
    of our Common Stock that may be offered for resale for the account of the Selling Stockholders under this prospectus, and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number and percentage
    of shares of our Common Stock beneficially owned by the Selling Stockholders after the offering of the shares (assuming all
    of the offered shares are sold by the Selling Stockholders).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.55in">Each Selling Stockholder may offer for
sale all or part of the Shares from time to time. The table below assumes that the Selling Stockholders will sell all of the Shares
offered for sale. A Selling Stockholder is under no obligation, however, to sell any Shares pursuant to this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; border-bottom: Black 1pt solid">Name&nbsp;of&nbsp;Selling&nbsp;Stockholder</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Shares&nbsp;of<BR> Common Stock<BR> Beneficially<BR> Owned&nbsp;Prior<BR> to&nbsp;Offering (1)</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Maximum<BR> Number&nbsp;of<BR> Shares&nbsp;of<BR> Common<BR> Stock&nbsp;to&nbsp;be Sold</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number&nbsp;of<BR> Shares&nbsp;of<BR> Common<BR> Stock<BR> Owned&nbsp;After<BR> Offering<BR> (2)</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Percentage<BR> Ownership<BR> After<BR> Offering<BR> (3)</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 48%; text-align: left">LU, PO-YEN</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">599,994</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">200,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">399,994</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">67</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">CHANG, YANG-CHING</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">449,996</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">134,998</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">314,998</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">70</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">LEE, WU-HIS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">699,994</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">250,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">449,994</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">64</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">CHAO, YU-LIEN</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100,001</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">70,001</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">70</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">WU, HSIN-CHOU</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">199,997</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">60,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">139,997</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">70</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">KUO, KUN-JUNG</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">200,098</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">60,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">140,098</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">70</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">TENG, CHIN-CHUN</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,499,985</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,499,985</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">LIN, YI-LUN</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">149,999</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">99,999</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">67</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">YU, LI-LING</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">166,665</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">141,665</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">85</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">HUANG, WEI-TAO</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">249,999</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">70,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">179,999</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">72</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">CHANG, CHIA-HAO</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">154,535</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,180</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">131,355</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">85</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">TSAI, MING-SHIH</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">299,997</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45,000,</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">254,997</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">85</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">PACIFIC CONCORD INTERNATIOINAL (4)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">499,997</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">150,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">349,997</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">70</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">LEE, TSUNG-LIN</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">206,999</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">31,050</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">175,949</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">85</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">LIU, CHUN-AN</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">549,996</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">549,996</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">YUANGENE CORPORATION (5)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">147,842,856</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">139,842,856</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">95</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">EURO-ASIA INVESTMENT &amp; FINANCE CORP LTD (6)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,227,425</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,227,425</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">BIOHOPEKING CORPORATION (7)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,484,987</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,484,987</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">BUFFETT INVESTMENT CORPORATION (8)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,094,917</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,094,917</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">56</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">LIONGENE CORPORATION (9)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,657,913</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,657,913</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">CHEN YANG, LAI-CHUN</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">199,997</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">199,997</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">SHEN, SHU-HUI</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">199,997</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">199,997</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">SHEN, CHIA-CHI</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100,001</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100,001</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">LIU, SU-LIEN</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">349,996</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">349,996</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">WU, PENG-YU</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">999,991</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">999,991</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">CHEN, YEN-CHIA</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,001</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,001</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">FAITH TEAM CORPORATION LIMITED (10)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">299,997</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">299,997</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">THALIA MEDIA LIMITED (11)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">249,999</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">249,999</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">KIMHO CONSULTANTS CO,(12)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">49,999</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">49,999</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">RGENE CORPORATION (13)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,319,916</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,500,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,819,916</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">84</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">WU, TZY-YN</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,499,988</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">749,994</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">749,994</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">CHANG, ERIC-YUAN</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">999,991</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">149,999</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">849,992</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">85</TD><TD STYLE="text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
selling stockholders acquired their shares pursuant to the Share Exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since
we do not have the ability to control how many, if any, of their shares each of the selling shareholders listed above will sell,
we have assumed that the selling shareholders will sell all of the shares offered herein for purposes of determining how many
shares they will own after the Offering and their percentage of ownership following the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
Percentages have been rounded up to the nearest one hundredth of one percent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">4)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
person having voting, dispositive or investment power over Pacific Concord International is Shih Yun Lin. The address for Pacific
Concord International is Level 2, Lotemau Centre, Vaea Street, P.O. Box 3271, Apia, Western Samoa.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">5)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
person having voting, dispositive or investment power over Yuangene Corporation is Eugene Jiang. The address for Yuangene corporation
is 3F, No. 248, Sec 1 Neihu Rd, Taipei City 11493, Taiwan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">6)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
person having voting, dispositive or investment power over Euro-Asia Investment &amp; Finance Corp Ltd is Shum Kwok Keung. The
address for Euro-Asia Investment &amp; Finance Corp Ltd is Unit 604G, Block A, Po Lung Centre, No. 11 Wang Chiu Road, Kowloon
Bay Kin, Hong Kong.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">7)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
person having voting, dispositive or investment power over Biohopeking Corporation is Mei Na Huang. The address for Biohopeking
Corporation is 3F, No. 248 Sect 1 Neihu Rd, Taipei City 11493, Taiwan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">8)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
person having voting, dispositive or investment power over Buffett Investment Corporation is Yu Ching Kuo. The address for Buffett
Investment Corporation is 3F, No. 248 Sect 1 Neihu Rd, Taipei City 11493, Taiwan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">9)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
person having voting, dispositive or investment power over Liongene Corporation is Ya Jing Rui. The address for Liongene Corporation
is 3F, No. 248, Sect 1 Neihu Rd, Taipei City 11493, Taiwan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">10)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
person having voting, dispositive or investment power over Faith Team Corporation Limited is Shum Kwok Keung. The address for
Faith Team Corporation Limited is BLK 1, 7/F, Enterpaise Square I 9, Speung Yuet Road, Kowloon bay, Kowlon, Hongkong.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">11)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
person having voting, dispositive or investment power over Thalia Media Limited is Sze Ho Yeung Freddy. The address for Thalia
Media Limited is RM 604 G, Block A, 6/F, Po Lung Centre 11 Wang Chiu Road, Kowloon Bay Kowloon, Hongkong.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">12)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
person having voting, dispositive or investment power over Kimho Consultants Co. is Kimberly Leung. The address for Timho Consultants
Co. is RM 3, Block 2, 13/F Greer Park Villa, Speung Sriu, NT, HongKong.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">13)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
person having voting, dispositive or investment power over Rgene Corporation is Ya Jing Rui. The address for Rgene Corporation
is 3F, No. 248, Sec 1 Neihu Rd, Taipei City 11493, Taiwan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="s1_015"></A>PLAN OF DISTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The selling stockholders
and any of their respective pledgees, donees, assignees and other successors-in-interest may, from time to time, sell any or all
of their shares of common stock on any stock exchange, market or trading facility on which the shares are traded or in private
transactions. These sales may be at fixed or negotiated prices. The selling stockholders may use any one or more of the following
methods when selling shares:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary brokerage transactions
    and transactions in which the broker-dealer solicits the purchaser;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">block trades in which the
    broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the block as principal;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">facilitate the transaction;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchases by a broker-dealer
    as principal and resale by the broker-dealer for its account;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an exchange distribution
    in accordance with the rules of the applicable exchange;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">privately-negotiated transactions;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">broker-dealers may agree
    with the selling stockholders to sell a specified number of such shares at a stipulated price per share;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through the writing of options
    on the shares;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a combination of any such
    methods of sale; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any other method permitted
    pursuant to applicable law.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The selling stockholders
may also sell shares under Rule 144 of the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), if available,
rather than under this prospectus. The selling stockholders shall have the sole and absolute discretion not to accept any purchase
offer or make any sale of shares if it deems the purchase price to be unsatisfactory at any particular time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The selling stockholders
or their respective pledgees, donees, transferees or other successors in interest, may also sell the shares directly to market
makers acting as principals and/or broker-dealers acting as agents for themselves or their customers. Such broker-dealers may
receive compensation in the form of discounts, concessions or commissions from the selling stockholders and/or the purchasers
of shares for whom such broker-dealers may act as agents or to whom they sell as principal or both, which compensation as to a
particular broker-dealer might be in excess of customary commissions. Market makers and block purchasers purchasing the shares
will do so for their own account and at their own risk. It is possible that a selling stockholder will attempt to sell shares
of common stock in block transactions to market makers or other purchasers at a price per share which may be below the then existing
market price. We cannot assure that all or any of the shares offered in this prospectus will be issued to, or sold by, the selling
stockholders. The selling stockholders and any brokers, dealers or agents, upon effecting the sale of any of the shares offered
in this prospectus, may be deemed to be &ldquo;underwriters&rdquo; as that term is defined under the Securities Act, the Exchange
Act and the rules and regulations of such acts. In such event, any commissions received by such broker-dealers or agents and any
profit on the resale of the shares purchased by them may be deemed to be underwriting commissions or discounts under the Securities
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We are required
to pay all fees and expenses incident to the registration of the shares, including fees and disbursements of counsel to the selling
stockholders, but excluding brokerage commissions or underwriter discounts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The selling stockholders,
alternatively, may sell all or any part of the shares offered in this prospectus through an underwriter.&nbsp;&nbsp;The selling
stockholders have not entered into any agreement with a prospective underwriter and there is no assurance that any such agreement
will be entered into.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The selling stockholders
may pledge their shares to their brokers under the margin provisions of customer agreements. If a selling stockholder defaults
on a margin loan, the broker may, from time to time, offer and sell the pledged shares. The selling stockholders and any other
persons participating in the sale or distribution of the shares will be subject to applicable provisions of the Exchange Act,
and the rules and regulations under such act, including, without limitation, Regulation M. These provisions may restrict certain
activities of, and limit the timing of purchases and sales of any of the shares by, the selling stockholders or any other such
person. In the event that any of the selling stockholders are deemed an affiliated purchaser or distribution participant within
the meaning of Regulation M, then the selling stockholders will not be permitted to engage in short sales of common stock. Furthermore,
under Regulation M, persons engaged in a distribution of securities are prohibited from simultaneously engaging in market making
and certain other activities with respect to such securities for a specified period of time prior to the commencement of such
distributions, subject to specified exceptions or exemptions. In addition, if a short sale is deemed to be a stabilizing activity,
then the selling stockholders will not be permitted to engage in a short sale of our common stock. All of these limitations may
affect the marketability of the shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; text-indent: 0.5in">If a selling stockholder notifies
us that it has a material arrangement with a broker-dealer for the resale of the common stock, then we would be required to amend
the registration statement of which this prospectus is a part, and file a prospectus supplement to describe the agreements between
the selling stockholder and the broker-dealer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">In compliance
with the guidelines of the Financial Industry Regulatory Authority, Inc., or FINRA, the maximum consideration or discount to be
received by any member of the FINRA may not exceed 8% of the aggregate amount of the securities offered pursuant to this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Selling stockholders
hereunder that are FINRA members, or affiliates of FINRA members, are precluded from, directly or indirectly, offering, selling,
agreeing to offer or sell, transferring, assigning, pledging, hypothecating or subjecting to hedging, short sale, derivative,
put or call transaction, all or any portion of those certain placement agents&rsquo; warrants of the Company issued to such selling
stockholders on January 5, 2010, or any shares of the company&rsquo;s common stock thereunder, for the period beginning on the
later of: (i) the date of effectiveness of the registration statement of which this prospectus forms a part or (ii) the date of
commencement of sales pursuant to this prospectus and ending on the six (6) month anniversary of such date, except in accordance
with FINRA Rule 5110 (g)(2).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>


<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="s1_016"></A>MARKET FOR OUR COMMON STOCK, DIVIDENDS
AND</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>RELATED STOCKHOLDER INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of September 13, 2016, our company's common
stock is quoted on the&nbsp;OTCQB&nbsp;under the symbol&nbsp;ABVC; prior thereto, since December 16, 2015, our symbol was
MTOO.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table sets forth the quarterly high and low bid
prices for&nbsp;the last two fiscal years.&nbsp;&nbsp;The prices set forth below represent inter-dealer quotations, without retail
markup, markdown or commission and may not be reflective of actual transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">High</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Low</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic">Fiscal 2014</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 74%">Quarter ended December 31, 2013</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">0.02</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">0.00</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Quarter ended March 31, 2014</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.01</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.01</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Quarter ended June 30, 2014</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.01</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.01</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Quarter ended September 30, 2014</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.01</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.02</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-style: italic">Fiscal 2015</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Quarter ended December 31, 2014</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.02</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.01</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Quarter ended March 31, 2015</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.01</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.00</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Quarter ended June 30, 2015</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.00</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.00</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Quarter ended September 30, 2015</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">28.00</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.00</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic">Fiscal 2016</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Quarter ended December 31, 2015</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25.00</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.00</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Quarter ended March 31, 2016</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7.96</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.62</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Quarter ended June 30, 2016</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.00</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.00</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On&nbsp;September 10, 2016, the closing bid price
of the common stock was $2.00.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Holders</U>.&nbsp;&nbsp;As of&nbsp; September 13, 2016,
there were&nbsp;171 stockholders of record and an aggregate of 213,303,222 shares of our common stock were issued
and outstanding. Our common shares are issued in registered form.&nbsp;&nbsp;The transfer agent of our company's common stock
is&nbsp;Olde&nbsp;Monmouth Stock Transfer, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Dividend Policy</U>.&nbsp;We have not paid any cash dividends
on our common stock and have no present intention of paying any dividends on the shares of our common stock. Our current policy
is to retain earnings, if any, for use in our operations and in the development of our business. Our future dividend policy will
be determined from time to time by our board of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Securities Authorized for Issuance under Equity Compensation
Plans</U>. We do not have in effect any compensation plans under which our equity securities are authorized for issuance and we
do not have any outstanding stock options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="s1_017"></A>LEGAL MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Certain legal matters with respect to the shares of common
stock offered hereby have be passed upon for us by Hunter Taubman&nbsp;Fischer &amp; Li LLC, New York, New York 10018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><A NAME="s1_018"></A><B>EXPERTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The audited consolidated financial statements of American BriVision
(Holing) Inc. and subsidiaries included herein and elsewhere in the registration statement have been audited by AWC(CPA) Limited
for the periods and to the extent set forth in their Report appearing herein and elsewhere in the registration statement. Such
financial statements have been so included in reliance upon the report of such firm given upon the firm&rsquo;s authority as experts
in accounting and auditing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><A NAME="s1_019"></A><B>DISCLOSURE
OF COMMISSION POSITION ON INDEMNIFICATION FOR SECURITIES ACT LIABILITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Insofar as indemnification
for liabilities arising under the Securities Act of 1933 may be permitted to our directors, officers and controlling persons pursuant
to the foregoing provisions, or otherwise, we have been advised that in the opinion of the SEC&nbsp;such indemnification is against
public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by us of expenses incurred or paid by one of our directors, officers or controlling
persons in the successful defense of any action, suit or proceeding) is asserted by that director, officer or controlling person
in connection with the securities being registered, we will, unless in the opinion of our counsel the matter has been settled
by controlling precedent, submit to a court of appropriate jurisdiction the question whether that indemnification by us is against
public policy as expressed in the Securities Act and will be governed by the final adjudication of that issue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 92%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 8%; text-align: right; vertical-align: bottom; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pages</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#fin1_001">Consolidated Balance Sheets as of June 30, 2016 and September 30, 2015</A></FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom">F-2</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#fin1_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Statements of Operations (unaudited) for the three-months ended June 30, 2016 and for the period from July 21, 2015 (inception) to September 30, 2015</FONT></A></TD>
    <TD STYLE="text-align: right; vertical-align: bottom">F-3</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#fin1_003">Consolidated Statements of Cash Flows (unaudited) for the nine-months ended June 30, 2016 and for the period from July 21, 2015 (inception) to September 30, 2015</A></FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom">F-4</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#fin1_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes to the Consolidated Financial Statements</FONT></A></TD>
    <TD STYLE="text-align: right; vertical-align: bottom">F-5</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#s1fin_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Report of Independent Registered Public Accounting Firm</FONT></A></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-10</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#s1fin_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Balance Sheets at September 30, 2015 and 2014</FONT></A></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-11</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#s1fin_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Statements of Operations for the years ended September 30, 2015 and 2014</FONT></A></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-12</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#s1fin_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Statements of Changes in Stockholders' Equity (Deficit) for the years ended September 30, 2015 and 2014</FONT></A></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-13</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#s1fin_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Statements of Cash Flows for the years ended September 30, 2015 and 2014</FONT></A></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-14</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#s1fin_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes to Consolidated Financial Statements</FONT></A></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-15</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 53; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="fin1_001"></A>American BriVision (Holding) Corporation.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(formerly METU BRANDS, INC.)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONDENSED CONSOLIDATED BALANCE SHEETS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">June 30, 2016</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">September 30,<BR> 2015</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">(Unaudited)</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">(Audited)</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: center">Assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 70%; padding-left: 9.9pt">Cash</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">84,904</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">994,830</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 9.9pt">Prepayment</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,500,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,815</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 29.7pt">Total Current Assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,584,904</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">998,645</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1pt">Deposit</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,815</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,815</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 13.2pt">Total Assets</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">3,588,719</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,002,460</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: center">Liabilities and Equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Accounts Payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,446</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Other payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">300,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Due to related party</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,517</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Due to shareholder</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">46,586</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Short term loan</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,050,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Total Liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,061,446</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">369,103</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Commitments and Contingencies</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Stockholders&rsquo; equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -5.5pt; padding-left: 17.6pt">Common Stock 360,000,000 authorized at $0.001 par value; shares issued and outstanding 209,352,897 and&nbsp;3,113,856 at June 30, 2016 and September 30, 2015</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">209,353</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,114</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -5.5pt; padding-left: 17.6pt">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,987,127</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,295,845</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -5.5pt; padding-left: 17.6pt">Subscription receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(350,000</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -5.5pt; padding-left: 17.6pt">Retained earnings-beginning</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(315,602</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -5.5pt; padding-left: 17.6pt">Retained earnings</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(353,605</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(315,602</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 13.2pt">Total equity</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,527,273</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">633,357</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 13.2pt">Total liabilities and equity</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">3,588,719</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,002,460</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&quot;The accompanying notes are an integral
part of these condensed consolidated financial statements.&quot;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="fin1_002"></A>American BriVision (Holding) Corporation.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(formerly METU BRANDS, INC.)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONDENSED CONSOLIDATED STATEMENTS OF
OPERATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">For&nbsp;the&nbsp;three<BR> months&nbsp;ended<BR> June 30,&nbsp;2016</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">For&nbsp;the&nbsp;period&nbsp;<BR> From&nbsp;July&nbsp;21,&nbsp;2015<BR> (inception)&nbsp;to&nbsp;<BR> September&nbsp;30,&nbsp;2015</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">Revenues</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 1pt">Cost of sales</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Gross loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Operating expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 70%; text-align: left; padding-bottom: 1pt">Selling, general and administrative expenses</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; border-bottom: Black 1pt solid; text-align: right">289,098</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; border-bottom: Black 1pt solid; text-align: right">315,602</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Net loss from operations</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(289,098</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(315,602</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Other income(expense)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9.9pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9.9pt">Bank Interest Income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">361</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9.9pt">Gain on exchange differences</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">89</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9.9pt">Sundry income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 9.9pt">Interest Expense</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(3,753</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 29.7pt">Total Other Income</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(3,303</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; text-indent: -5.5pt; padding-left: 5.5pt">Loss from continuing operations before income taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(292,401</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(315,602</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Income taxes</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(836</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(293,237</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(315,602</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Basic and Diluted loss per share</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; padding-left: 9.9pt">Basic and diluted loss per share</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.00</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.1</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt; text-indent: -5.5pt; padding-left: 5.5pt">Weighted average number of shares outstanding&nbsp; basic and diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">208,779,424</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">3,113,856</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&quot;The accompanying notes are an integral
part of these condensed consolidated financial statements.&quot;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 55; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="fin1_003"></A>American BriVision (Holding) Corporation.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(formerly METU BRANDS, INC.)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONDENSED CONSOLIDATED STATEMENTS OF
CASH FLOW</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">For&nbsp;the&nbsp;nine<BR> months&nbsp;ended<BR> June 30,&nbsp;2016</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">For&nbsp;the&nbsp;period&nbsp;<BR> From&nbsp;July&nbsp;21,&nbsp;2015<BR> (inception)&nbsp;to&nbsp;<BR> September&nbsp;30,&nbsp;2015</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Cash flows from operating activities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 70%; text-align: left; padding-left: 9.9pt">Net loss from continuing operations</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">(353,605</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">(315,602</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -5.5pt; padding-left: 17.6pt">Adjustments to reconcile net loss to net cash used by operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -5.5pt; padding-left: 17.6pt">(Increase) decrease in deposit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,815</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -5.5pt; padding-left: 17.6pt">(Increase) decrease in prepayment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,496,185</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,815</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -5.5pt; padding-left: 17.6pt">(Increase) decrease in due from related party</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">350,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -5.5pt; padding-left: 17.6pt">Increase (decrease) in other payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(300,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">300,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -5.5pt; padding-left: 17.6pt">Increase (decrease) in due to related party</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(22,517</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,517</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -5.5pt; padding-left: 17.6pt">Increase (decrease) in due to shareholder</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(46,586</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">46,586</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -5.5pt; padding-left: 17.6pt">Increase (decrease) in accounts payable</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">11,446</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Net cash used in operating activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(3,857,447</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">45,871</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Cash flows from investing activities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Net cash provided(used) by investing activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Cash flows from financing activities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Proceeds from short term loans</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,050,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt">Proceeds from issuance of shares</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">897,521</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">948,959</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Net cash provided(used) by financing activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,947,521</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">948,959</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Effect Of Exchange Rates On Cash</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Net increase(decrease) in cash</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(909,926</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">994,830</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 1pt">Cash, beginning of period</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">994,830</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt">Cash, end of period</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">84,904</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">994,830</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Supplemental disclosure of cash flow information</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Interest paid</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Income taxes paid</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&quot;The accompanying notes are an integral
part of these condensed consolidated financial statements.&quot;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 56; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="fin1_004"></A>American BriVision (Holding) Corporation.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(formerly METU BRANDS, INC.)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>AS OF JUNE 30, 2016 AND SEPTEMBER 30,
2015</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(Unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>1. ORGANIZATION AND DESCRIPTION OF BUSINESS</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">American BriVision (Holding) Corporation
(the &ldquo;Company&rdquo; or &ldquo;Holding entity&rdquo;), a Nevada corporation, thru the Company&rsquo;s operating entity, American
BriVision Corporation (&ldquo;BriVision&rdquo;), which was incorporated in July 2015 in the State of Delaware, engages in biotechnology
and focuses on the development of new drugs and innovative medical devices to fulfill unmet medical needs. &nbsp;The business model
of the Company is to integrate research achievements from world-famous institutions (such as Memorial Sloan Kettering Cancer Center
(&ldquo;MSKCC&rdquo;) and MD Anderson Cancer Center), conduct clinical trials of translational medicine for Proof of Concept (&ldquo;POC&rdquo;),
out-license to international pharmaceutical companies, and exploit global markets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">REVERSE MERGER</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 8, 2016, a Share Exchange Agreement
(&ldquo;Share Exchange Agreement&rdquo;) was entered into by and among American BriVision (Holding) Corporation (the&nbsp;&ldquo;Company&rdquo;),
American BriVision Corporation&nbsp;(&ldquo;BriVision&rdquo;), Euro-Asia Investment &amp; Finance Corp. Limited, a company incorporated
under the laws of Hong Kong Special Administrative Region of Taiwan (&ldquo;Euro-Asia&rdquo;), being the owners of record of 52,336,000
shares of common stock of the Company, and the owners of record of all of the issued share capital of BriVision (the&nbsp;&ldquo;BriVision
Stock&rdquo;). Pursuant to the Share Exchange Agreement, upon surrender by the BriVision Shareholders and the cancellation by BriVision
of the certificates evidencing the BriVision Stock as registered in the name of each BriVision Shareholder, and pursuant to the
registration of the Company in the register of members maintained by BriVision as the new holder of the BriVision Stock and the
issuance of the certificates evidencing the aforementioned registration of the BriVision Stock in the name of the Company, the
Company should issue 52,936,583 shares (the&nbsp;&ldquo;Acquisition Stock&rdquo;) (subject to adjustment for fractionalized shares
as set forth below) of the Company&rsquo;s common stock to the BriVision Shareholders (or their designees), and 51,945,225 shares
of the Company&rsquo;s common stock owned by Euro-Asia should be cancelled and retired to treasury. The Acquisition Stock collectively
should represent 79.70% of the issued and outstanding common stock of the Company immediately after the Closing, in exchange for
the BriVision Stock, representing 100% of the issued share capital of BriVision.&nbsp;&nbsp;Because of the exchange of the BriVision
Stock for the Acquisition Stock (the&nbsp;&ldquo;Share Exchange&rdquo;), BriVision became a wholly owned subsidiary (the &ldquo;Subsidiary&rdquo;)
of the Company and there was a change of control of the Company following the closing.&nbsp;&nbsp;There were no warrants, options
or other equity instruments issued in connection with the share exchange agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because&nbsp;of the consummation of the
Share Exchange,&nbsp;BriVision&nbsp;is now our wholly owned subsidiary and its shareholders own approximately&nbsp;79.70% of our
issued and outstanding common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Following the Share Exchange, we have abandoned
our prior business plan and we are now pursuing&nbsp;BriVision&rsquo;s&nbsp;historical businesses and proposed businesses, which
focus on the development of new drugs and innovative medical devices to fulfill unmet medical needs.&nbsp;&nbsp;The business model
of the Company is to integrate research achievements from world-famous institutions, conduct clinical trials of translational medicine
for Proof of Concept (&ldquo;POC&rdquo;), out-license to international pharmaceutical companies, and exploit global markets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Accounting Treatment of the Reverse Merger</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For financial reporting purposes, the Share
Exchange represents a&nbsp;&ldquo;reverse merger&rdquo;&nbsp;rather than a business combination and&nbsp;BriVision&nbsp;is deemed
the accounting acquirer in the transaction. The&nbsp;Share Exchange is being accounted for as a reverse-merger and recapitalization.
BriVision&nbsp;is the acquirer for financial reporting purposes and the&nbsp;Company&nbsp;is the acquired company. Consequently,
the assets and liabilities and the operations reflected in the historical financial statements prior to the Share Exchange will
be those of&nbsp;BriVision&nbsp;and recorded at the historical cost basis of&nbsp;BriVision. In addition, the consolidated financial
statements after completion of the Share Exchange will include the assets and liabilities of the Company and BriVision, and the
historical operations of&nbsp;BriVision&nbsp;and operations of the Combined Company from the closing date of the Share Exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 57; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Basis of Presentation</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying audited financial statements
and related notes have been prepared in accordance with generally accepted accounting principles in the United States of America
(U.S. GAAP). This basis of accounting involves the application of accrual accounting. Consequently, revenues and gains are recognized
when earned, and expenses and losses are recognized when incurred. The Company&rsquo;s financial statements are expressed in U.S.
dollars. The condensed financial statements include all adjustments that, in the opinion of management, are necessary in order
not to make the financial statements misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain information and footnote disclosure
normally included in financial statements prepared in accordance with US GAAP have been condensed or omitted. The results of operations
for the periods ended June 30, 2016 are not necessarily indicative of the operating results for the full year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Use of Estimates</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of consolidated financial
statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts
of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements
and the amount of revenues and expenses during the reporting periods. Actual results could differ materially from those results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Forward Stock split</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 21, 2016, the Board of Directors
of the Company approved an amendment to Articles of Incorporation to effect a forward split at a ratio of 1 to 3:141 and increase
the number of our authorized shares of common stock, par value $0.001 per share, to 360,000,000, which was effective on April 8,
2016. The majority of the shareholders of the Company approved the amendment to Articles of Incorporation. See Note 4 for more
details.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Fair Value Measurements</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company applies the provisions of ASC
Subtopic 820-10,&nbsp;&ldquo;Fair Value Measurements&rdquo;,&nbsp;for fair value measurements of financial assets and financial
liabilities and for fair value measurements of nonfinancial items that are recognized or disclosed at fair value in the financial
statements.&nbsp;&nbsp;ASC 820 also establishes a framework for measuring fair value and expands disclosures about fair value measurements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fair value is defined as the price that
would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the
measurement date.&nbsp;&nbsp;When determining the fair value measurements for assets and liabilities, the Company considers the
principal or most advantageous market in which it would transact and it considers assumptions that market participants would use
when pricing the asset or liability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASC 820 establishes a fair value hierarchy
that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair
value. ASC 820 establishes three levels of inputs to measure fair value. The hierarchy gives the highest priority to unadjusted
quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements
involving significant unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&middot;&nbsp;</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&middot;&nbsp;</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs
that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial
instruments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&middot;&nbsp;&nbsp;</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Level 3 inputs to the valuation methodology are unobservable and significant to the fair value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There were no assets or liabilities measured
at fair value on a recurring basis subject to the disclosure requirements of ASC 820 as of&nbsp;September 30, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 58; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Cash and Cash Equivalents</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company considers highly liquid investments
with maturities of three months or less, when purchased, to be cash equivalents. As of June 30, 2016, the Company&rsquo;s cash
and cash equivalents amounted $84,904. As of September 30, 2015, the Company&rsquo;s cash and cash equivalents amounted $994,830.
All&nbsp;of the Company&rsquo;s cash deposits are held in a financial institution located in PRC where there is currently regulation
mandated on obligatory insurance of bank accounts. The Company believes this financial institution is of high credit quality.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Income Taxes</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for income taxes using
the asset and liability approach which allows the recognition and measurement of deferred tax assets to be based upon the likelihood
of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net
tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and
the amounts used for income tax purposes. A valuation allowance is provided for deferred tax assets if it is more likely than not
these items will expire before the Company is able to realize their benefits, or future deductibility is uncertain.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under ASC 740, a tax position is recognized
as a benefit only if it is&nbsp;&ldquo;more likely than not&rdquo;&nbsp;that the tax position would be sustained in a tax examination,
with a tax examination being presumed to occur. The evaluation of a tax position is a two-step process. The first step is to determine
whether it is more-likely-than-not that a tax position will be sustained upon examination, including the resolution of any related
appeals or litigations based on the technical merits of that position. The second step is to measure a tax position that meets
the more-likely-than-not threshold to determine the amount of benefits recognized in the financial statements. A tax position is
measured at the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. Tax
positions that previously failed to meet the more-likely-than-not recognition threshold should be recognized in the first subsequent
period in which the threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not criteria
should be de-recognized in the first subsequent financial reporting period in which the threshold is no longer satisfied. Penalties
and interest incurred related to underpayment of income tax are classified as income tax expense in the year incurred. No significant
penalty or interest relating to income taxes has been incurred during the period from July 21, 2015 (inception) to September 30,
2015. GAAP also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosures
and transition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2016 and September 30, 2015,
the Company&rsquo;s income tax expense amounted $836 and $0, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Recent Accounting Pronouncements</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From time to time, new accounting standards
issued by the Financial Accounting Standards Board (&ldquo;FASB&rdquo;) or other standard setting bodies are adopted by the Company
as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards
that are not yet effective will not have a material impact on its financial position or results of operations upon adoption. The
recent accounting standards are not expected to have a material impact on the consolidated financial statements upon adoption.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>3. COLLAOBRATIVE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B>On December
29, 2015, American BriVision Corporation entered into a Collaborative Agreement with BioLite Inc., a related party, pursuant to
which BioLite granted the Company sole licensing rights for drug and therapeutic use of five products: BLI-1005 CNS-Major Depressive
Disorder; BLI-1008 CNS-Attention Deficit Hyperactivity Disorder; BLI-1401-1 Anti-Tumor Combination Therapy-Solid Tumor with Anti-PD-1;
BLI-1401-2 Anti-Tumor Combination Therapy-Triple Negative Breast Cancer; and BLI-1501 Hematology-Chronic Lymphocytic Leukemia,
in USA and Canada. The total consideration of obtaining such grant would be $100,000,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the Collaborative Agreement, an upfront payment
of $3,500,000 (the &ldquo;Milestone Payment&rdquo;), which is 3.5% of total payments due under the Collaborative Agreement, was
to be paid by the Company upon signing of that agreement. On May 6, 2016, we and Biolite agreed to amend the Collaborative Agreement,
through entry into the Milestone Payment Agreement, whereby we have agreed to pay the Milestone Payment to BioLite $2,600,000 in
cash and $900,000 in newly issued shares of our common stock, at the price of $1.60 per share, for an aggregate number of 562,500
shares. The cash payment and shares issuance were completed in June 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 59; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This Collaborative Agreement shall, once signed by both Parties,
remain in effect for fifteen years as of the first commercial sales of the Product in the Territory and automatically renew for
five more years unless either party gives the other party six month written notice of termination prior to the expiration date
of the term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company determined to record the intangible assets and begin
to amortize once the first commercial sales was consummated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The process related to first commercial sales has not begun
as of June 30, 2016.&nbsp;The Company cannot&nbsp;make a reasonably reliable&nbsp;estimate&nbsp;of when the first commercial sales
would take place.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>4. RELATED PARTIES TRANSACTIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2016 and September 30, 2015,
the amount due to a related party, BioLite, Inc (&ldquo;Biolite&rdquo;) was $0 and $22,517 respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2016 and September 30, 2015,
the amount due to shareholder, YuanGene Corporation, was $0 and $46,586 respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>5. ACCOUNTS PAYABLE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2016 and September 30, 2015,
the amount Accounts Payable to LiteArt, Inc. was $11,446 and $0 respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>6. EQUTIY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During October 2015, $350,000 of subscription
receivable was fully collected from the shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 21, 2016, the Board of Directors
of the Company approved an amendment to Articles of Incorporation to effect a forward split at a ratio of 1 to 3:141 (the &ldquo;Forward&nbsp;Stock&nbsp;Split&rdquo;)
and increase the number of our authorized shares of common stock, par value $0.001 per share, to 360,000,000, which was effective
on April 8, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The majority of the shareholders of the
Company approved the amendment to Articles of Incorporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>7. COMMITMENTS AND CONTINGENCIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Capital Commitment</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 29, 2015, the Company entered
into the agreement with Biolite, a related party, that Biolite would grant the Company sole licensing rights of a series of technology
for 15 years. The total consideration of obtaining such grant would be $100,000,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 60; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Metu Brands, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Index to the Financial Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 88%">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 10%; text-decoration: none; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Page</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#s1fin_001">Report of Independent Registered Public Accounting Firm</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">F-10</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#s1fin_002"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Consolidated Balance Sheets at September 30, 2015 and 2014</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">F-11</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#s1fin_003"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Consolidated Statements of Operations for the years ended September 30, 2015 and 2014</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">F-12</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#s1fin_004"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Consolidated Statements of Changes in Stockholders' Equity (Deficit) for the years ended September 30, 2015 and 2014</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">F-13</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#s1fin_005"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Consolidated Statements of Cash Flows for the years ended September 30, 2015 and 2014</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">F-14</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#s1fin_006"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Notes to Consolidated Financial Statements</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">F-15</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 61; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Scrudato &amp; Co., PA</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>CERTIFIED PUBLIC ACCOUNTING FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="s1fin_001"></A>REPORT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To the Board of Directors and Stockholders of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Metu Brands, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(formerly Ecology Coatings, Inc.)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have audited the accompanying balance sheet of Metu Brands,
Inc. (formerly Ecology Coatings, Inc.) as of September 30, 2015 and 2014 and the related consolidated statements of operations,
changes in stockholders&rsquo; deficit and cash flows for the year ended September 30, 2015 and the period September 19, 2014 through
September 30, 2014(post bankruptcy), the period October 1, 2013 through September 18, 2014. These financial statements are the
responsibility of the Company management. Our responsibility is to express an opinion on these financial statements based on our
audit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We conducted our audit in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain
reasonable assurance about whether the consolidated financial statements are free of material misstatement. The Company is not
required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included
consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the
circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company&rsquo;s internal control over
financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting
the amounts and disclosures in the consolidated financial statements, assessing the accounting principles used and significant
estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audit provide
a reasonable basis for our opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In our opinion, the financial statements referred to above present
fairly, in all material respects, the financial position of Metu Brands, Inc. (formerly Ecology Coatings, Inc.) &nbsp;as of September
30, 2015 and 2014, and the results of their operations and their cash flows for the year ended September 30, 2015 and the period
September 19, 2014 through September 30, 2014(post bankruptcy), the period October 1, 2013 through September 18, 2014 in conformity
with accounting principles generally accepted in the United States of America.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The accompanying financial statements have been prepared assuming
that Metu Brands, Inc. (formerly Ecology Coatings, Inc.) &nbsp;will continue as a going concern. As more fully described in Note
9, the Company had an accumulated deficit at September 30, 2015, a net loss and net cash used in operating activities for the fiscal
year then ended. These conditions raise substantial doubt about the ability of the Company to continue as a going concern. Management&rsquo;s
plans in regards to these matters are also described in Note 9. The financial statements do not include any adjustments to reflect
the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities
that may result from the outcome of this uncertainty.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">/s/ Scrudato &amp; Co., PA</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Califon, New Jersey</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">October 31, 2015</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 62; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="s1fin_002"></A>METU BRANDS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Formerly Ecology Coatings, Inc.)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSOLIDATED BALANCE SHEETS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SEPTEMBER 30, 2015 AND 2014</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Audited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; padding-bottom: 1pt; border-bottom: Black 1pt solid">9/30/2015</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; padding-bottom: 1pt; border-bottom: Black 1pt solid">9/30/2014</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 70%; padding-left: 9pt">Cash</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">3,360</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">0</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt; padding-left: 9pt">Inventory</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">274</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">795</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.25in">Total Current Assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,634</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">795</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Property, plant and equipment, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Intangible assets, net</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">64,594</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">64,594</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; padding-left: 0.25in">Total Assets</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">68,228</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">65,389</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Liabilities and Equity (Deficit)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Accrued expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,150</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,030</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Note payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Related party note payable</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">9,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">9,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt">Total Liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">39,150</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,030</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Commitments and Contingencies (Note 5)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.1in; padding-left: 16.2pt">Preferred stock 10,000,000 authorized at $0.001 par value<BR> shares; issued and outstanding 271 and 271 at September 30,<BR> 2015 and September 30, 2014</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.1in; padding-left: 16.2pt">Common stock 90,000,000 authorized at $0.001 par value;<BR> shares issued and outstanding 60,011,144 and 11,144 at<BR> September 30, 2015 and September 30, 2014</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">60,011</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.1in; padding-left: 16.2pt">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,582</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">54,582</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -0.1in; padding-left: 16.2pt">Retained earnings</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(55,516</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(23,235</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total equity (deficit)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">29,078</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">31,359</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Total liabilities and equity (deficit)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">68,228</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">65,389</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part
of these consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 63; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="s1fin_003"></A>METU BRANDS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(Formerly Ecology Coatings, Inc.)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>STATEMENTS OF OPERATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>FOR THE YEARS ENDED SEPTEMBER 30, 2015
AND 2014</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(Audited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">For the<BR> year ended<BR> September<BR> 30, 2015</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">For the<BR> period<BR> from<BR>
September<BR> 19, 2014<BR> through<BR> September<BR> 30, 2014</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">For the<BR> period<BR> from<BR> October 1,<BR> 2013<BR> through<BR> September<BR> 18, 2014</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 55%">Revenues</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">3,360</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">0</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">0</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt">Cost of sales</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">521</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Gross profit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,839</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Operating expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">35,120</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">23,235</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">70</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Net income (loss) from operations</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(32,281</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(23,235</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(70</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Other income (expense)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Interest expense</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total Other Income (Expense)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Income (loss) from continuing operations before income taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(32,281</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(23,235</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(70</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Income taxes</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Net income (loss)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(32,281</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(23,235</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(70</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Basic and Diluted income per share</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.01</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(2.08</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.01</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt">Weighted average number of shares outstanding - basic and diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">5,000,929</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">11,144</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">11,144</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part
of these consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 64; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="s1fin_004"></A>METU BRANDS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Formerly Ecology Coatings, Inc.)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSOLIDATED STATEMENTS OF CHANGES IN
STOCKHOLDERS&rsquo; (DEFICIENCY) FOR THE YEARS ENDED SEPTEMBER 30, 2015 AND 2014</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Audited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center">Common stock</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center">Preferred stock</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Additional<BR> paid-in</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Accumulated</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">Shares</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">Amount</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">Shares</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">Amount</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">Capital</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">Deficit</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">Total</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 23%; padding-bottom: 1pt">Balance at October 1, 2013</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; border-bottom: Black 1pt solid; text-align: right">11,144</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="width: 8%; border-bottom: Black 1pt solid; text-align: right">11</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; border-bottom: Black 1pt solid; text-align: right">271</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="width: 8%; border-bottom: Black 1pt solid; text-align: right">1</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="width: 8%; border-bottom: Black 1pt solid; text-align: right">28,670,072</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="width: 8%; border-bottom: Black 1pt solid; text-align: right">(30,550,258</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="width: 8%; border-bottom: Black 1pt solid; text-align: right">(1,880,174</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Fresh start adjustments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(30,495,734</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,550,328</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">54,594</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Reorganization adjustments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,880,244</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,880,244</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1pt">Net income for the period ended September 18, 2014</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(70</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(70</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1pt">Balance at September 18, 2014</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">11,144</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">11</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">271</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">54,582</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">54,594</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">(POST BANKRUPTCY)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1pt">Net income for the period ended September 30, 2014</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(23,235</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(23,235</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1pt">Balance at September 30, 2014</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">11,144</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">11</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">271</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">54,582</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(23,235</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">31,359</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Stock issued as compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Bankruptcy shares issued</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(30,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Net income for the year ended September 30, 2015</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(32,281</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(32,281</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">Balance at September 30, 2015</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">60,011,144</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">60,011</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">271</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">24,582</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(55,516</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">29,078</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part
of these consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 65; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="s1fin_005"></A><B>METU BRANDS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Formerly Ecology Coatings, Inc.)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSOLIDATED STATEMENTS OF CASH FLOWS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FOR THE YEARS ENDED SEPTEMBER 30, 2015
AND 2014</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Audited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">For the<BR> year<BR> ended<BR> September<BR> 30, 2015</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">For the<BR> period<BR> from<BR> September<BR> 19, 2014<BR> through<BR> September<BR> 30, 2014</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">For the<BR> period from<BR> October 1,<BR> 2013<BR>
through<BR> September<BR> 19, 2014</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD COLSPAN="13">Cash flows from operating activities:</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 55%; text-align: left">&nbsp;&nbsp;Net income (loss) from continuing operations</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">(32,281</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">(23,235</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">(70</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD COLSPAN="13">Adjustments to reconcile net loss to net cash used by operating activities:</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;&nbsp;Stock issued as compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;&nbsp;(Increase) decrease in accounts receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,238</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;&nbsp;(Increase) decrease in inventory</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">521</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(795</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">&nbsp;&nbsp;Increase (decrease) in accrued expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,120</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">17,235</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Net cash used in operating activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,360</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(6,795</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,168</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD COLSPAN="13">Cash flows from investing activities:</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">&nbsp;&nbsp;Acquisition of intangible assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(64,594</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Net cash provided (used) by investing activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(64,594</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD COLSPAN="13">Cash flows from financing activities:</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;&nbsp;Fresh start adjustment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,389</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;&nbsp;Capital injection to bankruptcy trustee</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;&nbsp;Proceeds from related party</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">&nbsp;&nbsp;Proceeds from note payable</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">7,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Net cash provided (used) by financing activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">71,389</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Net increase (decrease) in cash</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,360</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,168</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt">Cash, beginning of period</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">618</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">Cash, end of period</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">3,360</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,786</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD COLSPAN="13">Supplemental disclosure of cash flow information:</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;&nbsp;Interest paid</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;&nbsp;Income taxes paid</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD COLSPAN="13">Supplemental disclosure of non-cash activities:</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;&nbsp;Fresh start adjustment</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">30,550,328</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;&nbsp;Bankruptcy reorganization</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,880,244</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See report of independent registered public
accounting firm and notes to consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 66; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="s1fin_006"></A>METU BRANDS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>FOR THE YEARS ENDED SEPTEMBER 30, 2015
AND 2013</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Note 1 &mdash; Summary of Significant Accounting Policies</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Description of the Company</I></B>. &nbsp;&nbsp;We were
originally incorporated on March 12, 1990 in California (&ldquo;Ecology-CA&rdquo;). &nbsp;Our current entity was incorporated in
Nevada on February 6, 2002 as OCIS Corp. (&ldquo;OCIS&rdquo;). &nbsp;OCIS completed a merger with Ecology-CA on July 26, 2007 (the
&ldquo;Merger&rdquo;). In the Merger, OCIS changed its name from OCIS Corporation to Ecology Coatings, Inc. &nbsp;The Company filed
for Chapter 7 bankruptcy protection on May 15, 2013 and subsequently the corporate shell emerged as its only unencumbered asset
on September 19, 2014 using &quot;fresh start&quot; accounting under section 852-10-45-17 as of date of sale corporate shell to
reflect intangible assets sale through section 363. On that same day the Company acquired the assets of Metu Brands, Inc including
the trade name &quot;Metu&quot; in exchange for cash and a note. On April 28, 2015 the Company amended its articles of incorporation
to change its name to Metu Brands, Inc. Any business description below and all reporting results of the operating results reported
in this filing for the fiscal period ending September 30, 2014 are post &quot;fresh start&quot; activity and not comparable to
prior results. Post bankruptcy the company has been operating a web site for the sale of women's apparel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Reclassifications</I></B>. &nbsp;&nbsp;Reclassifications
have been made to the prior year financial statements to conform with the current year presentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Basis of Preparation</I></B>. The financial statements
of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America and
are presented in US dollars.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Principles of Consolidation</I></B>. &nbsp;&nbsp;The consolidated
financial statements include all of our accounts and the accounts of our wholly owned subsidiary Ecology-CA. &nbsp;All significant
intercompany transactions have been eliminated in consolidation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Use of Estimates</U></B>. &nbsp;&nbsp;The preparation
of financial statements in conformity with accounting principles generally accepted in the United States of America requires management
to make estimates and assumptions that affect the amounts of assets and liabilities at the date of the financial statements, and
the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Revenue Recognition</U></B>. &nbsp;&nbsp;The Company applies
paragraph 605-10-S99-1 of the FASB Accounting Standards Codification for revenue recognition. The Company recognizes revenue when
it is realized or realizable and earned. The Company considers revenue realized or realizable and earned when all of the following
criteria are met: (i) persuasive evidence of an arrangement exists, (ii) the sales price is fixed or determinable, (iii) collectability
is reasonably assured and (iv) goods have been shipped and/or services rendered. &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Loss Per Share</I></B>. Basic loss per share is computed
by dividing the net loss available to common shareholders by the weighted average number of shares of common stock outstanding
during the period. &nbsp;Diluted loss per share is computed by dividing the net loss available to common shareholders by the weighted
average number of shares of common stock and potentially dilutive securities outstanding during the period. &nbsp;Potentially dilutive
shares consist of the incremental common shares issuable upon the exercise of stock options and warrants and the conversion of
convertible debt and convertible preferred stock. Potentially dilutive shares are excluded from the weighted average number of
shares if their effect is anti-dilutive. &nbsp;None of the stock options or warrants outstanding or stock associated with the convertible
debt or with the convertible preferred shares during each of the periods presented was included in the computation of diluted loss
per share as they were anti-dilutive. &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Property and Equipment</I></B>. &nbsp;&nbsp;Property and
equipment is stated at cost less accumulated depreciation. &nbsp;Depreciation is recorded using the straight-line method over the
following useful lives:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 65%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.15in">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 67%; text-align: left">Computer equipment</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 32%; text-align: center">3-10 years</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Furniture and fixtures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">3-7 years</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Test equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">5-7 years</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Signs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7 years</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Software</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">3 years</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Marketing and Promotional Video</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">3 years</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 67; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Repairs and maintenance costs are charged to operations as incurred.
Betterments or renewals are capitalized as incurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Patents</I></B>. &nbsp;&nbsp;It is our policy to capitalize
costs associated with securing a patent. &nbsp;Costs consist of legal and filing fees. &nbsp;Once a patent is issued, it will be
amortized on a straight-line basis over its estimated useful life. &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Long-Lived Assets</I></B>. We review long-lived assets
for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.
&nbsp;Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the undiscounted
future net cash flows expected to be generated by the asset. &nbsp;If such assets are considered to be impaired, the impairment
recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Stock-Based Compensation</I></B>. &nbsp;&nbsp;Employee
and director stock-based compensation expense is measured utilizing the fair-value method with expense charged to earnings over
the vesting period on a straight-line basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We account for stock options granted to non-employees under
the fair-value method with stock-based compensation expense being charged to earnings on the earlier of the date services are performed
or a performance commitment exists.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Recent Accounting Pronouncements</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have reviewed all Accounting Standards Updates issued by
the Financial Accounting Standards Board since we last issued financial statements and have determined none of them would have
a material effect on the consolidated financial statements upon adoption.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 68; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Note 2 &mdash; &quot;Fresh Start&quot; Accounting</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">METU BRANDS, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Formerly Ecology Coatings, Inc.)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">FRESH START ADJUSTMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">9/19/2014</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">Dr(CR)<BR>
Reorganization<BR>
Adjustments</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">Dr(CR) Fresh Start<BR>
Adjustments</TD><TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">9/19/2014</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">Assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 38%">&nbsp;&nbsp;Cash</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">548</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(548</FONT></TD><TD STYLE="width: 4%; text-align: left">) (1)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 4%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">0</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">&nbsp;&nbsp;Accounts receivable</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,238</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(1,238</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left">) (1)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;&nbsp;&nbsp;&nbsp;Total Current Assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,786</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;&nbsp;Property, plant and equipment, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">37,249</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(37,249</FONT></TD><TD STYLE="text-align: left">) (1)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">&nbsp;&nbsp;Intangible assets, net</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">192,864</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(192,864</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left">) (1)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">54,594</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2)</FONT></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">54,594</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">&nbsp;&nbsp;&nbsp;&nbsp;Total Assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">231,899</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">54,594</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Liabilities and Equity (Deficit) </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Total liabilities subject to compromise</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,112,143</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2,112,143 </FONT></TD><TD STYLE="text-align: left">(1)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Commitments and Contingencies (Note 5)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Metu Brands, Inc. ("MTOO") shareholders' deficit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;&nbsp;Predecessor Preferred Stock 10,000,000 authorized at $0.001 par value shares issued and outstanding 271 at September 19, 2014</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(1
                                         </FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3)</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;&nbsp;Successor Preferred Stock 10,000,000 authorized at $0.001 par value; shares issued and outstanding 54,593,032 at September 19, 2014</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1
                                         </FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2)</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;&nbsp;Predecessor/Successor Common Stock 90,000,000 authorized at $0.001 par value; shares issued and outstanding 54,593,032 at September 19, 2014</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">54,593</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">54,593</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;&nbsp;Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">28,615,490</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(1,880,244</FONT></TD><TD STYLE="text-align: left">) (1)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">30,495,734</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3)</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">&nbsp;&nbsp;Retained earnings</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(30,550,328</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(30,550,328)</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4)</FONT></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">&nbsp;&nbsp;&nbsp;&nbsp;Total equity (deficit)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,880,244</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">54,594</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and equity (deficit)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">231,899</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">54,594</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(1) Reorganization adjustments reflect
the transfer of $2,112,143 of liabilities subject to compromise and assets to the bankruptcy trustee in accordance with the plan
of bankruptcy provisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(2) Fresh-start adjustments under section
852-10-45-17 as of the date of sale of the corporate shell to reflect intangible assets sale through section 363 of the bankruptcy
code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(3) Fresh-start adjustments under ASC 852-10-45-17
to predecessor preferred stock and APIC reflect the cancellation of the predecessor&rsquo;s preferred stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(4) Fresh-start adjustment to retained
earnings (accumulated deficit) resets accumulated deficit to zero.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(5) $20,000 was paid to the trustee by
Shulamit Lazar for the subsequent issue of 30,000,000 common shares and $5,000 was paid to the trustee by Innovation Consulting
LLC for the purchase of 271 preferred shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 69; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Note 3 &mdash; Related Party Transactions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have borrowed funds for our operations from certain major
stockholders, directors and officers as disclosed below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have an unsecured demand note payable due of $9,000 to Shulamit
Lazar, our sole officer and director for funds advanced the Company through the bankruptcy process. This is unsecured with a zero
percent interest rate and is payable on demand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As part of the bankruptcy sale Shulamit Lazar was awarded all
271 of the convertible preferred shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shulamit Lazar received compensation of 30,000,000 shares valued
at $30,000 during the year ended September 30, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Note 4 &mdash; Notes Payable</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have the following notes as of September 30, 2015 and 2014:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Post bankruptcy the Company acquired the assets of Metu Brands
Inc. (a ready to operate web site business). &nbsp;In addition to a $3,000 deposit the Company signed a note payable for $7,000.
This note was due September 24, 2014 and carries a zero percent interest rate. This note is note in default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Note 5 &mdash; Commitments and Contingencies</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Contingencies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">All contingencies have been settled through our bankruptcy petition
in September 2014 subsequent to this financial reporting period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Lease Commitments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Note 6 &mdash; Equity</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Common Stock</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of September 30, 2014 the Company had 11,144 common shares
issued and outstanding and 90,000,000 shares of Common Stock authorized par value $0.001 and the holders of the Company's common
stock are entitled to one vote per each share of common stock held. Additionally as part of the bankruptcy sale the Company has
had a reverse stock split of &nbsp;5,000 for 1 on August 13, 2014 which has been reflected retroactively in these financial statements.
30,000,000 shares of common stock was issued to Shulamit Lazar for her initial $20,000 deposit to purchase the company. The Company
also issued 30,000,000 shares of common stock in the year ended September 30, 2015 to a related party (Shulamit Lazar) for services
valued at $30,000. As of September 30, 2015 the company had 60,011,144 common shares outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Preferred Stock</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of September 30, 2015 the Company had 10,000,000 shares of
Preferred Stock authorized par value $.001 and the holders of the Company's Preferred Stock can convert each share into 100,000
shares of voting Common Stock. Additionally each Preferred Share is entitled to the voting rights 100,000 common stock shares.
Subsequent to the date of these financial statements but prior to issuance the preferred shares have been amended to carry voting
and conversion rights equal to 20,000 common shares each. The Company had 271 shares issued during bankruptcy to Innovation Consulting
LLC for $5,000 and 271 shares were issued and outstanding as of September 30, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 70; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Note 7 &mdash; Stock Options</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There were no stock options issued during the fiscal years ended
September 30 2015 and 2014. &nbsp;As part of our bankruptcy agreement approved on September 19, 2014 all common conversion rights
of any kind including the equity compensation plan without limitation , warrants, options and convertible notes were cancelled
and extinguished for the current and prior fiscal years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Note 8 &mdash; Income Taxes</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of September 30, 2015, the Company had approximately $85,516
in post bankruptcy net operating loss carry forwards for federal income tax purposes which expire between 2015 and 2033. &nbsp;Generally,
these can be carried forward and applied against future taxable income at the tax rate applicable at that time. We are currently
using a 15% effective tax rate for our projected available net operating loss carry-forward. However, as a result of potential
stock offerings and stock issuance in connection with potential acquisitions, as well as the possibility of the Company not realizing
its business plan objectives and having future taxable income to offset, the Company&rsquo;s use of these NOLs may be limited under
the provisions of Section 382 of the Internal Revenue Code of 1986, as amended. &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Components of deferred tax assets and (liabilities) are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 85%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2015</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2014</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 70%; text-align: left">Net operating loss carry forwards valuation available</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">85,516</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">23,235</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Valuation Allowances</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(29,075</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,485</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Deferred Tax Asset</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">29,075</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,485</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Net Deferred Tax Asset</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-0-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-0-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In accordance with FASB ASC 740 &ldquo;Income Taxes&rdquo;,
valuation allowances are provided against deferred tax assets, if based on the weight of available evidence, some or all of the
deferred tax assets may or will not be realized. The Company has evaluated its ability to realize some or all of the deferred tax
assets on its balance sheet for the coming year and has established a valuation allowance in the amount of $29,075 at September
30, 2015 During the period ended September 30, 2015 the company did not utilize any of its NOL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Note 9 &ndash; Going Concern</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The accompanying financial statements have been prepared assuming
that the Company will continue as a going concern. Currently, the Company has limited post bankruptcy operations and a working
capital deficit as of September 30, 2015. These factors raise substantial doubt about the Company&rsquo;s ability to continue as
a going concern. Management believes that the Company&rsquo;s capital requirements will depend on many factors including the success
of the Company&rsquo;s development efforts and its efforts to raise capital. Management also believes the Company needs to raise
additional capital for working capital purposes. There is no assurance that such financing will be available in the future. &nbsp;&nbsp;The
conditions described above raise substantial doubt about our ability to continue as a going concern. The financial statements of
the Company do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts
and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 71; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Note 10 - Acquisitions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On September 25, 2014 the company entered into an agreement
to buy the ready to operate business assets of Metu Brands Inc. The cost of this acquisition was $10,000 which was allocated $795
to inventory and $9,205 to the intangible assets of the &quot;MeTu&quot; trade name and web site MeTuBoutique.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Note 11 - Net Income (Loss) Per Share</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company reports basic and diluted earnings per share (EPS)
according to the provisions of ASC Topic 260, which requires the presentation of basic EPS and, for companies with complex capital
structures, diluted EPS. Basic EPS excludes dilution and is computed by dividing net income (loss) available to common stockholders
by the weighted average number of common shares outstanding during the period. Diluted EPS is computed by dividing net income (loss)
available to common stockholders, adjusted by other changes in income or loss that would result from the assumed conversion of
those potential common shares, by the weighted number of common shares and common share equivalents (unless their effect is anti-dilutive)
outstanding. Common stock equivalents are not included in the computation of diluted earnings per share when the Company reports
a loss because to do so would be anti-dilutive. Thus, these equivalents are not included in the calculation of diluted loss per
share, resulting in basic and diluted loss per share being equal. The following is a reconciliation of the computation for basic
and diluted EPS for the years ended September 30, 2015 and 2014:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 85%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2015</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2014</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 70%; text-align: left; padding-bottom: 1pt">Net (Loss)</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="width: 12%; border-bottom: Black 1pt solid; text-align: right">(32,281</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="width: 12%; border-bottom: Black 1pt solid; text-align: right">(23,235</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD COLSPAN="9">Weighted-average common shares outstanding basic</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Weighted-average common stock equivalents</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,000,929</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,144</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;&nbsp;Stock options</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;&nbsp;Warrants</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">&nbsp;&nbsp;Preferred stock</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">27,100,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">27,100,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Weighted-average common shares outstanding - basic and diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">3,303,773</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">10,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Note 11 - Subsequent Events</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have evaluated subsequent events and transactions that occurred
through the date and time our financial statements were issued for potential recognition or disclosure in the accompanying financial
statements. Other than the change in preferred shares rights itemized in note 6 above, we did not identify any events or transactions
that should be recognized or disclosed in the accompanying financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 72; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><B>32,409,505 SHARES
OF COMMON STOCK</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><B>American BriVision
(Holding) Corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">The date of this
prospectus is September 13, 2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 73 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><B><A NAME="s1_020"></A>PART II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><B>INFORMATION
NOT REQUIRED IN PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><A NAME="s1_021"></A><B>ITEM 13.&nbsp;&nbsp;OTHER EXPENSES
OF ISSUANCE AND DISTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
following table sets forth estimated expenses we expect to incur in connection with the sale of the shares being registered. All
such expenses are estimated except for the SEC and FINRA registration fees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 87%; text-align: left">SEC registration fee</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">6,528</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Printing expenses*</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3,550</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Fee and expenses of counsel for the Company*</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Fee and expenses of accountants for Company**</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Miscellaneous*</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Total**</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">* Estimated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">** To be provided by amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><A NAME="s1_022"></A>ITEM 14.&nbsp;&nbsp;INDEMNIFICATION
OF DIRECTORS AND OFFICERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Our officers
and directors are indemnified as provided by the Nevada Revised Statutes (&ldquo;NRS&rdquo;) and our bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Under the NRS,
director immunity from liability to a company or its shareholders for monetary liabilities applies automatically unless it is
specifically limited by a company&rsquo;s articles of incorporation that is not the case with our articles of incorporation. Excepted
from that immunity are:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">(1)&nbsp;&nbsp;a
willful failure to deal fairly with the company or its shareholders in connection with a matter in which the director has a material
conflict of interest;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">(2)&nbsp;&nbsp;a
violation of criminal law (unless the director had reasonable cause to believe that his or her conduct was lawful or no reasonable
cause to believe that his or her conduct was unlawful);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">(3)&nbsp;&nbsp;a
transaction from which the director derived an improper personal profit; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">(4)&nbsp;&nbsp;willful
misconduct.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white">Our
Articles of Incorporation permits us to indemnify our officers and directors to the fullest extent authorized or permitted by
law in connection with any proceeding arising by reason of the fact any person is or was our officer or director. Notwithstanding
this indemnity, a director shall be liable to the extent provided by law for any liability incurred by him by his own fraud or
willful default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Our bylaws provide
that we will indemnify our directors and officers to the fullest extent not prohibited by Nevada law. Our bylaws provide that
we will advance all expenses incurred to any person who was or is a party or is threatened to be made a party to any threatened,
pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact
that he is or was our director or officer, or is or was serving at our request as a director or executive officer of another company,
partnership, joint venture, trust or other enterprise, prior to the final disposition of the proceeding, promptly following request.
This advance of expenses is to be made upon receipt of an undertaking by or on behalf of such person to repay said amounts should
it be ultimately determined that the person was not entitled to be indemnified under our bylaws or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>


<!-- Field: Page; Sequence: 74; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><A NAME="s1_023"></A>ITEM 15.&nbsp;&nbsp;RECENT
SALES OF UNREGISTERED SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Recent Sales of Unregistered Equity Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As more fully described above, in connection with the Exchange
Agreement, the Company issued a total of&nbsp;52,936,583&nbsp;shares of our common stock to&nbsp;BriVision&rsquo;s&nbsp;shareholders.
Reference is made to the disclosures set forth under Item 2.01 of this Form 8-K, which disclosures are incorporated herein by
reference. The issuance of the common stock to the&nbsp;BriVision&rsquo;s shareholders pursuant to the Exchange Agreement was
exempt from registration in reliance upon Section 4(a)(2) of the Securities Act of 1933, as amended (the&nbsp;&ldquo;Securities
Act&rdquo;) and Regulation S of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In September 2015, 30,000,000 shares of common stock was issued
to Shulamit Lazar &ndash; the Company&rsquo;s former CEO - for her initial $20,000 deposit to purchase the company; she also received
another 30,000,000 shares in September 2015 pursuant to an employment agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Innovation Consulting LLC paid $5,000 for 271 shares of preferred
stock. The shares converted into 5,420,000 shares of common stocks on November 30, 2015. These shares were sold to Euro-Asia Investment
&amp; Finance Corp. Limited on December 18, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On May 6, 2016, we issued an aggregate number of 562,500 shares
to BioLite pursuant to certain Milestone Payment Agreement. The issuance of the common stock to BioLite was exempt from registration
in reliance upon Section 4(a)(2) of the Securities Act and Regulation S of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On August 26, 2016, we issued an aggregate number of 1,468,750
newly issued restricted shares to BioLite pursuant to certain Stock Purchase Agreement. The issuance of the common stock to BioLite
was exempt from registration in reliance upon Section 4(a)(2) of the Securities Act and Regulation S of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Repurchases of Equity Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have not repurchased&nbsp;any equity securities during the
periods covered by this Report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 75; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><A NAME="s1_024"></A>ITEM 16.&nbsp; EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(a). Exhibits</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following exhibits are filed as part of this registration
statement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 10%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit&nbsp;No.</B></FONT></TD>
    <TD NOWRAP STYLE="width: 1%">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 89%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share Exchange Agreement, dated February 8,
    2016 (1)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Articles of Incorporation of the Company (2)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bylaws of the Company (3)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">3.3</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Certificate of Amendment to Articles of Incorporation
    filed on March 21, 2016 (4)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Amendment to Articles of Incorporation
    filed on December 21, 2016 +</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion of Legal Opinion of Hunter Taubman Fischer
    &amp; Li, LLC **</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collaboration Agreement dated December 29, 2015
    (5)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collaborative Agreement and Milestone Payment
    Agreement dated May 6, 2016 (6)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;Subsidiaries of the Registrant +</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;Consent of AWC CPA +</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;Consent of Hunter Taubman Fischer &amp;
    Li, LLC (included in Exhibit 5.1)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">101.INS</TD>
    <TD NOWRAP>***</TD>
    <TD>&nbsp;&nbsp;XBRL Instance Document</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">101.SCH</TD>
    <TD NOWRAP>***</TD>
    <TD>&nbsp;XBRL Taxonomy Extension Schema Document&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">101.CAL</TD>
    <TD NOWRAP>***</TD>
    <TD>&nbsp;XBRL Taxonomy Extension Calculation Linkbase Document&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">101.DEF</TD>
    <TD NOWRAP>***</TD>
    <TD>&nbsp;XBRL Taxonomy Extension Definition Linkbase Document&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">101.LAB</TD>
    <TD NOWRAP>***</TD>
    <TD>&nbsp;XBRL Taxonomy Extension Label Linkbase Document XBRL&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">101.PRE</TD>
    <TD NOWRAP>***</TD>
    <TD>&nbsp;Taxonomy Extension Presentation Linkbase Document&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="width: 94%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">+</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed herewith</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To be filed by amendment</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>***</TD>
    <TD>XBRL (Extensible Business Reporting Language) information is furnished and not filed herewith, is not a part of a
    registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, as amended, is deemed
    not filed for purposes of section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to
    liability under these sections.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 10.1 the
    Company&rsquo;s Current Report of Form 8-K, filed on February 16, 2016.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 3.01 to
    the Company&rsquo;s Form SB-2 filed on</FONT> June 28, 2002</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 3.02 to
    the Company&rsquo;s Form SB-2, filed on June 28, 2002</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 4.1 to
    the Company&rsquo;s Current Report on Form 8-K, filed on March 28, 2016.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 10.2 the
    Company&rsquo;s Current Report of Form 8-K, filed on February 16, 2016.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 99.1 to
    the Company&rsquo;s Current Report on Form 8-K, filed on May 10, 2016.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><A NAME="s1_025"></A>ITEM 17.&nbsp;&nbsp;UNDERTAKINGS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 49.5pt">The undersigned registrant hereby undertakes
to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 49.5pt">(1) File, during any period in which offers
or sales are being made, a post-effective amendment to this registration statement to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 69.3pt">(i) Include any prospectus required by
Section 10(a)(3) of the Securities Act of 1933, as amended (the &quot;Securities Act&quot;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 69.3pt">(ii) Reflect in the prospectus any facts
or events which, individually or together, represent a fundamental change in the information in the registration statement. Notwithstanding
the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of the securities offered would
not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be
reflected in the form of a prospectus filed with the Commission pursuant to Rule 424(b) under the Securities Act if, in the aggregate,
the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the &quot;Calculation
of Registration Fee&quot; table in the effective registration statement, and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 76; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 69.3pt">(iii) Include any additional or changed
material information on the plan of distribution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 49.5pt">(2) For determining liability under the
Securities Act, treat each post-effective amendment as a new registration statement of the securities offered, and the offering
of the securities at that time to be the initial bona fide offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 49.5pt">(3) File a post-effective amendment to
remove from registration any of the securities that remain unsold at the end of the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 49.5pt">(4) Insofar as indemnification for liabilities
arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to
the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission
such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 49.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 49.5pt">(5) Each prospectus filed pursuant to
Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B
or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement
as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or
prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into
the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract
of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that
was part of the registration statement or made in any such document immediately prior to such date of first use.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 49.5pt">In the event that a claim for indemnification
against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling
person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or
controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel
the matter has been settled by controlling precedent, submit to a court of&nbsp; appropriate jurisdiction the question whether
such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication
of such issue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 49.5pt">&nbsp;</P>


<!-- Field: Page; Sequence: 77; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt">Pursuant to the requirements of the Securities
Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing
on Form S-1 and has duly caused this Form S-1 Registration Statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in the City of Taipei, Taiwan, on September 13, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">American&nbsp;BriVision&nbsp;(Holding)
    Corporation</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 46%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Eugene
    Jiang&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eugene Jiang</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer, Chief <BR>
Financial Officer
    and Chairman</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt">Pursuant to the requirements of the Securities
Act of 1933, this Registration Statement has been signed below by the following persons in the capacities and on the dates indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR>
    <TD STYLE="vertical-align: bottom; width: 28%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: black 0.75pt solid"><B>Signature</B></P></TD>
    <TD STYLE="vertical-align: top; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 40%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: black 0.75pt solid"><B>Title</B></P></TD>
    <TD STYLE="vertical-align: top; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 28%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: black 0.75pt solid"><B>Date</B></P></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Eugene Jiang</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E Eugene Jiang
    </FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    13, 2016</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive
    Officer and Chairman, <BR>
Director, Secretary, Treasurer</FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">((Principal Executive Officer)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Kira Huang</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kira Huang</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    13, 2016</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial
    Officer, Principal <BR>
Accounting Officer</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 78 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><B>INDEX TO EXHIBITS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following exhibits are filed as part of this registration
statement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 10%; border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Exhibit&nbsp;No.</B></FONT></TD>
    <TD NOWRAP STYLE="width: 1%">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 89%; border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Share Exchange Agreement, dated February 8,
    2016 (1)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">3.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Articles of Incorporation of the Company (2)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">3.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Bylaws of the Company (3)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">3.3</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Certificate of Amendment to Articles of Incorporation
    filed on March 21, 2016 (4)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">3.4</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Certificate of Amendment to Articles of Incorporation
    filed on December 21, 2016 +</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">5.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Opinion of Legal Opinion of Hunter Taubman Fischer
    &amp; Li, LLC **</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">10.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Collaboration Agreement dated December 29, 2015
    (5)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">10.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Collaborative Agreement and Milestone Payment
    Agreement dated May 6, 2016 (6)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">21.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;Subsidiaries of the Registrant +</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">23.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;Consent of AWC CPA +</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">23.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;Consent of Hunter Taubman Fischer &amp;
    Li, LLC (included in Exhibit 5.1)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">101.INS***</TD>
    <TD NOWRAP></TD>
    <TD>&nbsp;&nbsp;XBRL Instance Document</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">101.SCH***</TD>
    <TD NOWRAP></TD>
    <TD>&nbsp;XBRL Taxonomy Extension Schema Document&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">101.CAL***</TD>
    <TD NOWRAP></TD>
    <TD>&nbsp;XBRL Taxonomy Extension Calculation Linkbase Document&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">101.DEF***</TD>
    <TD NOWRAP></TD>
    <TD>&nbsp;XBRL Taxonomy Extension Definition Linkbase Document&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">101.LAB***</TD>
    <TD NOWRAP></TD>
    <TD>&nbsp;XBRL Taxonomy Extension Label Linkbase Document XBRL&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">101.PRE***</TD>
    <TD NOWRAP></TD>
    <TD>&nbsp;Taxonomy Extension Presentation Linkbase Document&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">*</FONT></TD>
    <TD STYLE="width: 94%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Previously filed</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">+</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Filed herewith</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">**</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">To be filed by amendment</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>***</TD>
    <TD>XBRL (Extensible Business Reporting Language) information is furnished and not filed herewith, is not a part of a
    registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, as amended, is deemed
    not filed for purposes of section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to
    liability under these sections.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(1)</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Incorporated by reference to Exhibit 10.1 the
    Company&rsquo;s Current Report of Form 8-K, filed on February 16, 2016.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(2)</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Incorporated by reference to Exhibit 3.01 to
    the Company&rsquo;s Form SB-2 filed on</FONT> June 28, 2002</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(3)</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Incorporated by reference to Exhibit 3.02 to
    the Company&rsquo;s Form SB-2, filed on June 28, 2002</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(4)</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Incorporated by reference to Exhibit 4.1 to
    the Company&rsquo;s Current Report on Form 8-K, filed on March 28, 2016.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(5)</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Incorporated by reference to Exhibit 10.2 the
    Company&rsquo;s Current Report of Form 8-K, filed on February 16, 2016.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(6)</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Incorporated by reference to Exhibit 99.1 to
    the Company&rsquo;s Current Report on Form 8-K, filed on May 10, 2016.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 79; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.4
<SEQUENCE>2
<FILENAME>s104086_ex3-4.htm
<DESCRIPTION>EXHIBIT 3-4
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 3.4&nbsp;</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><img src="ex3-4_pg2.jpg"></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><img src="ex3-4_pg3.jpg"></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>3
<FILENAME>s104086_ex21-1.htm
<DESCRIPTION>EXHIBIT 21-1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 21.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">American BriVision Corporation (a wholly owned subsidiary)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Incorporated in the State of Delaware&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>s104086_ex23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 23.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; font-size: 10pt"><IMG SRC="tex23-1logo.jpg" ALT="">&nbsp;</TD>
    <TD STYLE="width: 80%">
        <P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0"><I>DCAW (CPA) LIMITED</I></P>
        <P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Certified Public Accountants (Practising)</I></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#27491;&#22823;&#26371;&#35336;&#24107;&#20107;&#21209;&#25152;&#26377;&#38480;&#20844;&#21496;</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">HK office: 7th Floor, Nan Dao Commercial Building, 359-361 Queen&rsquo;s
Road Central, Hong Kong.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#39321;&#28207;&#30343;&#21518;&#22823;&#36947;&#20013;&#19977;&#20116;&#20061;&#33267;&#19977;&#20845;&#19968;&#34399;&#21335;&#23798;&#21830;&#26989;&#22823;&#19971;&#27155;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Tel : (852) 2851 7954 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fax: (852) 2545 4086</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Kowloon office: Room 2105, 21/F., Office Tower, Langham Place,
8 Argyle Street, Mongkok, Kowloon, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#20061;&#40845;&#26106;&#35282;&#20126;&#30342;&#32769;&#34903;&#20843;&#34399;&#26391;&#35946;&#22346;&#36774;&#20844;&#22823;&#27155;2105-06&#23460;<BR>
Tel: (852) 2780 0607 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fax: (852) 2780 0013</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To the Board of Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">American BriVision (Holding) Corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby consent to the incorporation by reference into Form S-1 of American BriVision (Holding) Corporation to be filed with the
Securities and Exchange Commission on or about </FONT>September 13, 2016<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
filed pursuant to the Securities Act of 1933, of our report dated </FONT>September 13, 2016<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
with respect to the financial statements of American BriVision (Holding) Corporation, for the period ended June 30, 2016 and 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ DCAW (CPA) Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
</FONT>September 13, 2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>5
<FILENAME>abvc-20160630.xml
<DESCRIPTION>XBRL INSTANCE FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Created by S2 Filings, LLC- http://www.s2filings.com -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2016-01-31" xmlns:us-roles="http://fasb.org/us-roles/2016-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:abvc="http://metuboutique.com/20160630">
    <link:schemaRef xlink:href="abvc-20160630.xsd" xlink:type="simple" />
    <xbrli:context id="From2015-10-01to2016-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-10-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-04-01to2016-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-04-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-21to2015-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-21</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-07-20">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-07-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-02-08_custom_ShareExchangeAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">abvc:ShareExchangeAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-02-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-02-08_custom_ShareExchangeAgreementMember_custom_AmericanBriVisionHoldingCorporationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">abvc:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:AmericanBriVisionHoldingCorporationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-02-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-02-08_custom_ShareExchangeAgreementMember_custom_EuroAsiaInvestmentAndFinanceCorpLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">abvc:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:EuroAsiaInvestmentAndFinanceCorpLimitedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-02-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-02-08_custom_ShareExchangeAgreementMember_custom_AmericanBriVisionCorporationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">abvc:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:AmericanBriVisionCorporationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-02-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-03-21">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-03-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-03-20to2016-03-21">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-03-20</xbrli:startDate>
        <xbrli:endDate>2016-03-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_BioLiteIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">abvc:BioLiteIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-09-30_custom_BioLiteIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">abvc:BioLiteIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_YuanGeneCorporationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">abvc:YuanGeneCorporationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-09-30_custom_YuanGeneCorporationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">abvc:YuanGeneCorporationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_LiteArtIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:LiteArtIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-09-30_custom_LiteArtIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:LiteArtIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-10-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-12-28to2015-12-29_custom_BioLiteIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">abvc:BioLiteIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-12-28</xbrli:startDate>
        <xbrli:endDate>2015-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-12-28to2015-12-29_custom_CollaborativeAgreementMember_custom_BioLiteIncMember_custom_LicensingRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">abvc:CollaborativeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">abvc:BioLiteIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">abvc:LicensingRightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-12-28</xbrli:startDate>
        <xbrli:endDate>2015-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-05-05to2016-05-06_custom_CollaborativeAgreementMember_custom_BioLiteIncMember_custom_LicensingRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">abvc:CollaborativeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">abvc:BioLiteIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">abvc:LicensingRightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-05-05</xbrli:startDate>
        <xbrli:endDate>2016-05-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-05-06_custom_CollaborativeAgreementMember_custom_BioLiteIncMember_custom_LicensingRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">abvc:CollaborativeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">abvc:BioLiteIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">abvc:LicensingRightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-05-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-10-01to2016-06-30_custom_CollaborativeAgreementMember_custom_BioLiteIncMember_custom_LicensingRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">abvc:CollaborativeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">abvc:BioLiteIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">abvc:LicensingRightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-10-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember_us-gaap_ComputerEquipmentMember_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-10-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember_us-gaap_ComputerEquipmentMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-10-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember_us-gaap_FurnitureAndFixturesMember_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-10-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember_us-gaap_FurnitureAndFixturesMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-10-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember_us-gaap_EquipmentMember_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-10-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember_us-gaap_EquipmentMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-10-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember_custom_SignsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">abvc:SignsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-10-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember_us-gaap_SoftwareDevelopmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-10-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember_custom_MarketingAndPromotionalVideoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">abvc:MarketingAndPromotionalVideoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-10-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-09-30_custom_MetuBrandsIncMember_us-gaap_UnsecuredDebtMember_us-gaap_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-02_custom_MetuBrandsIncMember_us-gaap_UnsecuredDebtMember_us-gaap_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember_us-gaap_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-10-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-09-30_custom_MetuBrandsIncMember_us-gaap_NotesPayableOtherPayablesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-09-30_custom_MetuBrandsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-09-30_custom_MetuBrandsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-10-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-09-17to2014-09-30_custom_MetuBrandsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-09-17</xbrli:startDate>
        <xbrli:endDate>2014-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-10-01to2014-09-18_custom_MetuBrandsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-10-01</xbrli:startDate>
        <xbrli:endDate>2014-09-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-10-01to2014-09-30_custom_MetuBrandsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-10-01</xbrli:startDate>
        <xbrli:endDate>2014-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-08-12to2014-08-13_custom_MetuBrandsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-08-12</xbrli:startDate>
        <xbrli:endDate>2014-08-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember_us-gaap_ConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-10-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-09-30_custom_MetuBrandsIncMember_us-gaap_ConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-09-30_custom_MetuBrandsIncMember_us-gaap_ConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-09-30_custom_MetuBrandsIncMember_us-gaap_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-10-01to2015-09-30_us-gaap_SubsequentEventMember_custom_MetuBrandsIncMember_us-gaap_ConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-10-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-09-25_custom_MetuBrandsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-09-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-09-18_custom_MetuBrandsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-09-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-09-30_custom_MetuBrandsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-10-01to2015-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-10-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-09-18_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-09-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-09-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-09-18_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-09-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-09-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-09-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-10-01to2015-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-10-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-09-18_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-09-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-10-01to2015-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-10-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-10-01to2014-09-18">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-10-01</xbrli:startDate>
        <xbrli:endDate>2014-09-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-10-01to2015-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-10-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-09-18">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-09-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-10-01to2014-09-18_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-10-01</xbrli:startDate>
        <xbrli:endDate>2014-09-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-10-01to2014-09-18_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-10-01</xbrli:startDate>
        <xbrli:endDate>2014-09-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember_custom_InnovationConsultingLLCMember_us-gaap_ConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">abvc:InnovationConsultingLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-10-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember_us-gaap_ConvertiblePreferredStockMember_us-gaap_UnsecuredDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-10-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-09-18_custom_RestatementAdjustmentOneMember_custom_MetuBrandsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">abvc:RestatementAdjustmentOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-09-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-09-18_us-gaap_RestatementAdjustmentMember_custom_MetuBrandsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:RestatementAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-09-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-09-17to2014-09-18_us-gaap_ChiefExecutiveOfficerMember_custom_MetuBrandsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-09-17</xbrli:startDate>
        <xbrli:endDate>2014-09-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-09-17to2014-09-18_custom_InnovationConsultingLLCMember_custom_MetuBrandsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">abvc:InnovationConsultingLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-09-17</xbrli:startDate>
        <xbrli:endDate>2014-09-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-09-17to2014-09-18_custom_InnovationConsultingLLCMember_custom_MetuBrandsIncMember_us-gaap_ConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">abvc:InnovationConsultingLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-09-17</xbrli:startDate>
        <xbrli:endDate>2014-09-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-09-18_us-gaap_ScenarioAdjustmentMember_custom_MetuBrandsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-09-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-09-18_custom_FreshStartAdustmentsMember_custom_MetuBrandsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">abvc:FreshStartAdustmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abvc:MetuBrandsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-09-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-09-19to2014-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-09-19</xbrli:startDate>
        <xbrli:endDate>2014-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-09-19to2014-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-09-19</xbrli:startDate>
        <xbrli:endDate>2014-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <us-gaap:Liabilities contextRef="AsOf2016-06-30" unitRef="USD" decimals="0">2061446</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2015-09-30" unitRef="USD" decimals="0">369103</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">39150</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">34030</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2014-09-18_custom_RestatementAdjustmentOneMember_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">2112143</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2014-09-18_us-gaap_RestatementAdjustmentMember_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:Liabilities>
    <us-gaap:ShortTermBorrowings contextRef="AsOf2016-06-30" unitRef="USD" decimals="0">2050000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings contextRef="AsOf2015-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:DueToOfficersOrStockholdersCurrentAndNoncurrent contextRef="AsOf2016-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:DueToOfficersOrStockholdersCurrentAndNoncurrent contextRef="AsOf2015-09-30" unitRef="USD" decimals="0">46586</us-gaap:DueToOfficersOrStockholdersCurrentAndNoncurrent>
    <us-gaap:RelatedPartyTransactionDueFromToRelatedParty contextRef="AsOf2016-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:RelatedPartyTransactionDueFromToRelatedParty contextRef="AsOf2015-09-30" unitRef="USD" decimals="0">-22517</us-gaap:RelatedPartyTransactionDueFromToRelatedParty>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="AsOf2016-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="AsOf2015-09-30" unitRef="USD" decimals="0">300000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="0">11446</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2015-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2016-06-30_custom_LiteArtIncMember" unitRef="USD" decimals="0">11446</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2015-09-30_custom_LiteArtIncMember" unitRef="USD" decimals="0">0</us-gaap:AccountsPayableCurrent>
    <us-gaap:Assets contextRef="AsOf2016-06-30" unitRef="USD" decimals="0">3588719</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2015-09-30" unitRef="USD" decimals="0">1002460</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">68228</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">65389</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2014-09-18_custom_RestatementAdjustmentOneMember_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">231899</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2014-09-18_us-gaap_RestatementAdjustmentMember_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">54594</us-gaap:Assets>
    <us-gaap:DepositsAssetsNoncurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="0">3815</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:DepositsAssetsNoncurrent contextRef="AsOf2015-09-30" unitRef="USD" decimals="0">3815</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="0">3584904</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2015-09-30" unitRef="USD" decimals="0">998645</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">3634</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">795</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2014-09-18_custom_RestatementAdjustmentOneMember_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">1786</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2014-09-18_us-gaap_RestatementAdjustmentMember_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:AssetsCurrent>
    <abvc:Prepayment contextRef="AsOf2016-06-30" unitRef="USD" decimals="0">3500000</abvc:Prepayment>
    <abvc:Prepayment contextRef="AsOf2015-09-30" unitRef="USD" decimals="0">3815</abvc:Prepayment>
    <us-gaap:Cash contextRef="AsOf2016-06-30" unitRef="USD" decimals="0">84904</us-gaap:Cash>
    <us-gaap:Cash contextRef="AsOf2015-09-30" unitRef="USD" decimals="0">994830</us-gaap:Cash>
    <us-gaap:Cash contextRef="AsOf2015-07-20" unitRef="USD" xsi:nil="true" />
    <us-gaap:Cash contextRef="AsOf2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">3360</us-gaap:Cash>
    <us-gaap:Cash contextRef="AsOf2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:Cash>
    <us-gaap:Cash contextRef="AsOf2014-09-18_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:Cash>
    <us-gaap:Cash contextRef="AsOf2013-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">618</us-gaap:Cash>
    <us-gaap:Cash contextRef="AsOf2014-09-18_custom_RestatementAdjustmentOneMember_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">548</us-gaap:Cash>
    <us-gaap:Cash contextRef="AsOf2014-09-18_us-gaap_RestatementAdjustmentMember_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:Cash>
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2016-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2015-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2014-09-18_custom_RestatementAdjustmentOneMember_custom_MetuBrandsIncMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2014-09-18_us-gaap_RestatementAdjustmentMember_custom_MetuBrandsIncMember" unitRef="USD" xsi:nil="true" />
    <abvc:RetainedEarningsAccumulatedDeficit1 contextRef="AsOf2016-06-30" unitRef="USD" decimals="0">-315602</abvc:RetainedEarningsAccumulatedDeficit1>
    <abvc:RetainedEarningsAccumulatedDeficit1 contextRef="AsOf2015-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommonStockShareSubscribedButUnissuedSubscriptionsReceivable contextRef="AsOf2016-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommonStockShareSubscribedButUnissuedSubscriptionsReceivable contextRef="AsOf2015-09-30" unitRef="USD" decimals="0">350000</us-gaap:CommonStockShareSubscribedButUnissuedSubscriptionsReceivable>
    <us-gaap:CommonStockShareSubscribedButUnissuedSubscriptionsReceivable contextRef="AsOf2015-10-31" unitRef="USD" decimals="0">350000</us-gaap:CommonStockShareSubscribedButUnissuedSubscriptionsReceivable>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2016-06-30" unitRef="USD" decimals="0">1987127</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2015-09-30" unitRef="USD" decimals="0">1295845</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">24582</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">54582</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2014-09-18_custom_RestatementAdjustmentOneMember_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">28615490</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2014-09-18_us-gaap_RestatementAdjustmentMember_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:AdditionalPaidInCapital>
    <us-gaap:CommonStockValue contextRef="AsOf2016-06-30" unitRef="USD" decimals="0">209353</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2015-09-30" unitRef="USD" decimals="0">3114</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">60011</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">11</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2014-09-18_custom_RestatementAdjustmentOneMember_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">54593</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2014-09-18_us-gaap_RestatementAdjustmentMember_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">54593</us-gaap:CommonStockValue>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-06-30" unitRef="USD" decimals="0">1527273</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2015-09-30" unitRef="USD" decimals="0">633357</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">29078</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">31359</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2013-09-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">11</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2014-09-18_us-gaap_CommonStockMember" unitRef="USD" decimals="0">11</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2014-09-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">11</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2015-09-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">60011</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2013-09-30_us-gaap_PreferredStockMember" unitRef="USD" decimals="0">1</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2014-09-18_us-gaap_PreferredStockMember" unitRef="USD" decimals="0">1</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2014-09-30_us-gaap_PreferredStockMember" unitRef="USD" decimals="0">1</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2015-09-30_us-gaap_PreferredStockMember" unitRef="USD" decimals="0">1</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2013-09-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">28670072</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2014-09-18_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">54582</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2014-09-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">54582</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2015-09-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">24582</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2013-09-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-30550258</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2014-09-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-23235</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2015-09-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-55516</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2013-09-30" unitRef="USD" decimals="0">-1880174</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2014-09-18" unitRef="USD" decimals="0">54594</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2014-09-30" unitRef="USD" decimals="0">31359</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2014-09-18_custom_RestatementAdjustmentOneMember_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">-1880244</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2014-09-18_us-gaap_RestatementAdjustmentMember_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">54594</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2016-06-30" unitRef="USD" decimals="0">3588719</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2015-09-30" unitRef="USD" decimals="0">1002460</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">68228</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">65389</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2014-09-18_custom_RestatementAdjustmentOneMember_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">231899</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2014-09-18_us-gaap_RestatementAdjustmentMember_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">54594</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2016-06-30" unitRef="USD" decimals="0">-353605</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2015-09-30" unitRef="USD" decimals="0">-315602</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">-55516</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">-23235</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2014-09-18_custom_RestatementAdjustmentOneMember_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">-30550328</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2014-09-18_us-gaap_RestatementAdjustmentMember_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2016-06-30" unitRef="Shares" decimals="INF">360000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2015-09-30" unitRef="Shares" decimals="INF">360000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2016-03-21" unitRef="Shares" decimals="INF">360000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2015-09-30_custom_MetuBrandsIncMember" unitRef="Shares" decimals="INF">90000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2014-09-30_custom_MetuBrandsIncMember" unitRef="Shares" decimals="INF">90000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2014-09-18_custom_MetuBrandsIncMember" unitRef="Shares" decimals="INF">90000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2016-06-30" unitRef="USDPShares" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2015-09-30" unitRef="USDPShares" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2016-03-21" unitRef="USDPShares" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2015-09-30_custom_MetuBrandsIncMember" unitRef="USDPShares" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2014-09-30_custom_MetuBrandsIncMember" unitRef="USDPShares" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2014-09-18_custom_MetuBrandsIncMember" unitRef="USDPShares" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2016-06-30" unitRef="Shares" decimals="INF">209352897</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2015-09-30" unitRef="Shares" decimals="INF">3113856</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2016-02-08_custom_ShareExchangeAgreementMember_custom_AmericanBriVisionHoldingCorporationMember" unitRef="Shares" decimals="INF">52936583</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2016-02-08_custom_ShareExchangeAgreementMember_custom_EuroAsiaInvestmentAndFinanceCorpLimitedMember" unitRef="Shares" decimals="INF">51945225</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2016-02-08_custom_ShareExchangeAgreementMember_custom_AmericanBriVisionCorporationMember" unitRef="Shares" decimals="INF">52336000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2015-09-30_custom_MetuBrandsIncMember" unitRef="Shares" decimals="INF">60011144</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2014-09-30_custom_MetuBrandsIncMember" unitRef="Shares" decimals="INF">11144</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2014-09-18_custom_MetuBrandsIncMember" unitRef="Shares" decimals="INF">54593032</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2016-06-30" unitRef="Shares" decimals="INF">209352897</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2015-09-30" unitRef="Shares" decimals="INF">3113856</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2015-09-30_custom_MetuBrandsIncMember" unitRef="Shares" decimals="INF">60011144</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2014-09-30_custom_MetuBrandsIncMember" unitRef="Shares" decimals="INF">11144</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2014-09-18_custom_MetuBrandsIncMember" unitRef="Shares" decimals="INF">54593032</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:SalesRevenueNet contextRef="From2016-04-01to2016-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:SalesRevenueNet contextRef="From2015-07-21to2015-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:SalesRevenueNet contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">3360</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2014-09-17to2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2013-10-01to2014-09-18_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:SalesRevenueNet>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2016-04-01to2016-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2015-07-21to2015-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">521</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2014-09-17to2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2013-10-01to2014-09-18_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit contextRef="From2016-04-01to2016-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:GrossProfit contextRef="From2015-07-21to2015-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:GrossProfit contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">2839</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2014-09-17to2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2013-10-01to2014-09-18_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">289098</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2015-07-21to2015-09-30" unitRef="USD" decimals="0">315602</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">-289098</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2015-07-21to2015-09-30" unitRef="USD" decimals="0">-315602</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">-32281</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2014-09-17to2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">-23235</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2013-10-01to2014-09-18_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">-70</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">361</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="From2015-07-21to2015-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">89</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="From2015-07-21to2015-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherIncome contextRef="From2016-04-01to2016-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherIncome contextRef="From2015-07-21to2015-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:InterestExpense contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">3753</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2015-07-21to2015-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:InterestExpense contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2014-09-17to2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2013-10-01to2014-09-18_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:InterestExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">-3303</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2015-07-21to2015-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:NonoperatingIncomeExpense contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2014-09-17to2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2013-10-01to2014-09-18_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">-292401</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2015-07-21to2015-09-30" unitRef="USD" decimals="0">-315602</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">-32281</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2014-09-17to2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">-23235</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2013-10-01to2014-09-18_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">-70</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2015-10-01to2016-06-30" unitRef="USD" decimals="0">836</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">836</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2015-07-21to2015-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2014-09-17to2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2013-10-01to2014-09-18_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="From2015-10-01to2016-06-30" unitRef="USD" decimals="0">-353605</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">-293237</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2015-07-21to2015-09-30" unitRef="USD" decimals="0">-315602</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">-32281</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2014-09-17to2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">-23235</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2013-10-01to2014-09-18_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">-70</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2013-10-01to2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">-23235</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2014-10-01to2015-09-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-32281</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2013-10-01to2014-09-18" unitRef="USD" decimals="0">-70</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2014-10-01to2015-09-30" unitRef="USD" decimals="0">-32281</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2013-10-01to2014-09-18_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-70</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2014-09-19to2014-09-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-23235</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2014-09-19to2014-09-30" unitRef="USD" decimals="0">-23235</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2016-04-01to2016-06-30" unitRef="USDPShares" decimals="INF">0.00</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2015-07-21to2015-09-30" unitRef="USDPShares" decimals="INF">-0.1</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember" unitRef="USDPShares" decimals="INF">-0.01</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2014-09-17to2014-09-30_custom_MetuBrandsIncMember" unitRef="USDPShares" decimals="INF">-2.08</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2013-10-01to2014-09-18_custom_MetuBrandsIncMember" unitRef="USDPShares" decimals="INF">-0.01</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2016-04-01to2016-06-30" unitRef="Shares" decimals="INF">208779424</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2015-07-21to2015-09-30" unitRef="Shares" decimals="INF">3113856</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember" unitRef="Shares" decimals="INF">5000929</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2014-09-17to2014-09-30_custom_MetuBrandsIncMember" unitRef="Shares" decimals="INF">11144</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2013-10-01to2014-09-18_custom_MetuBrandsIncMember" unitRef="Shares" decimals="INF">11144</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2013-10-01to2014-09-30_custom_MetuBrandsIncMember" unitRef="Shares" decimals="INF">10000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:IncomeTaxesPaid contextRef="From2015-10-01to2016-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncomeTaxesPaid contextRef="From2015-07-21to2015-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncomeTaxesPaid contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="From2014-09-17to2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="From2013-10-01to2014-09-18_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxesPaid>
    <us-gaap:InterestPaid contextRef="From2015-10-01to2016-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:InterestPaid contextRef="From2015-07-21to2015-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:InterestPaid contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:InterestPaid>
    <us-gaap:InterestPaid contextRef="From2014-09-17to2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:InterestPaid>
    <us-gaap:InterestPaid contextRef="From2013-10-01to2014-09-18_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:InterestPaid>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2015-10-01to2016-06-30" unitRef="USD" decimals="0">-909926</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2015-07-21to2015-09-30" unitRef="USD" decimals="0">994830</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">3360</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2014-09-17to2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2013-10-01to2014-09-18_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">1168</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="From2015-10-01to2016-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="From2015-07-21to2015-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="From2015-10-01to2016-06-30" unitRef="USD" decimals="0">2947521</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="From2015-07-21to2015-09-30" unitRef="USD" decimals="0">948959</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="From2014-09-17to2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">71389</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="From2013-10-01to2014-09-18_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2015-10-01to2016-06-30" unitRef="USD" decimals="0">897521</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2015-07-21to2015-09-30" unitRef="USD" decimals="0">948959</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromShortTermDebt contextRef="From2015-10-01to2016-06-30" unitRef="USD" decimals="0">2050000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt contextRef="From2015-07-21to2015-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="From2015-10-01to2016-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="From2015-07-21to2015-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="From2014-09-17to2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">-64594</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="From2013-10-01to2014-09-18_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="From2015-10-01to2016-06-30" unitRef="USD" decimals="0">-3857447</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="From2015-07-21to2015-09-30" unitRef="USD" decimals="0">45871</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">3360</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="From2014-09-17to2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">-6795</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="From2013-10-01to2014-09-18_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">1168</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties contextRef="From2015-10-01to2016-06-30" unitRef="USD" decimals="0">11446</us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties>
    <us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties contextRef="From2015-07-21to2015-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncreaseDecreaseInDueToOfficersAndStockholdersCurrent contextRef="From2015-10-01to2016-06-30" unitRef="USD" decimals="0">-46586</us-gaap:IncreaseDecreaseInDueToOfficersAndStockholdersCurrent>
    <us-gaap:IncreaseDecreaseInDueToOfficersAndStockholdersCurrent contextRef="From2015-07-21to2015-09-30" unitRef="USD" decimals="0">46586</us-gaap:IncreaseDecreaseInDueToOfficersAndStockholdersCurrent>
    <us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent contextRef="From2015-10-01to2016-06-30" unitRef="USD" decimals="0">-22517</us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent>
    <us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent contextRef="From2015-07-21to2015-09-30" unitRef="USD" decimals="0">22517</us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="From2015-10-01to2016-06-30" unitRef="USD" decimals="0">-300000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="From2015-07-21to2015-09-30" unitRef="USD" decimals="0">300000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent contextRef="From2015-10-01to2016-06-30" unitRef="USD" decimals="0">-350000</us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent>
    <us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent contextRef="From2015-07-21to2015-09-30" unitRef="USD" xsi:nil="true" />
    <abvc:IncreaseDecreaseInPrepayment contextRef="From2015-10-01to2016-06-30" unitRef="USD" decimals="0">3496185</abvc:IncreaseDecreaseInPrepayment>
    <abvc:IncreaseDecreaseInPrepayment contextRef="From2015-07-21to2015-09-30" unitRef="USD" decimals="0">3815</abvc:IncreaseDecreaseInPrepayment>
    <us-gaap:IncreaseDecreaseInDepositOtherAssets contextRef="From2015-10-01to2016-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncreaseDecreaseInDepositOtherAssets contextRef="From2015-07-21to2015-09-30" unitRef="USD" decimals="0">3815</us-gaap:IncreaseDecreaseInDepositOtherAssets>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2015-10-01to2016-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;1.&#13;ORGANIZATION AND DESCRIPTION OF BUSINESS&lt;/b&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;American&#13;BriVision (Holding) Corporation (the &amp;#147;Company&amp;#148; or &amp;#147;Holding entity&amp;#148;), a Nevada corporation, thru the Company&amp;#146;s&#13;operating entity, American BriVision Corporation (&amp;#147;BriVision&amp;#148;), which was incorporated in July 2015 in the State of&#13;Delaware, engages in biotechnology and focuses on the development of new drugs and innovative medical devices to fulfill unmet&#13;medical needs. &amp;#160;The business model of the Company is to integrate research achievements from world-famous institutions (such&#13;as Memorial Sloan Kettering Cancer Center (&amp;#147;MSKCC&amp;#148;) and MD Anderson Cancer Center), conduct clinical trials of translational&#13;medicine for Proof of Concept (&amp;#147;POC&amp;#148;), out-license to international pharmaceutical companies, and exploit global markets.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;REVERSE&#13;MERGER&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;February 8, 2016, a Share Exchange Agreement (&amp;#147;Share Exchange Agreement&amp;#148;) was entered into by and among American BriVision&#13;(Holding) Corporation (the&amp;#160;&amp;#147;Company&amp;#148;), American BriVision Corporation&amp;#160;(&amp;#147;BriVision&amp;#148;), Euro-Asia&#13;Investment &amp;#38; Finance Corp. Limited, a company incorporated under the laws of Hong Kong Special Administrative Region of Taiwan&#13;(&amp;#147;Euro-Asia&amp;#148;), being the owners of record of 52,336,000 shares of common stock of the Company, and the owners of record&#13;of all of the issued share capital of BriVision (the&amp;#160;&amp;#147;BriVision Stock&amp;#148;). Pursuant to the Share Exchange Agreement,&#13;upon surrender by the BriVision Shareholders and the cancellation by BriVision of the certificates evidencing the BriVision Stock&#13;as registered in the name of each BriVision Shareholder, and pursuant to the registration of the Company in the register of members&#13;maintained by BriVision as the new holder of the BriVision Stock and the issuance of the certificates evidencing the aforementioned&#13;registration of the BriVision Stock in the name of the Company, the Company should issue 52,936,583 shares (the&amp;#160;&amp;#147;Acquisition&#13;Stock&amp;#148;) (subject to adjustment for fractionalized shares as set forth below) of the Company&amp;#146;s common stock to the&#13;BriVision Shareholders (or their designees), and 51,945,225 shares of the Company&amp;#146;s common stock owned by Euro-Asia should&#13;be cancelled and retired to treasury. The Acquisition Stock collectively should represent 79.70% of the issued and outstanding&#13;common stock of the Company immediately after the Closing, in exchange for the BriVision Stock, representing 100% of the issued&#13;share capital of BriVision.&amp;#160;&amp;#160;Because of the exchange of the BriVision Stock for the Acquisition Stock (the&amp;#160;&amp;#147;Share&#13;Exchange&amp;#148;), BriVision became a wholly owned subsidiary (the &amp;#147;Subsidiary&amp;#148;) of the Company and there was a change&#13;of control of the Company following the closing.&amp;#160;&amp;#160;There were no warrants, options or other equity instruments issued&#13;in connection with the share exchange agreement.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Because&amp;#160;of&#13;the consummation of the Share Exchange,&amp;#160;BriVision&amp;#160;is now our wholly owned subsidiary and its shareholders own approximately&amp;#160;79.70%&#13;of our issued and outstanding common stock.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.2pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Following&#13;the Share Exchange, we have abandoned our prior business plan and we are now pursuing&amp;#160;BriVision&amp;#146;s&amp;#160;historical businesses&#13;and proposed businesses, which focus on the development of new drugs and innovative medical devices to fulfill unmet medical needs.&amp;#160;&amp;#160;The&#13;business model of the Company is to integrate research achievements from world-famous institutions, conduct clinical trials of&#13;translational medicine for Proof of Concept (&amp;#147;POC&amp;#148;), out-license to international pharmaceutical companies, and exploit&#13;global markets.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.2pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accounting&#13;Treatment of the Reverse Merger&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;For&#13;financial reporting purposes, the Share Exchange represents a&amp;#160;&amp;#147;reverse merger&amp;#148;&amp;#160;rather than a business combination&#13;and&amp;#160;BriVision&amp;#160;is deemed the accounting acquirer in the transaction. The&amp;#160;Share Exchange is being accounted for as&#13;a reverse-merger and recapitalization. BriVision&amp;#160;is the acquirer for financial reporting purposes and the&amp;#160;Company&amp;#160;is&#13;the acquired company. Consequently, the assets and liabilities and the operations reflected in the historical financial statements&#13;prior to the Share Exchange will be those of&amp;#160;BriVision&amp;#160;and recorded at the historical cost basis of&amp;#160;BriVision.&#13;In addition, the consolidated financial statements after completion of the Share Exchange will include the assets and liabilities&#13;of the Company and BriVision, and the historical operations of&amp;#160;BriVision&amp;#160;and operations of the Combined Company from&#13;the closing date of the Share Exchange.&lt;/font&gt;&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock contextRef="From2015-10-01to2016-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2.&#13;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Basis&#13;of Presentation&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;accompanying audited financial statements and related notes have been prepared in accordance with generally accepted accounting&#13;principles in the United States of America (U.S. GAAP). This basis of accounting involves the application of accrual accounting.&#13;Consequently, revenues and gains are recognized when earned, and expenses and losses are recognized when incurred. The Company&amp;#146;s&#13;financial statements are expressed in U.S. dollars. The condensed financial statements include all adjustments that, in the opinion&#13;of management, are necessary in order not to make the financial statements misleading.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Certain&#13;information and footnote disclosure normally included in financial statements prepared in accordance with US GAAP have been condensed&#13;or omitted. The results of operations for the periods ended June 30, 2016 are not necessarily indicative of the operating results&#13;for the full year.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Use&#13;of Estimates&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions&#13;that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of&#13;the consolidated financial statements and the amount of revenues and expenses during the reporting periods. Actual results could&#13;differ materially from those results.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Forward&#13;Stock split&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;March 21, 2016, the Board of Directors of the Company approved an amendment to Articles of Incorporation to effect a forward split&#13;at a ratio of 1 to 3:141 and increase the number of our authorized shares of common stock, par value $0.001 per share, to 360,000,000,&#13;which was effective on April 8, 2016. The majority of the shareholders of the Company approved the amendment to Articles of Incorporation.&#13;See Note 4 for more details.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Fair&#13;Value Measurements&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company applies the provisions of ASC Subtopic 820-10,&amp;#160;&amp;#147;Fair Value Measurements&amp;#148;,&amp;#160;for fair value measurements&#13;of financial assets and financial liabilities and for fair value measurements of nonfinancial items that are recognized or disclosed&#13;at fair value in the financial statements.&amp;#160;&amp;#160;ASC 820 also establishes a framework for measuring fair value and expands&#13;disclosures about fair value measurements.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Fair&#13;value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction&#13;between market participants at the measurement date.&amp;#160;&amp;#160;When determining the fair value measurements for assets and liabilities,&#13;the Company considers the principal or most advantageous market in which it would transact and it considers assumptions that market&#13;participants would use when pricing the asset or liability.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;ASC&#13;820 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of&#13;unobservable inputs when measuring fair value. ASC 820 establishes three levels of inputs to measure fair value. The hierarchy&#13;gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements)&#13;and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements). The three levels of&#13;the fair value hierarchy are as follows:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#149;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/b&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&#13;Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#149;&lt;/b&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&#13;Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs&#13;that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial&#13;instruments.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#149;&lt;/b&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&#13;Level 3 inputs to the valuation methodology are unobservable and significant to the fair value.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;There&#13;were no assets or liabilities measured at fair value on a recurring basis subject to the disclosure requirements of ASC 820 as&#13;of&amp;#160;September 30, 2015.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Cash&#13;and Cash Equivalents&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company considers highly liquid investments with maturities of three months or less, when purchased, to be cash equivalents. As&#13;of June 30, 2016, the Company&amp;#146;s cash and cash equivalents amounted $84,904. As of September 30, 2015, the Company&amp;#146;s&#13;cash and cash equivalents amounted $994,830. All&amp;#160;of the Company&amp;#146;s cash deposits are held in a financial institution&#13;located in PRC where there is currently regulation mandated on obligatory insurance of bank accounts. The Company believes this&#13;financial institution is of high credit quality.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Income&#13;Taxes&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.2pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company accounts for income taxes using the asset and liability approach which allows the recognition and measurement of deferred&#13;tax assets to be based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach,&#13;deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities&#13;for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred&#13;tax assets if it is more likely than not these items will expire before the Company is able to realize their benefits, or future&#13;deductibility is uncertain.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.2pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Under&#13;ASC 740, a tax position is recognized as a benefit only if it is&amp;#160;&amp;#147;more likely than not&amp;#148;&amp;#160;that the tax position&#13;would be sustained in a tax examination, with a tax examination being presumed to occur. The evaluation of a tax position is a&#13;two-step process. The first step is to determine whether it is more-likely-than-not that a tax position will be sustained upon&#13;examination, including the resolution of any related appeals or litigations based on the technical merits of that position. The&#13;second step is to measure a tax position that meets the more-likely-than-not threshold to determine the amount of benefits recognized&#13;in the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50 percent likely&#13;of being realized upon ultimate settlement. Tax positions that previously failed to meet the more-likely-than-not recognition&#13;threshold should be recognized in the first subsequent period in which the threshold is met. Previously recognized tax positions&#13;that no longer meet the more-likely-than-not criteria should be de-recognized in the first subsequent financial reporting period&#13;in which the threshold is no longer satisfied. Penalties and interest incurred related to underpayment of income tax are classified&#13;as income tax expense in the year incurred. No significant penalty or interest relating to income taxes has been incurred during&#13;the period from July 21, 2015 (inception) to September 30, 2015. GAAP also provides guidance on de-recognition, classification,&#13;interest and penalties, accounting in interim periods, disclosures and transition.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;As&#13;of June 30, 2016 and September 30, 2015, the Company&amp;#146;s income tax expense amounted $836 and $0, respectively.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Recent&#13;Accounting Pronouncements&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;From&#13;time to time, new accounting standards issued by the Financial Accounting Standards Board (&amp;#147;FASB&amp;#148;) or other standard&#13;setting bodies are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes&#13;that the impact of recently issued standards that are not yet effective will not have a material impact on its financial position&#13;or results of operations upon adoption. The recent accounting standards are not expected to have a material impact on the consolidated&#13;financial statements upon adoption.&lt;/font&gt;&lt;/p&gt;</us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember">&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note&#13;1 &amp;#151; Summary of Significant Accounting Policies&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Description&#13;of the Company.&amp;#160;&amp;#160; &lt;/i&gt;&lt;/b&gt;We were originally incorporated on March 12, 1990 in California (&amp;#147;Ecology-CA&amp;#148;).&amp;#160;&amp;#160;Our&#13;current entity was incorporated in Nevada on February&amp;#160;6, 2002 as OCIS Corp. (&amp;#147;OCIS&amp;#148;).&amp;#160;&amp;#160;OCIS completed&#13;a merger with Ecology-CA on July&amp;#160;26, 2007 (the &amp;#147;Merger&amp;#148;). In the Merger, OCIS changed its name from OCIS Corporation&#13;to Ecology Coatings, Inc.&amp;#160;&amp;#160;The Company filed for Chapter 7 bankruptcy protection on May 15, 2013 and subsequently the&#13;corporate shell emerged as its only unencumbered asset on September 19, 2014 using "fresh start" accounting under section 852-10-45-17&#13;as of date of sale corporate shell to reflect intangible assets sale through section 363. On April 28, 2015 the Company amended&#13;its articles of incorporation to change its name to Metu Brands, Inc. Any business description below and all reporting results&#13;of the operating results reported in this filing for the fiscal period ending September 30, 2014 are post "fresh start" activity&#13;and not comparable to prior results. Post bankruptcy the company has been operating a web site for the sale of women's apparel.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Reclassifications.&#13;&lt;/i&gt;&lt;/b&gt;&amp;#160;&amp;#160;Reclassifications have been made to the prior year financial statements to conform with the current year presentation.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Basis&#13;of Preparation.&lt;/i&gt;&lt;/b&gt; The financial statements of the Company have been prepared in accordance with generally accepted accounting&#13;principles in the United States of America and are presented in US dollars.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Principles&#13;of Consolidation.&amp;#160;&amp;#160; &lt;/i&gt;&lt;/b&gt;The consolidated financial statements include all of our accounts and the accounts of our&#13;wholly owned subsidiary Ecology-CA.&amp;#160;&amp;#160;All significant intercompany transactions have been eliminated in consolidation.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&lt;u&gt;Use&#13;of Estimates.&lt;/u&gt;&amp;#160;&amp;#160; &lt;/i&gt;&lt;/b&gt;The preparation of financial statements in conformity with accounting principles generally&#13;accepted in the United States of America requires management to make estimates and assumptions that affect the amounts of assets&#13;and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting&#13;period. Actual results could differ from those estimates.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&lt;u&gt;Revenue&#13;Recognition.&amp;#160;&lt;/u&gt;&amp;#160; &lt;/i&gt;&lt;/b&gt;The Company applies paragraph 605-10-S99-1 of the FASB Accounting Standards Codification&#13;for revenue recognition. The Company recognizes revenue when it is realized or realizable and earned. The Company considers revenue&#13;realized or realizable and earned when all of the following criteria are met: (i) persuasive evidence of an arrangement exists,&#13;(ii) the sales price is fixed or determinable, (iii) collectability is reasonably assured and (iv) goods have been shipped and/or&#13;services rendered.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Loss&#13;Per Share.&lt;/i&gt;&lt;/b&gt; Basic loss per share is computed by dividing the net loss available to common shareholders by the weighted&#13;average number of shares of common stock outstanding during the period.&amp;#160;&amp;#160;Diluted loss per share is computed by dividing&#13;the net loss available to common shareholders by the weighted average number of shares of common stock and potentially dilutive&#13;securities outstanding during the period.&amp;#160;&amp;#160;Potentially dilutive shares consist of the incremental common shares issuable&#13;upon the exercise of stock options and warrants and the conversion of convertible debt and convertible preferred stock. Potentially&#13;dilutive shares are excluded from the weighted average number of shares if their effect is anti-dilutive.&amp;#160;&amp;#160;None of the&#13;stock options or warrants outstanding or stock associated with the convertible debt or with the convertible preferred shares during&#13;each of the periods presented was included in the computation of diluted loss per share as they were anti-dilutive.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Property&#13;and Equipment.&amp;#160;&amp;#160; &lt;/i&gt;&lt;/b&gt;Property and equipment is stated at cost less accumulated depreciation.&amp;#160;&amp;#160;Depreciation&#13;is recorded using the straight-line method over the following useful lives:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; width: 90%; margin-left: 0.5in; border-collapse: collapse; font-size-adjust: none; font-stretch: normal"&gt;&#13;&lt;tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="width: 70%; text-align: center; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Computer&#13;    equipment&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 30%; text-align: center; font: 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3-10&#13;    years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: center; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Furniture&#13;    and fixtures&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3-7&#13;    years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: center; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Test&#13;    equipment&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5-7&#13;    years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: center; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Signs&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7&#13;    years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: center; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Software&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&#13;    years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: center; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Marketing&#13;    and Promotional Video&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&#13;    years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Repairs&#13;and maintenance costs are charged to operations as incurred. Betterments or renewals are capitalized as incurred.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Patents.&amp;#160;&amp;#160;&#13;&lt;/i&gt;&lt;/b&gt;It is our policy to capitalize costs associated with securing a patent.&amp;#160;&amp;#160;Costs consist of legal and filing fees.&amp;#160;&amp;#160;Once&#13;a patent is issued, it will be amortized on a straight-line basis over its estimated useful life.&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Long-Lived&#13;Assets.&lt;/i&gt;&lt;/b&gt; We review long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying&#13;amount of an asset may not be recoverable.&amp;#160;&amp;#160;Recoverability of assets to be held and used is measured by a comparison&#13;of the carrying amount of an asset to the undiscounted future net cash flows expected to be generated by the asset.&amp;#160;&amp;#160;If&#13;such assets are considered to be impaired, the impairment recognized is measured by the amount by which the carrying amount of&#13;the assets exceeds the fair value of the assets.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Stock-Based&#13;Compensation.&amp;#160;&amp;#160; &lt;/i&gt;&lt;/b&gt;Employee and director stock-based compensation expense is measured utilizing the fair-value&#13;method with expense charged to earnings over the vesting period on a straight-line basis.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;We&#13;account for stock options granted to non-employees under the fair-value method with stock-based compensation expense being charged&#13;to earnings on the earlier of the date services are performed or a performance commitment exists.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Recent&#13;Accounting Pronouncements&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;We&#13;have reviewed all Accounting Standards Updates issued by the Financial Accounting Standards Board since we last issued financial&#13;statements and have determined none of them would have a material effect on the consolidated financial statements upon adoption.&lt;/font&gt;&lt;/p&gt;</us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2015-10-01to2016-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;4.&#13;RELATED PARTIES TRANSACTIONS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;As&#13;of June 30, 2016 and September 30, 2015, the amount due to a related party, BioLite, Inc (&amp;#147;Biolite&amp;#148;) was $0&#13;and $22,517 respectively.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;As&#13;of June 30, 2016 and September 30, 2015, the amount due to shareholder, YuanGene Corporation, was $0 and $46,586 respectively.&lt;/font&gt;&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note&#13;3 &amp;#151; Related Party Transactions&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;We&#13;have borrowed funds for our operations from certain major stockholders, directors and officers as disclosed below.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;We&#13;have an unsecured demand note payable due of $9,000 to Shulamit Lazar, our sole officer and director for funds advanced the Company&#13;through the bankruptcy process. This is unsecured with a zero percent interest rate and is payable on demand.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;As&#13;part of the bankruptcy sale Shulamit Lazar was awarded all 271 of the convertible preferred shares.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Shulamit&#13;Lazar received compensation of 30,000,000 shares valued at $30,000 during the year ended September 30, 2015.&lt;/font&gt;&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2015-10-01to2016-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;5.&#13;ACCOUNTS PAYABLE&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;As&#13;of June 30, 2016 and September 30, 2015, the amount Accounts Payable to LiteArt, Inc. was $11,446 and $0 respectively.&lt;/font&gt;&lt;/p&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2015-10-01to2016-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;6.&#13;EQUTIY&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;During&#13;October 2015, $350,000 of subscription receivable was fully collected from the shareholders.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;March 21, 2016, the Board of Directors of the Company approved an amendment to Articles of Incorporation to effect a forward split&#13;at a ratio of 1 to 3:141 (the &amp;#147;Forward&amp;#160;Stock&amp;#160;Split&amp;#148;) and increase the number of our authorized shares of&#13;common stock, par value $0.001 per share, to 360,000,000, which was effective on April 8, 2016.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;majority of the shareholders of the Company approved the amendment to Articles of Incorporation.&lt;/font&gt;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note&#13;6 &amp;#151; Equity&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Common&#13;Stock&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;As&#13;of September 30, 2014 the Company had 11,144 common shares issued and outstanding and 90,000,000 shares of Common Stock authorized&#13;par value $0.001 and the holders of the Company's common stock are entitled to one vote per each share of common stock held. Additionally&#13;as part of the bankruptcy sale the Company has had a reverse stock split of &amp;#160;5,000 for 1 on August 13, 2014 which has been&#13;reflected retroactively in these financial statements. 30,000,000 shares of common stock was issued to Shulamit Lazar for her&#13;initial $20,000 deposit to purchase the company. The Company also issued 30,000,000 shares of common stock in the year ended September&#13;30, 2015 to a related party (Shulamit Lazar) for services valued at $30,000. As of September 30, 2015 the company had 60,011,144&#13;common shares outstanding.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Preferred&#13;Stock&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;As&#13;of September 30, 2015 the Company had 10,000,000 shares of Preferred Stock authorized par value $.001 and the holders of the Company's&#13;Preferred Stock can convert each share into 100,000 shares of voting Common Stock. Additionally each Preferred Share is entitled&#13;to the voting rights 100,000 common stock shares. Subsequent to the date of these financial statements but prior to issuance the&#13;preferred shares have been amended to carry voting and conversion rights equal to 20,000 common shares each. The Company had 271&#13;shares issued during bankruptcy to Innovation Consulting LLC for $5,000 and 271 shares were issued and outstanding as of September&#13;30, 2015.&lt;/font&gt;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2015-10-01to2016-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;7.&#13;COMMITMENTS AND CONTINGENCIES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Capital&#13;Commitment&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;December 29, 2015, the Company entered into the agreement with Biolite, a related party, that Biolite would grant the Company&#13;sole licensing rights of a series of technology for 10 years. The total consideration of obtaining such grant would be $100,000,000.&lt;/font&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note&#13;5 &amp;#151; Commitments and Contingencies&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Contingencies.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;All&#13;contingencies have been settled through our bankruptcy petition in September 2014 subsequent to this financial reporting period.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Lease&#13;Commitments.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;None.&lt;/font&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2015-10-01to2016-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Basis&#13;of Presentation&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;accompanying audited financial statements and related notes have been prepared in accordance with generally accepted accounting&#13;principles in the United States of America (U.S. GAAP). This basis of accounting involves the application of accrual accounting.&#13;Consequently, revenues and gains are recognized when earned, and expenses and losses are recognized when incurred. The Company&amp;#146;s&#13;financial statements are expressed in U.S. dollars. The condensed financial statements include all adjustments that, in the opinion&#13;of management, are necessary in order not to make the financial statements misleading.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Certain&#13;information and footnote disclosure normally included in financial statements prepared in accordance with US GAAP have been condensed&#13;or omitted. The results of operations for the periods ended June 30, 2016 are not necessarily indicative of the operating results&#13;for the full year.&lt;/font&gt;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Basis&#13;of Preparation&lt;/i&gt;&lt;/b&gt;. The financial statements of the Company have been prepared in accordance with generally accepted accounting&#13;principles in the United States of America and are presented in US dollars.&lt;/font&gt;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2015-10-01to2016-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Use&#13;of Estimates&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions&#13;that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of&#13;the consolidated financial statements and the amount of revenues and expenses during the reporting periods. Actual results could&#13;differ materially from those results.&lt;/font&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:UseOfEstimates contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;u&gt;Use&#13;of Estimates&lt;/u&gt;&lt;/b&gt;. The preparation of financial statements in conformity with accounting principles generally accepted&#13;in the United States of America requires management to make estimates and assumptions that affect the amounts of assets and liabilities&#13;at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual&#13;results could differ from those estimates.&lt;/font&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <abvc:ForwardStockSplitPolicyTextBlock contextRef="From2015-10-01to2016-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Forward&#13;Stock split&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;March 21, 2016, the Board of Directors of the Company approved an amendment to Articles of Incorporation to effect a forward split&#13;at a ratio of 1 to 3:141 and increase the number of our authorized shares of common stock, par value $0.001 per share, to 360,000,000,&#13;which was effective on April 8, 2016. The majority of the shareholders of the Company approved the amendment to Articles of Incorporation.&#13;See Note 4 for more details.&lt;/font&gt;&lt;/p&gt;</abvc:ForwardStockSplitPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="From2015-10-01to2016-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Fair&#13;Value Measurements&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company applies the provisions of ASC Subtopic 820-10,&amp;#160;&amp;#147;Fair Value Measurements&amp;#148;,&amp;#160;for fair value measurements&#13;of financial assets and financial liabilities and for fair value measurements of nonfinancial items that are recognized or disclosed&#13;at fair value in the financial statements.&amp;#160;&amp;#160;ASC 820 also establishes a framework for measuring fair value and expands&#13;disclosures about fair value measurements.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Fair&#13;value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction&#13;between market participants at the measurement date.&amp;#160;&amp;#160;When determining the fair value measurements for assets and liabilities,&#13;the Company considers the principal or most advantageous market in which it would transact and it considers assumptions that market&#13;participants would use when pricing the asset or liability.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;ASC&#13;820 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of&#13;unobservable inputs when measuring fair value. ASC 820 establishes three levels of inputs to measure fair value. The hierarchy&#13;gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements)&#13;and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements). The three levels of&#13;the fair value hierarchy are as follows:&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#149;&lt;/b&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&#13;Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#149;&lt;/b&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&#13;Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs&#13;that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial&#13;instruments.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#149;&lt;/b&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&#13;Level 3 inputs to the valuation methodology are unobservable and significant to the fair value.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;There&#13;were no assets or liabilities measured at fair value on a recurring basis subject to the disclosure requirements of ASC 820 as&#13;of&amp;#160;September 30, 2015.&lt;/font&gt;&lt;/p&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2015-10-01to2016-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Cash&#13;and Cash Equivalents&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company considers highly liquid investments with maturities of three months or less, when purchased, to be cash equivalents. As&#13;of June 30, 2016, the Company&amp;#146;s cash and cash equivalents amounted $84,904. As of September 30, 2015, the Company&amp;#146;s&#13;cash and cash equivalents amounted $994,830. All&amp;#160;of the Company&amp;#146;s cash deposits are held in a financial institution&#13;located in PRC where there is currently regulation mandated on obligatory insurance of bank accounts. The Company believes this&#13;financial institution is of high credit quality.&lt;/font&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2015-10-01to2016-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Income&#13;Taxes&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.2pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company accounts for income taxes using the asset and liability approach which allows the recognition and measurement of deferred&#13;tax assets to be based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach,&#13;deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities&#13;for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred&#13;tax assets if it is more likely than not these items will expire before the Company is able to realize their benefits, or future&#13;deductibility is uncertain.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.2pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Under&#13;ASC 740, a tax position is recognized as a benefit only if it is&amp;#160;&amp;#147;more likely than not&amp;#148;&amp;#160;that the tax position&#13;would be sustained in a tax examination, with a tax examination being presumed to occur. The evaluation of a tax position is a&#13;two-step process. The first step is to determine whether it is more-likely-than-not that a tax position will be sustained upon&#13;examination, including the resolution of any related appeals or litigations based on the technical merits of that position. The&#13;second step is to measure a tax position that meets the more-likely-than-not threshold to determine the amount of benefits recognized&#13;in the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50 percent likely&#13;of being realized upon ultimate settlement. Tax positions that previously failed to meet the more-likely-than-not recognition&#13;threshold should be recognized in the first subsequent period in which the threshold is met. Previously recognized tax positions&#13;that no longer meet the more-likely-than-not criteria should be de-recognized in the first subsequent financial reporting period&#13;in which the threshold is no longer satisfied. Penalties and interest incurred related to underpayment of income tax are classified&#13;as income tax expense in the year incurred. No significant penalty or interest relating to income taxes has been incurred during&#13;the period from July 21, 2015 (inception) to September 30, 2015. GAAP also provides guidance on de-recognition, classification,&#13;interest and penalties, accounting in interim periods, disclosures and transition.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;As&#13;of June 30, 2016 and September 30, 2015, the Company&amp;#146;s income tax expense amounted $836 and $0, respectively.&lt;/font&gt;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2015-10-01to2016-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Recent&#13;Accounting Pronouncements&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;From&#13;time to time, new accounting standards issued by the Financial Accounting Standards Board (&amp;#147;FASB&amp;#148;) or other standard&#13;setting bodies are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes&#13;that the impact of recently issued standards that are not yet effective will not have a material impact on its financial position&#13;or results of operations upon adoption. The recent accounting standards are not expected to have a material impact on the consolidated&#13;financial statements upon adoption.&lt;/font&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Recent&#13;Accounting Pronouncements&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;We&#13;have reviewed all Accounting Standards Updates issued by the Financial Accounting Standards Board since we last issued financial&#13;statements and have determined none of them would have a material effect on the consolidated financial statements upon adoption.&lt;/font&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2016-02-08_custom_ShareExchangeAgreementMember" unitRef="Pure" decimals="INF">0.7970</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2016-02-08_custom_ShareExchangeAgreementMember_custom_AmericanBriVisionHoldingCorporationMember" unitRef="Pure" decimals="INF">1.00</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="From2016-03-20to2016-03-21">&lt;p&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1 to 3:141&lt;/font&gt;&lt;/p&gt;</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="From2014-08-12to2014-08-13_custom_MetuBrandsIncMember">&lt;p&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5,000 for 1&lt;/font&gt;&lt;/p&gt;</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2016-06-30" unitRef="USD" decimals="0">84904</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2015-09-30" unitRef="USD" decimals="0">994830</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent contextRef="AsOf2016-06-30_custom_BioLiteIncMember" unitRef="USD" decimals="0">0</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent contextRef="AsOf2015-09-30_custom_BioLiteIncMember" unitRef="USD" decimals="0">22517</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent contextRef="AsOf2016-06-30_custom_YuanGeneCorporationMember" unitRef="USD" decimals="0">0</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent contextRef="AsOf2015-09-30_custom_YuanGeneCorporationMember" unitRef="USD" decimals="0">46586</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent contextRef="AsOf2015-09-30_custom_MetuBrandsIncMember_us-gaap_UnsecuredDebtMember_us-gaap_ChiefExecutiveOfficerMember" unitRef="USD" decimals="0">9000</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="From2015-12-28to2015-12-29_custom_BioLiteIncMember" unitRef="USD" decimals="0">100000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <abvc:AgreementPeriod contextRef="From2015-12-28to2015-12-29_custom_BioLiteIncMember">P15Y</abvc:AgreementPeriod>
    <abvc:CallaobrativeAgreementDisclosureTextBlock contextRef="From2015-10-01to2016-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;3.&#13;COLLAOBRATIVE AGREEMENT&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;December 29, 2015, American BriVision Corporation entered into a Collaborative Agreement with BioLite Inc., a related party, pursuant&#13;to which BioLite granted the Company sole licensing rights for drug and therapeutic use of five products: BLI-1005 CNS-Major Depressive&#13;Disorder; BLI-1008 CNS-Attention Deficit Hyperactivity Disorder; BLI-1401-1 Anti-Tumor Combination Therapy-Solid Tumor with Anti-PD-1;&#13;BLI-1401-2 Anti-Tumor Combination Therapy-Triple Negative Breast Cancer; and BLI-1501 Hematology-Chronic Lymphocytic Leukemia,&#13;in USA and Canada. The total consideration of obtaining such grant would be $100,000,000.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Pursuant&#13;to the Collaborative Agreement, an upfront payment of $3,500,000 (the &amp;#147;Milestone Payment&amp;#148;), which is 3.5% of total&#13;payments due under the Collaborative Agreement, was to be paid by the Company upon signing of that agreement. On May 6 , 2016,&#13;we and Biolite agreed to amend the Collaborative Agreement, through entry into the Milestone Payment Agreement, whereby we have&#13;agreed to pay the Milestone Payment to BioLite $2,600,000 in cash and $900,000 in newly issued shares of our common stock, at&#13;the price of $1.60 per share, for an aggregate number of 562,500 shares. The cash payment and shares issuance were completed in&#13;June 2016.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;This&#13;Collaborative Agreement shall, once signed by both Parties, remain in effect for fifteen years as of the first commercial sales&#13;of the Product in the Territory and automatically renew for five more years unless either party gives the other party six month&#13;written notice of termination prior to the expiration date of the term.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company determined to record the intangible assets and begin to amortize once the first commercial sales was consummated.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;process related to first commercial sales has not begun as of June 30, 2016.&amp;#160;The Company cannot&amp;#160;make a reasonably reliable&amp;#160;estimate&amp;#160;of&#13;when the first commercial sales would take place.&lt;/font&gt;&lt;/p&gt;</abvc:CallaobrativeAgreementDisclosureTextBlock>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="From2015-12-28to2015-12-29_custom_CollaborativeAgreementMember_custom_BioLiteIncMember_custom_LicensingRightsMember" unitRef="USD" decimals="0">100000000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="From2016-05-05to2016-05-06_custom_CollaborativeAgreementMember_custom_BioLiteIncMember_custom_LicensingRightsMember" unitRef="USD" decimals="0">2600000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="From2014-09-17to2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">64594</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="From2013-10-01to2014-09-18_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:PaymentsToAcquireIntangibleAssets>
    <abvc:UpfrontPayment contextRef="From2015-12-28to2015-12-29_custom_CollaborativeAgreementMember_custom_BioLiteIncMember_custom_LicensingRightsMember" unitRef="USD" decimals="0">3500000</abvc:UpfrontPayment>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2016-05-05to2016-05-06_custom_CollaborativeAgreementMember_custom_BioLiteIncMember_custom_LicensingRightsMember" unitRef="USD" decimals="0">900000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions contextRef="From2016-05-05to2016-05-06_custom_CollaborativeAgreementMember_custom_BioLiteIncMember_custom_LicensingRightsMember" unitRef="Shares" decimals="INF">562500</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:SharePrice contextRef="AsOf2016-05-06_custom_CollaborativeAgreementMember_custom_BioLiteIncMember_custom_LicensingRightsMember" unitRef="USDPShares" decimals="INF">1.60</us-gaap:SharePrice>
    <abvc:DescriptionOfAgreementTerms contextRef="From2015-10-01to2016-06-30_custom_CollaborativeAgreementMember_custom_BioLiteIncMember_custom_LicensingRightsMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;a name="a_DV_C39"&gt;&lt;/a&gt;This&#13;Collaborative Agreement shall, once signed by both Parties, remain in effect for fifteen years as of the first commercial sales&#13;of the Product in the Territory and automatically renew for five more years unless either party gives the other party six month&#13;written notice of termination prior to the expiration date of the term.&lt;/font&gt;&lt;/p&gt;</abvc:DescriptionOfAgreementTerms>
    <dei:EntityRegistrantName contextRef="From2015-10-01to2016-06-30">American BriVision (Holding) Corp</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey contextRef="From2015-10-01to2016-06-30">0001173313</dei:EntityCentralIndexKey>
    <dei:TradingSymbol contextRef="From2015-10-01to2016-06-30">ABVC</dei:TradingSymbol>
    <dei:DocumentType contextRef="From2015-10-01to2016-06-30">S-1</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2015-10-01to2016-06-30">2016-06-30</dei:DocumentPeriodEndDate>
    <dei:AmendmentFlag contextRef="From2015-10-01to2016-06-30">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2015-10-01to2016-06-30">--09-30</dei:CurrentFiscalYearEndDate>
    <dei:EntityFilerCategory contextRef="From2015-10-01to2016-06-30">Smaller Reporting Company</dei:EntityFilerCategory>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember_us-gaap_ComputerEquipmentMember_us-gaap_MinimumMember">P3Y</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember_us-gaap_ComputerEquipmentMember_us-gaap_MaximumMember">P10Y</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember_us-gaap_FurnitureAndFixturesMember_us-gaap_MinimumMember">P3Y</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember_us-gaap_FurnitureAndFixturesMember_us-gaap_MaximumMember">P7Y</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember_us-gaap_EquipmentMember_us-gaap_MinimumMember">P5Y</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember_us-gaap_EquipmentMember_us-gaap_MaximumMember">P7Y</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember_custom_SignsMember">P7Y</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember_us-gaap_SoftwareDevelopmentMember">P3Y</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember_custom_MarketingAndPromotionalVideoMember">P3Y</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <abvc:DebtInstrumentCancelledAmount contextRef="AsOf2015-12-02_custom_MetuBrandsIncMember_us-gaap_UnsecuredDebtMember_us-gaap_ChiefExecutiveOfficerMember" unitRef="USD" decimals="0">9000</abvc:DebtInstrumentCancelledAmount>
    <us-gaap:StockIssuedDuringPeriodSharesOther contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember_custom_InnovationConsultingLLCMember_us-gaap_ConvertiblePreferredStockMember" unitRef="Shares" decimals="INF">271</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodSharesOther contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember_us-gaap_ConvertiblePreferredStockMember_us-gaap_UnsecuredDebtMember" unitRef="Shares" decimals="INF">271</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodSharesOther contextRef="From2014-09-17to2014-09-18_us-gaap_ChiefExecutiveOfficerMember_custom_MetuBrandsIncMember" unitRef="Shares" decimals="INF">30000000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodSharesOther contextRef="From2014-09-17to2014-09-18_custom_InnovationConsultingLLCMember_custom_MetuBrandsIncMember_us-gaap_ConvertiblePreferredStockMember" unitRef="Shares" decimals="INF">271</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember_us-gaap_ChiefExecutiveOfficerMember" unitRef="Shares" decimals="INF">30000000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember_us-gaap_ChiefExecutiveOfficerMember" unitRef="USD" decimals="0">30000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2015-09-30_custom_MetuBrandsIncMember_us-gaap_NotesPayableOtherPayablesMember" unitRef="USD" decimals="0">7000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InventoryNet contextRef="AsOf2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">274</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">795</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2014-09-18_custom_RestatementAdjustmentOneMember_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">37249</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2014-09-18_us-gaap_RestatementAdjustmentMember_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">64594</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">64594</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">23150</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">18030</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingExpenses contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">35120</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2014-09-17to2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">23235</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2013-10-01to2014-09-18_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">70</us-gaap:OperatingExpenses>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2015-09-30_custom_MetuBrandsIncMember_us-gaap_ConvertiblePreferredStockMember" unitRef="USDPShares" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2014-09-30_custom_MetuBrandsIncMember_us-gaap_ConvertiblePreferredStockMember" unitRef="USDPShares" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2014-09-18_custom_MetuBrandsIncMember" unitRef="USDPShares" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2015-09-30_custom_MetuBrandsIncMember_us-gaap_ConvertiblePreferredStockMember" unitRef="Shares" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2014-09-30_custom_MetuBrandsIncMember_us-gaap_ConvertiblePreferredStockMember" unitRef="Shares" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2014-09-18_custom_MetuBrandsIncMember" unitRef="Shares" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2015-09-30_custom_MetuBrandsIncMember_us-gaap_ConvertiblePreferredStockMember" unitRef="Shares" decimals="INF">271</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2014-09-30_custom_MetuBrandsIncMember_us-gaap_ConvertiblePreferredStockMember" unitRef="Shares" decimals="INF">271</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2014-09-18_custom_MetuBrandsIncMember" unitRef="Shares" decimals="INF">271</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2015-09-30_custom_MetuBrandsIncMember_us-gaap_ConvertiblePreferredStockMember" unitRef="Shares" decimals="INF">271</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2014-09-30_custom_MetuBrandsIncMember_us-gaap_ConvertiblePreferredStockMember" unitRef="Shares" decimals="INF">271</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2014-09-18_custom_MetuBrandsIncMember" unitRef="Shares" decimals="INF">271</us-gaap:PreferredStockSharesOutstanding>
    <abvc:FreshStartAdjustmentTextBlock contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note&#13;2 &amp;#151; "Fresh Start" Accounting&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;METU&#13;BRANDS, INC.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(Formerly&#13;Ecology Coatings, Inc.)&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;FRESH&#13;START ADJUSTMENTS&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" nowrap="nowrap" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;9/19/2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" nowrap="nowrap" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Dr(CR)&lt;br /&gt;Reorganization&lt;br /&gt;Adjustments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" nowrap="nowrap" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Dr(CR)&#13;    Fresh Start&lt;br /&gt;Adjustments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" nowrap="nowrap" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;9/19/2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Current assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="width: 40%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;Cash&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 11%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;548&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 11%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(548&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 3%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;) (1)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 11%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 3%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 11%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;Accounts&#13;    receivable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,238&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1,238&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&#13;    (1)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Total&#13;    Current Assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,786&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;Property,&#13;    plant and equipment, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;37,249&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(37,249&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;) (1)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;Intangible&#13;    assets, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;192,864&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(192,864&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&#13;    (1)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;54,594&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;54,594&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Total&#13;    Assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;231,899&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;54,594&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Liabilities and Equity&#13;    (Deficit)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total liabilities subject&#13;    to compromise&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,112,143&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,112,143 &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Commitments and Contingencies&#13;    (Note 5)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Metu Brands, Inc. ("MTOO")&#13;    shareholders' deficit&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;Predecessor&#13;    Preferred Stock 10,000,000 authorized at $0.001 par value shares issued and outstanding 271 at September 19, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1 &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(3)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;Successor&#13;    Preferred Stock 10,000,000 authorized at $0.001 par value; shares issued and outstanding 54,593,032 at September 19, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1 &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;Predecessor/Successor&#13;    Common Stock 90,000,000 authorized at $0.001 par value; shares issued and outstanding 54,593,032 at September 19, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;54,593&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;54,593&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;Additional&#13;    paid-in capital&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;28,615,490&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1,880,244&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;) (1)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;30,495,734&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(3)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;Retained&#13;    earnings&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(30,550,328&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(30,550,328)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(4)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Total&#13;    equity (deficit)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1,880,244&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;54,594&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Total&#13;    liabilities and equity (deficit)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;231,899&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;54,594&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1)&#13;Reorganization adjustments reflect the transfer of $2,112,143 of liabilities subject to compromise and assets to the bankruptcy&#13;trustee in accordance with the plan of bankruptcy provisions.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2)&#13;Fresh-start adjustments under section 852-10-45-17 as of the date of sale of the corporate shell to reflect intangible assets&#13;sale through section 363 of the bankruptcy code.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(3)&#13;Fresh-start adjustments under ASC 852-10-45-17 to predecessor preferred stock and APIC reflect the cancellation of the predecessor&amp;#146;s&#13;preferred stock.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(4)&#13;Fresh-start adjustment to retained earnings (accumulated deficit) resets accumulated deficit to zero.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(5)&#13;$20,000 was paid to the trustee by Shulamit Lazar for the subsequent issue of 30,000,000 common shares and $5,000 was paid to&#13;the trustee by Innovation Consulting LLC for the purchase of 271 preferred shares.&lt;/font&gt;&lt;/p&gt;</abvc:FreshStartAdjustmentTextBlock>
    <us-gaap:ShortTermDebtTextBlock contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note&#13;4 &amp;#151; Notes Payable&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;We&#13;have the following notes as of September 30, 2015 and 2014:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Post&#13;bankruptcy the Company acquired the assets of Metu Brands Inc. (a ready to operate web site business). &amp;#160;In addition to a&#13;$3,000 deposit the Company signed a note payable for $7,000. This note was due September 24, 2014 and carries a zero percent interest&#13;rate. This note is note in default.&lt;/font&gt;&lt;/p&gt;</us-gaap:ShortTermDebtTextBlock>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note&#13;7 &amp;#151; Stock Options&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;There&#13;were no stock options issued during the fiscal years ended September 30 2015 and 2014. &amp;#160;As part of our bankruptcy agreement&#13;approved on September 19, 2014 all common conversion rights of any kind including the equity compensation plan without limitation&#13;, warrants, options and convertible notes were cancelled and extinguished for the current and prior fiscal years.&lt;/font&gt;&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note&#13;8 &amp;#151; Income Taxes&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;As&#13;of September 30, 2015, the Company had approximately $85,516 in post bankruptcy net operating loss carry forwards for federal&#13;income tax purposes which expire between 2015 and 2033. &amp;#160;Generally, these can be carried forward and applied against future&#13;taxable income at the tax rate applicable at that time. We are currently using a 15% effective tax rate for our projected available&#13;net operating loss carry-forward. However, as a result of potential stock offerings and stock issuance in connection with potential&#13;acquisitions, as well as the possibility of the Company not realizing its business plan objectives and having future taxable income&#13;to offset, the Company&amp;#146;s use of these NOLs may be limited under the provisions of Section 382 of the Internal Revenue Code&#13;of 1986, as amended. &amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Components&#13;of deferred tax assets and (liabilities) are as follows:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 85%; border-collapse: collapse; font-size: 10pt; margin-left: 0.5in"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; width: 72%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net operating&#13;    loss carry forwards valuation available&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 11%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;85,516&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 11%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;23,235&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Valuation Allowances&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(29,075&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(3,485&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Deferred&#13;    Tax Asset&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;29,075&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3,485&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net&#13;    Deferred Tax Asset&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-0-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-0-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;accordance with FASB ASC 740 &amp;#147;Income Taxes&amp;#148;, valuation allowances are provided against deferred tax assets, if based&#13;on the weight of available evidence, some or all of the deferred tax assets may or will not be realized. The Company has evaluated&#13;its ability to realize some or all of the deferred tax assets on its balance sheet for the coming year and has established a valuation&#13;allowance in the amount of $29,075 at September 30, 2015 During the period ended September 30, 2015 the company did not utilize&#13;any of its NOL.&lt;/font&gt;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note&#13;9 &amp;#150; Going Concern&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;accompanying financial statements have been prepared assuming that the Company will continue as a going concern. Currently, the&#13;Company has limited post bankruptcy operations and a working capital deficit as of September 30, 2015. These factors raise substantial&#13;doubt about the Company&amp;#146;s ability to continue as a going concern. Management believes that the Company&amp;#146;s capital requirements&#13;will depend on many factors including the success of the Company&amp;#146;s development efforts and its efforts to raise capital.&#13;Management also believes the Company needs to raise additional capital for working capital purposes. There is no assurance that&#13;such financing will be available in the future. &amp;#160;&amp;#160;The conditions described above raise substantial doubt about our ability&#13;to continue as a going concern. The financial statements of the Company do not include any adjustments relating to the recoverability&#13;and classification of recorded assets, or the amounts and classifications of liabilities that might be necessary should the Company&#13;be unable to continue as a going concern.&lt;/font&gt;&lt;/p&gt;</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note&#13;10 - Acquisitions&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;September 25, 2014 the company entered into an agreement to buy the ready to operate business assets of Metu Brands Inc. The cost&#13;of this acquisition was $10,000 which was allocated $795 to inventory and $9,205 to the intangible assets of the "MeTu" trade&#13;name and web site MeTuBoutique.com.&lt;/font&gt;&lt;/p&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:EarningsPerShareTextBlock contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note&#13;11 - Net Income (Loss) Per Share&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company reports basic and diluted earnings per share (EPS) according to the provisions of ASC Topic 260, which requires the presentation&#13;of basic EPS and, for companies with complex capital structures, diluted EPS. Basic EPS excludes dilution and is computed by dividing&#13;net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period.&#13;Diluted EPS is computed by dividing net income (loss) available to common stockholders, adjusted by other changes in income or&#13;loss that would result from the assumed conversion of those potential common shares, by the weighted number of common shares and&#13;common share equivalents (unless their effect is anti-dilutive) outstanding. Common stock equivalents are not included in the&#13;computation of diluted earnings per share when the Company reports a loss because to do so would be anti-dilutive. Thus, these&#13;equivalents are not included in the calculation of diluted loss per share, resulting in basic and diluted loss per share being&#13;equal. The following is a reconciliation of the computation for basic and diluted EPS for the years ended September 30, 2015 and&#13;2014:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 85%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; width: 72%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net&#13;    (Loss)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right; width: 11%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(32,281&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right; width: 11%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(23,235&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td colspan="9"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted-average common shares outstanding&#13;    basic&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted-average common&#13;    stock equivalents&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5,000,929&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;11,144&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;Stock options&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;Warrants&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;Preferred&#13;    stock&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;27,100,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;27,100,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted-average&#13;    common shares outstanding - basic and diluted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3,303,773&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;10,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note&#13;11 - Subsequent Events&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;We&#13;have evaluated subsequent events and transactions that occurred through the date and time our financial statements were issued&#13;for potential recognition or disclosure in the accompanying financial statements. Other than the change in preferred shares rights&#13;itemized in note 6 above, we did not identify any events or transactions that should be recognized or disclosed in the accompanying&#13;financial statements.&lt;/font&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:NatureOfOperations contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Description&#13;of the Company&lt;/i&gt;&lt;/b&gt;. &amp;#160;&amp;#160;We were originally incorporated on March 12, 1990 in California (&amp;#147;Ecology-CA&amp;#148;).&#13;&amp;#160;Our current entity was incorporated in Nevada on February 6, 2002 as OCIS Corp. (&amp;#147;OCIS&amp;#148;). &amp;#160;OCIS completed&#13;a merger with Ecology-CA on July 26, 2007 (the &amp;#147;Merger&amp;#148;). In the Merger, OCIS changed its name from OCIS Corporation&#13;to Ecology Coatings, Inc. The Company filed for Chapter 7 bankruptcy protection on May 15, 2013 and subsequently the corporate&#13;shell emerged as its only unencumbered asset on September 19, 2014 using "fresh start" accounting under section 852-10-45-17 as&#13;of date of sale corporate shell to reflect intangible assets sale through section 363. On that same day the Company acquired the&#13;assets of Metu Brands, Inc including the trade name "Metu" in exchange for cash and a note. On April 28, 2015 the Company amended&#13;its articles of incorporation to change its name to Metu Brands, Inc. Any business description below and all reporting results&#13;of the operating results reported in this filing for the fiscal period ending September 30, 2014 are post "fresh start" activity&#13;and not comparable to prior results. Post bankruptcy the company has been operating a web site for the sale of women's apparel.&lt;/font&gt;&lt;/p&gt;</us-gaap:NatureOfOperations>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Reclassifications&lt;/i&gt;&lt;/b&gt;.&#13;Reclassifications have been made to the prior year financial statements to conform with the current year&#13;presentation.&lt;/font&gt;&lt;/p&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Principles&#13;of Consolidation&lt;/i&gt;&lt;/b&gt;. The consolidated financial statements include all of our accounts and the accounts of our wholly&#13;owned subsidiary Ecology-CA. All significant intercompany transactions have been eliminated in consolidation.&lt;/font&gt;&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember">&lt;p&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;u&gt;Revenue Recognition&lt;/u&gt;&lt;/b&gt;. The&#13;Company applies paragraph 605-10-S99-1 of the FASB Accounting Standards Codification for revenue recognition. The Company recognizes&#13;revenue when it is realized or realizable and earned. The Company considers revenue realized or realizable and earned when all&#13;of the following criteria are met: (i) persuasive evidence of an arrangement exists, (ii) the sales price is fixed or determinable,&#13;(iii) collectability is reasonably assured and (iv) goods have been shipped and/or services rendered.&lt;/font&gt;&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember">&lt;p&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Loss Per Share&lt;/i&gt;&lt;/b&gt;. Basic loss per share&#13;is computed by dividing the net loss available to common shareholders by the weighted average number of shares of common stock&#13;outstanding during the period. &amp;#160;Diluted loss per share is computed by dividing the net loss available to common shareholders&#13;by the weighted average number of shares of common stock and potentially dilutive securities outstanding during the period. Potentially&#13;dilutive shares consist of the incremental common shares issuable upon the exercise of stock options and warrants and the conversion&#13;of convertible debt and convertible preferred stock. Potentially dilutive shares are excluded from the weighted average number&#13;of shares if their effect is anti-dilutive. None of the stock options or warrants outstanding or stock associated with the&#13;convertible debt or with the convertible preferred shares during each of the periods presented was included in the computation&#13;of diluted loss per share as they were anti-dilutive.&lt;/font&gt;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Property&#13;and Equipment&lt;/i&gt;&lt;/b&gt;. Property and equipment is stated at cost less accumulated depreciation. sDepreciation&#13;is recorded using the straight-line method over the following useful lives:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 65%; border-collapse: collapse; font-size: 10pt; margin-left: 0.15in"&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; width: 68%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Computer&#13;    equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center; width: 31%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3-10&#13;    years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Furniture and fixtures&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3-7 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Test equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5-7 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Signs&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Software&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Marketing and Promotional&#13;    Video&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Repairs&#13;and maintenance costs are charged to operations as incurred. Betterments or renewals are capitalized as incurred.&lt;/font&gt;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember">&lt;p&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Patents&lt;/i&gt;.&lt;/b&gt; It is our policy to capitalize&#13;costs associated with securing a patent. Costs consist of legal and filing fees. Once a patent is issued, it will be amortized&#13;on a straight-line basis over its estimated useful life.&lt;/font&gt;&lt;/p&gt;</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Long-Lived&#13;Assets&lt;/i&gt;&lt;/b&gt;. We review long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying&#13;amount of an asset may not be recoverable. &amp;#160;Recoverability of assets to be held and used is measured by a comparison of the&#13;carrying amount of an asset to the undiscounted future net cash flows expected to be generated by the asset. If such assets&#13;are considered to be impaired, the impairment recognized is measured by the amount by which the carrying amount of the assets&#13;exceeds the fair value of the assets.&lt;/font&gt;&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Stock-Based&#13;Compensation&lt;/i&gt;&lt;/b&gt;. Employee and director stock-based compensation expense is measured utilizing the fair-value&#13;method with expense charged to earnings over the vesting period on a straight-line basis.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;We&#13;account for stock options granted to non-employees under the fair-value method with stock-based compensation expense being charged&#13;to earnings on the earlier of the date services are performed or a performance commitment exists.&lt;/font&gt;&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Depreciation&#13;is recorded using the straight-line method over the following useful lives:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 65%; border-collapse: collapse; font-size: 10pt; margin-left: 0.15in"&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; width: 68%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Computer&#13;    equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center; width: 31%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3-10&#13;    years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Furniture and fixtures&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3-7 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Test equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5-7 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Signs&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Software&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Marketing and Promotional&#13;    Video&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:ScheduleOfFreshStartAdjustmentsTextBlock contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" nowrap="nowrap" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;9/19/2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" nowrap="nowrap" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Dr(CR)&lt;br /&gt;Reorganization&lt;br /&gt;Adjustments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" nowrap="nowrap" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Dr(CR)&#13;    Fresh Start&lt;br /&gt;Adjustments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" nowrap="nowrap" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;9/19/2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Current assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="width: 40%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;Cash&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 11%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;548&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 11%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(548)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 3%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt; (1)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 11%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 3%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 11%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;Accounts&#13;    receivable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,238&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1,238&lt;/font&gt;)&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;    (1)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Total&#13;    Current Assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,786&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;Property,&#13;    plant and equipment, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;37,249&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(37,249)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt; (1)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;Intangible&#13;    assets, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;192,864&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(192,864)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;    (1)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;54,594&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;54,594&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Total&#13;    Assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;231,899&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;54,594&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Liabilities and Equity&#13;    (Deficit)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total liabilities subject&#13;    to compromise&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,112,143&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,112,143 &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Commitments and Contingencies&#13;    (Note 5)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Metu Brands, Inc. ("MTOO")&#13;    shareholders' deficit&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;Predecessor&#13;    Preferred Stock 10,000,000 authorized at $0.001 par value shares issued and outstanding 271 at September 19, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1 &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(3)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;Successor&#13;    Preferred Stock 10,000,000 authorized at $0.001 par value; shares issued and outstanding 54,593,032 at September 19, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1 &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;Predecessor/Successor&#13;    Common Stock 90,000,000 authorized at $0.001 par value; shares issued and outstanding 54,593,032 at September 19, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;54,593&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;54,593&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;Additional&#13;    paid-in capital&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;28,615,490&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1,880,244)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt; (1)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;30,495,734&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(3)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;Retained&#13;    earnings&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(30,550,328&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(30,550,328)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(4)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Total&#13;    equity (deficit)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1,880,244&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;54,594&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Total&#13;    liabilities and equity (deficit)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;231,899&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;54,594&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1)&#13;Reorganization adjustments reflect the transfer of $2,112,143 of liabilities subject to compromise and assets to the bankruptcy&#13;trustee in accordance with the plan of bankruptcy provisions.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2)&#13;Fresh-start adjustments under section 852-10-45-17 as of the date of sale of the corporate shell to reflect intangible assets&#13;sale through section 363 of the bankruptcy code.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(3)&#13;Fresh-start adjustments under ASC 852-10-45-17 to predecessor preferred stock and APIC reflect the cancellation of the predecessor&amp;#146;s&#13;preferred stock.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(4)&#13;Fresh-start adjustment to retained earnings (accumulated deficit) resets accumulated deficit to zero.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(5)&#13;$20,000 was paid to the trustee by Shulamit Lazar for the subsequent issue of 30,000,000 common shares and $5,000 was paid to&#13;the trustee by Innovation Consulting LLC for the purchase of 271 preferred shares.&lt;/font&gt;&lt;/p&gt;</us-gaap:ScheduleOfFreshStartAdjustmentsTextBlock>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Components&#13;of deferred tax assets and (liabilities) are as follows:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 85%; border-collapse: collapse; font-size: 10pt; margin-left: 0.5in"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; width: 72%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net operating&#13;    loss carry forwards valuation available&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 11%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;85,516&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 11%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;23,235&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Valuation Allowances&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(29,075&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(3,485&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Deferred&#13;    Tax Asset&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;29,075&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3,485&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net&#13;    Deferred Tax Asset&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-0-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-0-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;following is a reconciliation of the computation for basic and diluted EPS for the years ended September 30, 2015 and 2014:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 85%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; width: 72%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net&#13;    (Loss)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right; width: 11%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(32,281&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right; width: 11%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(23,235&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td colspan="9"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted-average common shares outstanding&#13;    basic&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted-average common&#13;    stock equivalents&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5,000,929&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;11,144&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;Stock options&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;Warrants&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;Preferred&#13;    stock&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;27,100,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;27,100,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted-average&#13;    common shares outstanding - basic and diluted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3,303,773&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;10,000&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:OtherPaymentsToAcquireBusinesses contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">3000</us-gaap:OtherPaymentsToAcquireBusinesses>
    <us-gaap:CommonStockVotingRights contextRef="From2013-10-01to2014-09-30_custom_MetuBrandsIncMember">&lt;p&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Entitled to one vote per each share of common stock&#13;held.&lt;/font&gt;&lt;/p&gt;</us-gaap:CommonStockVotingRights>
    <us-gaap:ConversionOfStockSharesConverted1 contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember_us-gaap_ConvertiblePreferredStockMember" unitRef="Shares" decimals="INF">100000</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesConverted1 contextRef="From2014-10-01to2015-09-30_us-gaap_SubsequentEventMember_custom_MetuBrandsIncMember_us-gaap_ConvertiblePreferredStockMember" unitRef="Shares" decimals="INF">20000</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:PreferredStockVotingRights contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember_us-gaap_ConvertiblePreferredStockMember">&lt;p&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Each Preferred Share is entitled to the voting rights&#13;100,000 common stock shares.&lt;/font&gt;&lt;/p&gt;</us-gaap:PreferredStockVotingRights>
    <us-gaap:PreferredStockValue contextRef="AsOf2015-09-30_custom_MetuBrandsIncMember_us-gaap_ConvertiblePreferredStockMember" unitRef="USD" decimals="0">1</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2014-09-30_custom_MetuBrandsIncMember_us-gaap_ConvertiblePreferredStockMember" unitRef="USD" decimals="0">1</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2014-09-18_custom_RestatementAdjustmentOneMember_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">1</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2014-09-18_us-gaap_RestatementAdjustmentMember_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:PreferredStockValue>
    <us-gaap:DepositAssets contextRef="AsOf2015-09-30_custom_MetuBrandsIncMember_us-gaap_ChiefExecutiveOfficerMember" unitRef="USD" decimals="0">20000</us-gaap:DepositAssets>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">85516</us-gaap:OperatingLossCarryforwards>
    <abvc:OperatingLossCarryforwardsExpirationPeriodDescription contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember">&lt;p&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expire between 2015 and 2033&lt;/font&gt;&lt;/p&gt;</abvc:OperatingLossCarryforwardsExpirationPeriodDescription>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember" unitRef="Pure" decimals="INF">0.15</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">85516</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">23235</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">29075</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">3485</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">29075</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">3485</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="AsOf2014-09-25_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">10000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory contextRef="AsOf2014-09-25_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">795</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="AsOf2014-09-25_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">9205</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember" unitRef="Shares" decimals="INF">5000929</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2013-10-01to2014-09-30_custom_MetuBrandsIncMember" unitRef="Shares" decimals="INF">11144</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">27100000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants contextRef="From2013-10-01to2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">27100000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2013-10-01to2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:ShareBasedCompensation contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">30000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2014-09-17to2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2013-10-01to2014-09-18_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:ShareBasedCompensation>
    <us-gaap:NotesPayable contextRef="AsOf2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">7000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">7000</us-gaap:NotesPayable>
    <us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent contextRef="AsOf2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">9000</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent contextRef="AsOf2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">9000</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2014-09-17to2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2013-10-01to2014-09-18_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">-1238</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">-521</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2014-09-17to2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">795</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2013-10-01to2014-09-18_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">5120</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="From2014-09-17to2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">17235</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="From2013-10-01to2014-09-18_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <abvc:ProceedsFromFreshStartAdjustments contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</abvc:ProceedsFromFreshStartAdjustments>
    <abvc:ProceedsFromFreshStartAdjustments contextRef="From2014-09-17to2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">30389</abvc:ProceedsFromFreshStartAdjustments>
    <abvc:ProceedsFromFreshStartAdjustments contextRef="From2013-10-01to2014-09-18_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</abvc:ProceedsFromFreshStartAdjustments>
    <abvc:ProceedsFromCapitalInjectionToBankruptcyTrustee contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</abvc:ProceedsFromCapitalInjectionToBankruptcyTrustee>
    <abvc:ProceedsFromCapitalInjectionToBankruptcyTrustee contextRef="From2014-09-17to2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">25000</abvc:ProceedsFromCapitalInjectionToBankruptcyTrustee>
    <abvc:ProceedsFromCapitalInjectionToBankruptcyTrustee contextRef="From2013-10-01to2014-09-18_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</abvc:ProceedsFromCapitalInjectionToBankruptcyTrustee>
    <us-gaap:ProceedsFromRelatedPartyDebt contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt contextRef="From2014-09-17to2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">9000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt contextRef="From2013-10-01to2014-09-18_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromNotesPayable contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable contextRef="From2014-09-17to2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">7000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable contextRef="From2013-10-01to2014-09-18_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:ProceedsFromNotesPayable>
    <abvc:NonCashFreshStartAdjustment contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</abvc:NonCashFreshStartAdjustment>
    <abvc:NonCashFreshStartAdjustment contextRef="From2014-09-17to2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</abvc:NonCashFreshStartAdjustment>
    <abvc:NonCashFreshStartAdjustment contextRef="From2013-10-01to2014-09-18_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">30550328</abvc:NonCashFreshStartAdjustment>
    <us-gaap:ReorganizationItems contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:ReorganizationItems>
    <us-gaap:ReorganizationItems contextRef="From2014-09-17to2014-09-30_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:ReorganizationItems>
    <us-gaap:ReorganizationItems contextRef="From2013-10-01to2014-09-18_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">1880244</us-gaap:ReorganizationItems>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember_custom_InnovationConsultingLLCMember_us-gaap_ConvertiblePreferredStockMember" unitRef="Shares" decimals="INF">5000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2014-10-01to2015-09-30_custom_MetuBrandsIncMember_us-gaap_ChiefExecutiveOfficerMember" unitRef="Shares" decimals="INF">30000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2014-09-18_custom_RestatementAdjustmentOneMember_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">1238</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2014-09-18_us-gaap_RestatementAdjustmentMember_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2014-09-18_custom_RestatementAdjustmentOneMember_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">192864</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2014-09-18_us-gaap_RestatementAdjustmentMember_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">54594</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <abvc:PreferredStockValueOne contextRef="AsOf2014-09-18_custom_RestatementAdjustmentOneMember_custom_MetuBrandsIncMember" unitRef="USD" xsi:nil="true" />
    <abvc:PreferredStockValueOne contextRef="AsOf2014-09-18_us-gaap_RestatementAdjustmentMember_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">1</abvc:PreferredStockValueOne>
    <us-gaap:RepaymentsOfDebt contextRef="From2014-09-17to2014-09-18_us-gaap_ChiefExecutiveOfficerMember_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">20000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt contextRef="From2014-09-17to2014-09-18_custom_InnovationConsultingLLCMember_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">5000</us-gaap:RepaymentsOfDebt>
    <us-gaap:ReorganizationValueCashInExcessOfNormalOperatingNeeds contextRef="AsOf2014-09-18_us-gaap_ScenarioAdjustmentMember_custom_MetuBrandsIncMember" unitRef="USD" id="Foot-00-0" decimals="0">-548</us-gaap:ReorganizationValueCashInExcessOfNormalOperatingNeeds>
    <abvc:ReorganizationValueNetRealizableValueOfAccountsReceivableDispositions contextRef="AsOf2014-09-18_us-gaap_ScenarioAdjustmentMember_custom_MetuBrandsIncMember" unitRef="USD" id="Foot-00-1" decimals="0">-1238</abvc:ReorganizationValueNetRealizableValueOfAccountsReceivableDispositions>
    <abvc:ReorganizationValueNetRealizableValueOfPropertyPlantAndEquipmentDispositions contextRef="AsOf2014-09-18_us-gaap_ScenarioAdjustmentMember_custom_MetuBrandsIncMember" unitRef="USD" id="Foot-00-2" decimals="0">-37249</abvc:ReorganizationValueNetRealizableValueOfPropertyPlantAndEquipmentDispositions>
    <abvc:ReorganizationValueNetRealizableValueOfIntangibleAssetDispositions contextRef="AsOf2014-09-18_us-gaap_ScenarioAdjustmentMember_custom_MetuBrandsIncMember" unitRef="USD" id="Foot-00-3" decimals="0">-192864</abvc:ReorganizationValueNetRealizableValueOfIntangibleAssetDispositions>
    <abvc:ReorganizationValueNetRealizableValueOfTotalliabilitiestDispositions contextRef="AsOf2014-09-18_us-gaap_ScenarioAdjustmentMember_custom_MetuBrandsIncMember" unitRef="USD" id="Foot-00-4" decimals="0">2112143</abvc:ReorganizationValueNetRealizableValueOfTotalliabilitiestDispositions>
    <abvc:ReorganizationValueNetRealizableValueOfAdditionalPaidInCapitalDispositions contextRef="AsOf2014-09-18_us-gaap_ScenarioAdjustmentMember_custom_MetuBrandsIncMember" unitRef="USD" id="Foot-00-5" decimals="0">-1880244</abvc:ReorganizationValueNetRealizableValueOfAdditionalPaidInCapitalDispositions>
    <abvc:ReorganizationValueNetRealizableValueOfLiabilitiesAndStockholdersEquityDispositions contextRef="AsOf2014-09-18_us-gaap_ScenarioAdjustmentMember_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</abvc:ReorganizationValueNetRealizableValueOfLiabilitiesAndStockholdersEquityDispositions>
    <us-gaap:FreshStartAdjustmentIncreaseDecreaseAmortizableIntangibleAssets contextRef="AsOf2014-09-18_custom_FreshStartAdustmentsMember_custom_MetuBrandsIncMember" unitRef="USD" id="Foot-01-0" decimals="0">54594</us-gaap:FreshStartAdjustmentIncreaseDecreaseAmortizableIntangibleAssets>
    <us-gaap:FreshStartAdjustmentIncreaseDecreasePreferredStock contextRef="AsOf2014-09-18_custom_FreshStartAdustmentsMember_custom_MetuBrandsIncMember" unitRef="USD" id="Foot-02-0" decimals="0">-1</us-gaap:FreshStartAdjustmentIncreaseDecreasePreferredStock>
    <abvc:FreshStartAdjustmentIncreaseDecreasePreferredStock1 contextRef="AsOf2014-09-18_custom_FreshStartAdustmentsMember_custom_MetuBrandsIncMember" unitRef="USD" id="Foot-01-1" decimals="0">1</abvc:FreshStartAdjustmentIncreaseDecreasePreferredStock1>
    <us-gaap:FreshStartAdjustmentIncreaseDecreaseAdditionalPaidInCapital contextRef="AsOf2014-09-18_custom_FreshStartAdustmentsMember_custom_MetuBrandsIncMember" unitRef="USD" id="Foot-02-1" decimals="0">30495734</us-gaap:FreshStartAdjustmentIncreaseDecreaseAdditionalPaidInCapital>
    <us-gaap:FreshStartAdjustmentIncreaseDecreaseRetainedEarningsDeficit contextRef="AsOf2014-09-18_custom_FreshStartAdustmentsMember_custom_MetuBrandsIncMember" unitRef="USD" id="Foot-03-0" decimals="0">-30550328</us-gaap:FreshStartAdjustmentIncreaseDecreaseRetainedEarningsDeficit>
    <us-gaap:FreshStartAdjustmentIncreaseDecreaseLiabilitiesAndStockholdersEquity contextRef="AsOf2014-09-18_custom_FreshStartAdustmentsMember_custom_MetuBrandsIncMember" unitRef="USD" decimals="0">0</us-gaap:FreshStartAdjustmentIncreaseDecreaseLiabilitiesAndStockholdersEquity>
    <us-gaap:SharesOutstanding contextRef="AsOf2013-09-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">11144</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2014-09-18_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">11144</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2014-09-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">11144</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2015-09-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">60011144</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2013-09-30_us-gaap_PreferredStockMember" unitRef="Shares" decimals="INF">271</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2014-09-18_us-gaap_PreferredStockMember" unitRef="Shares" decimals="INF">271</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2014-09-30_us-gaap_PreferredStockMember" unitRef="Shares" decimals="INF">271</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2015-09-30_us-gaap_PreferredStockMember" unitRef="Shares" decimals="INF">271</us-gaap:SharesOutstanding>
    <abvc:AdjustmentsToAdditionalPaidInCapitalFreshStartAdjustments contextRef="From2013-10-01to2014-09-18" unitRef="USD" decimals="0">54594</abvc:AdjustmentsToAdditionalPaidInCapitalFreshStartAdjustments>
    <abvc:AdjustmentsToAdditionalPaidInCapitalFreshStartAdjustments contextRef="From2013-10-01to2014-09-18_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">-30495734</abvc:AdjustmentsToAdditionalPaidInCapitalFreshStartAdjustments>
    <abvc:AdjustmentsToAdditionalPaidInCapitalFreshStartAdjustments contextRef="From2013-10-01to2014-09-18_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">30550328</abvc:AdjustmentsToAdditionalPaidInCapitalFreshStartAdjustments>
    <abvc:AdjustmentsToAdditionalPaidInCapitalReorganizationAdjustments contextRef="From2013-10-01to2014-09-18" unitRef="USD" decimals="0">-1880244</abvc:AdjustmentsToAdditionalPaidInCapitalReorganizationAdjustments>
    <abvc:AdjustmentsToAdditionalPaidInCapitalReorganizationAdjustments contextRef="From2013-10-01to2014-09-18_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">1880244</abvc:AdjustmentsToAdditionalPaidInCapitalReorganizationAdjustments>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2014-10-01to2015-09-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">30000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2014-10-01to2015-09-30" unitRef="USD" decimals="0">30000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="From2014-10-01to2015-09-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">30000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <abvc:BankruptcySharesIssuedValue contextRef="From2014-10-01to2015-09-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">30000</abvc:BankruptcySharesIssuedValue>
    <abvc:BankruptcySharesIssuedValue contextRef="From2014-10-01to2015-09-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">-30000</abvc:BankruptcySharesIssuedValue>
    <abvc:BankruptcySharesIssuedShares contextRef="From2014-10-01to2015-09-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">30000000</abvc:BankruptcySharesIssuedShares>
    <abvc:PreferredStockSharesAuthorizedOne contextRef="AsOf2014-09-18_custom_MetuBrandsIncMember" unitRef="Shares" decimals="INF">10000000</abvc:PreferredStockSharesAuthorizedOne>
    <abvc:PreferredStockParOrStatedValuePerShareOne contextRef="AsOf2014-09-18_custom_MetuBrandsIncMember" unitRef="USDPShares" decimals="INF">0.001</abvc:PreferredStockParOrStatedValuePerShareOne>
    <abvc:PreferredStockSharesIssuedOne contextRef="AsOf2014-09-18_custom_MetuBrandsIncMember" unitRef="Shares" decimals="INF">54593032</abvc:PreferredStockSharesIssuedOne>
    <abvc:PreferredStockSharesOutstandingOne contextRef="AsOf2014-09-18_custom_MetuBrandsIncMember" unitRef="Shares" decimals="INF">54593032</abvc:PreferredStockSharesOutstandingOne>
    <link:footnoteLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="#Foot-00-0" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-1" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-2" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-3" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-4" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-5" xlink:label="Foot-00_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-00_loc" xlink:to="Footnote-01" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-0" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-1" xlink:label="Foot-01_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-01_loc" xlink:to="Footnote-02" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-0" xlink:label="Foot-02_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-1" xlink:label="Foot-02_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-02_loc" xlink:to="Footnote-03" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-03-0" xlink:label="Foot-03_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-03_loc" xlink:to="Footnote-04" order="1" />
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-01" xml:lang="en-US">Reorganization adjustments reflect the transfer of $2,112,143 of liabilities subject to compromise and assets to the bankruptcy trustee in accordance with the plan of bankruptcy provisions.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-02" xml:lang="en-US">Fresh-start adjustments under section 852-10-45-17 as of the date of sale of the corporate shell to reflect intangible assets sale through section 363 of the bankruptcy code.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-03" xml:lang="en-US">Fresh-start adjustments under ASC 852-10-45-17 to predecessor preferred stock and APIC reflect the cancellation of the predecessor's preferred stock.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-04" xml:lang="en-US">Fresh-start adjustment to retained earnings (accumulated deficit) resets accumulated deficit to zero.</link:footnote>
    </link:footnoteLink>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>abvc-20160630.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Created by S2 Filings, LLC- http://www.s2filings.com -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2016-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:abvc="http://metuboutique.com/20160630" elementFormDefault="qualified" targetNamespace="http://metuboutique.com/20160630">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://metuboutique.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
	  <link:definition>00000001 - Document - Document and Entity Information</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/CondensedConsolidatedBalanceSheets" id="CondensedConsolidatedBalanceSheets">
	  <link:definition>00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/CondensedConsolidatedBalanceSheetsParenthetical" id="CondensedConsolidatedBalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/CondensedConsolidatedStatementsOfOperations" id="CondensedConsolidatedStatementsOfOperations">
	  <link:definition>00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" id="ConsolidatedStatementsOfChangesInStockholdersEquityDeficiency">
	  <link:definition>00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIENCY)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/CondensedConsolidatedStatementsOfCashFlow" id="CondensedConsolidatedStatementsOfCashFlow">
	  <link:definition>00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/OrganizationAndDescriptionOfBusiness" id="OrganizationAndDescriptionOfBusiness">
	  <link:definition>00000007 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
	  <link:definition>00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/CollaobrativeAgreement" id="CollaobrativeAgreement">
	  <link:definition>00000009 - Disclosure - COLLAOBRATIVE AGREEMENT</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/FreshStartAccounting" id="FreshStartAccounting">
	  <link:definition>00000010 - Disclosure - Fresh Start Accounting</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/RelatedPartiesTransactions" id="RelatedPartiesTransactions">
	  <link:definition>00000011 - Disclosure - RELATED PARTIES TRANSACTIONS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/AccountsPayable" id="AccountsPayable">
	  <link:definition>00000012 - Disclosure - ACCOUNTS PAYABLE</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/NotesPayable" id="NotesPayable">
	  <link:definition>00000013 - Disclosure - Notes Payable</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/Equtiy" id="Equtiy">
	  <link:definition>00000014 - Disclosure - EQUTIY</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
	  <link:definition>00000015 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/StockOptions" id="StockOptions">
	  <link:definition>00000016 - Disclosure - Stock Options</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/IncomeTaxes" id="IncomeTaxes">
	  <link:definition>00000017 - Disclosure - Income Taxes</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/GoingConcern" id="GoingConcern">
	  <link:definition>00000018 - Disclosure - Going Concern</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/Acquisitions" id="Acquisitions">
	  <link:definition>00000019 - Disclosure - Acquisitions</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/NetIncomeLossPerShare" id="NetIncomeLossPerShare">
	  <link:definition>00000020 - Disclosure - Net Income (Loss) Per Share</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000021 - Disclosure - Subsequent Events</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
	  <link:definition>00000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
	  <link:definition>00000023 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/FreshStartAccountingTables" id="FreshStartAccountingTables">
	  <link:definition>00000024 - Disclosure - Fresh Start Accounting (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
	  <link:definition>00000025 - Disclosure - Income Taxes (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/NetIncomeLossPerShareTables" id="NetIncomeLossPerShareTables">
	  <link:definition>00000026 - Disclosure - Net Income (Loss) Per Share (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" id="OrganizationAndDescriptionOfBusinessDetailsNarrative">
	  <link:definition>00000027 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/SummaryOfSignificantAccountingPoliciesDetails" id="SummaryOfSignificantAccountingPoliciesDetails">
	  <link:definition>00000028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
	  <link:definition>00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/CollaobrativeAgreementDetailsNarrative" id="CollaobrativeAgreementDetailsNarrative">
	  <link:definition>00000030 - Disclosure - COLLAOBRATIVE AGREEMENT (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/FreshStartAccountingDetails" id="FreshStartAccountingDetails">
	  <link:definition>00000031 - Disclosure - Fresh Start Accounting (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/RelatedPartiesTransactionsDetailsNarrative" id="RelatedPartiesTransactionsDetailsNarrative">
	  <link:definition>00000032 - Disclosure - RELATED PARTIES TRANSACTIONS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/AccountsPayableDetailsNarrative" id="AccountsPayableDetailsNarrative">
	  <link:definition>00000033 - Disclosure - ACCOUNTS PAYABLE (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/NotesPayableDetailsNarrative" id="NotesPayableDetailsNarrative">
	  <link:definition>00000034 - Disclosure - Notes Payable (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/EqutiyDetailsNarrative" id="EqutiyDetailsNarrative">
	  <link:definition>00000035 - Disclosure - EQUTIY (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
	  <link:definition>00000036 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
	  <link:definition>00000037 - Disclosure - Income Taxes (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/IncomeTaxesDetails" id="IncomeTaxesDetails">
	  <link:definition>00000038 - Disclosure - Income Taxes (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/AcquisitionsDetailsNarrative" id="AcquisitionsDetailsNarrative">
	  <link:definition>00000039 - Disclosure - Acquisitions (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://metuboutique.com/role/NetIncomeLossPerShareDetails" id="NetIncomeLossPerShareDetails">
	  <link:definition>00000040 - Disclosure - Net Income (Loss) Per Share (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="abvc-20160630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="abvc-20160630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="abvc-20160630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="abvc-20160630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-types-2016-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <element id="abvc_Prepayment" name="Prepayment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_RetainedEarningsAccumulatedDeficit1" name="RetainedEarningsAccumulatedDeficit1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_IncreaseDecreaseInPrepayment" name="IncreaseDecreaseInPrepayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_ForwardStockSplitPolicyTextBlock" name="ForwardStockSplitPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_AgreementPeriod" name="AgreementPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_CallaobrativeAgreementDisclosureTextBlock" name="CallaobrativeAgreementDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_UpfrontPayment" name="UpfrontPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_DescriptionOfAgreementTerms" name="DescriptionOfAgreementTerms" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_DebtInstrumentCancelledAmount" name="DebtInstrumentCancelledAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_FreshStartAdjustmentTextBlock" name="FreshStartAdjustmentTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_OperatingLossCarryforwardsExpirationPeriodDescription" name="OperatingLossCarryforwardsExpirationPeriodDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_ProceedsFromFreshStartAdjustments" name="ProceedsFromFreshStartAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_ProceedsFromCapitalInjectionToBankruptcyTrustee" name="ProceedsFromCapitalInjectionToBankruptcyTrustee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_NonCashFreshStartAdjustment" name="NonCashFreshStartAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_PreferredStockValueOne" name="PreferredStockValueOne" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_ReorganizationValueNetRealizableValueOfAccountsReceivableDispositions" name="ReorganizationValueNetRealizableValueOfAccountsReceivableDispositions" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_ReorganizationValueNetRealizableValueOfPropertyPlantAndEquipmentDispositions" name="ReorganizationValueNetRealizableValueOfPropertyPlantAndEquipmentDispositions" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_ReorganizationValueNetRealizableValueOfIntangibleAssetDispositions" name="ReorganizationValueNetRealizableValueOfIntangibleAssetDispositions" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_ReorganizationValueNetRealizableValueOfTotalliabilitiestDispositions" name="ReorganizationValueNetRealizableValueOfTotalliabilitiestDispositions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_ReorganizationValueNetRealizableValueOfAdditionalPaidInCapitalDispositions" name="ReorganizationValueNetRealizableValueOfAdditionalPaidInCapitalDispositions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_ReorganizationValueNetRealizableValueOfLiabilitiesAndStockholdersEquityDispositions" name="ReorganizationValueNetRealizableValueOfLiabilitiesAndStockholdersEquityDispositions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_FreshStartAdjustmentIncreaseDecreasePreferredStock1" name="FreshStartAdjustmentIncreaseDecreasePreferredStock1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_AdjustmentsToAdditionalPaidInCapitalFreshStartAdjustments" name="AdjustmentsToAdditionalPaidInCapitalFreshStartAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_AdjustmentsToAdditionalPaidInCapitalReorganizationAdjustments" name="AdjustmentsToAdditionalPaidInCapitalReorganizationAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_BankruptcySharesIssuedValue" name="BankruptcySharesIssuedValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_BankruptcySharesIssuedShares" name="BankruptcySharesIssuedShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_PreferredStockSharesAuthorizedOne" name="PreferredStockSharesAuthorizedOne" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_PreferredStockParOrStatedValuePerShareOne" name="PreferredStockParOrStatedValuePerShareOne" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_PreferredStockSharesIssuedOne" name="PreferredStockSharesIssuedOne" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_PreferredStockSharesOutstandingOne" name="PreferredStockSharesOutstandingOne" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_ShareExchangeAgreementMember" name="ShareExchangeAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_AmericanBriVisionHoldingCorporationMember" name="AmericanBriVisionHoldingCorporationMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_EuroAsiaInvestmentAndFinanceCorpLimitedMember" name="EuroAsiaInvestmentAndFinanceCorpLimitedMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_AmericanBriVisionCorporationMember" name="AmericanBriVisionCorporationMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_BioLiteIncMember" name="BioLiteIncMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_YuanGeneCorporationMember" name="YuanGeneCorporationMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_LiteArtIncMember" name="LiteArtIncMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_CollaborativeAgreementMember" name="CollaborativeAgreementMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_LicensingRightsMember" name="LicensingRightsMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_MetuBrandsIncMember" name="MetuBrandsIncMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_SignsMember" name="SignsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_MarketingAndPromotionalVideoMember" name="MarketingAndPromotionalVideoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_SeeneLLCMember" name="SeeneLLCMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_InnovationConsultingLLCMember" name="InnovationConsultingLLCMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_RestatementAdjustmentOneMember" name="RestatementAdjustmentOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_FreshStartAdustmentsMember" name="FreshStartAdustmentsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_CollaobrativeAgreementAbstract" name="CollaobrativeAgreementAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_NotesToFinancialStatementsAbstract" name="NotesToFinancialStatementsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_FreshStartAccountingTablesAbstract" name="FreshStartAccountingTablesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_SummaryOfSignificantAccountingPoliciesDetailsAbstract" name="SummaryOfSignificantAccountingPoliciesDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="abvc_CollaobrativeAgreementDetailsNarrativeAbstract" name="CollaobrativeAgreementDetailsNarrativeAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>abvc-20160630_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Created by S2 Filings, LLC- http://www.s2filings.com -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://metuboutique.com/role/DocumentAndEntityInformation" xlink:href="abvc-20160630.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/CondensedConsolidatedBalanceSheets" xlink:href="abvc-20160630.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="abvc-20160630.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/CondensedConsolidatedStatementsOfOperations" xlink:href="abvc-20160630.xsd#CondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" xlink:href="abvc-20160630.xsd#ConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/CondensedConsolidatedStatementsOfCashFlow" xlink:href="abvc-20160630.xsd#CondensedConsolidatedStatementsOfCashFlow" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/OrganizationAndDescriptionOfBusiness" xlink:href="abvc-20160630.xsd#OrganizationAndDescriptionOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="abvc-20160630.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/CollaobrativeAgreement" xlink:href="abvc-20160630.xsd#CollaobrativeAgreement" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/FreshStartAccounting" xlink:href="abvc-20160630.xsd#FreshStartAccounting" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/RelatedPartiesTransactions" xlink:href="abvc-20160630.xsd#RelatedPartiesTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/AccountsPayable" xlink:href="abvc-20160630.xsd#AccountsPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/NotesPayable" xlink:href="abvc-20160630.xsd#NotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/Equtiy" xlink:href="abvc-20160630.xsd#Equtiy" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/CommitmentsAndContingencies" xlink:href="abvc-20160630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/StockOptions" xlink:href="abvc-20160630.xsd#StockOptions" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/IncomeTaxes" xlink:href="abvc-20160630.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/GoingConcern" xlink:href="abvc-20160630.xsd#GoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/Acquisitions" xlink:href="abvc-20160630.xsd#Acquisitions" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/NetIncomeLossPerShare" xlink:href="abvc-20160630.xsd#NetIncomeLossPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/SubsequentEvents" xlink:href="abvc-20160630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="abvc-20160630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="abvc-20160630.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/FreshStartAccountingTables" xlink:href="abvc-20160630.xsd#FreshStartAccountingTables" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/IncomeTaxesTables" xlink:href="abvc-20160630.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/NetIncomeLossPerShareTables" xlink:href="abvc-20160630.xsd#NetIncomeLossPerShareTables" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" xlink:href="abvc-20160630.xsd#OrganizationAndDescriptionOfBusinessDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:href="abvc-20160630.xsd#SummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="abvc-20160630.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/CollaobrativeAgreementDetailsNarrative" xlink:href="abvc-20160630.xsd#CollaobrativeAgreementDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/FreshStartAccountingDetails" xlink:href="abvc-20160630.xsd#FreshStartAccountingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/RelatedPartiesTransactionsDetailsNarrative" xlink:href="abvc-20160630.xsd#RelatedPartiesTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/AccountsPayableDetailsNarrative" xlink:href="abvc-20160630.xsd#AccountsPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/NotesPayableDetailsNarrative" xlink:href="abvc-20160630.xsd#NotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/EqutiyDetailsNarrative" xlink:href="abvc-20160630.xsd#EqutiyDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="abvc-20160630.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/IncomeTaxesDetailsNarrative" xlink:href="abvc-20160630.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/IncomeTaxesDetails" xlink:href="abvc-20160630.xsd#IncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/AcquisitionsDetailsNarrative" xlink:href="abvc-20160630.xsd#AcquisitionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/NetIncomeLossPerShareDetails" xlink:href="abvc-20160630.xsd#NetIncomeLossPerShareDetails" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/CondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCash" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_Prepayment" xlink:label="loc_abvcPrepayment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_abvcPrepayment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaapDepositsAssetsNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapDepositsAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionDueFromToRelatedParty" xlink:label="loc_us-gaapRelatedPartyTransactionDueFromToRelatedParty" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapRelatedPartyTransactionDueFromToRelatedParty" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DueToOfficersOrStockholdersCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToOfficersOrStockholdersCurrentAndNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapDueToOfficersOrStockholdersCurrentAndNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapShortTermBorrowings" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapNotesPayableRelatedPartiesCurrentAndNoncurrent" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapNotesPayableRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:label="loc_us-gaapCommonStockShareSubscribedButUnissuedSubscriptionsReceivable" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_RetainedEarningsAccumulatedDeficit1" xlink:label="loc_abvcRetainedEarningsAccumulatedDeficit1" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_abvcRetainedEarningsAccumulatedDeficit1" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/CondensedConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaapSalesRevenueNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapSalesRevenueNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaapInvestmentIncomeInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInvestmentIncomeInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaapOtherIncome" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIENCY)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/CondensedConsolidatedStatementsOfCashFlow" xlink:title="00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInDepositOtherAssets" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInDepositOtherAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_IncreaseDecreaseInPrepayment" xlink:label="loc_abvcIncreaseDecreaseInPrepayment" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_abvcIncreaseDecreaseInPrepayment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent" xlink:label="loc_us-gaapIncreaseDecreaseInDueFromRelatedPartiesCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInDueFromRelatedPartiesCurrent" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:label="loc_us-gaapIncreaseDecreaseInDueToRelatedPartiesCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInDueToOfficersAndStockholdersCurrent" xlink:label="loc_us-gaapIncreaseDecreaseInDueToOfficersAndStockholdersCurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInDueToOfficersAndStockholdersCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableRelatedParties" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromShortTermDebt" xlink:label="loc_us-gaapProceedsFromShortTermDebt" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_us-gaapProceedsFromShortTermDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_ProceedsFromFreshStartAdjustments" xlink:label="loc_abvcProceedsFromFreshStartAdjustments" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_abvcProceedsFromFreshStartAdjustments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_ProceedsFromCapitalInjectionToBankruptcyTrustee" xlink:label="loc_abvcProceedsFromCapitalInjectionToBankruptcyTrustee" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_abvcProceedsFromCapitalInjectionToBankruptcyTrustee" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashAndCashEquivalents" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/OrganizationAndDescriptionOfBusiness" xlink:title="00000007 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/CollaobrativeAgreement" xlink:title="00000009 - Disclosure - COLLAOBRATIVE AGREEMENT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/FreshStartAccounting" xlink:title="00000010 - Disclosure - Fresh Start Accounting" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/RelatedPartiesTransactions" xlink:title="00000011 - Disclosure - RELATED PARTIES TRANSACTIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/AccountsPayable" xlink:title="00000012 - Disclosure - ACCOUNTS PAYABLE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/NotesPayable" xlink:title="00000013 - Disclosure - Notes Payable" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/Equtiy" xlink:title="00000014 - Disclosure - EQUTIY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/CommitmentsAndContingencies" xlink:title="00000015 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/StockOptions" xlink:title="00000016 - Disclosure - Stock Options" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/IncomeTaxes" xlink:title="00000017 - Disclosure - Income Taxes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/GoingConcern" xlink:title="00000018 - Disclosure - Going Concern" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/Acquisitions" xlink:title="00000019 - Disclosure - Acquisitions" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/NetIncomeLossPerShare" xlink:title="00000020 - Disclosure - Net Income (Loss) Per Share" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/SubsequentEvents" xlink:title="00000021 - Disclosure - Subsequent Events" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000023 - Disclosure - Summary of Significant Accounting Policies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/FreshStartAccountingTables" xlink:title="00000024 - Disclosure - Fresh Start Accounting (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/IncomeTaxesTables" xlink:title="00000025 - Disclosure - Income Taxes (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/NetIncomeLossPerShareTables" xlink:title="00000026 - Disclosure - Net Income (Loss) Per Share (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" xlink:title="00000027 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:title="00000028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/CollaobrativeAgreementDetailsNarrative" xlink:title="00000030 - Disclosure - COLLAOBRATIVE AGREEMENT (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/FreshStartAccountingDetails" xlink:title="00000031 - Disclosure - Fresh Start Accounting (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/RelatedPartiesTransactionsDetailsNarrative" xlink:title="00000032 - Disclosure - RELATED PARTIES TRANSACTIONS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/AccountsPayableDetailsNarrative" xlink:title="00000033 - Disclosure - ACCOUNTS PAYABLE (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/NotesPayableDetailsNarrative" xlink:title="00000034 - Disclosure - Notes Payable (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/EqutiyDetailsNarrative" xlink:title="00000035 - Disclosure - EQUTIY (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000036 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000037 - Disclosure - Income Taxes (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/IncomeTaxesDetails" xlink:title="00000038 - Disclosure - Income Taxes (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/AcquisitionsDetailsNarrative" xlink:title="00000039 - Disclosure - Acquisitions (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/NetIncomeLossPerShareDetails" xlink:title="00000040 - Disclosure - Net Income (Loss) Per Share (Details)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>abvc-20160630_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Created by S2 Filings, LLC- http://www.s2filings.com -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://metuboutique.com/role/DocumentAndEntityInformation" xlink:href="abvc-20160630.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/CondensedConsolidatedBalanceSheets" xlink:href="abvc-20160630.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="abvc-20160630.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/CondensedConsolidatedStatementsOfOperations" xlink:href="abvc-20160630.xsd#CondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" xlink:href="abvc-20160630.xsd#ConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/CondensedConsolidatedStatementsOfCashFlow" xlink:href="abvc-20160630.xsd#CondensedConsolidatedStatementsOfCashFlow" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/OrganizationAndDescriptionOfBusiness" xlink:href="abvc-20160630.xsd#OrganizationAndDescriptionOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="abvc-20160630.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/CollaobrativeAgreement" xlink:href="abvc-20160630.xsd#CollaobrativeAgreement" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/FreshStartAccounting" xlink:href="abvc-20160630.xsd#FreshStartAccounting" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/RelatedPartiesTransactions" xlink:href="abvc-20160630.xsd#RelatedPartiesTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/AccountsPayable" xlink:href="abvc-20160630.xsd#AccountsPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/NotesPayable" xlink:href="abvc-20160630.xsd#NotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/Equtiy" xlink:href="abvc-20160630.xsd#Equtiy" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/CommitmentsAndContingencies" xlink:href="abvc-20160630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/StockOptions" xlink:href="abvc-20160630.xsd#StockOptions" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/IncomeTaxes" xlink:href="abvc-20160630.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/GoingConcern" xlink:href="abvc-20160630.xsd#GoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/Acquisitions" xlink:href="abvc-20160630.xsd#Acquisitions" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/NetIncomeLossPerShare" xlink:href="abvc-20160630.xsd#NetIncomeLossPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/SubsequentEvents" xlink:href="abvc-20160630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="abvc-20160630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="abvc-20160630.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/FreshStartAccountingTables" xlink:href="abvc-20160630.xsd#FreshStartAccountingTables" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/IncomeTaxesTables" xlink:href="abvc-20160630.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/NetIncomeLossPerShareTables" xlink:href="abvc-20160630.xsd#NetIncomeLossPerShareTables" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" xlink:href="abvc-20160630.xsd#OrganizationAndDescriptionOfBusinessDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:href="abvc-20160630.xsd#SummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="abvc-20160630.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/CollaobrativeAgreementDetailsNarrative" xlink:href="abvc-20160630.xsd#CollaobrativeAgreementDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/FreshStartAccountingDetails" xlink:href="abvc-20160630.xsd#FreshStartAccountingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/RelatedPartiesTransactionsDetailsNarrative" xlink:href="abvc-20160630.xsd#RelatedPartiesTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/AccountsPayableDetailsNarrative" xlink:href="abvc-20160630.xsd#AccountsPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/NotesPayableDetailsNarrative" xlink:href="abvc-20160630.xsd#NotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/EqutiyDetailsNarrative" xlink:href="abvc-20160630.xsd#EqutiyDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="abvc-20160630.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/IncomeTaxesDetailsNarrative" xlink:href="abvc-20160630.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/IncomeTaxesDetails" xlink:href="abvc-20160630.xsd#IncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/AcquisitionsDetailsNarrative" xlink:href="abvc-20160630.xsd#AcquisitionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/NetIncomeLossPerShareDetails" xlink:href="abvc-20160630.xsd#NetIncomeLossPerShareDetails" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/CondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="loc_us-gaapConvertiblePreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapConvertiblePreferredStockMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapAssetsCurrentAbstract_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_70" xlink:to="loc_us-gaapCash_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_Prepayment" xlink:label="loc_abvcPrepayment_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_70" xlink:to="loc_abvcPrepayment_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_70" xlink:to="loc_us-gaapInventoryNet_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_70" xlink:to="loc_us-gaapAssetsCurrent_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaapDepositsAssetsNoncurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapDepositsAssetsNoncurrent_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapAssets_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent_70" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapNotesPayable_70" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapAccountsPayableCurrent_70" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapNotesPayableRelatedPartiesCurrentAndNoncurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapNotesPayableRelatedPartiesCurrentAndNoncurrent_70" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent_70" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionDueFromToRelatedParty" xlink:label="loc_us-gaapRelatedPartyTransactionDueFromToRelatedParty_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapRelatedPartyTransactionDueFromToRelatedParty_70" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DueToOfficersOrStockholdersCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToOfficersOrStockholdersCurrentAndNoncurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapDueToOfficersOrStockholdersCurrentAndNoncurrent_70" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapShortTermBorrowings_70" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapLiabilities_70" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapCommitmentsAndContingencies_70" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapStockholdersEquityAbstract_70" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapPreferredStockValue_70" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapCommonStockValue_70" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapAdditionalPaidInCapital_70" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:label="loc_us-gaapCommonStockShareSubscribedButUnissuedSubscriptionsReceivable_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapCommonStockShareSubscribedButUnissuedSubscriptionsReceivable_70" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_RetainedEarningsAccumulatedDeficit1" xlink:label="loc_abvcRetainedEarningsAccumulatedDeficit1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_abvcRetainedEarningsAccumulatedDeficit1_70" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_70" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapStockholdersEquity_70" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_70" xlink:type="arc" order="29" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="loc_us-gaapConvertiblePreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapConvertiblePreferredStockMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_70" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/CondensedConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaapSalesRevenueNet_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSalesRevenueNet_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGrossProfit_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingExpensesAbstract_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_60" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_60" xlink:to="loc_us-gaapOperatingExpenses_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaapInvestmentIncomeInterest_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_60" xlink:to="loc_us-gaapInvestmentIncomeInterest_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_60" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaapOtherIncome_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_60" xlink:to="loc_us-gaapOtherIncome_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_60" xlink:to="loc_us-gaapInterestExpense_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_60" xlink:to="loc_us-gaapNonoperatingIncomeExpense_60" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_60" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_60" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_60" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract_60" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract_60" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted_60" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract_60" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted_60" xlink:type="arc" order="18" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIENCY)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapPreferredStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward_60" xlink:to="loc_us-gaapStockholdersEquity_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward_60" xlink:to="loc_us-gaapSharesOutstanding_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_AdjustmentsToAdditionalPaidInCapitalFreshStartAdjustments" xlink:label="loc_abvcAdjustmentsToAdditionalPaidInCapitalFreshStartAdjustments_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward_60" xlink:to="loc_abvcAdjustmentsToAdditionalPaidInCapitalFreshStartAdjustments_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_AdjustmentsToAdditionalPaidInCapitalReorganizationAdjustments" xlink:label="loc_abvcAdjustmentsToAdditionalPaidInCapitalReorganizationAdjustments_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward_60" xlink:to="loc_abvcAdjustmentsToAdditionalPaidInCapitalReorganizationAdjustments_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward_60" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward_60" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_BankruptcySharesIssuedValue" xlink:label="loc_abvcBankruptcySharesIssuedValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward_60" xlink:to="loc_abvcBankruptcySharesIssuedValue_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_BankruptcySharesIssuedShares" xlink:label="loc_abvcBankruptcySharesIssuedShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward_60" xlink:to="loc_abvcBankruptcySharesIssuedShares_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward_60" xlink:to="loc_us-gaapNetIncomeLoss_60" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/CondensedConsolidatedStatementsOfCashFlow" xlink:title="00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_60" xlink:to="loc_us-gaapNetIncomeLoss_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_60" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_60" xlink:to="loc_us-gaapShareBasedCompensation_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInDepositOtherAssets_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_60" xlink:to="loc_us-gaapIncreaseDecreaseInDepositOtherAssets_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_IncreaseDecreaseInPrepayment" xlink:label="loc_abvcIncreaseDecreaseInPrepayment_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_60" xlink:to="loc_abvcIncreaseDecreaseInPrepayment_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent" xlink:label="loc_us-gaapIncreaseDecreaseInDueFromRelatedPartiesCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_60" xlink:to="loc_us-gaapIncreaseDecreaseInDueFromRelatedPartiesCurrent_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_60" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:label="loc_us-gaapIncreaseDecreaseInDueToRelatedPartiesCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_60" xlink:to="loc_us-gaapIncreaseDecreaseInDueToRelatedPartiesCurrent_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInDueToOfficersAndStockholdersCurrent" xlink:label="loc_us-gaapIncreaseDecreaseInDueToOfficersAndStockholdersCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_60" xlink:to="loc_us-gaapIncreaseDecreaseInDueToOfficersAndStockholdersCurrent_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableRelatedParties_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_60" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableRelatedParties_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_60" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_60" xlink:to="loc_us-gaapIncreaseDecreaseInInventories_60" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_60" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities_60" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_60" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations_60" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_60" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_60" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets_60" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_60" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations_60" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_60" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_ProceedsFromFreshStartAdjustments" xlink:label="loc_abvcProceedsFromFreshStartAdjustments_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_60" xlink:to="loc_abvcProceedsFromFreshStartAdjustments_60" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_ProceedsFromCapitalInjectionToBankruptcyTrustee" xlink:label="loc_abvcProceedsFromCapitalInjectionToBankruptcyTrustee_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_60" xlink:to="loc_abvcProceedsFromCapitalInjectionToBankruptcyTrustee_60" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_60" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt_60" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_60" xlink:to="loc_us-gaapProceedsFromNotesPayable_60" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromShortTermDebt" xlink:label="loc_us-gaapProceedsFromShortTermDebt_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_60" xlink:to="loc_us-gaapProceedsFromShortTermDebt_60" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_60" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock_60" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_60" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations_60" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashAndCashEquivalents_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_60" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashAndCashEquivalents_60" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease_60" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCash_60" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract_60" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaapInterestPaid_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract_60" xlink:to="loc_us-gaapInterestPaid_60" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaapIncomeTaxesPaid_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract_60" xlink:to="loc_us-gaapIncomeTaxesPaid_60" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract_60" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_NonCashFreshStartAdjustment" xlink:label="loc_abvcNonCashFreshStartAdjustment_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract_60" xlink:to="loc_abvcNonCashFreshStartAdjustment_60" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReorganizationItems" xlink:label="loc_us-gaapReorganizationItems_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract_60" xlink:to="loc_us-gaapReorganizationItems_60" xlink:type="arc" order="35" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/OrganizationAndDescriptionOfBusiness" xlink:title="00000007 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="loc_us-gaapBusinessDescriptionAndAccountingPoliciesTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessDescriptionAndAccountingPoliciesTextBlock_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/CollaobrativeAgreement" xlink:title="00000009 - Disclosure - COLLAOBRATIVE AGREEMENT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/FreshStartAccounting" xlink:title="00000010 - Disclosure - Fresh Start Accounting">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_FreshStartAdjustmentTextBlock" xlink:label="loc_abvcFreshStartAdjustmentTextBlock_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_abvcFreshStartAdjustmentTextBlock_20" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/RelatedPartiesTransactions" xlink:title="00000011 - Disclosure - RELATED PARTIES TRANSACTIONS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/AccountsPayable" xlink:title="00000012 - Disclosure - ACCOUNTS PAYABLE" />
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/NotesPayable" xlink:title="00000013 - Disclosure - Notes Payable">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTextBlock" xlink:label="loc_us-gaapShortTermDebtTextBlock_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShortTermDebtTextBlock_20" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/Equtiy" xlink:title="00000014 - Disclosure - EQUTIY">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/CommitmentsAndContingencies" xlink:title="00000015 - Disclosure - COMMITMENTS AND CONTINGENCIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/StockOptions" xlink:title="00000016 - Disclosure - Stock Options">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_20" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/IncomeTaxes" xlink:title="00000017 - Disclosure - Income Taxes">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock_20" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/GoingConcern" xlink:title="00000018 - Disclosure - Going Concern">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock_20" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/Acquisitions" xlink:title="00000019 - Disclosure - Acquisitions">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaapBusinessCombinationDisclosureTextBlock_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationDisclosureTextBlock_20" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/NetIncomeLossPerShare" xlink:title="00000020 - Disclosure - Net Income (Loss) Per Share">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaapEarningsPerShareTextBlock_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareTextBlock_20" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/SubsequentEvents" xlink:title="00000021 - Disclosure - Subsequent Events">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSubsequentEventsTextBlock_20" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaapNatureOfOperations_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNatureOfOperations_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConsolidationPolicyTextBlock_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapUseOfEstimates_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="loc_us-gaapIntangibleAssetsFiniteLivedPolicy_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIntangibleAssetsFiniteLivedPolicy_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy_30" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_ForwardStockSplitPolicyTextBlock" xlink:label="loc_abvcForwardStockSplitPolicyTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_abvcForwardStockSplitPolicyTextBlock_30" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock_30" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock_30" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock_30" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock_30" xlink:type="arc" order="15" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000023 - Disclosure - Summary of Significant Accounting Policies (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock_20" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/FreshStartAccountingTables" xlink:title="00000024 - Disclosure - Fresh Start Accounting (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFreshStartAdjustmentsTextBlock" xlink:label="loc_us-gaapScheduleOfFreshStartAdjustmentsTextBlock_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfFreshStartAdjustmentsTextBlock_20" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/IncomeTaxesTables" xlink:title="00000025 - Disclosure - Income Taxes (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_20" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/NetIncomeLossPerShareTables" xlink:title="00000026 - Disclosure - Net Income (Loss) Per Share (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_20" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" xlink:title="00000027 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_ShareExchangeAgreementMember" xlink:label="loc_abvcShareExchangeAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_abvcShareExchangeAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_AmericanBriVisionHoldingCorporationMember" xlink:label="loc_abvcAmericanBriVisionHoldingCorporationMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcAmericanBriVisionHoldingCorporationMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_EuroAsiaInvestmentAndFinanceCorpLimitedMember" xlink:label="loc_abvcEuroAsiaInvestmentAndFinanceCorpLimitedMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcEuroAsiaInvestmentAndFinanceCorpLimitedMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_AmericanBriVisionCorporationMember" xlink:label="loc_abvcAmericanBriVisionCorporationMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcAmericanBriVisionCorporationMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_50" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:title="00000028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaapEquipmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapEquipmentMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_SignsMember" xlink:label="loc_abvcSignsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_abvcSignsMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="loc_us-gaapSoftwareDevelopmentMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapSoftwareDevelopmentMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MarketingAndPromotionalVideoMember" xlink:label="loc_abvcMarketingAndPromotionalVideoMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_abvcMarketingAndPromotionalVideoMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="loc_us-gaapPropertyPlantAndEquipmentEstimatedUsefulLives_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentEstimatedUsefulLives_100" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/CollaobrativeAgreementDetailsNarrative" xlink:title="00000030 - Disclosure - COLLAOBRATIVE AGREEMENT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_CollaborativeAgreementMember" xlink:label="loc_abvcCollaborativeAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_abvcCollaborativeAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_BioLiteIncMember" xlink:label="loc_abvcBioLiteIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_abvcBioLiteIncMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_LicensingRightsMember" xlink:label="loc_abvcLicensingRightsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_abvcLicensingRightsMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_UpfrontPayment" xlink:label="loc_abvcUpfrontPayment_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_abvcUpfrontPayment_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharePrice_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_DescriptionOfAgreementTerms" xlink:label="loc_abvcDescriptionOfAgreementTerms_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_abvcDescriptionOfAgreementTerms_50" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/FreshStartAccountingDetails" xlink:title="00000031 - Disclosure - Fresh Start Accounting (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaapStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementScenarioAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaapScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementScenarioAxis" xlink:to="loc_us-gaapScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaapScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementScenarioAxis" xlink:to="loc_us-gaapScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_RestatementAdjustmentOneMember" xlink:label="loc_abvcRestatementAdjustmentOneMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_abvcRestatementAdjustmentOneMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestatementAdjustmentMember" xlink:label="loc_us-gaapRestatementAdjustmentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_us-gaapRestatementAdjustmentMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioAdjustmentMember" xlink:label="loc_us-gaapScenarioAdjustmentMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_us-gaapScenarioAdjustmentMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_FreshStartAdustmentsMember" xlink:label="loc_abvcFreshStartAdustmentsMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_abvcFreshStartAdustmentsMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ChiefExecutiveOfficerMember" xlink:label="loc_us-gaapChiefExecutiveOfficerMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapChiefExecutiveOfficerMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_InnovationConsultingLLCMember" xlink:label="loc_abvcInnovationConsultingLLCMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_abvcInnovationConsultingLLCMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="loc_us-gaapConvertiblePreferredStockMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapConvertiblePreferredStockMember_50" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_90" xlink:to="loc_us-gaapAssetsCurrentAbstract_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_90" xlink:to="loc_us-gaapCash_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_90" xlink:to="loc_us-gaapAccountsReceivableNetCurrent_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_90" xlink:to="loc_us-gaapAssetsCurrent_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_90" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_90" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_90" xlink:to="loc_us-gaapAssets_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:to="loc_us-gaapLiabilities_90" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:to="loc_us-gaapCommitmentsAndContingencies_90" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:to="loc_us-gaapStockholdersEquityAbstract_90" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_90" xlink:to="loc_us-gaapPreferredStockValue_90" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_PreferredStockValueOne" xlink:label="loc_abvcPreferredStockValueOne_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_90" xlink:to="loc_abvcPreferredStockValueOne_90" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_90" xlink:to="loc_us-gaapCommonStockValue_90" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_90" xlink:to="loc_us-gaapAdditionalPaidInCapital_90" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_90" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_90" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_90" xlink:to="loc_us-gaapStockholdersEquity_90" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_90" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_90" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_90" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_90" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_90" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_PreferredStockSharesAuthorizedOne" xlink:label="loc_abvcPreferredStockSharesAuthorizedOne_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_abvcPreferredStockSharesAuthorizedOne_90" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_PreferredStockParOrStatedValuePerShareOne" xlink:label="loc_abvcPreferredStockParOrStatedValuePerShareOne_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_abvcPreferredStockParOrStatedValuePerShareOne_90" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_PreferredStockSharesIssuedOne" xlink:label="loc_abvcPreferredStockSharesIssuedOne_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_abvcPreferredStockSharesIssuedOne_90" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_PreferredStockSharesOutstandingOne" xlink:label="loc_abvcPreferredStockSharesOutstandingOne_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_abvcPreferredStockSharesOutstandingOne_90" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_90" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_90" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_90" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_90" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaapRepaymentsOfDebt_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRepaymentsOfDebt_90" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther_90" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReorganizationValueCashInExcessOfNormalOperatingNeeds" xlink:label="loc_us-gaapReorganizationValueCashInExcessOfNormalOperatingNeeds_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapReorganizationValueCashInExcessOfNormalOperatingNeeds_90" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_ReorganizationValueNetRealizableValueOfAccountsReceivableDispositions" xlink:label="loc_abvcReorganizationValueNetRealizableValueOfAccountsReceivableDispositions_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_abvcReorganizationValueNetRealizableValueOfAccountsReceivableDispositions_90" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_ReorganizationValueNetRealizableValueOfPropertyPlantAndEquipmentDispositions" xlink:label="loc_abvcReorganizationValueNetRealizableValueOfPropertyPlantAndEquipmentDispositions_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_abvcReorganizationValueNetRealizableValueOfPropertyPlantAndEquipmentDispositions_90" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_ReorganizationValueNetRealizableValueOfIntangibleAssetDispositions" xlink:label="loc_abvcReorganizationValueNetRealizableValueOfIntangibleAssetDispositions_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_abvcReorganizationValueNetRealizableValueOfIntangibleAssetDispositions_90" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_ReorganizationValueNetRealizableValueOfTotalliabilitiestDispositions" xlink:label="loc_abvcReorganizationValueNetRealizableValueOfTotalliabilitiestDispositions_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_abvcReorganizationValueNetRealizableValueOfTotalliabilitiestDispositions_90" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_ReorganizationValueNetRealizableValueOfAdditionalPaidInCapitalDispositions" xlink:label="loc_abvcReorganizationValueNetRealizableValueOfAdditionalPaidInCapitalDispositions_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_abvcReorganizationValueNetRealizableValueOfAdditionalPaidInCapitalDispositions_90" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_ReorganizationValueNetRealizableValueOfLiabilitiesAndStockholdersEquityDispositions" xlink:label="loc_abvcReorganizationValueNetRealizableValueOfLiabilitiesAndStockholdersEquityDispositions_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_abvcReorganizationValueNetRealizableValueOfLiabilitiesAndStockholdersEquityDispositions_90" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FreshStartAdjustmentIncreaseDecreaseAmortizableIntangibleAssets" xlink:label="loc_us-gaapFreshStartAdjustmentIncreaseDecreaseAmortizableIntangibleAssets_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFreshStartAdjustmentIncreaseDecreaseAmortizableIntangibleAssets_90" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FreshStartAdjustmentIncreaseDecreasePreferredStock" xlink:label="loc_us-gaapFreshStartAdjustmentIncreaseDecreasePreferredStock_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFreshStartAdjustmentIncreaseDecreasePreferredStock_90" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_FreshStartAdjustmentIncreaseDecreasePreferredStock1" xlink:label="loc_abvcFreshStartAdjustmentIncreaseDecreasePreferredStock1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_abvcFreshStartAdjustmentIncreaseDecreasePreferredStock1_90" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FreshStartAdjustmentIncreaseDecreaseAdditionalPaidInCapital" xlink:label="loc_us-gaapFreshStartAdjustmentIncreaseDecreaseAdditionalPaidInCapital_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFreshStartAdjustmentIncreaseDecreaseAdditionalPaidInCapital_90" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FreshStartAdjustmentIncreaseDecreaseRetainedEarningsDeficit" xlink:label="loc_us-gaapFreshStartAdjustmentIncreaseDecreaseRetainedEarningsDeficit_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFreshStartAdjustmentIncreaseDecreaseRetainedEarningsDeficit_90" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FreshStartAdjustmentIncreaseDecreaseLiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapFreshStartAdjustmentIncreaseDecreaseLiabilitiesAndStockholdersEquity_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFreshStartAdjustmentIncreaseDecreaseLiabilitiesAndStockholdersEquity_90" xlink:type="arc" order="45" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/RelatedPartiesTransactionsDetailsNarrative" xlink:title="00000032 - Disclosure - RELATED PARTIES TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_BioLiteIncMember" xlink:label="loc_abvcBioLiteIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_abvcBioLiteIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_YuanGeneCorporationMember" xlink:label="loc_abvcYuanGeneCorporationMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_abvcYuanGeneCorporationMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ChiefExecutiveOfficerMember" xlink:label="loc_us-gaapChiefExecutiveOfficerMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapChiefExecutiveOfficerMember_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnsecuredDebtMember" xlink:label="loc_us-gaapUnsecuredDebtMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_us-gaapUnsecuredDebtMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="loc_us-gaapConvertiblePreferredStockMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapConvertiblePreferredStockMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:label="loc_us-gaapNotesPayableRelatedPartiesClassifiedCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapNotesPayableRelatedPartiesClassifiedCurrent_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_DebtInstrumentCancelledAmount" xlink:label="loc_abvcDebtInstrumentCancelledAmount_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_abvcDebtInstrumentCancelledAmount_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_90" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/AccountsPayableDetailsNarrative" xlink:title="00000033 - Disclosure - ACCOUNTS PAYABLE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_LiteArtIncMember" xlink:label="loc_abvcLiteArtIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcLiteArtIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsPayableCurrent_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/NotesPayableDetailsNarrative" xlink:title="00000034 - Disclosure - Notes Payable (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember" xlink:label="loc_us-gaapNotesPayableOtherPayablesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_us-gaapNotesPayableOtherPayablesMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherPaymentsToAcquireBusinesses" xlink:label="loc_us-gaapOtherPaymentsToAcquireBusinesses_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherPaymentsToAcquireBusinesses_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_30" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/EqutiyDetailsNarrative" xlink:title="00000035 - Disclosure - EQUTIY (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ChiefExecutiveOfficerMember" xlink:label="loc_us-gaapChiefExecutiveOfficerMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapChiefExecutiveOfficerMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_InnovationConsultingLLCMember" xlink:label="loc_abvcInnovationConsultingLLCMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_abvcInnovationConsultingLLCMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="loc_us-gaapConvertiblePreferredStockMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapConvertiblePreferredStockMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_140" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_140" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_140" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_140" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockVotingRights" xlink:label="loc_us-gaapCommonStockVotingRights_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockVotingRights_140" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_140" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepositAssets" xlink:label="loc_us-gaapDepositAssets_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepositAssets_140" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_140" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_140" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_140" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_140" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockSharesConverted1_140" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockVotingRights" xlink:label="loc_us-gaapPreferredStockVotingRights_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockVotingRights_140" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther_140" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_140" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_140" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_140" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit_140" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:label="loc_us-gaapCommonStockShareSubscribedButUnissuedSubscriptionsReceivable_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockShareSubscribedButUnissuedSubscriptionsReceivable_140" xlink:type="arc" order="18" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000036 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaapLossContingenciesLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaapLossContingenciesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapLossContingenciesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_BioLiteIncMember" xlink:label="loc_abvcBioLiteIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_abvcBioLiteIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_AgreementPeriod" xlink:label="loc_abvcAgreementPeriod_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_abvcAgreementPeriod_20" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000037 - Disclosure - Income Taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_OperatingLossCarryforwardsExpirationPeriodDescription" xlink:label="loc_abvcOperatingLossCarryforwardsExpirationPeriodDescription_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_abvcOperatingLossCarryforwardsExpirationPeriodDescription_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations_30" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/IncomeTaxesDetails" xlink:title="00000038 - Disclosure - Income Taxes (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsGross_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsNet_30" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/AcquisitionsDetailsNarrative" xlink:title="00000039 - Disclosure - Acquisitions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_20" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/NetIncomeLossPerShareDetails" xlink:title="00000040 - Disclosure - Net Income (Loss) Per Share (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:label="loc_us-gaapEarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_30" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_30" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_30" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_30" xlink:to="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_30" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted_30" xlink:type="arc" order="6" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>abvc-20160630_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Created by S2 Filings, LLC- http://www.s2filings.com -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_ShareExchangeAgreementMember" xlink:label="abvc_ShareExchangeAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_ShareExchangeAgreementMember" xlink:to="abvc_ShareExchangeAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_ShareExchangeAgreementMember_lbl" xml:lang="en-US">Share Exchange Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Type of Arrangement and Non-arrangement Transactions [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_AmericanBriVisionHoldingCorporationMember" xlink:label="abvc_AmericanBriVisionHoldingCorporationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_AmericanBriVisionHoldingCorporationMember" xlink:to="abvc_AmericanBriVisionHoldingCorporationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_AmericanBriVisionHoldingCorporationMember_lbl" xml:lang="en-US">American BriVision (Holding) Corporation [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_EuroAsiaInvestmentAndFinanceCorpLimitedMember" xlink:label="abvc_EuroAsiaInvestmentAndFinanceCorpLimitedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_EuroAsiaInvestmentAndFinanceCorpLimitedMember" xlink:to="abvc_EuroAsiaInvestmentAndFinanceCorpLimitedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_EuroAsiaInvestmentAndFinanceCorpLimitedMember_lbl" xml:lang="en-US">Euro-Asia Investment &amp; Finance Corp. Limited [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_AmericanBriVisionCorporationMember" xlink:label="abvc_AmericanBriVisionCorporationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_AmericanBriVisionCorporationMember" xlink:to="abvc_AmericanBriVisionCorporationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_AmericanBriVisionCorporationMember_lbl" xml:lang="en-US">American BriVision Corporation [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_BioLiteIncMember" xlink:label="abvc_BioLiteIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_BioLiteIncMember" xlink:to="abvc_BioLiteIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_BioLiteIncMember_lbl" xml:lang="en-US">BioLite, Inc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_YuanGeneCorporationMember" xlink:label="abvc_YuanGeneCorporationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_YuanGeneCorporationMember" xlink:to="abvc_YuanGeneCorporationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_YuanGeneCorporationMember_lbl" xml:lang="en-US">YuanGene Corporation [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_LiteArtIncMember" xlink:label="abvc_LiteArtIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_LiteArtIncMember" xlink:to="abvc_LiteArtIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_LiteArtIncMember_lbl" xml:lang="en-US">LiteArt, Inc. [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_CollaborativeAgreementMember" xlink:label="abvc_CollaborativeAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_CollaborativeAgreementMember" xlink:to="abvc_CollaborativeAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_CollaborativeAgreementMember_lbl" xml:lang="en-US">Collaborative Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_BioLiteIncMember" xlink:to="abvc_BioLiteIncMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="abvc_BioLiteIncMember_2_lbl" xml:lang="en-US">BioLite Inc., [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_LicensingRightsMember" xlink:label="abvc_LicensingRightsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_LicensingRightsMember" xlink:to="abvc_LicensingRightsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_LicensingRightsMember_lbl" xml:lang="en-US">Licensing Rights For Drug And Therapeutic Use of Five Products [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="abvc_MetuBrandsIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_MetuBrandsIncMember" xlink:to="abvc_MetuBrandsIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_MetuBrandsIncMember_lbl" xml:lang="en-US">Metu Brands, Inc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xml:lang="en-US">Computer Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinimumMember" xlink:to="us-gaap_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RangeAxis_lbl" xml:lang="en-US">Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MaximumMember" xlink:to="us-gaap_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquipmentMember" xlink:to="us-gaap_EquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquipmentMember_lbl" xml:lang="en-US">Test Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_SignsMember" xlink:label="abvc_SignsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_SignsMember" xlink:to="abvc_SignsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_SignsMember_lbl" xml:lang="en-US">Signs [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="us-gaap_SoftwareDevelopmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareDevelopmentMember" xlink:to="us-gaap_SoftwareDevelopmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SoftwareDevelopmentMember_lbl" xml:lang="en-US">Software [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MarketingAndPromotionalVideoMember" xlink:label="abvc_MarketingAndPromotionalVideoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_MarketingAndPromotionalVideoMember" xlink:to="abvc_MarketingAndPromotionalVideoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_MarketingAndPromotionalVideoMember_lbl" xml:lang="en-US">Marketing And Promotional Video [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnsecuredDebtMember" xlink:label="us-gaap_UnsecuredDebtMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnsecuredDebtMember" xlink:to="us-gaap_UnsecuredDebtMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnsecuredDebtMember_lbl" xml:lang="en-US">0% Unsecured Note Due On Demand [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ChiefExecutiveOfficerMember" xlink:label="us-gaap_ChiefExecutiveOfficerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChiefExecutiveOfficerMember" xlink:to="us-gaap_ChiefExecutiveOfficerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ChiefExecutiveOfficerMember_lbl" xml:lang="en-US">Mr.Shulamit Lazar [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember" xlink:label="us-gaap_NotesPayableOtherPayablesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableOtherPayablesMember" xlink:to="us-gaap_NotesPayableOtherPayablesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableOtherPayablesMember_lbl" xml:lang="en-US">0% Notes Payable Due September 24, 2014 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xml:lang="en-US">Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-In Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Accumulated Deficit [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_InnovationConsultingLLCMember" xlink:label="abvc_InnovationConsultingLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_InnovationConsultingLLCMember" xlink:to="abvc_InnovationConsultingLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_InnovationConsultingLLCMember_lbl" xml:lang="en-US">Innovation Consulting LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_RestatementAdjustmentOneMember" xlink:label="abvc_RestatementAdjustmentOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_RestatementAdjustmentOneMember" xlink:to="abvc_RestatementAdjustmentOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_RestatementAdjustmentOneMember_lbl" xml:lang="en-US">Prior Bankruptcy [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_StatementScenarioAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestatementAdjustmentMember" xlink:label="us-gaap_RestatementAdjustmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestatementAdjustmentMember" xlink:to="us-gaap_RestatementAdjustmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestatementAdjustmentMember_lbl" xml:lang="en-US">Post Bankruptcy [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioAdjustmentMember" xlink:label="us-gaap_ScenarioAdjustmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScenarioAdjustmentMember" xlink:to="us-gaap_ScenarioAdjustmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScenarioAdjustmentMember_lbl" xml:lang="en-US">Dr(CR) Reorganization Adjustments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_FreshStartAdustmentsMember" xlink:label="abvc_FreshStartAdustmentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_FreshStartAdustmentsMember" xlink:to="abvc_FreshStartAdustmentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_FreshStartAdustmentsMember_lbl" xml:lang="en-US">Dr(CR) Fresh Start Adustments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_DocumentAndEntityInformationAbstract" xlink:label="abvc_DocumentAndEntityInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_DocumentAndEntityInformationAbstract" xlink:to="abvc_DocumentAndEntityInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US">Document And Entity Information</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_Prepayment" xlink:label="abvc_Prepayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_Prepayment" xlink:to="abvc_Prepayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_Prepayment_lbl" xml:lang="en-US">Prepayment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="us-gaap_DepositsAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssetsNoncurrent" xlink:to="us-gaap_DepositsAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositsAssetsNoncurrent_lbl" xml:lang="en-US">Deposit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property, plant and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayable_lbl" xml:lang="en-US">Note payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent" xlink:label="us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent" xlink:to="us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Related party note payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Other payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionDueFromToRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionDueFromToRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDueFromToRelatedParty" xlink:to="us-gaap_RelatedPartyTransactionDueFromToRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RelatedPartyTransactionDueFromToRelatedParty_lbl" xml:lang="en-US">Due to related party</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DueToOfficersOrStockholdersCurrentAndNoncurrent" xlink:label="us-gaap_DueToOfficersOrStockholdersCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToOfficersOrStockholdersCurrentAndNoncurrent" xlink:to="us-gaap_DueToOfficersOrStockholdersCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToOfficersOrStockholdersCurrentAndNoncurrent_lbl" xml:lang="en-US">Due to shareholder</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:label="us-gaap_ShortTermBorrowings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermBorrowings" xlink:to="us-gaap_ShortTermBorrowings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermBorrowings_lbl" xml:lang="en-US">Short term loan</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders'equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:label="us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:to="us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable_lbl" xml:lang="en-US">Subscription receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_RetainedEarningsAccumulatedDeficit1" xlink:label="abvc_RetainedEarningsAccumulatedDeficit1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_RetainedEarningsAccumulatedDeficit1" xlink:to="abvc_RetainedEarningsAccumulatedDeficit1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_RetainedEarningsAccumulatedDeficit1_lbl" xml:lang="en-US">Retained earnings-beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Retained earnings</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common Stock, par value (in dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common Stock, authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common Stock, issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common Stock, outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="us-gaap_SalesRevenueNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNet" xlink:to="us-gaap_SalesRevenueNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNet_lbl" xml:lang="en-US">Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xml:lang="en-US">Cost of sales</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross profit loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Net income (loss) from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other income (expense)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xml:lang="en-US">Bank Interest Income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xml:lang="en-US">Gain on exchange differences</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncome" xlink:label="us-gaap_OtherIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncome_lbl" xml:lang="en-US">Sundry income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total Other Income (Expense)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Income (loss) from continuing operations before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net income (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" xml:lang="en-US">Basic and Diluted loss per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">Basic and Diluted income (loss) per share (in dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Weighted average number of shares outstanding basic and diluted (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Balance at beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance at beginning (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_AdjustmentsToAdditionalPaidInCapitalFreshStartAdjustments" xlink:label="abvc_AdjustmentsToAdditionalPaidInCapitalFreshStartAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_AdjustmentsToAdditionalPaidInCapitalFreshStartAdjustments" xlink:to="abvc_AdjustmentsToAdditionalPaidInCapitalFreshStartAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_AdjustmentsToAdditionalPaidInCapitalFreshStartAdjustments_lbl" xml:lang="en-US">Fresh start adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_AdjustmentsToAdditionalPaidInCapitalReorganizationAdjustments" xlink:label="abvc_AdjustmentsToAdditionalPaidInCapitalReorganizationAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_AdjustmentsToAdditionalPaidInCapitalReorganizationAdjustments" xlink:to="abvc_AdjustmentsToAdditionalPaidInCapitalReorganizationAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_AdjustmentsToAdditionalPaidInCapitalReorganizationAdjustments_lbl" xml:lang="en-US">Reorganization adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xml:lang="en-US">Stock issued as compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xml:lang="en-US">Stock issued as compensation (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_BankruptcySharesIssuedValue" xlink:label="abvc_BankruptcySharesIssuedValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_BankruptcySharesIssuedValue" xlink:to="abvc_BankruptcySharesIssuedValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_BankruptcySharesIssuedValue_lbl" xml:lang="en-US">Bankruptcy shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_BankruptcySharesIssuedShares" xlink:label="abvc_BankruptcySharesIssuedShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_BankruptcySharesIssuedShares" xlink:to="abvc_BankruptcySharesIssuedShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_BankruptcySharesIssuedShares_lbl" xml:lang="en-US">Bankruptcy shares issued (in shares)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Balance at ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Balance at ending (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_lbl" xml:lang="en-US">Cash flows from operating activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Net income (loss) from continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash used by operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock issued as compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInDepositOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets_lbl" xml:lang="en-US">(Increase) decrease in deposit</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_IncreaseDecreaseInPrepayment" xlink:label="abvc_IncreaseDecreaseInPrepayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_IncreaseDecreaseInPrepayment" xlink:to="abvc_IncreaseDecreaseInPrepayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="abvc_IncreaseDecreaseInPrepayment_lbl" xml:lang="en-US">(Increase) decrease in prepayment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent" xlink:to="us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent_lbl" xml:lang="en-US">(Increase) decrease in due from related party</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Increase (decrease) in other payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:to="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent_lbl" xml:lang="en-US">Increase (decrease) in due to related party</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInDueToOfficersAndStockholdersCurrent" xlink:label="us-gaap_IncreaseDecreaseInDueToOfficersAndStockholdersCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueToOfficersAndStockholdersCurrent" xlink:to="us-gaap_IncreaseDecreaseInDueToOfficersAndStockholdersCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDueToOfficersAndStockholdersCurrent_lbl" xml:lang="en-US">Increase (decrease) in due to shareholder</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties_lbl" xml:lang="en-US">Increase (decrease) in accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">(Increase) decrease in accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">(Increase) decrease in inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US">Increase (decrease) in accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_lbl" xml:lang="en-US">Cash flows from investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Acquisition of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_lbl" xml:lang="en-US">Net cash provided (used) by investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_lbl" xml:lang="en-US">Cash flows from financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_ProceedsFromFreshStartAdjustments" xlink:label="abvc_ProceedsFromFreshStartAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_ProceedsFromFreshStartAdjustments" xlink:to="abvc_ProceedsFromFreshStartAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_ProceedsFromFreshStartAdjustments_lbl" xml:lang="en-US">Fresh start adjustment</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_ProceedsFromCapitalInjectionToBankruptcyTrustee" xlink:label="abvc_ProceedsFromCapitalInjectionToBankruptcyTrustee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_ProceedsFromCapitalInjectionToBankruptcyTrustee" xlink:to="abvc_ProceedsFromCapitalInjectionToBankruptcyTrustee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_ProceedsFromCapitalInjectionToBankruptcyTrustee_lbl" xml:lang="en-US">Capital injection to bankruptcy trustee</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xml:lang="en-US">Proceeds from related party</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl" xml:lang="en-US">Proceeds from note payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromShortTermDebt" xlink:label="us-gaap_ProceedsFromShortTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromShortTermDebt" xlink:to="us-gaap_ProceedsFromShortTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromShortTermDebt_lbl" xml:lang="en-US">Proceeds from short term loans</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from issuance of shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_lbl" xml:lang="en-US">Net cash provided(used) by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_lbl" xml:lang="en-US">Effect Of Exchange Rates On Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xml:lang="en-US">Net increase(decrease) in cash</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_Cash_2_lbl" xml:lang="en-US">Cash, beginning of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_Cash_3_lbl" xml:lang="en-US">Cash, end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xml:lang="en-US">Supplemental disclosure of non-cash activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaid" xlink:to="us-gaap_InterestPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaid_lbl" xml:lang="en-US">Interest paid</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xml:lang="en-US">Income taxes paid</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental disclosure of cash flow information</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_NonCashFreshStartAdjustment" xlink:label="abvc_NonCashFreshStartAdjustment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_NonCashFreshStartAdjustment" xlink:to="abvc_NonCashFreshStartAdjustment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="abvc_NonCashFreshStartAdjustment_lbl" xml:lang="en-US">Fresh start adjustment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReorganizationItems" xlink:label="us-gaap_ReorganizationItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReorganizationItems" xlink:to="us-gaap_ReorganizationItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReorganizationItems_lbl" xml:lang="en-US">Bankruptcy reorganization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">ORGANIZATION AND DESCRIPTION OF BUSINESS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_CollaobrativeAgreementAbstract" xlink:label="abvc_CollaobrativeAgreementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_CollaobrativeAgreementAbstract" xlink:to="abvc_CollaobrativeAgreementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_CollaobrativeAgreementAbstract_lbl" xml:lang="en-US">Collaobrative Agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_CallaobrativeAgreementDisclosureTextBlock" xlink:label="abvc_CallaobrativeAgreementDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_CallaobrativeAgreementDisclosureTextBlock" xlink:to="abvc_CallaobrativeAgreementDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_CallaobrativeAgreementDisclosureTextBlock_lbl" xml:lang="en-US">COLLAOBRATIVE AGREEMENT</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_FreshStartAdjustmentTextBlock" xlink:label="abvc_FreshStartAdjustmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_FreshStartAdjustmentTextBlock" xlink:to="abvc_FreshStartAdjustmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_FreshStartAdjustmentTextBlock_lbl" xml:lang="en-US">Fresh Start Accounting</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">RELATED PARTIES TRANSACTIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">ACCOUNTS PAYABLE</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTextBlock" xlink:label="us-gaap_ShortTermDebtTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTextBlock" xlink:to="us-gaap_ShortTermDebtTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtTextBlock_lbl" xml:lang="en-US">Notes Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">EQUTIY</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Stock Options</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:to="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xml:lang="en-US">Going Concern</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xml:lang="en-US">Acquisitions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US">Net Income (Loss) Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NatureOfOperations_lbl" xml:lang="en-US">Description of the Company</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xml:lang="en-US">Reclassifications</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Loss Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xml:lang="en-US">Patents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Long-Lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Stock-Based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_ForwardStockSplitPolicyTextBlock" xlink:label="abvc_ForwardStockSplitPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_ForwardStockSplitPolicyTextBlock" xlink:to="abvc_ForwardStockSplitPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_ForwardStockSplitPolicyTextBlock_lbl" xml:lang="en-US">Forward Stock split</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xml:lang="en-US">Fair Value Measurements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of equipment useful life</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFreshStartAdjustmentsTextBlock" xlink:label="us-gaap_ScheduleOfFreshStartAdjustmentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFreshStartAdjustmentsTextBlock" xlink:to="us-gaap_ScheduleOfFreshStartAdjustmentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFreshStartAdjustmentsTextBlock_lbl" xml:lang="en-US">Schedule of Fresh-Start Adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of deferred tax assets and liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Schedule of reconciliation for basic and diluted EPS</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesIssued_2_lbl" xml:lang="en-US">Common stock, issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Percentage of common shares issued and outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" xml:lang="en-US">Property and equipment, useful lives</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xml:lang="en-US">Description of forward split</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_2_lbl" xml:lang="en-US">Common stock, authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Income tax expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xml:lang="en-US">Total consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_UpfrontPayment" xlink:label="abvc_UpfrontPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_UpfrontPayment" xlink:to="abvc_UpfrontPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_UpfrontPayment_lbl" xml:lang="en-US">Upfront payment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xml:lang="en-US">Value of shares issued for aquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xml:lang="en-US">Number of shares issued for aquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Share price (in dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_DescriptionOfAgreementTerms" xlink:label="abvc_DescriptionOfAgreementTerms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_DescriptionOfAgreementTerms" xlink:to="abvc_DescriptionOfAgreementTerms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_DescriptionOfAgreementTerms_lbl" xml:lang="en-US">Description of agreement terms</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Total Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Intangible assets, net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Total Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_2_lbl" xml:lang="en-US">Liabilities and Equity (Deficit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Total liabilities subject to compromise</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommitmentsAndContingencies_2_lbl" xml:lang="en-US">Commitments and Contingencies (Note 5)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_2_lbl" xml:lang="en-US">Metu Brands, Inc. (""MTOO"") shareholders' deficit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockValue_2_lbl" xml:lang="en-US">Predecessor Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_PreferredStockValueOne" xlink:label="abvc_PreferredStockValueOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_PreferredStockValueOne" xlink:to="abvc_PreferredStockValueOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_PreferredStockValueOne_lbl" xml:lang="en-US">Successor Preferred Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockValue_2_lbl" xml:lang="en-US">Predecessor/Successor Common Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Total equity (deficit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Total liabilities and equity (deficit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_2_lbl" xml:lang="en-US">Predecessor Preferred Stock, authorized</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_2_lbl" xml:lang="en-US">Predecessor Preferred Stock, par value (in dollars per share)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockSharesIssued_2_lbl" xml:lang="en-US">Predecessor Preferred Stock, issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockSharesOutstanding_2_lbl" xml:lang="en-US">Predecessor Preferred Stock, outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_PreferredStockSharesAuthorizedOne" xlink:label="abvc_PreferredStockSharesAuthorizedOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_PreferredStockSharesAuthorizedOne" xlink:to="abvc_PreferredStockSharesAuthorizedOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_PreferredStockSharesAuthorizedOne_lbl" xml:lang="en-US">Successor Preferred Stock, authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_PreferredStockParOrStatedValuePerShareOne" xlink:label="abvc_PreferredStockParOrStatedValuePerShareOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_PreferredStockParOrStatedValuePerShareOne" xlink:to="abvc_PreferredStockParOrStatedValuePerShareOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_PreferredStockParOrStatedValuePerShareOne_lbl" xml:lang="en-US">Successor Preferred Stock, par value (in dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_PreferredStockSharesIssuedOne" xlink:label="abvc_PreferredStockSharesIssuedOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_PreferredStockSharesIssuedOne" xlink:to="abvc_PreferredStockSharesIssuedOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_PreferredStockSharesIssuedOne_lbl" xml:lang="en-US">Successor Preferred Stock, issued</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_PreferredStockSharesOutstandingOne" xlink:label="abvc_PreferredStockSharesOutstandingOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_PreferredStockSharesOutstandingOne" xlink:to="abvc_PreferredStockSharesOutstandingOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_PreferredStockSharesOutstandingOne_lbl" xml:lang="en-US">Successor Preferred Stock, outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_3_lbl" xml:lang="en-US">Predecessor/Successor Common Stock, authorized</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_3_lbl" xml:lang="en-US">Predecessor/Successor Common Stock, par value (in dollars per share)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesIssued_3_lbl" xml:lang="en-US">Predecessor/Successor Common Stock, issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_2_lbl" xml:lang="en-US">Predecessor/Successor Common Stock, outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfDebt_lbl" xml:lang="en-US">Amount paid to trustee</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xml:lang="en-US">Number of shares issued upon bankruptcy</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReorganizationValueCashInExcessOfNormalOperatingNeeds" xlink:label="us-gaap_ReorganizationValueCashInExcessOfNormalOperatingNeeds" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReorganizationValueCashInExcessOfNormalOperatingNeeds" xlink:to="us-gaap_ReorganizationValueCashInExcessOfNormalOperatingNeeds_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReorganizationValueCashInExcessOfNormalOperatingNeeds_lbl" xml:lang="en-US">Cash - reorganization adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_ReorganizationValueNetRealizableValueOfAccountsReceivableDispositions" xlink:label="abvc_ReorganizationValueNetRealizableValueOfAccountsReceivableDispositions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_ReorganizationValueNetRealizableValueOfAccountsReceivableDispositions" xlink:to="abvc_ReorganizationValueNetRealizableValueOfAccountsReceivableDispositions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_ReorganizationValueNetRealizableValueOfAccountsReceivableDispositions_lbl" xml:lang="en-US">Accounts receivable - reorganization adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_ReorganizationValueNetRealizableValueOfPropertyPlantAndEquipmentDispositions" xlink:label="abvc_ReorganizationValueNetRealizableValueOfPropertyPlantAndEquipmentDispositions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_ReorganizationValueNetRealizableValueOfPropertyPlantAndEquipmentDispositions" xlink:to="abvc_ReorganizationValueNetRealizableValueOfPropertyPlantAndEquipmentDispositions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_ReorganizationValueNetRealizableValueOfPropertyPlantAndEquipmentDispositions_lbl" xml:lang="en-US">Property, plant and equipment, net - reorganization adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_ReorganizationValueNetRealizableValueOfIntangibleAssetDispositions" xlink:label="abvc_ReorganizationValueNetRealizableValueOfIntangibleAssetDispositions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_ReorganizationValueNetRealizableValueOfIntangibleAssetDispositions" xlink:to="abvc_ReorganizationValueNetRealizableValueOfIntangibleAssetDispositions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_ReorganizationValueNetRealizableValueOfIntangibleAssetDispositions_lbl" xml:lang="en-US">Intangible assets, net - reorganization adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_ReorganizationValueNetRealizableValueOfTotalliabilitiestDispositions" xlink:label="abvc_ReorganizationValueNetRealizableValueOfTotalliabilitiestDispositions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_ReorganizationValueNetRealizableValueOfTotalliabilitiestDispositions" xlink:to="abvc_ReorganizationValueNetRealizableValueOfTotalliabilitiestDispositions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_ReorganizationValueNetRealizableValueOfTotalliabilitiestDispositions_lbl" xml:lang="en-US">Total liabilities subject to compromise - reorganization adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_ReorganizationValueNetRealizableValueOfAdditionalPaidInCapitalDispositions" xlink:label="abvc_ReorganizationValueNetRealizableValueOfAdditionalPaidInCapitalDispositions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_ReorganizationValueNetRealizableValueOfAdditionalPaidInCapitalDispositions" xlink:to="abvc_ReorganizationValueNetRealizableValueOfAdditionalPaidInCapitalDispositions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_ReorganizationValueNetRealizableValueOfAdditionalPaidInCapitalDispositions_lbl" xml:lang="en-US">Additional paid-in capital - reorganization adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_ReorganizationValueNetRealizableValueOfLiabilitiesAndStockholdersEquityDispositions" xlink:label="abvc_ReorganizationValueNetRealizableValueOfLiabilitiesAndStockholdersEquityDispositions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_ReorganizationValueNetRealizableValueOfLiabilitiesAndStockholdersEquityDispositions" xlink:to="abvc_ReorganizationValueNetRealizableValueOfLiabilitiesAndStockholdersEquityDispositions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_ReorganizationValueNetRealizableValueOfLiabilitiesAndStockholdersEquityDispositions_lbl" xml:lang="en-US">Total liabilities and equity (deficit) - reorganization adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FreshStartAdjustmentIncreaseDecreaseAmortizableIntangibleAssets" xlink:label="us-gaap_FreshStartAdjustmentIncreaseDecreaseAmortizableIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FreshStartAdjustmentIncreaseDecreaseAmortizableIntangibleAssets" xlink:to="us-gaap_FreshStartAdjustmentIncreaseDecreaseAmortizableIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FreshStartAdjustmentIncreaseDecreaseAmortizableIntangibleAssets_lbl" xml:lang="en-US">Intangible assets, net - fresh start adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FreshStartAdjustmentIncreaseDecreasePreferredStock" xlink:label="us-gaap_FreshStartAdjustmentIncreaseDecreasePreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FreshStartAdjustmentIncreaseDecreasePreferredStock" xlink:to="us-gaap_FreshStartAdjustmentIncreaseDecreasePreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FreshStartAdjustmentIncreaseDecreasePreferredStock_lbl" xml:lang="en-US">Predecessor Preferred Stock - fresh start adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_FreshStartAdjustmentIncreaseDecreasePreferredStock1" xlink:label="abvc_FreshStartAdjustmentIncreaseDecreasePreferredStock1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_FreshStartAdjustmentIncreaseDecreasePreferredStock1" xlink:to="abvc_FreshStartAdjustmentIncreaseDecreasePreferredStock1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_FreshStartAdjustmentIncreaseDecreasePreferredStock1_lbl" xml:lang="en-US">Successor Preferred Stock - fresh start adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FreshStartAdjustmentIncreaseDecreaseAdditionalPaidInCapital" xlink:label="us-gaap_FreshStartAdjustmentIncreaseDecreaseAdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FreshStartAdjustmentIncreaseDecreaseAdditionalPaidInCapital" xlink:to="us-gaap_FreshStartAdjustmentIncreaseDecreaseAdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FreshStartAdjustmentIncreaseDecreaseAdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital - fresh start adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FreshStartAdjustmentIncreaseDecreaseRetainedEarningsDeficit" xlink:label="us-gaap_FreshStartAdjustmentIncreaseDecreaseRetainedEarningsDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FreshStartAdjustmentIncreaseDecreaseRetainedEarningsDeficit" xlink:to="us-gaap_FreshStartAdjustmentIncreaseDecreaseRetainedEarningsDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FreshStartAdjustmentIncreaseDecreaseRetainedEarningsDeficit_lbl" xml:lang="en-US">Retained earnings - fresh start adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FreshStartAdjustmentIncreaseDecreaseLiabilitiesAndStockholdersEquity" xlink:label="us-gaap_FreshStartAdjustmentIncreaseDecreaseLiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FreshStartAdjustmentIncreaseDecreaseLiabilitiesAndStockholdersEquity" xlink:to="us-gaap_FreshStartAdjustmentIncreaseDecreaseLiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FreshStartAdjustmentIncreaseDecreaseLiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and equity (deficit) - fresh start adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:label="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:to="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_lbl" xml:lang="en-US">Notes payable due</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_DebtInstrumentCancelledAmount" xlink:label="abvc_DebtInstrumentCancelledAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_DebtInstrumentCancelledAmount" xlink:to="abvc_DebtInstrumentCancelledAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_DebtInstrumentCancelledAmount_lbl" xml:lang="en-US">Notes payable cancelled</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_2_lbl" xml:lang="en-US">Number of shares issued upon bankruptcy sale</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Number of shares issued upon services rendered</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Value of shares issued upon services rendered</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsPayableCurrent_2_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherPaymentsToAcquireBusinesses" xlink:label="us-gaap_OtherPaymentsToAcquireBusinesses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherPaymentsToAcquireBusinesses" xlink:to="us-gaap_OtherPaymentsToAcquireBusinesses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherPaymentsToAcquireBusinesses_lbl" xml:lang="en-US">Deposit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Debt face amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_3_lbl" xml:lang="en-US">Common stock, outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockVotingRights" xlink:label="us-gaap_CommonStockVotingRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockVotingRights" xlink:to="us-gaap_CommonStockVotingRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockVotingRights_lbl" xml:lang="en-US">Description common sharesholders voting rights</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Number of shares issued upon initial deposit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepositAssets" xlink:label="us-gaap_DepositAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositAssets" xlink:to="us-gaap_DepositAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositAssets_lbl" xml:lang="en-US">Intial deposit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xml:lang="en-US">Each preferred shares converted into voting common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockVotingRights" xlink:label="us-gaap_PreferredStockVotingRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockVotingRights" xlink:to="us-gaap_PreferredStockVotingRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockVotingRights_lbl" xml:lang="en-US">Description preferred sharesholders voting rights</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Number of shares issued upon conversion</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:to="us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable_2_lbl" xml:lang="en-US">Subscription receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_LossContingenciesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingenciesTable_lbl" xml:lang="en-US">Loss Contingencies [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingenciesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingenciesLineItems_lbl" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xml:lang="en-US">Total consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_AgreementPeriod" xlink:label="abvc_AgreementPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_AgreementPeriod" xlink:to="abvc_AgreementPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_AgreementPeriod_lbl" xml:lang="en-US">Agreement period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Post bankruptcy operating loss carryforward</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_OperatingLossCarryforwardsExpirationPeriodDescription" xlink:label="abvc_OperatingLossCarryforwardsExpirationPeriodDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_OperatingLossCarryforwardsExpirationPeriodDescription" xlink:to="abvc_OperatingLossCarryforwardsExpirationPeriodDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_OperatingLossCarryforwardsExpirationPeriodDescription_lbl" xml:lang="en-US">Description of operating loss expiration period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Current effective tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating loss carry forwards valuation available</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation Allowances</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Deferred Tax Asset</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Net Deferred Tax Asset</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_lbl" xml:lang="en-US">Purchase price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_lbl" xml:lang="en-US">Purchase price allocated to inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_lbl" xml:lang="en-US">Purchase price allocated to intangible assets ("MeTu" trade name and web site MeTuBoutique.com)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLoss_4_lbl" xml:lang="en-US">Net Income (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_lbl" xml:lang="en-US">Weighted-average common shares outstanding basic</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted-average common stock (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Stock options exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:to="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_lbl" xml:lang="en-US">Preferred stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_lbl" xml:lang="en-US">Weighted-average common shares outstanding- basic and diluted (in shares)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_Prepayment" xlink:to="abvc_Prepayment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_Prepayment_doc" xml:lang="en-US">Represents information pertaining to prepayment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_RetainedEarningsAccumulatedDeficit1" xlink:to="abvc_RetainedEarningsAccumulatedDeficit1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_RetainedEarningsAccumulatedDeficit1_doc" xml:lang="en-US">The cumulative amount of the reporting entity's undistributed earnings or deficit.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_IncreaseDecreaseInPrepayment" xlink:to="abvc_IncreaseDecreaseInPrepayment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_IncreaseDecreaseInPrepayment_doc" xml:lang="en-US">Represents information pertaining to increase decrease in prepayment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_ForwardStockSplitPolicyTextBlock" xlink:to="abvc_ForwardStockSplitPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_ForwardStockSplitPolicyTextBlock_doc" xml:lang="en-US">Represents information pertaining to forward stock split policy.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_ShareExchangeAgreementMember" xlink:to="abvc_ShareExchangeAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_ShareExchangeAgreementMember_doc" xml:lang="en-US">Information by category of arrangement, including but not limited to collaborative arrangements and non-collaborative arrangements.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_AmericanBriVisionHoldingCorporationMember" xlink:to="abvc_AmericanBriVisionHoldingCorporationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_AmericanBriVisionHoldingCorporationMember_doc" xml:lang="en-US">The set of legal entities associated with a report.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_EuroAsiaInvestmentAndFinanceCorpLimitedMember" xlink:to="abvc_EuroAsiaInvestmentAndFinanceCorpLimitedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_EuroAsiaInvestmentAndFinanceCorpLimitedMember_doc" xml:lang="en-US">The set of legal entities associated with a report.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_AmericanBriVisionCorporationMember" xlink:to="abvc_AmericanBriVisionCorporationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_AmericanBriVisionCorporationMember_doc" xml:lang="en-US">The set of legal entities associated with a report.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_BioLiteIncMember" xlink:to="abvc_BioLiteIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_BioLiteIncMember_doc" xml:lang="en-US">Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_YuanGeneCorporationMember" xlink:to="abvc_YuanGeneCorporationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_YuanGeneCorporationMember_doc" xml:lang="en-US">Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_LiteArtIncMember" xlink:to="abvc_LiteArtIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_LiteArtIncMember_doc" xml:lang="en-US">Refers to as a legal entity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_AgreementPeriod" xlink:to="abvc_AgreementPeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_AgreementPeriod_doc" xml:lang="en-US">Agreement period in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_CallaobrativeAgreementDisclosureTextBlock" xlink:to="abvc_CallaobrativeAgreementDisclosureTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_CallaobrativeAgreementDisclosureTextBlock_doc" xml:lang="en-US">The entire disclosure pertaining to the information about callaobrative agreement with related party.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_CollaborativeAgreementMember" xlink:to="abvc_CollaborativeAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_CollaborativeAgreementMember_doc" xml:lang="en-US">Information about collabrative agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_LicensingRightsMember" xlink:to="abvc_LicensingRightsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_LicensingRightsMember_doc" xml:lang="en-US">It refers to licensing rights.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_UpfrontPayment" xlink:to="abvc_UpfrontPayment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_UpfrontPayment_doc" xml:lang="en-US">Amount of partial payment made.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_DescriptionOfAgreementTerms" xlink:to="abvc_DescriptionOfAgreementTerms_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_DescriptionOfAgreementTerms_doc" xml:lang="en-US">Description of agreement terms.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_SignsMember" xlink:to="abvc_SignsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_SignsMember_doc" xml:lang="en-US">Information about property plant and equipment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_MarketingAndPromotionalVideoMember" xlink:to="abvc_MarketingAndPromotionalVideoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_MarketingAndPromotionalVideoMember_doc" xml:lang="en-US">Information about marketing and promotional video.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_DebtInstrumentCancelledAmount" xlink:to="abvc_DebtInstrumentCancelledAmount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_DebtInstrumentCancelledAmount_doc" xml:lang="en-US">Refer the amount of the debt instrument that was cancelled.</link:label>
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_SeeneLLCMember" xlink:label="abvc_SeeneLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_SeeneLLCMember" xlink:to="abvc_SeeneLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_SeeneLLCMember_doc" xml:lang="en-US">Information by business combination or series of individually immaterial business combinations.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_MetuBrandsIncMember" xlink:to="abvc_MetuBrandsIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_MetuBrandsIncMember_doc" xml:lang="en-US">Information about legal entity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_FreshStartAdjustmentTextBlock" xlink:to="abvc_FreshStartAdjustmentTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_FreshStartAdjustmentTextBlock_doc" xml:lang="en-US">The entire disclosure about fresh start adjustment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_OperatingLossCarryforwardsExpirationPeriodDescription" xlink:to="abvc_OperatingLossCarryforwardsExpirationPeriodDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_OperatingLossCarryforwardsExpirationPeriodDescription_doc" xml:lang="en-US">Refers to description of expiration period for operatin loss carryforward between periods.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_ProceedsFromFreshStartAdjustments" xlink:to="abvc_ProceedsFromFreshStartAdjustments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_ProceedsFromFreshStartAdjustments_doc" xml:lang="en-US">Amount of cash inflow from fresh start adjustment..</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_ProceedsFromCapitalInjectionToBankruptcyTrustee" xlink:to="abvc_ProceedsFromCapitalInjectionToBankruptcyTrustee_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_ProceedsFromCapitalInjectionToBankruptcyTrustee_doc" xml:lang="en-US">Amount of cash inflow from capital injection to bankruptcy trustee.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_NonCashFreshStartAdjustment" xlink:to="abvc_NonCashFreshStartAdjustment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_NonCashFreshStartAdjustment_doc" xml:lang="en-US">Amount of cash inflow from debt non cash fresh start adjustment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_AdjustmentsToAdditionalPaidInCapitalFreshStartAdjustments" xlink:to="abvc_AdjustmentsToAdditionalPaidInCapitalFreshStartAdjustments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_AdjustmentsToAdditionalPaidInCapitalFreshStartAdjustments_doc" xml:lang="en-US">Amount of increase decrease in additional paid in capital (APIC) resulting from adjustments to additional paid in capital fresh start adjustments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_AdjustmentsToAdditionalPaidInCapitalReorganizationAdjustments" xlink:to="abvc_AdjustmentsToAdditionalPaidInCapitalReorganizationAdjustments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_AdjustmentsToAdditionalPaidInCapitalReorganizationAdjustments_doc" xml:lang="en-US">Amount of increase decrease in additional paid in capital (APIC) resulting from adjustments to additional paid in capital reorganization adjustments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_BankruptcySharesIssuedValue" xlink:to="abvc_BankruptcySharesIssuedValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_BankruptcySharesIssuedValue_doc" xml:lang="en-US">Equity impact of the value of bankruptcy shares issued during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_BankruptcySharesIssuedShares" xlink:to="abvc_BankruptcySharesIssuedShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_BankruptcySharesIssuedShares_doc" xml:lang="en-US">Number of bankruptcy shares issued during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_InnovationConsultingLLCMember" xlink:to="abvc_InnovationConsultingLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_InnovationConsultingLLCMember_doc" xml:lang="en-US">Information about related party.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_RestatementAdjustmentOneMember" xlink:to="abvc_RestatementAdjustmentOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_RestatementAdjustmentOneMember_doc" xml:lang="en-US">Effect of a correction of an error, other prior year adjustment, or application of a new accounting pronouncement on a financial statement line item or any per share amounts. The cumulative effect of the change on retained earnings or net assets in the statement of financial position would also be represented under this domain member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_FreshStartAdustmentsMember" xlink:to="abvc_FreshStartAdustmentsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_FreshStartAdustmentsMember_doc" xml:lang="en-US">Information about fresh start adjustments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_PreferredStockValueOne" xlink:to="abvc_PreferredStockValueOne_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_PreferredStockValueOne_doc" xml:lang="en-US">Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_PreferredStockSharesAuthorizedOne" xlink:to="abvc_PreferredStockSharesAuthorizedOne_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_PreferredStockSharesAuthorizedOne_doc" xml:lang="en-US">The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_PreferredStockParOrStatedValuePerShareOne" xlink:to="abvc_PreferredStockParOrStatedValuePerShareOne_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_PreferredStockParOrStatedValuePerShareOne_doc" xml:lang="en-US">Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_PreferredStockSharesIssuedOne" xlink:to="abvc_PreferredStockSharesIssuedOne_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_PreferredStockSharesIssuedOne_doc" xml:lang="en-US">Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_PreferredStockSharesOutstandingOne" xlink:to="abvc_PreferredStockSharesOutstandingOne_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_PreferredStockSharesOutstandingOne_doc" xml:lang="en-US">Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_ReorganizationValueNetRealizableValueOfAccountsReceivableDispositions" xlink:to="abvc_ReorganizationValueNetRealizableValueOfAccountsReceivableDispositions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_ReorganizationValueNetRealizableValueOfAccountsReceivableDispositions_doc" xml:lang="en-US">Amount of fresh-start adjustment to receivables.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_ReorganizationValueNetRealizableValueOfPropertyPlantAndEquipmentDispositions" xlink:to="abvc_ReorganizationValueNetRealizableValueOfPropertyPlantAndEquipmentDispositions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_ReorganizationValueNetRealizableValueOfPropertyPlantAndEquipmentDispositions_doc" xml:lang="en-US">Total fresh-start adjustment to property and equipment, net.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_ReorganizationValueNetRealizableValueOfIntangibleAssetDispositions" xlink:to="abvc_ReorganizationValueNetRealizableValueOfIntangibleAssetDispositions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_ReorganizationValueNetRealizableValueOfIntangibleAssetDispositions_doc" xml:lang="en-US">Total fresh-start adjustment to intangible assets.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_ReorganizationValueNetRealizableValueOfTotalliabilitiestDispositions" xlink:to="abvc_ReorganizationValueNetRealizableValueOfTotalliabilitiestDispositions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_ReorganizationValueNetRealizableValueOfTotalliabilitiestDispositions_doc" xml:lang="en-US">Total fresh-start adjustment to total liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_ReorganizationValueNetRealizableValueOfAdditionalPaidInCapitalDispositions" xlink:to="abvc_ReorganizationValueNetRealizableValueOfAdditionalPaidInCapitalDispositions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_ReorganizationValueNetRealizableValueOfAdditionalPaidInCapitalDispositions_doc" xml:lang="en-US">Total fresh-start adjustment additional paid in capital.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_ReorganizationValueNetRealizableValueOfLiabilitiesAndStockholdersEquityDispositions" xlink:to="abvc_ReorganizationValueNetRealizableValueOfLiabilitiesAndStockholdersEquityDispositions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_ReorganizationValueNetRealizableValueOfLiabilitiesAndStockholdersEquityDispositions_doc" xml:lang="en-US">Total fresh-start adjustment to liabilities and stockholders equity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_FreshStartAdjustmentIncreaseDecreasePreferredStock1" xlink:to="abvc_FreshStartAdjustmentIncreaseDecreasePreferredStock1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="abvc_FreshStartAdjustmentIncreaseDecreasePreferredStock1_doc" xml:lang="en-US">Amount of fresh-start adjustment to preferred stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDueFromToRelatedParty" xlink:to="us-gaap_RelatedPartyTransactionDueFromToRelatedParty_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionDueFromToRelatedParty_2_lbl" xml:lang="en-US">Related Party Transaction, Due from (to) Related Party</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_2_lbl" xml:lang="en-US">Interest Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_2_lbl" xml:lang="en-US">Share-based Compensation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInDepositOtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Deposit Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_IncreaseDecreaseInPrepayment" xlink:to="abvc_IncreaseDecreaseInPrepayment_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_IncreaseDecreaseInPrepayment_3_lbl" xml:lang="en-US">IncreaseDecreaseInPrepayment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent" xlink:to="us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent_2_lbl" xml:lang="en-US">Increase (Decrease) in Due from Related Parties, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_2_lbl" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_NonCashFreshStartAdjustment" xlink:to="abvc_NonCashFreshStartAdjustment_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_NonCashFreshStartAdjustment_3_lbl" xml:lang="en-US">NonCashFreshStartAdjustment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_2_lbl" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherPaymentsToAcquireBusinesses" xlink:to="us-gaap_OtherPaymentsToAcquireBusinesses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherPaymentsToAcquireBusinesses_2_lbl" xml:lang="en-US">Other Payments to Acquire Businesses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_2_lbl" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:to="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_2_lbl" xml:lang="en-US">Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abvc_SeeneLLCMember" xlink:to="abvc_SeeneLLCMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abvc_SeeneLLCMember_2_lbl" xml:lang="en-US">SeeneLLCMember</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>abvc-20160630_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Created by S2 Filings, LLC- http://www.s2filings.com -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://metuboutique.com/role/DocumentAndEntityInformation" xlink:href="abvc-20160630.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/CondensedConsolidatedBalanceSheets" xlink:href="abvc-20160630.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="abvc-20160630.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/CondensedConsolidatedStatementsOfOperations" xlink:href="abvc-20160630.xsd#CondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" xlink:href="abvc-20160630.xsd#ConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/CondensedConsolidatedStatementsOfCashFlow" xlink:href="abvc-20160630.xsd#CondensedConsolidatedStatementsOfCashFlow" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/OrganizationAndDescriptionOfBusiness" xlink:href="abvc-20160630.xsd#OrganizationAndDescriptionOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="abvc-20160630.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/CollaobrativeAgreement" xlink:href="abvc-20160630.xsd#CollaobrativeAgreement" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/FreshStartAccounting" xlink:href="abvc-20160630.xsd#FreshStartAccounting" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/RelatedPartiesTransactions" xlink:href="abvc-20160630.xsd#RelatedPartiesTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/AccountsPayable" xlink:href="abvc-20160630.xsd#AccountsPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/NotesPayable" xlink:href="abvc-20160630.xsd#NotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/Equtiy" xlink:href="abvc-20160630.xsd#Equtiy" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/CommitmentsAndContingencies" xlink:href="abvc-20160630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/StockOptions" xlink:href="abvc-20160630.xsd#StockOptions" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/IncomeTaxes" xlink:href="abvc-20160630.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/GoingConcern" xlink:href="abvc-20160630.xsd#GoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/Acquisitions" xlink:href="abvc-20160630.xsd#Acquisitions" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/NetIncomeLossPerShare" xlink:href="abvc-20160630.xsd#NetIncomeLossPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/SubsequentEvents" xlink:href="abvc-20160630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="abvc-20160630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="abvc-20160630.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/FreshStartAccountingTables" xlink:href="abvc-20160630.xsd#FreshStartAccountingTables" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/IncomeTaxesTables" xlink:href="abvc-20160630.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/NetIncomeLossPerShareTables" xlink:href="abvc-20160630.xsd#NetIncomeLossPerShareTables" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" xlink:href="abvc-20160630.xsd#OrganizationAndDescriptionOfBusinessDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:href="abvc-20160630.xsd#SummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="abvc-20160630.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/CollaobrativeAgreementDetailsNarrative" xlink:href="abvc-20160630.xsd#CollaobrativeAgreementDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/FreshStartAccountingDetails" xlink:href="abvc-20160630.xsd#FreshStartAccountingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/RelatedPartiesTransactionsDetailsNarrative" xlink:href="abvc-20160630.xsd#RelatedPartiesTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/AccountsPayableDetailsNarrative" xlink:href="abvc-20160630.xsd#AccountsPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/NotesPayableDetailsNarrative" xlink:href="abvc-20160630.xsd#NotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/EqutiyDetailsNarrative" xlink:href="abvc-20160630.xsd#EqutiyDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="abvc-20160630.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/IncomeTaxesDetailsNarrative" xlink:href="abvc-20160630.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/IncomeTaxesDetails" xlink:href="abvc-20160630.xsd#IncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/AcquisitionsDetailsNarrative" xlink:href="abvc-20160630.xsd#AcquisitionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://metuboutique.com/role/NetIncomeLossPerShareDetails" xlink:href="abvc-20160630.xsd#NetIncomeLossPerShareDetails" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information">
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_DocumentAndEntityInformationAbstract" xlink:label="loc_abvcDocumentAndEntityInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvcDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvcDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvcDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvcDocumentAndEntityInformationAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvcDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvcDocumentAndEntityInformationAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvcDocumentAndEntityInformationAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvcDocumentAndEntityInformationAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvcDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/CondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="loc_us-gaapConvertiblePreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_Prepayment" xlink:label="loc_abvcPrepayment" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_abvcPrepayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaapDepositsAssetsNoncurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapDepositsAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapNotesPayableRelatedPartiesCurrentAndNoncurrent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapNotesPayableRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionDueFromToRelatedParty" xlink:label="loc_us-gaapRelatedPartyTransactionDueFromToRelatedParty" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionDueFromToRelatedParty" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DueToOfficersOrStockholdersCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToOfficersOrStockholdersCurrentAndNoncurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapDueToOfficersOrStockholdersCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapShortTermBorrowings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:label="loc_us-gaapCommonStockShareSubscribedButUnissuedSubscriptionsReceivable" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_RetainedEarningsAccumulatedDeficit1" xlink:label="loc_abvcRetainedEarningsAccumulatedDeficit1" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_abvcRetainedEarningsAccumulatedDeficit1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="loc_us-gaapConvertiblePreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/CondensedConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaapSalesRevenueNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSalesRevenueNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaapInvestmentIncomeInterest" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInvestmentIncomeInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaapOtherIncome" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapOtherIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIENCY)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="50" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_abvcMetuBrandsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_AdjustmentsToAdditionalPaidInCapitalFreshStartAdjustments" xlink:label="loc_abvcAdjustmentsToAdditionalPaidInCapitalFreshStartAdjustments" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_abvcAdjustmentsToAdditionalPaidInCapitalFreshStartAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_AdjustmentsToAdditionalPaidInCapitalReorganizationAdjustments" xlink:label="loc_abvcAdjustmentsToAdditionalPaidInCapitalReorganizationAdjustments" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_abvcAdjustmentsToAdditionalPaidInCapitalReorganizationAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_BankruptcySharesIssuedValue" xlink:label="loc_abvcBankruptcySharesIssuedValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_abvcBankruptcySharesIssuedValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_BankruptcySharesIssuedShares" xlink:label="loc_abvcBankruptcySharesIssuedShares" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_abvcBankruptcySharesIssuedShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/CondensedConsolidatedStatementsOfCashFlow" xlink:title="00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInDepositOtherAssets" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDepositOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_IncreaseDecreaseInPrepayment" xlink:label="loc_abvcIncreaseDecreaseInPrepayment" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_abvcIncreaseDecreaseInPrepayment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent" xlink:label="loc_us-gaapIncreaseDecreaseInDueFromRelatedPartiesCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDueFromRelatedPartiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:label="loc_us-gaapIncreaseDecreaseInDueToRelatedPartiesCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInDueToOfficersAndStockholdersCurrent" xlink:label="loc_us-gaapIncreaseDecreaseInDueToOfficersAndStockholdersCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDueToOfficersAndStockholdersCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableRelatedParties" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_ProceedsFromFreshStartAdjustments" xlink:label="loc_abvcProceedsFromFreshStartAdjustments" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="loc_abvcProceedsFromFreshStartAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_ProceedsFromCapitalInjectionToBankruptcyTrustee" xlink:label="loc_abvcProceedsFromCapitalInjectionToBankruptcyTrustee" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="loc_abvcProceedsFromCapitalInjectionToBankruptcyTrustee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromShortTermDebt" xlink:label="loc_us-gaapProceedsFromShortTermDebt" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapProceedsFromShortTermDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashAndCashEquivalents" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCash" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_2" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCash_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaapInterestPaid" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_us-gaapInterestPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaapIncomeTaxesPaid" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_us-gaapIncomeTaxesPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_NonCashFreshStartAdjustment" xlink:label="loc_abvcNonCashFreshStartAdjustment" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_abvcNonCashFreshStartAdjustment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReorganizationItems" xlink:label="loc_us-gaapReorganizationItems" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapReorganizationItems" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/OrganizationAndDescriptionOfBusiness" xlink:title="00000007 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="loc_us-gaapBusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/CollaobrativeAgreement" xlink:title="00000009 - Disclosure - COLLAOBRATIVE AGREEMENT">
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_CollaobrativeAgreementAbstract" xlink:label="loc_abvcCollaobrativeAgreementAbstract" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_CallaobrativeAgreementDisclosureTextBlock" xlink:label="loc_abvcCallaobrativeAgreementDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvcCollaobrativeAgreementAbstract" xlink:to="loc_abvcCallaobrativeAgreementDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/FreshStartAccounting" xlink:title="00000010 - Disclosure - Fresh Start Accounting">
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_NotesToFinancialStatementsAbstract" xlink:label="loc_abvcNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvcNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_FreshStartAdjustmentTextBlock" xlink:label="loc_abvcFreshStartAdjustmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_abvcFreshStartAdjustmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/RelatedPartiesTransactions" xlink:title="00000011 - Disclosure - RELATED PARTIES TRANSACTIONS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/AccountsPayable" xlink:title="00000012 - Disclosure - ACCOUNTS PAYABLE">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/NotesPayable" xlink:title="00000013 - Disclosure - Notes Payable">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayableAbstract" xlink:label="loc_us-gaapNotesPayableAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNotesPayableAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTextBlock" xlink:label="loc_us-gaapShortTermDebtTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShortTermDebtTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/Equtiy" xlink:title="00000014 - Disclosure - EQUTIY">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/CommitmentsAndContingencies" xlink:title="00000015 - Disclosure - COMMITMENTS AND CONTINGENCIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/StockOptions" xlink:title="00000016 - Disclosure - Stock Options">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/IncomeTaxes" xlink:title="00000017 - Disclosure - Income Taxes">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/GoingConcern" xlink:title="00000018 - Disclosure - Going Concern">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/Acquisitions" xlink:title="00000019 - Disclosure - Acquisitions">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaapBusinessCombinationDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/NetIncomeLossPerShare" xlink:title="00000020 - Disclosure - Net Income (Loss) Per Share">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaapEarningsPerShareTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/SubsequentEvents" xlink:title="00000021 - Disclosure - Subsequent Events">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaapNatureOfOperations" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNatureOfOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="loc_us-gaapIntangibleAssetsFiniteLivedPolicy" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIntangibleAssetsFiniteLivedPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_ForwardStockSplitPolicyTextBlock" xlink:label="loc_abvcForwardStockSplitPolicyTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_abvcForwardStockSplitPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000023 - Disclosure - Summary of Significant Accounting Policies (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/FreshStartAccountingTables" xlink:title="00000024 - Disclosure - Fresh Start Accounting (Tables)">
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_FreshStartAccountingTablesAbstract" xlink:label="loc_abvcFreshStartAccountingTablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvcFreshStartAccountingTablesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFreshStartAdjustmentsTextBlock" xlink:label="loc_us-gaapScheduleOfFreshStartAdjustmentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfFreshStartAdjustmentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/IncomeTaxesTables" xlink:title="00000025 - Disclosure - Income Taxes (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/NetIncomeLossPerShareTables" xlink:title="00000026 - Disclosure - Net Income (Loss) Per Share (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" xlink:title="00000027 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_ShareExchangeAgreementMember" xlink:label="loc_abvcShareExchangeAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_abvcShareExchangeAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_AmericanBriVisionHoldingCorporationMember" xlink:label="loc_abvcAmericanBriVisionHoldingCorporationMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcAmericanBriVisionHoldingCorporationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_EuroAsiaInvestmentAndFinanceCorpLimitedMember" xlink:label="loc_abvcEuroAsiaInvestmentAndFinanceCorpLimitedMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcEuroAsiaInvestmentAndFinanceCorpLimitedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_AmericanBriVisionCorporationMember" xlink:label="loc_abvcAmericanBriVisionCorporationMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcAmericanBriVisionCorporationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:title="00000028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)">
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_SummaryOfSignificantAccountingPoliciesDetailsAbstract" xlink:label="loc_abvcSummaryOfSignificantAccountingPoliciesDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvcSummaryOfSignificantAccountingPoliciesDetailsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaapEquipmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_SignsMember" xlink:label="loc_abvcSignsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_abvcSignsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="loc_us-gaapSoftwareDevelopmentMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapSoftwareDevelopmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MarketingAndPromotionalVideoMember" xlink:label="loc_abvcMarketingAndPromotionalVideoMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_abvcMarketingAndPromotionalVideoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="loc_us-gaapPropertyPlantAndEquipmentEstimatedUsefulLives" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentEstimatedUsefulLives" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/CollaobrativeAgreementDetailsNarrative" xlink:title="00000030 - Disclosure - COLLAOBRATIVE AGREEMENT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_CollaobrativeAgreementDetailsNarrativeAbstract" xlink:label="loc_abvcCollaobrativeAgreementDetailsNarrativeAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvcCollaobrativeAgreementDetailsNarrativeAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_CollaborativeAgreementMember" xlink:label="loc_abvcCollaborativeAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_abvcCollaborativeAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_BioLiteIncMember" xlink:label="loc_abvcBioLiteIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_abvcBioLiteIncMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_LicensingRightsMember" xlink:label="loc_abvcLicensingRightsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_abvcLicensingRightsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_UpfrontPayment" xlink:label="loc_abvcUpfrontPayment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_abvcUpfrontPayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_DescriptionOfAgreementTerms" xlink:label="loc_abvcDescriptionOfAgreementTerms" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_abvcDescriptionOfAgreementTerms" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/FreshStartAccountingDetails" xlink:title="00000031 - Disclosure - Fresh Start Accounting (Details)">
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_FreshStartAccountingTablesAbstract" xlink:label="loc_abvcFreshStartAccountingTablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abvcFreshStartAccountingTablesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaapStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementScenarioAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaapScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementScenarioAxis" xlink:to="loc_us-gaapScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_RestatementAdjustmentOneMember" xlink:label="loc_abvcRestatementAdjustmentOneMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_abvcRestatementAdjustmentOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestatementAdjustmentMember" xlink:label="loc_us-gaapRestatementAdjustmentMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_us-gaapRestatementAdjustmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioAdjustmentMember" xlink:label="loc_us-gaapScenarioAdjustmentMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_us-gaapScenarioAdjustmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_FreshStartAdustmentsMember" xlink:label="loc_abvcFreshStartAdustmentsMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_abvcFreshStartAdustmentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ChiefExecutiveOfficerMember" xlink:label="loc_us-gaapChiefExecutiveOfficerMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapChiefExecutiveOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_InnovationConsultingLLCMember" xlink:label="loc_abvcInnovationConsultingLLCMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_abvcInnovationConsultingLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="loc_us-gaapConvertiblePreferredStockMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_PreferredStockValueOne" xlink:label="loc_abvcPreferredStockValueOne" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_abvcPreferredStockValueOne" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_PreferredStockSharesAuthorizedOne" xlink:label="loc_abvcPreferredStockSharesAuthorizedOne" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_abvcPreferredStockSharesAuthorizedOne" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_PreferredStockParOrStatedValuePerShareOne" xlink:label="loc_abvcPreferredStockParOrStatedValuePerShareOne" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_abvcPreferredStockParOrStatedValuePerShareOne" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_PreferredStockSharesIssuedOne" xlink:label="loc_abvcPreferredStockSharesIssuedOne" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_abvcPreferredStockSharesIssuedOne" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_PreferredStockSharesOutstandingOne" xlink:label="loc_abvcPreferredStockSharesOutstandingOne" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_abvcPreferredStockSharesOutstandingOne" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaapRepaymentsOfDebt" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRepaymentsOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReorganizationValueCashInExcessOfNormalOperatingNeeds" xlink:label="loc_us-gaapReorganizationValueCashInExcessOfNormalOperatingNeeds" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapReorganizationValueCashInExcessOfNormalOperatingNeeds" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_ReorganizationValueNetRealizableValueOfAccountsReceivableDispositions" xlink:label="loc_abvcReorganizationValueNetRealizableValueOfAccountsReceivableDispositions" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_abvcReorganizationValueNetRealizableValueOfAccountsReceivableDispositions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_ReorganizationValueNetRealizableValueOfPropertyPlantAndEquipmentDispositions" xlink:label="loc_abvcReorganizationValueNetRealizableValueOfPropertyPlantAndEquipmentDispositions" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_abvcReorganizationValueNetRealizableValueOfPropertyPlantAndEquipmentDispositions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_ReorganizationValueNetRealizableValueOfIntangibleAssetDispositions" xlink:label="loc_abvcReorganizationValueNetRealizableValueOfIntangibleAssetDispositions" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_abvcReorganizationValueNetRealizableValueOfIntangibleAssetDispositions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_ReorganizationValueNetRealizableValueOfTotalliabilitiestDispositions" xlink:label="loc_abvcReorganizationValueNetRealizableValueOfTotalliabilitiestDispositions" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_abvcReorganizationValueNetRealizableValueOfTotalliabilitiestDispositions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_ReorganizationValueNetRealizableValueOfAdditionalPaidInCapitalDispositions" xlink:label="loc_abvcReorganizationValueNetRealizableValueOfAdditionalPaidInCapitalDispositions" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_abvcReorganizationValueNetRealizableValueOfAdditionalPaidInCapitalDispositions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_ReorganizationValueNetRealizableValueOfLiabilitiesAndStockholdersEquityDispositions" xlink:label="loc_abvcReorganizationValueNetRealizableValueOfLiabilitiesAndStockholdersEquityDispositions" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_abvcReorganizationValueNetRealizableValueOfLiabilitiesAndStockholdersEquityDispositions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FreshStartAdjustmentIncreaseDecreaseAmortizableIntangibleAssets" xlink:label="loc_us-gaapFreshStartAdjustmentIncreaseDecreaseAmortizableIntangibleAssets" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFreshStartAdjustmentIncreaseDecreaseAmortizableIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FreshStartAdjustmentIncreaseDecreasePreferredStock" xlink:label="loc_us-gaapFreshStartAdjustmentIncreaseDecreasePreferredStock" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFreshStartAdjustmentIncreaseDecreasePreferredStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_FreshStartAdjustmentIncreaseDecreasePreferredStock1" xlink:label="loc_abvcFreshStartAdjustmentIncreaseDecreasePreferredStock1" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_abvcFreshStartAdjustmentIncreaseDecreasePreferredStock1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FreshStartAdjustmentIncreaseDecreaseAdditionalPaidInCapital" xlink:label="loc_us-gaapFreshStartAdjustmentIncreaseDecreaseAdditionalPaidInCapital" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFreshStartAdjustmentIncreaseDecreaseAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FreshStartAdjustmentIncreaseDecreaseRetainedEarningsDeficit" xlink:label="loc_us-gaapFreshStartAdjustmentIncreaseDecreaseRetainedEarningsDeficit" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFreshStartAdjustmentIncreaseDecreaseRetainedEarningsDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FreshStartAdjustmentIncreaseDecreaseLiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapFreshStartAdjustmentIncreaseDecreaseLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFreshStartAdjustmentIncreaseDecreaseLiabilitiesAndStockholdersEquity" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/RelatedPartiesTransactionsDetailsNarrative" xlink:title="00000032 - Disclosure - RELATED PARTIES TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_BioLiteIncMember" xlink:label="loc_abvcBioLiteIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_abvcBioLiteIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_YuanGeneCorporationMember" xlink:label="loc_abvcYuanGeneCorporationMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_abvcYuanGeneCorporationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ChiefExecutiveOfficerMember" xlink:label="loc_us-gaapChiefExecutiveOfficerMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapChiefExecutiveOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnsecuredDebtMember" xlink:label="loc_us-gaapUnsecuredDebtMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_us-gaapUnsecuredDebtMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="loc_us-gaapConvertiblePreferredStockMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:label="loc_us-gaapNotesPayableRelatedPartiesClassifiedCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapNotesPayableRelatedPartiesClassifiedCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_DebtInstrumentCancelledAmount" xlink:label="loc_abvcDebtInstrumentCancelledAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_abvcDebtInstrumentCancelledAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/AccountsPayableDetailsNarrative" xlink:title="00000033 - Disclosure - ACCOUNTS PAYABLE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_LiteArtIncMember" xlink:label="loc_abvcLiteArtIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcLiteArtIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/NotesPayableDetailsNarrative" xlink:title="00000034 - Disclosure - Notes Payable (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayableAbstract" xlink:label="loc_us-gaapNotesPayableAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNotesPayableAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember" xlink:label="loc_us-gaapNotesPayableOtherPayablesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_us-gaapNotesPayableOtherPayablesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherPaymentsToAcquireBusinesses" xlink:label="loc_us-gaapOtherPaymentsToAcquireBusinesses" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherPaymentsToAcquireBusinesses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/EqutiyDetailsNarrative" xlink:title="00000035 - Disclosure - EQUTIY (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ChiefExecutiveOfficerMember" xlink:label="loc_us-gaapChiefExecutiveOfficerMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapChiefExecutiveOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_InnovationConsultingLLCMember" xlink:label="loc_abvcInnovationConsultingLLCMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_abvcInnovationConsultingLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="loc_us-gaapConvertiblePreferredStockMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockVotingRights" xlink:label="loc_us-gaapCommonStockVotingRights" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockVotingRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepositAssets" xlink:label="loc_us-gaapDepositAssets" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepositAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockSharesConverted1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockVotingRights" xlink:label="loc_us-gaapPreferredStockVotingRights" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockVotingRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:label="loc_us-gaapCommonStockShareSubscribedButUnissuedSubscriptionsReceivable" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000036 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaapLossContingenciesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLossContingenciesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaapLossContingenciesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_us-gaapLossContingenciesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_BioLiteIncMember" xlink:label="loc_abvcBioLiteIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_abvcBioLiteIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_AgreementPeriod" xlink:label="loc_abvcAgreementPeriod" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_abvcAgreementPeriod" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000037 - Disclosure - Income Taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_OperatingLossCarryforwardsExpirationPeriodDescription" xlink:label="loc_abvcOperatingLossCarryforwardsExpirationPeriodDescription" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_abvcOperatingLossCarryforwardsExpirationPeriodDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/IncomeTaxesDetails" xlink:title="00000038 - Disclosure - Income Taxes (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/AcquisitionsDetailsNarrative" xlink:title="00000039 - Disclosure - Acquisitions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/NetIncomeLossPerShareDetails" xlink:title="00000040 - Disclosure - Net Income (Loss) Per Share (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="abvc-20160630.xsd#abvc_MetuBrandsIncMember" xlink:label="loc_abvcMetuBrandsIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_abvcMetuBrandsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:label="loc_us-gaapEarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>ex3-4_pg2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex3-4_pg2.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" 0; RH# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@!"<>O^>OY?_JR:C1Y&DF5XC&B,@BD+HWG*R*Q8
M(I+1A7+1XD"L2NY05(J6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJQPK U7.J:9]J-C_ &C8?; XC-I]LM_M0D*+*$-OYGG!S$RR!=FXHP?&T@D
MOT50BU73)U#0:C83*9H[<-%>6\JFXESY4 *2,/.EPVR,$NV"54X.+P.?P_S_
M )Z\8/>@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH ***/\_Y_P#U4 %%'7I10 4444 %%%% !1110 4444 %%%%
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MM9_V!-J/@SQ?*/#-_I^G:5::5_:=A_9=QH*O+<17'^A71@?Y[].OKT'X<=*
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M4/B=X^C?1_!EA<P:C=ZY<6NOZIIVE36VEW&K:3_HBXXP.!_G_/K2@8_S^/\
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M@-XX^#O@3X=Z_KOQ$\2?%OXP^(+KPM\)O!GPZM&2S\.>*KSXA:Y8:A;:-?\
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MB;2HKRVDECBN;O3;ZUGM]1TC4-1TZY@NY0#Z_HI,\X_S_D_YSR M "'C_/\
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M'A^]U%_!?PCO+.X\ :M>>))O$WQ2N?[(U[5?%MU<^(9;;PWI@!_7/G^6<?\
MZ\?KBBOC3]@C5?BKKW[-'@[7OC-XV^/?COQQK&H^([NYU7]IGX'^ OV>/C+:
M::NL7-II>F>+/AA\-;'3O">D^3:6JW6EW=K;1WM]I5Y9RZJD&I"ZMH?LN@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "O@;]H?]@GX:?$?PIH5S\%= ^&?P/\
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MB]>HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML++X8:CI][9VNA1^%EL+.UO-+\/MI5XUA%8_Q+_ ?6+CX2^*O&GBR70OV9?
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MGG\.N.AZ49_D?S'!_7WY]>.0!:* <_Y_S_GK10 4444 %%%% !1110 4444
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M^#_Q:%IXZ\B\N/#_ (VT/X+W_P ,O'VHZ%\<);31]2TK4] L['5+34\[1?\
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M$;XPZ1\ YY)UTG5O&?Q!OM;^+.E?%?05-I);:C#;1:E;^&9]/T^]_HX\5_\
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M\-^#_$'[)?[.5KXDF70M4\5?"C5[K5OA-\4_AAK?BO3-&\#W.M>%] F;PEX
MN)8K_7+.:73;74>2_P""J'_!%O\ : _X)L>+_&/QT_9T\-:Y\?OV-M=N'2RU
M^['B+Q[\8OV?YM?DLY%T+XLZ9##J0\8?"GP]+H&G:/X<^,D&EQ>+_#/AN70?
M#7C+6VM-#2Y\5_GEX4^.NM?M%?&I/B=X\^)>H>(?B?HOC/0O&DOB7X3:U\-O
M#&N:?I>D^'Y;C4Y_"WC/X;6VB:-I_P#PK[PYI6K_ &*7PMH\^JWCPV%E(SZ/
M'+IEP ?TC?%C]DSXV_L\^ F\&_LYP_$3Q1X)\:_"KPO+XM\/?!'P!\$M9\(:
M/X?UWP_J6E7OQ6U+X2#P-9?&OPF/B/X,T_4/!6B>&]4OM4\/6DD]AXZUO48)
M='O/!$'Y]7?_  43/_!/)K3_ (5W\9KGQ[X9U@:[8:CX*U3X$>./&GCNX\8>
M#+J32],^$OCF]\8:'X0UCP%\0-'OUL/!&M>-M:O=,UK3O$VFZ]K.@Q:S +JX
MT_H-;_;$^/-OXD^)7A_XJ+X2^*]UX+^%W@36-)^._C[QKH7[/G[5L?AKXB7N
MGVW@34=4_:<^ &E:M\*O$ND_#SPWXC^&_CGQI+\7_ .E6UAX7\/W-MJ5I903
MZG%<>H^(?^"P/_"<66L?'C7_ ()_\% O 6E^.O"\>E):?#C]K?\ 9UU/P+H]
MS%/;_#2UO/#VJ^,;'P=X@_M7PWXHT+5M2LK;6M/*2OJLWB37[?5++Q61& =M
M\)OAG^W/\+?C'=>/K'X"?!3XB^-/'VCV.L>,KCX"/\2OB9X$_9*\<:YI&H:7
MI?A_XD?%F'XY_"%$\>>#=!T+2+;Q?K>A^(6\.0>%;*:PL;[2;74+.[U3ZGM_
MAWX\_:K\4^ /$W[;2^'?&_A_P] FK2Z'^SSX[\2^'?V:/V?;7PX);/Q?XZ^,
M7[5.I^(-3UGQ-*FOZ?J T;X/>'+_ ,1?#7PI?6\MOXA\<PRV[ZY#\:?$O_@H
M[\2?B/J7Q)TKPO\ LHZ-H?Q=^#OQ>\!^%;5OVR_VKM=UW1-.U[XIVWAKPU\.
MM5\(>$O@YI?@(ZYX!T749M OO''B>P\>:/9^'-7U'3+V]G\2O,MOIWYC_%[Q
M;^U-^TSX<UGQ7\8?B=H]G;_ WXP"T\;?L;>"O#?@SX!_LH>'-)\(>);W3M9^
M(&C6&F+K.A?%+Q!X;^)ZW7AKQ+H'Q#EU/XGZBNG:<8]3\0V.K79M@#Y2^,/P
MY^'$/Q\L/A=HO[3C?M,V_@7Q7JT'@W]I_2]&\0Z'XBU;79_#D?A6XT+X?^-/
M$>L3Z2^GG3K*Y\>:0NF:CXI\,:#K$MO+:+JUEJUSH^BPWOPTM/'7BR\_9&_8
MNTOXR>,I/CK\1)OAE\)/AC^T')X>L/%VG:+<2^%=$TO2;_2/"USH/@&RTN&*
MS^)6O_$/QGX2CU8^&?"&AZ)XNTC3/#]_K%_?7??_  ME_:6_:=^)/P8_8]^#
MO@_QC\8/$-OX[\:_$#1?A98OX:CC\-:=XQTNUN->UR;Q[J7VW6?A!\,;F'28
MK?7-3\<>+KFU\)1RP^'_  #X9\2:E;QZ/!_=7_P2"_X(_>"_^"<WP_B\;?$_
M6M,^-7[9'C'2KJR\<?&:Y@DO;;P!X5U9M,O3\$/@[=ZC:6=_8?#70K[3H9[S
M6[C3]+\0_$'6A+K_ (@M=/LUT/PSX= /K[_@F[^PUX,_X)Z_LF?#C]G?PW=P
M>)/%6G6;^)?C!\1S %U+XH_%[Q&$OO&WC&_NI8(+RXLGOR-%\*6U_ON=&\&:
M3X>T21Y&T]I9/N^BB@ K\5_^"B5I<Z/_ ,%)/^"'WQ#\37;6?PHTG]HC]JGX
M=ZC<SS_8](MOC)\5?V4?&FG?!1=0N9M4M;=]1UJZT+Q=X:\-6QTZXGNM3UJ3
M3;6<3ZK#97G[45^+/_!3+_@H'IW[#OQY^ &F?&7X7_"[QM^SQ\2?@G^U+\4M
M#\5>)-*FO/&G@;]I#]D'P+!\<_ ::4UZM[H<\'B3P[#KEIX<$-OH?B31?%%B
MVN:7XFB2WFTV[ $_9H^"/[4WP^7_ (*T_M@^*_@_=2?M9?'+XH?%32_V5?A]
MXH\5>#M>CU'X"?L^_#E_#/[(?@W2]6M?$EQHGA#PY\1O&1\1>.M8\/:K>^%3
MH^L^-[M_$MG#-9#6[W\]_B3_ ,$W/C7X1_8*_P""<OARW_9*^-WQ8_:8^"_@
M'XK^-OB!XC_9A_:T\$_LS?&GX,?MF_'7X876J>-_CC)XH'B7P5X<^+DGBSXL
M:OJ'AOQG?1>/H9?#/AZ2\U*RT;XBZ->W&AUVO[.G_!=?XR>*?#7[.&I?M/?"
MKX2_ W7O#7@?]O7XA?\ !1[03>>+GO/@/X/_ &3K?P!!\/-=\!PF_P!<BAF^
M+FM_$GPO8:/H.O:AXEA\0B>_B\*^)KB\LH[>Z]$^)O\ P<!>!+SPM\ ?&?P#
M^$'Q)UB77OV]/A)^R=^T/\%/&?@"?4?VD_"/A'XT?";Q9\3?AMXB^'_PT\&>
M,K^'6?$/Q'L;/PQJ'@YUU/Q!ILFFR^(])O\ 3XO$.D:E;:* =-^P=IGQGU'_
M (*FZY)\8=;M?%?QF^!/_!'/]BSX*?MI^)M)D\/Q:-=_M1>+?B3X[^)VCVD<
M.AW"Q7>I-X6_X2_7[KRM(TFQTJR\0:9=:=%)IOB;3WKX4\,_\$T/^"CGPZ_;
M(^/NC?"WPYK \&_%/]KG]NGX_P"K_'KXS_%70?'O[('Q%^!O[1/P!URR^&GP
M9\1?LI)XLOI[+XBR_&?QC)I/Q0\8:5\'O#\^K^#M!U6.X\5ZYX<OK+PKJGZ1
MS?\ !>?]@72]5\&?\(-\/OVA/'?Q,^,3?$RY\7_#7X;_  (6X^.7@C4_V?/$
M2_#?XGV7QG\#7^LZ#XAM?$GPWO+*+3)/#MF_BCQ;J6E1V!\%Z+XAL9;;' ?%
MC_@LK\0?A/\ M/7WP>T'X7I^T'X:US_@H+\"_P!E&VTSX6_#7XEZ?\0OA!X"
M^+/[*.D_'"&]\8KKETN@^-_'^M:W<7FKZ);6,OA#2]#\(:;XPM/$5N-1\)S7
M3@'Y,?LS?\$6/^"DNL_"+XN_!NWTO0?V3O WCSX*?L.?#/XV:1^U/XD\,_M/
MS_M)>)?V9?$WBW5OB#X"^'GB3X/_ !*B\:?!S]CW5]/ET'PKX2^%S:SX=OF\
M#3_\(_I5EX.AGUJ1_P!1/^";W_!/W_@I[\$?V+OV._@]XZ_:2^&WP \/_"'P
M;\2/#'Q<_9-\'?!CPOJT?CG3M?\ ''C[Q/H%OJ'[0FE?$#Q1JGA+Q+?)XDM(
MM<\0?#73;.PCLYOM":9=:_9RSS?8'PH_X+1_LJ_&[XI?%OX3_#/PI\;?%6O>
M _#WQZUOX7WFE^"-,O--_:GU+]F6^_LCXS>#_P!G$VGB:YU#Q=XO\.:Y+:Z;
MIFB>(;#PG<^)8)V\0:&+OPN@UIOU%^'OC&3X@?#SP/\ $!O"7C#P/)XV\%^&
M?&+>!?B!H\?AWX@>$'\2:)9:T?"?C;P^;NZCT+QAH#7IT?Q)H[7]PFEZW9WM
MD;N58#.P!_+1^Q?^R+_P4[_9?^%O[8DOP/\ V=_B)^SIX?TC]@#2/A%^SA^R
M1\2?VO-"_:2\.:Q^W#I>N>.KBT^+_P $O%/C'XC>+]"^&_PH\,^'=2T#1-(T
M+Q7>^!8O$BP:3_;WAQ!H\E\+7[4W_!)_]JKP!\-?V(-%_9%^#/A#XJ-X,_X)
MU_M:?L&_''0O%?Q/TRPUWPA\0?VR?!WAB+6OVA!K'C?5DMO%6F:1\6+WQOXS
M^)T^FZMK/BN_T>^N;+POX8U@WT+Z5^C>G_\ !>K]@H6G@Q_%>L?$7P+J_C#P
M3^V'XWG\.^)/"VCC5_!'_##]_P")+;XX^#/'R:+XKUNST/QO8VOA75M2\-V4
M%Y?Z)XEL(8KRQUY;>]L7N<[PU_P7X_85U3Q#\(/!7C.R^-WP;^(?Q?\ BO\
M%3X36OPX^+/P^TWP_P"-OA_>?"/X9>&/BSXC\7_%'1])\5^(%\(>#-0\)^-?
M!\WAS47NKR_UJ375NK;2VT?3=7U6P /RM\,?\$C_ -MCX._\%"/@AXD\#?#R
M7QAX"^$OQ4_X)]>(_#7QZG^*W@_2?V;8_@]^S+^R;9_LX_&IOB3^SEXIU#Q?
M\1/$_P"U9XE@L]<LOAK\7[?0]<UGPYI6K>$CHWQ#\'6>D:K9)_84./Z?Y_\
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MKTMU?W3#4_$VK:E<6L$J:?8M:Z;;6MG#]2XS_G\?Z4?Y_P __6_PHH ****
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MN-7^$6F?%/XB^+?#7PZ6\O=,T_1;NRGVI^O_ ,-_"=]X!^'?@+P+JGC+Q/\
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MW;+&J-;:LDFH:_JR:K?:OK]QJ !^LG]H_P#!6G_H4/\ @G7[_P#%QOVEO?\
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MVEE:3S7,\,4GPY\>/BW\<?B=JW[*GP@^*/CO1?$D?PK_ ."Z7A3]E?Q/XO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MP3^'G[3]C<Z1!9_'3QC\._$/PU\-W/AWPEH/@W3-*\-6>J_!O4/BW\+OA/\
M%&ZTS1K+PSXM\:>(-3\5^ TT?P;X!\:06-W5_P#@H9\*_@Y^TQ^UMXUU37/$
MGQ%MK+2-(\$^#;+PQ<^(+WP-KWBGPOHOPZ;X<?"3PKJTSWG@&V\6>,/$GQ-U
M_5;36=/FC;61J7Q'NKR273/@_P"(ET@ _4B']DS]F"W^(TWQ>A_9[^#:?%"?
MQLOQ+D\>CX<^%#XI'Q(&B3^&G^(4.KMI9N[;QS/X?N9M&N_%MM)%K][II2TN
M]0FABA2/LO&?P1^#'Q%U>?Q#\0?A+\-?'&O77@S6OAQ=:UXO\#^&?$FJW7P\
M\2N9/$?@*YU#6-,O+JX\%>(9")-=\*S2OH.KNJ/J-A<M&A7\U/A?_P %I/V4
M/&G[.7P&^._C)/%?PXUOX^^.?@O\*_"'PIU;3M_BO7/B#\8M+\$:I'/X)FUC
M_A&X?&/PK\+6GC5-1U7XOPP:7X1N])T35IM-DN-3^Q:/>=-^WO\ %N?4/B-^
MR;\'-'U&YT#X<>/O&'Q/\5?%/X^Z-+:>)/#7PI\/^#? $G@.RCU[2M%U*[U"
MTEU3Q9\:?"<NG>+?%NA-\)?!NMVFA:I\0]4>PEMO#VN@'Z :%\)_@G\,-3O_
M ![X:^&_PR\ :U;>"M*\(:KXST;PKX7\+ZE#\._""//H7A?4?$5I965U'X,\
M*QB:71M$NKP:'H,?G/8VUHC2,:>M?L__  #\5ZI<^(O$'P5^$?B'6=1\9^&O
MB9=Z]JWP[\'ZIJNH?$3PAI<>C>#OB%<:I<Z1-=W7C3PMHL<6E>&/%LD\FO:'
MIB)8Z5?VEJBQ5\H>/- ^%=MXJ\!_LU>*/L^E_LO_ +,W[-\'Q<\7^&M>U*34
M?#OCOP]X'GN_AUX)\-^+[:[2YD\:^"/A=IG@_P 0>+/'NB:G)?6=YXHG^%US
MK]G=+$MM>Y.F_P#!6W_@GB2+>X_:%\/>%=+@T+]GR_L=7\4^&_&'A3PU>W/[
M2\(D^$/@K0]8U;P[9Z9JGCR[LS#=>)O .F37'B;X>V!GN_&VF:!:Z5K4FF '
MT/XS_8E_8Y^(>@Z3X6\=_LJ?L[>,O#6@_$6_^+VC>'O$OP;^'NL:)IOQ3U>9
M)]:^(MKI=]X?GL8O&FMS(LVO>)!!_:VN2*'U:ZO'YKVOQ_\ #CP!\5O!6O?#
M;XF>"_"_CWP!XGL4TWQ#X,\6Z)IVO^&=8L89X+JWM]0T;4K>YL+A;6\M;6\L
MVD@WV=[:6UW:M%<VT,R?)O[97[:OPW_9T_9X^-GC[0O&&C:U\3?#'[/GQ-^*
M?PQ\'Z25UG5/%NOZ!H:6W@?1]/MHX+JQDU3Q=XWUKPQH/AC1K]H[WQ/=7EVN
MCV.IP:3K/V+V']G3XXZ;\9?"VH6-P+VU^)'PQ'A'P7\;M"N[6QC'A'XN7GP^
M\)>,O%O@TZAHUWJ7AK5=1\,3>)X-+UZ7POJVKZ)I^M17NE6VI7+V4A4 VC^S
M5^SR^@> ?"T_P-^$UYX=^%6MR^)_AGI&H?#_ ,+:C9> ?%-Q/<75UXK\(17V
MEW'_  CWBJ[N[R]N[WQ-I9MM=O+N^OKJZU"6XO;J2:&?]F+]FZYB\407/P ^
M"\\/CCQKIOQ*\:0S?##P7)'XO^(^BW2WVC?$+Q.CZ*5U_P <Z1>I'>:7XNU4
M7?B#3[J&"XM-1AE@A=/;U=9%5T971U#HZG<K*0"K*PX92""&!PP((.#3Z /#
M=&_9C_9R\._%[QI^T#H/P'^$&C?'/XC:#'X7\?\ Q@TSX=>$[+XE>-/#D26D
M8T3Q1XTM]*C\0:WIDD5AIT5Q::C?W$-U#IFF17*S1Z;8K;V?@C^S?^S[^S3H
M&L^%?V>/@C\*?@=X:\1Z_>>*M?T'X3^ ?"_P_P!(UKQ)?A5N]<U33_"^F:7;
M7VIRQI' +NYCDEBM8H+2%H[6"&%/::* /&=(_9U^ WA_XD>*?C#H?P>^'&D?
M%3QO'<1^+_B!IWA#0[/Q9XC-[8Z?I>H3:MK,%FEY=W>J:9I&CZ;JU[)(;O5=
M/T?2+/49[FVTNPCM^I^'/PL^&7P?\.CP?\)?AYX(^%_A);Z]U1/"WP]\*:%X
M,\.1ZEJ4QN-2U"/0_#MAIVF1WNHW):YO[J.U6:\N7DN+EY)Y'D;O:* /S;_:
M)_:1^*W[*?[&'C;XM? W]FKXD_M:_%^/XK^._"?P\^"?PSTS5;Z_UWQ+XP^/
MGB_0[76/%6H:/IFM7?AGP#X:BN)M<\7>)VTRXM],TZS9;F2S2Y:_M?ST^&W_
M  6?^/?P1\7?MT_"#_@IG^SE\+_A1\5OV,?V1[+]M%;[]FWXH7/Q#\"_$7X9
MZE?-H-CX*C?Q3;6>J^%_B)>^++G1O#NDP:K.UIK%QJ4]^;73M*@TO4-?^U_V
MROVJ/C9^QY^P+\3/B_\ LV_LY?$3]J?X^M\2/B=X0^$OPE^'7@?Q?X^FN?%_
MB;XR^/[>V\4^,-&\#V&H>((_ ?@ZR@O?$/B&6U2S_M$V5EX<35]&N==M]5M/
MYY?V7?@)\1?VVOV*O^"GW[.GB']C7_@H9X$_;_\ VP_V<9/B9\9/VS_VZ_A/
M8?!_PW\=_C5X/O?#TWP^^ _PPGDFG\/?#SX7Z%XB3^R_ ?@.T\N+PYX%^U7^
MKZB%TO3AI8!^L/[!G_!7#]JWXJ_M*_ ']G;]NO\ 9/\ AW^SO<_MK_LU:Y^U
M=^R1XD^%WQ-U;QV)?!&@65IXCU+X:_%S1];T73[G1OB%IW@:]C\5W>K:9<6V
ME*@@TF70K34KN>+3KW['W_!<33_VW_\ @J+J7[&WP;^#/B#2/V94_9-\3_M!
M>!OC_P#$GPWXP\#>+?C1>^'OB7X<\!'Q/\./"/B*VTJ5?@S>W>IZYI&D>(-9
MTJ+6-?USPQJEU;Q6&GI'#-\9?L#Z5^U[^V%^W=_P3'^*7Q(_8J_:&_9(^'/_
M  2__8@^*'P1^,6N?M%>"(/!%C\1?V@?B%\/_"WPAU+0?@D]QK5UJ7Q \!#3
M_#-GXMT[QM#I%KIT=K;ZEIFH^5<W6C3:C]H3_!7XN)_P<PZ3\>8OA;X_7X%0
M_P#!(F;X8_\ "W8O!^O+\+X?B$/VE)]<C\!'QL+#_A&HO%IT,IJR>'#J*ZJ=
M,(O%M/LZ^;0!\S:W_P %D?\ @HS\5?VZ?VD_V8/V./@-^P;X]\$_ C]I74?V
M=M-_X7)^TMI?PP^.'C74_".DZ!?>/;SPS\-]4^(&F:CXO30[F]UF!+[PSI%Q
M:*=.^RW-NM_:WUNOH'[8W_!;K]I[X2?'3]MFU_9<_8_\!_'?]EO_ ()AZ=\.
M+C]M;XC>+_BO?>!O'>M:SX[LEUO6O#/P'TRST75='N;_ .&WA_[3>^*[CQ,E
MXLMSI6JV:6FGG^QI-<_&[]M7]B[XA_%CQ'^TY^R[\)?^"*OQ+^#7_!0_XI_\
M% -,^-OP;_X*4_#&'Q7XZ^!=MX%N?BKH_C75?CMJW[5OQ%\62^)?A?JVH:#9
MZQ?:O\'?#XMO#]GKVJOJFD>&M%\50V^C-]&_M>_!O]MG]F7XI_\ !<+]EOX6
M_L1_M%?M+6/_  6'LO!^M_LT?'7X2^%-)\0_"7PMXB\;^"-2\!?&G1OC_P"*
MY]:T/2O@Y;>&9O$>OWWA>_UQI5NTL+&:Z#:9J$>L1 'Z)?\ !0?_ (+4?'+X
M/?&O]DCX0_L1^!OV5/&Y_:5_9+D_:\NO$'[7GQFT_P#9_P##VB_#W7M9T#3/
MA_%9^*==\9>&-!CUGQ"NI:B?[#U&:2^O)[-ETJ6X%EJ*P^K?'']K'_@N-\/_
M (&?!;XJ^"OV,_V';^Z/P:\8?$/]JO4/&O[2$?A_X>_"76-!\3^(;NPE\+>*
MQXUBM-<\%M\*;#1O&6J^(&NM2MK2[N]1@^W)%9I$_P"=?[:W[,'AKX ?$K]F
M_3_VG_\ @C1XR_X*8^"_#'_!,CX:_LB^#_C_ /L^>'O&GQY\:>#OC!\/-%ET
MF3P?XH^"&M>(K3P!\-O"USJGVKQ!X;^-VAZ1!XS\/KXANWL=?U*X_M/1=/@\
M1_L>_M^?#[_@WF_8/_X)N^,?!_Q9\4?&K]H+X]?!C]G[]H:W\"VM_P"-]<^
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MRFO=]M]F_P#!5?\ 8!_:T_:JT;]BKPA^QOXX_9G\!?##]E[XHVGQ4\7?!/\
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M\?L]?MS_ +)OP\_9X;]N/]F_Q#^U1^R#XF^&/Q.U7QR\O@OPY86OB?4?AO\
M&#1M;T;3IM&\?V?@*]A\6W.L:7<6NEQH;;29]"M=1N[B+2?Q#_9F_P""0?QR
M_:=T'_@KE\4_ 'P>_;-^"/@3]I#]A71_V8_V=+;_ (*1>-)+S]KGXZ_&+P]K
M'A/XCWWB[XH?\)%>7UQX&\*Q^*/AGX7^'&CF]6PT*7PM?V&H:&\"6.K#3_OC
M]@?1OVO?VOOVZ?\ @ES\2/B/^Q3^T1^R3\/?^"6O[$OQ5^"GQFU_]HCP1;^!
M]-^(OQ^^(/PW\+?!F]T/X(R7&MW6J?$#P(UAX6LO%^G^-(=)M]-AL[?4M+OB
MEQ<:-<:H ?:O[(O_  7$L/VVO^"H]U^QI\&?@UX@TS]F8_LJ>+/CWX*_: ^)
M'AKQCX%\5?&:_P##/Q'T'P&WB;X:>$O$=MI4O_"FKJ]O]<T72O$6LZ7%J^O:
M]X9U:>VAL=/@CCN/TY_X*#_M=6G[!O[%_P"T+^UW>^!-6^)J? [P))XIM_ N
MC79TZY\1ZE=:MIGA[2;2ZU46>I'1M#BU76+.\\2:X-/U!]$\.VVJ:JMA>O9K
M:S?F5J/P5^+8_P"#EWPQ\>(?A9X]_P"%%6G_  2-OOAD_P 78?!^NCX7VWQ!
M'[2-]KD?@-_&ZV'_  C,7BTZ')%JT?AQM1353I;+>+:&U7S*X?\ ;Z_83_X*
MTR_LH_\ !0V3X)_\%%OB+^TKXN^-?PU\3Z!\$/V;;[X.?"#X0CP!H7B7XM^%
MO$7BGP[X&^*?AS4].\0ZKXH@^!]IXU^$_AFY\17UH-5DU_\ M"::UUQM/N+,
M ]U_X)^?\%*?VF_C7^U[XM_8I_:[^$/[/7ASXDO^R7X _;7^'WC_ /9/^*_B
M'XJ_#!?A5X_\3V'A2T\!?$&Y\5Z+H^IZ/\3+.[U2QU.SN](-]X8\3:+]KU/1
M96TH:3JFM4?A!_P62T_]H/\ X+"^)/\ @G3\'? NE^(?@;X!^"OQ0U_Q-^T5
M.NOI%XL^.'PI\5^&/#WCGP/\-+L"'PUKWA7X?7GB-?"GC#68/[2G;QQ8ZK86
M<UOI^FP76K_CK^Q%^R-^T!K7QV_:9E_X)<_LI?M&_P#!*+X*>/\ _@F*OP#\
M::M^U9X2\3?"S1_$'[=UOK]G;>"/B;X7\"ZU_P )?XIUK5?A]X+U;Q5;W'Q>
M\*6TVD:AJ<VH:BEJNHZBC>(I/V0?^">O_!6C]D3_ (*E?\$\O!-SIG[)4OP7
M^ G['/C'X:ZS\4?A'\'OVAD^$<?P6O\ XU:%XD^+7A3Q/XX\1SSV<G[7GQ4U
M>\U3QWHFM:OJ5CI6MW][K6OZEHEW&+P4 ?VJT4@/_P!<]L]/\]<=#@TM !11
M10 5^>'_  2N_P"3*_!W_99?VO\ _P!;%^/=?H?7YX?\$KO^3*_!W_99?VO_
M /UL7X]T ?H?1110 4444 %%%% !1110 4444 %'2B@_Y_SD4 ?S1_$'_@XH
MU[2_VB?VFOV?_@;_ ,$M/VXOVIW_ &5OBYK'PE^(WCWX&Z!:^+O#-OJ&D7MW
M;+J,ZZ3I6I3:,VJ6^EZOJ&EZ5K$EK<SVMG&\TUNDTTEIER_\'"W[0L6_'_!"
M?_@J8P?;)9G_ (5;.?.MWCN&1[CRM$E%K/YJ6R/; W#1I+.[N'MHXKKG_P#@
M@W;ZO%_P4K_X.*OM#JFDI^W)X-A@M+<.NGQZLNJ?'HZA)9H\0VDVITZ.3]\7
M$26HDB&$=OZD/\_Y_P _6@#^86;_ (.(OC]%YN?^"%O_  5&C\F%[M_M'PRG
MM\6<4\D,LWS:"<R 26"QP)O:6XNI;=&_<1/=6;'_ (.'?CO>1V3'_@AO_P %
M/5DNIMIBB^'UK(P@D,BV[0K/IUI-+<ROY"/;2PVPC,DNV:4Q(LW].&,# X_+
MZ?2EQ_GI_+\OI0!_,2G_  <0_':&VDEU/_@AQ_P4ZM9HB!)%:> (-1C0EE0Y
M9-)M[EMDAVN$LF<*I?9PRHU?^#BGXU(\4=S_ ,$/?^"H<;W,BFT^S_#2*Z62
MVE95A>X?^SH1:7!)836TV!;A=TDNW>4_IXQ_];V^E)@?YZ],?RX]?QH _F%M
MO^#B;XZO;_:;O_@AQ_P4YAC22\,OV;P!#<NMM;*0DD<4ND6D\T\LT<R/;B)
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M3VH _F9N/^#@O]HRW2>-_P#@A3_P4\6^L@9-0A?P);BTMK=GN4AF2^31Y/M
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M!#V4,-Q<_P#%$^&"JQ7'G^4T;BZV7#$6\V^.!I)(MJ^:J>9%O_HTQ_G)^O\
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M?B#\<_'>N:]\6OBI\0-$U+PU\2;;05U/Q7X)\3_#OQ,--_:!\<7VD>/$\/>
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M/C/K]._T[C@TM 'COE_'[_GY^#W_ (!>-?7/_/\ _G]32^7\?LY^T_![_P
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M_;S\*-YT>$#6[W_QTCM[40JBK&EJ8)F4AL-]H*[%V$M_4!7\K_\ P0/(N/\
M@I?_ ,'%5['JLEW%)^VQX#A%G(T+L)(M:_:%+W\ACGF83S%OLTR'<J26S)YA
MD#JO]4% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\6/AYJ_C+3=1\1_!6X_9P\5'P;XAU+Q*+#23;:O#XFUC5? -YX9CTV2*VO\
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MJMOX*TV+]DCXQ>'K73[KP?\ "3XP^,O%EOXQT5/$_P 3=!T[Q%XNN]>T^_\
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M@?3/"7@S5[32O,U73?&VI>"]5UWP3J-_;6,5WX=O-/DO+E9V:23YZ_X+:_\
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MTT#2_%6A:SI6E/8:I/=VEG<:C_9NH26_Z99_/T]O4^@]?3IR:_DA_9,_;_\
MV@/"/_!7[_@NIX"\:>+)_B!\ /V,O@'XL^,?PY^&$.D>!O!UAIUQX)T_PUXF
MNM)G\1>'O -OXJU6_P!1AN];LH=4U^_UQ+6>ZU*_D@U2ZO%NS\G_ +$6N?\
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M"EC)J7AW6/B'>OI6A>'_ .TV^(&HZFNNV=SK$]MHFA:!H?B:SOKN[U"?T/\
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MX)\)Z?I^EZ=90Q*FB^%-,NM6OY-0U_Q'=:UXBU34M6NKO[*WQ,\0?&K]E_\
M9P^,GBR+2X?%/Q:^ OP?^)OB6#1+>XM-&AU_QY\/?#OBG68M(M;NYO;FUTR/
M4=5N5L+>XO+J>&U$44US/(K3/[W0 4A./\_Y'YD?GQ2T4 ?"5C\5M4^$_AK1
M1XH^*/P9\"Z3X_\ C=\8/!GPYLO&7AKQ9<:UXE\43_$[XE:Q:>%-,ET[Q?9Q
M:YXFNM+TC5M2MM,T[3HKRZLM-U">VLY(["Y=?;_#&N?%GQIHEKXC\*^.O@MK
M6B7DM_!;ZC9>#/&K0M<:7J%UI.I6KJ_CY)(+O3M4L;W3K^UG1)[.^M+BTN8H
MYX9$7XI_:"^&/Q,^)G@_]D23X<>%/%?B*/X8?\%!_$_Q?\>:CX0U'P1IVJ^%
M? ?A;6OVD-%U'6+>/QQJ^FVNJ74^K^*]$TV'2=,LM8U*XBO;J=;**WM9KN#$
M^*G@?]J77_BEH_BWP3X7_:CT[1-"TO\ 95?P_;)\:? FB:3>Z_X _:MU&+XT
MZ]XW\&Z/\4-'\*ZG>^.?V<+B\U/QCHUSX;O=$\4:)J=EI]G9/\2]*TNRT( ^
M\YM;^+%OKEEX9F\?_ Z+Q!J.CZSX@L='?PIXL%_<Z'X<U#1M*U[5(;<_$(.U
MCI.I>(-$L-0N,;+:ZU6S@D(DF13N_8OCUSGQ)\(?K_PA/C/\O^2@#';!&<]\
M%1G\=/$W[(O[1(^%GBCX5>'_ (?_ !O?PY8_#C]L*SC\%?\ "]M!'@7QGXQD
M_;:^'WQI_9VUCP^+SXM_;[3Q?XF^&&D^-+;1M=\43^'(='L-2_X1;Q[<>'QJ
M<T4_UO\ LLZ9XFUG]I/]H&WT;XP:G\2_@!\-OB!JWBKP9.GQ9UWQYJWA'XO_
M !*T2#PQ\6_V:O'MTNL:UHMS:_L\:[X+US7]%\)/KFK1^$'^,^B^''TS2+SX
M?:?>:D >VK\?+E_#_P 0O%,?QV_9SFT'X2^-&^'7Q/O[;P[XNN?^%?\ CM9-
M#C/A/Q=:P^/Y+S0==<>)O#L\&GZE;VT\]EK^C:A"KV.I65Q-[,+/X]$!O^$D
M^$(! )SX(\: \@=0WC\,I]=PR.X&#7YU_$O]E3XOWOQ?\<?M'_ +PLO@/XD>
M*/C?X;\"?'?P9XKOO#>F>%?VK/V:K74/A[8Z?\0+BZT/5]:BL?B?\"HK/6_$
MOP8\4>);;3/%&I>&[#Q9\'?$VE6WAOQGX<U3PUY3\4?A1^WY/XH^).G^"-"_
M:$A\,Z+\//VV-+\(^(_#?[17A.QF\5^,_B#^U3\$OBW^R[=^%[36OB[!JD<?
M@WX6V?Q-\$_:?&UGX;B\+:-<:WX!C67PCJ&G6VH@'Z9_$KQ[X^^#O@3Q1\3_
M (H?$_X$>!OA_P""=)GUSQ7XM\0^$_&-EHN@Z1;&-)K_ %"Y;Q^PA@1Y$C!"
MNS-(BJI=E1NX%E\>CR/$GPASG_H2?&8SQZ'X@<'U';&#DC(_)WQG\ ?VL/%/
M_"\O"6D>&OV@+CPQ\1?"W[?7PPT2S^(?QOT7Q-X);P#\2?A?H5Y\ A>Z/XB^
M+?B6YBN;CXIS>+;/PMX@N](N?&_@[2]3O/#_ (CN_#_P^70]-M+'C;X'_MPZ
M<\NC_#^Z_:8O/@1\2OB5X_%GX8TG]H?X>?\ #3O[/9\9?#;X+VW@WXDI\1_C
M%KGB[0;OX<^!_BOX9^-VN7OPZM?%'Q6UGPY9_$;P]?>&_"/C?PSI<?PL\-@'
MZM_8_CUT'B3X0_\ A$^,_P O^1_&,9P/4<]^#[%\>_\ H9/A#_X1/C/]/^+@
M?Y_.O(?V4/ OQ"\,Q_&#6/BBWQ;'B+4_C3\5=/\ "A^)GQ)G\:6M[\(H_B'X
MG\2?#/5/#FB:?XQ\2>%_#EC/H_B>>V@4:9X>\80:7:Z7X9\0:?:Z3X9\,Z9I
MGUY^'^?QQ_GUH \A^Q?'K_H9/A#_ .$3XS_^>!2?8OCU_P!#)\(?_")\9\?3
M_BX'L,CIQ]:]?HH \@^P_'O_ *&3X0C_ +DGQGQ],_$ COCZ<4OV+X]\_P#%
M2?"'G_J2?&?H!_T4#VKUZB@#R#[#\>_^AD^$/;_F2?&?;_NH'YGK1]A^/7/_
M !4GPAY&/^1)\9_3G_BX'/''.?YUZ_10!Y#]B^/0Z>)/A#_X1/C/_P">!1]B
M^/?_ $,GPA_\(GQG_P#/ KUZB@#R#[#\>O\ H9/A#_X1/C/USU_X6!G\?<GK
MS2_8OCW_ -#)\(?_  B?&?Y?\E KUZB@#R..R^.^]/.\2?"3R]R>;Y7@CQD9
M FX;S&&^( 4L%SM#$ MC)Q7R)_P2C%V/V(? BW[VTM\OQ<_:W%[+9QRPVDEX
M/VP/CP+I[6&:6>:&V:?>T$4MQ<2Q1E8Y)I71I&_1>OSP_P""5W_)EG@_W^,O
M[7Y_'_AL7X]\_CU- 'Z'T444 %%%% !1110 4444 %%%% !110<]AF@#^5?_
M (("ZT^K_P#!2G_@XGGN[#4]&U"[_;7\":C/HU]$X2Q2XUS]H>-$EE>V@<:@
M6C87%NY1XHO)#V\;<G^JBOY8_P#@WTGM[C]O'_@X+E!U>&_D_;L\+RW&GZU:
MVQO;2SDO/C;]@>XU>+R)[ZYE=;Z*2QETVTM]/AM;:>VEN)-3NDMOZG* "BBB
M@ HHHH XWXC> /"OQ6^'_CCX8>.=,CUKP7\1?"/B/P/XMTB8XCU/PWXKT>\T
M+6[%FPVS[5IM_<PB0 M&SB1?F4&OXY?A1_P3T_X+\_\ !'>#XB_LX?\ !,G5
M/V9_VN/V4OB9XQ\4^//A<?CA=VGA[QW^S?J&I:F]A)<PV/B'QEX.T^_U2_T&
MZT1M=DL[GQUX;U74]/O=5M?"OAV\U#4(=7_M,HQ0!_*W^P?_ ,&_?Q'\/?LH
M?\%";?\ ;Q^.=QXV_;!_X*@^$?%>F?&36?!>IWFI_#GX0W'B.[U;Q7I$VA:0
M\&B:9XG\76'CS5H?$7B348;&TT*U@TC3_!W@@V>APZGK?B;\V_A;_P $H?\
M@N/\!_A=X6_8&^$7[+G_  2BTWPKX#\3[-._X*+^(_A=\*/'WQ-\4_#N3QM>
M>+IK?Q?X6^)VA>/-5\07-[+<PZ;)8:U\)+BZM[#2++1K7685M[/Q(O\ 8+^T
M!^W)\!OV;?'=M\-?']_XFU#QJ?@)\<?VGM9T/P?X=F\1W/A+X&?L^Z%'K'CK
MQ_XM:*XMHM$TJ\U&ZT[P?X/2>1[KQ3XQU&/2-,@:*SU:[T[Y@^"W_!8K]FSX
MQ)X6DU+X5?M:? R'XC_"KQ9\9/@_??M#?L^>(_AAHWQL\%^"?AY??%?Q*?A+
MXCNK_4O#GC#7K#X>:=<^,(_#MKJ\&K7WAN.;7]-MKO1;2]U"V /S3_X*-_\
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MJ>)KKXO^&_@UX[FN[FX\2ZKX8TWP3XXU2-=5T3P_;:M9^#/$@TBYO;S3S:2
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M3?\ A.]1&I0WOA1?'>HZ9K'A_P"'<]QI=S:^*_$>AZSI%G/'<Z=<! #^>_\
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M3XX? ;]H+Q_X;\'?%;X6_LG6?Q,TOXU_LA:5XPL+J_T_QSXA\0?$/Q!+X/\
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M\:ZI\*]"T2Z\/:K>Z59SVVM:1?>*(-(N==O1I$]YJ7GWQ;^'_P"TIX%^)_\
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M^*[7PC>)J;Z)XY/_ ,$K/VF==^!G[4OQ7UBQ^/\ K-S)_P %(?VLOVA/&?\
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MA7'P?L?B1XY\5?$JUM3XEN=9ETK2=0T33H?UR/-&/Z^G?\.W_P"O- 'XVP?
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M.WGN)_\ A244TD=O>2K:VLD=M:?:99GEO);>%XL1M#%(]Q(0L15H(/\ @O\
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M+Q+>.6Y8G_!?3]K:0L$_X(#?\%26VQRRG_BWMZH"0Q-+*<MX/"DJB,0H.]R
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M/A=>MXILQXE_:P\77?CCQ7X@GN=8N]#\,>!/A/H":\?"GC7798=)FL?M>_\
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M\^+$5W::=?7FKV_CKX17&JW'PGU.TUW5-0O]:L].^%RZ[K5C\.?#%K?P^%?
M^CZMJ.A^&-$TO1KR>P< _*?]A;_@L)\>/VM/VVH?@%JWPMTOP-\,M3_:0_;T
M^'%K!XT\'>*/!GQCT7X?_LO_  G_ &4_$?PXB\4^'-7U:V;PSX\UGQ)\9O%&
MH?$#3-4T9I;&"XT?0+/3-*?1[O4-0^<-+_X+1?MI_&'XE_&_]G?X>:=\&/A3
MX\^ WB/]NOX@ZO\ %#7?@G\7?C<OC'X7?LH_M(:=\$_ /P?\+? KX<>*;;Q[
MXF^('B^PUG2O%?Q>^(_A*[U2S^'?@:X?Q78?#MTAE$?[B?%K_@E;_P $]OCG
M/J-W\5/V6?AUXKOM6^*?CSXV7^I2/XCTC5)_BI\4-$\+>'/B%XR&J:!KNE:A
M#J7B_1_!7A:TUR&WN8K"\;1K:[>S%ZT]Q*_Q7_P2M_X)V>-_!&D?#CQ-^R!\
M%M0\&:#\2?$/Q>T;1H?#1TS^S?B)XPL;?3/&?B*TU'2;FQU:(^-;"TM+7QKI
M0OO[$\7Q6MN/$FFZF8(RH!^&NK?\'#GQ9U_P]\0X?AI\&-)\3:]!X\_X)CZ5
M\,/B/X'^$OQZ^)'[.[^'?VR?#/P/UWXMV/Q,^)UWIWP_B\"^)-(OO'WB_3_A
M#:>-+#P+KGB&UM/#,E[X3N[R\FCN/U2_X)L_M,?MG?M$?&3]N3PG^T9XB_9I
MU3P-^R?^T'XA_9DT'_A2?PP^*'A'7_$WC#0=#\&^/G\8:MK_ (S^)WC3P\NG
M+X6\=V'AS4O"&DZ?+J6E^)-*N+JZUF*VDBMKW['7]A7]CU-(\7>'8OV=/A;!
MX;\=:W\#?$/BGPS;>&[>V\-:GJG[-%CX4TSX"R)X=MS'HNG6?PLT_P #^%++
MPGI6EV-EI5C;:+;0O93(]P)O9? ?P<^%WPOU[XG>*/A]X&\/^$?$'QG\:)\1
MOBGJNB62V=UXY\<IX>T3PH/%&O%&*7.KMX>\.:)IDERJ1F6'3X7E#S-+*X!Z
M71110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 ?%W_!0O\ :^TO]A+]CWXU_M/7VE:-
MXBU3X>^'K2'P1X3\0:__ ,(KHWC+XD>*]9TWPC\._"&I>)GM;RW\.V/B'Q?K
M>D:=?:[?1QZ;H]E+<ZEJ=W86%K<WMO\ A#\?/^#B3XB:/X)_95^(GP"^!GPP
MOM#^/7[+_P"T;\=?$VA>/]9^,GC?Q)HGQ2_98\:R> OB9^SMX:D^!'PS\9VM
M]J&H>,;2Z\+>&/BYJEG;_#FZ9D\27ES:Z++I?]L_TA_'?]G#X&?M.^&?#?@O
M]H'X9>&/BUX.\)^/O"_Q.T;PGXSM9=4\-#QMX,DNIO#6KZKH+3II7B*#3)KV
MXE&B>(K35= NY&1[[2[IH(#'\*:__P $4?\ @G!JE[I>I^&O@5J?P?U+1=?^
M)6O:7>_L^_%CXN_ &6P@^,4&C6GQ1\*:?%\(?&_@^UTSP!XWT_0=.TW6_ >F
M6]GX5DT];JUM]+MTOKWSP#X,NO\ @MY\</$/@WXM?M5?#7]FOP!?_L3_ +(G
MAWX":U^UC/XN^(^I:=^T;?V_Q]^!?PW^-FHZK\%- TG1KSX77]I\!=(^)_AZ
M3Q5I6N>,[[4/BO:IJ5MX$NM%O[;2O^$@\_\ '_\ P<"?$OP_\)OC!+X:_9]^
M&6I?M$_LK_#C]M+QE^U[\-;[XF>)&\/_  5F_9H^*G@CX5_"J[LM6TGP9?S>
M)K#]H*^\>VNO:'87%SHM[I>D^%_%ENEU>7NF3"/]1]>_X(T?\$Z-=\4^#_$B
M_L_6GAS3O"=I\*=/O?AMX(\8>-_ WP4^).G_  *N(+CX+6GQL^"GA3Q#I/PN
M^-:_#!;6SL_"ES\4/"OBF^ATVRLM.U"ZU"SL[:&+U'QO_P $R_V)/B'=_MB:
MGXH^".FW6L_M[:#X0\-_M2:Y:>)/&&F:S\0]+\!:/#HO@Y+;4-/U^VF\'SZ%
M%;P7\%UX-.@SW>L00:MJ3WM]#%,@!\=?LV?\%)/V@OBS_P $^?VLOVJF\!?!
M/XZ?%CX#:?\ $&_^'G@O]GFW_:%\%>$?B+?>'?A]IOB_1/"=Y%^T?\,/A_XO
MAUI;V^$%[J7AJUUW3=?TN:QETFWTO7+A]#C_ "W\3_\ !QS\=_#WPY^!>JVG
M@?\ 8PU7QEXE^(W[2?@;XDSW_C3]I+PMI>J:E\ /A'\//B/I_@#0_A=K/PD_
MX7[\$_C/X_\ $'C:[^'.B^#?BWX UW2)]?TK3M2TCQ'K?AWQ'8:M%_1'X9_X
M)\_LZ:-\!/BU^S-XK/QF^-?P;^-ZSV_Q&\-_M#?M%_'?XZWVIZ;<Z=I^FS:+
MI'B?XE_$+Q#XG\):,T6FVUT-/\)ZOHD*ZD'U-<7S"=>+^ 7_  2Q_8P_9N\<
M>!_BC\// 7C#4?BC\.]:\;Z]X8^)GQ'^+_Q7^*?C^*]\?_#GP7\(M:@U;Q9X
M_P#&/B#6/$>EV7PR^'WA3P3X8T?Q!=:GIGA+0=--IX<M=--Q</( ?%%[_P %
MP_!EI^VO^P)^R7K'PDU/X?WW[7/PC^&_C/XIZ+\2-?M/#'Q=_9W^)'Q_\%^(
MO%?P(^%>O_#S4(+67Q)J>K7G@WQ#X=\=W6@WEW<^!=6OO"MMXATW2KK7[&TN
M?&[G_@LG^V'=_L6_&G_@HSHO[*?P2A_90N/A!^T)X^_9QLM5^,^HM\;K+5O@
M)XPN?!6F3?&OP7'I=GIOB#0/B[/IVO\ B>SM/A+JMQJ7PJTCP\VG>,;S6%UJ
MV\06'ZM>/O\ @F+^P7\4?%7Q.\??$#]F;X>>*?B)\7OB1X#^+?C3XE:I%JTO
MQ*/Q!^&%MX8M/ .O>%OB$NJ)XQ\ IX7A\'Z&-/T;P+K7AW06*:G]JTNX77M=
M74O%=1_X(H?\$YM4USXR:U=?!36S;_&SP9\:? NN>$T^+'Q67X=^!]%_:*OM
M/U7XW2_!;X<GQBW@CX*:K\2-7TNPU3Q+J?PRT+PS<7=U 8U,=G/<VLP!\R>
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M#\.EQZ1IJVP!^-7B?_@M;^V+I_Q8_;A^'VF?!K]GBT@_8A^"GC?X@^)+>_\
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M8^$_[-GA/Q)X\_8\_:[_ &@O@7XH^$Y^(M\5^(7PO_9K\;6EMX_\6^"->M=
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M\/:7\._&E_\ \)1%\3-6CD_X0#48M5U"UO;769%M[K\O_P!D;_@G_JTO[/\
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M\-Y=6UI-#<:M&\5U/#;R*DTJ(?XI/BM^RG\9[_PW^VWJ%]^S9XO^,?P4T_\
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M'7OB5_P45U_]H+2_#/Q5^!GQ5\&:];6NF?#KPWX,UG7;35K_ $S3]&T#7HK
MWVL^>_%+_@FU<R?\$Q_VQ/V@-#_8[\93_M>:E_P6W\7>-?AAXJC^%7BFW^.D
M?P"L/BKHVA:#?>"O(TQ/'L?PBN+C6/%5Y=SZ,L.B7FM)'XBN)Y9O#VGZA: '
M]S7[>'[<WPZ_8@_9[^.'Q=O[GP1XY^)'PB^$/B7XP:/\ [WXH^'? GCKX@Z%
MX7M[N\OQHL-[::]K<5H;33=5E35+3PKK$!?3;J 0EXY3%U/P<_;3^!GQ,^!_
MP:^,/BKXA?#3X2ZA\6?@?\&_CA=^ /&OQ/\ !MEKW@K1OC1X3TCQ-X:LM9;4
M+_297BEFU1]'T_5I+"QM=;O;.86,0D+01_Q>?\%+O@P)_CO_ ,%RO"7[27[!
MWQG_ &J?VA?VM/#OPT\6_P#!-[XU?##X'WWQATWPO\./AUX!NX5'A/XJ:18>
M*9?A%+\.[KPO9R>/?"VGRZ;KOC>+3-1TM]*M-)\065UJ'H?A_P#X)VS?%OX^
M?%O4/VB_V5;WX@MX(_X-KOV>/"7PNMOB#\,]2UC3O#'[5NA?!C3/"$7A/P@-
M1L_[.N/C=X8U70M:L[#38K6?QWX<OYV%A%I4CPO= ']OFE?%3X8Z[XQOOAWH
MGQ%\":Q\0-+T+3?$^I^!M+\7:!?^+]/\-ZQ'%-I/B"]\-VNH2ZS:Z)J<,]O+
MI^J3V26-Y'<026\[I+&S9GA7XW?!CQUXR\5_#GP3\7/ACXP^(/@.&.X\<>!?
M"WCWPMX@\8>#8)KR?3XYO%7AK2=4N]9\/1O?VMS9(^K65HK7<$EN#YJ,@_B?
M_91_8)\:_#+7O^#>WQG\%?@/XX^%WQCN?V/O^"@%Y^U7\<K;X=Z[\.M?TKXD
M?$?]FK5X/@YHO[1OCY8X_$=IK&D_$#Q$FC?#VW^(FLPE-&T>U@\+:7H^G:?:
MZ+IOA'_!(?\ 8]_:$^'G[6/_  3RT74?A_\ &_X%_&G]G+5?CC+^UMKL/[ )
M^$>GZIX+\>)J=WXS\,?M*?MG^+_C.FF?M1:3\0+E?#L'P>NO"'A+Q/J7AB;4
M([RP\/:==6"ZQ9@']Z&D?'CX'^(->\,>%=!^,GPJUSQ/XVL-7U3P;X<TCXA>
M$M1UWQ;IOAZ_U32_$&H^&M)L]7GO]=L=$U/0];T_5KG2[>ZATV^T75[2\DBG
MTV]C@^<_V2O^"AW[,_[:_P 0?VG?AO\  ;Q3=:_KG[*/Q<U+X-?$.XO%TJVL
M-<\1Z+!;_P!LZUX$-KJ]]?>(?!FG:M+/X<?Q-+8Z?976LV-RM@+O3IM.U&^_
MB2_9N_X)S^*_A?\ \$^?^"7_ ,6?#?[)OQ"\-_M7> _^"W'@^_\ BC\2Y_@[
MXH\/_'G2/V=K+XN>*]"N-8\6_9]'/Q \(? E]/L-&?5M(O#J7A.VU6]EU][Q
M(=7OYI_WN_X(T_L\_#_]EW_@H/\ \%=O ]Y^R3_PI?Q3KG[1NN_$GX'?&K0O
M@G?^#_A1K_[*'Q*7PM<^$OAI\/\ XJ1@>$+FPA\7^&M1U[_A77AU[6WM-9T[
MQ1=VMK'#HD^E>'P#]B?!?_!0']F[XA?ML_%3]@3PCXK;5_CY\%OAUHGQ$^(E
MI ^F-X?T:+Q$^FR:7X2AU*/4Y+F\\;+I.H?\)!JOAU+%+O1]$B6_O0L4\1KZ
MD\/?$GX=^+M<\0^&?"?CWP7XH\2>$;A;3Q7X?\.^*=#UK7/#%TV-MMXATG3;
MZYO]%G;<NV+4H+:1MP 4DC/\A?[0'[)'B_PW_P %I/\ @HQK_P $OV6/$6@_
M$S]KS_@G?XLU3]AG]K#P_P#"#4-?\ >#_P!LA?ACK_A_Q?XU7XY:1I/B/0O@
M7XI\2/JMUX9U_P 2Z[<>%QJ>MZCH<&J'/BS0;[7O ?V*?@);ZQ^UG_P1SMOV
M(/V#_P!J']C3XP_LLVGBO3?^"K?QR^)OP \7_!_2O&4#_#GPFOC?P-\3?B=X
MIU'['\<M6^+?C.T\0Z]X4C.H>))[2P\4>'?%>CPV<.DQV^A ']CW[6O[3/P\
M_8U_9J^-/[4?Q7&J2> /@CX$U?QSX@M-#MTNM;U9=/1(=.T'1K>66&W?5O$&
ML7.GZ)IAN[BVLH[W48)+ZYMK1)[B/P3_ ()[?\%%O@]_P4(_8ZT#]LOPGINI
M_"7P3=W_ (XT?QCX?^)VJ:'I^I_#C6/AWK-YI'B>U\6:I#=C1K&WM8[2/68[
MVYN+5!HM]8WMY%9M*\,7YH_\%]O!7[4?[7\7['W_  3F_99^',GB:W^/?QIM
M?BQ^T)\0_&?A'QWJO[.G@?X5?L^S0>-=$\'_ !V\6>#_  QJZ:%H/Q-\?V6G
M6=M86^LZ/XAU6]\+1:+8+,FM,\7Y*Z]\ /V^?V7_ /A^1^RS\9_@AX:\8:=_
MP4C_ &'/C1^U]\)=9_8I^'7Q?\1_LX6/[16A>&M?\'_$SX2^%(O$.B:KXDLO
MB-X^TJ\TKQD?#VHW_FS7%AI=OH<-VOB/2+6W /ZK_P!I+_@I'^R-^RQXA^!7
MA3XF?%'1[CQ!^T+\<_#G[/O@>R\*7^CZ_#I7C?Q#!:7S7WCS4HM5@TOP1X9T
M/2[^PU77-6UZ\MI8+"_LY;*ROC<(E=K\$/VF?$_Q<^,7[2GP]UWX(>+/A?X$
M^!6I>"H/ _QB\3>(/#&I>$/V@=!\8>')_$<_C+X?KH]]-<Z?X=\.PPPP7\^K
MAEO(M6TF_MKB.*66!/XP?C=_P3*^#OP+_8 _X(2?'6^_X)W:[XEU'2OC/^SS
M\1_^"D:Z/^SIXH^+/Q:O_"6O_#G2D^(R?&KP+-H>M_$74O#UQK$&S4?!5S:V
MF@6FL!--31[75=3LHW7]L/\ 9I_;-\<Z]_P<4Z=^S=\&OVFY/A]\2_BE_P $
MU?B#IWA'P-X/\5?#;Q#\</V?M*\ ZY%\7/AY\+H;W0WU+7+G3O#&K6%KJ/AK
M1/#^KRC1M#NM%U7P_JM[&GA6< _K7_;@_P""FGP)_8T_8Q\7?MNZ;+8_M&_"
M[PAXN\!^#[F+X)>-O!WB'^T=0\<>/]!^'Y&G>(+?4KSP])/H>H:[#=:C927Z
M3^7;RV^8YV0'[4?XO_#6PU+P!X<\1^.O!OA/QI\3[".^\"^!?$GBOP_I'C#Q
M2PT]=2O+7PWX>O=0AU3Q#<Z;;>;)?IHUK>?9D@FEDVQ1L]?P\?MN_"+X)_%S
M_@GM_P %%?#_ /P3:_X)??M<?L\^!O%M]_P3Z:'7%^&'QG^&?ACX_P#CS1_C
M_H=OX@TGX:_LHZ]X;TZ[L/$7PRTJ.Y_X33XM>#/#-M>:W,8XM:O[.P6Q;Q)Y
M5^WW^RU\=M7_ &Z?V_K?XQ?"+XOWU_\ %_Q/^SI_PQI\>_"'[ 'QM_:M^,\7
M@KPWX'\'V'A?0/V/_P!H;3/C)\-_ W[,7C#P)XIO4O/'"?$*70+.76TO+ZZU
MC2KU;O3KT _O5\5_&_X+^ _&'AOX>>.?B]\+O!GC_P 96[W?A#P-XK\?^%/#
MOC#Q7:1SO:R7/AOPSK&K6>MZ[;QW*/;//IEE=1+.C1,PD5D'J!( )/0#)/;'
MU_S_ "K_ #]_^"G_ .RU\1+#]L+X^^-M2^#'Q-_:3_:*\6_!7]E3PC=_"[]I
MS_@GE\3_ (]_"/\ :V\8?#OX:^#-!U/6_P!C+]JG]G#Q1XG\3?LNW\GB>.[O
M_B)I6K>/OAM;:9XKU&6VU;Q#K/AZY:QMOZI_^"AGPU_:^^-/_!'[XR_#7]G3
M0]0^'?[7_C3]F/P;8:1X(\)^.9M*U?0O%0M/"-]\1_AMX8\?/K=H[:G<>'[;
MQ=X'T/6+KQ!%!JUY<VO]H:I]FO;BZH _1W2?B[\*_$%AXRU3PY\1O!'B>Q^'
M<^KV?CR;PMXGT?Q,W@_4- M!?:UIGB*#0KO4+C2=5TRT9+B\TJ\BBU&&.2/?
M:@RQA_SR_P""9O\ P4_LO^"G^C_$?XJ?"C]F_P"*'P^_9D\/>(M:\,?"SX__
M !"\2> H[/XV:GX>\3:IH.L)H7PZT?6K[QYX32PL[.PU>>7Q;IMC"3JBZ7%)
M+?65VJ?S=?L*?LT?#7QU^T]_P3)\&?LO_L&?'/\ 9PM?A[^QQ\</A%_P68U#
MXL_LW?$_X5_#OXP:7K_P<T'PAJ/P9^*,7C32-'T7XX_$3Q[\2_[3\5:!XCT/
MQ%XBO;#1O$FE:Y=0Z[;Z7+IOAG]9/^#77]GR/X$?\$N?#\VM_!'7/@M\2O'O
MQF^-VK^.[7Q?X*U;P/XU\3VNC?$KQ)H?@34=<L?$$-KK=U:Z9X0M]/T31+F_
MM+(+9V;1VT,D7^FW8!^EG["/_!0WX>_MU:%^T'KWASP5XB^%\'[/_P"UO\5O
MV0;V/QSK7A>8^-?&_P +)=.%YJ_A:71]2N4ELM7M]3@FL].F_P!/62&[CA^V
MQ0?:7^W/"_CSP/XXT6X\1^"O&7A7QAX>L[_5M*N]>\+^(=(\0:-:ZIH%W/I^
MO:;<ZGI-Y=V4%_HE_;7-EJ]G+,MQIMW!-;7D<$T4B+_ /\6_V7_C/XP^"NG_
M  W\2?LL_'2?PWKO_!V!\6?&VL6]I\+_ !VNH:M^S_X[N!8ZQXTL] M-.L[Z
M#X>:QX9>ZTK_ (2K58++PY>V3R+IFJO$EX%]6_:+_8E^/G@%/^#C7X"?L:_L
MY_%[P3\%M6\9?\$XO%'P_P#@)\#?#'BCP1X4^(WPHMK*^U#]I[1_@9X9TBVT
M+3O%$GBGPLNI67B[PY\/KV.Z\2QYT&%99(;;2KP _NA\,^//!'C;19?$G@SQ
MEX4\7>'H);J";7_#'B+1]>T6&>Q)^W0RZII5Y=6,<MD ?M:-.'ML'S57:12:
M)X^\"^)=)U?7O#OC3PEK^AZ!=:E8Z[K6B^(]'U72=$O='3S=6L]7U"QO9[33
M;K2X_P!YJ5O>30RV2#?=)"M?Q!_'[X1^&OBM^R__ ,%,/#/_  1C_P"">O[7
MO[/VE^,_@I^S%H?Q4UC3O!_Q%^!GA;XO:=I'C;0&^.'P:^!'[+_CFW\+^(A\
M8$^'@O\ 1_B#X_TGP_K:^/K;POXO\'6<LMSXEL]8\>T+?]F7P9X\^,7[5/CS
M_@E?^R3\>_@=^QK>_P#!%O\ :8^#W[2_@/QO^SU\6?@MHGQ=_:#E^%WC*Q^!
M_@OPK\-_'.A:5>_%#]HJR\00Z+<>+O$G@W1?$6GSC2KJ2?Q)J'B/QH)?$ !_
M<#:_$SX<WUY9:?9>/_!-W?:E<P66G6-KXJT&XO+^]NM&/B.UM+*VAU!YKJYN
M/#RMKT$$$<DLNC*VJQJUB#/6SH_BGPUXAT.'Q/H'B'0M<\,W,%Q=6_B+1]7T
M_4]"GMK226*ZN(=6LKB;3Y8+>6WGBGE2X:.&2&5)&5HY O\ GZ?M-_L"_LN_
MLE_\$U/^""^OZW^S+XWU;Q+\>OVJ?V--=_;-\(>%;/X@WGQR^,>I>(?@[XOU
M;Q5X!N?"5J-9\5ZAK>EGQ/X@\'V7@GPUH]EXC_L6.Y\&:-#I]Q>D0];XP_9S
M_:,\??LS?\%@V_8>^"O[1GP]_P""9/Q#_;$_8[U[P+^RWI7PC^(_P<\1>/OV
M=]'\/V&I_MP:S\ /@]XLT#P[\3=&T/Q?J"^#;\Z#X-T_2XO%WA:SUS0+'PTE
MUI+^'X@#^\;P[\2OAUXO\)Q>//"?C[P5XH\#3F98/&?AWQ5H6M^$YFM[QM/G
M6+Q%IM_<Z/(T%^K64P2\)CO UL^V92E7K[QOX,TS2]<US4_%WA?3M%\,7?V#
MQ)K%]K^E6FE^'K[;9/\ 8M=U"XNX[32;O9J.GO\ 9K^6WFVW]F=F+F R?PE?
M$[X%Z3X]F_X*[>*?^"9W[)OQL^"__!//Q!_P2IU7X4^+OA=J7P%^-/PC\/\
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M@:AX*\-7&BV$LVF32@ [3XD?\$]O^#;;X;_MM?"7]@#XB?LD_#O0OVF?CO\
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M5KHMQ87=O%;^([;3KF<7MM9WEC, >D?L/?\ !.3_ (-Q_P!O#P-JWQD_9/\
MV9O /CS2O#?B;5O 7BFQUW6?VA?#?B[P/XHALDEO_#WB;X?^/O&>G:[X7FO-
M*G$EC]KT6UL=6TKS1I,UW907"Q?::_\ ! G_ ((^6&C_ -E?\,4^!8M LY&O
M(-+?QQ\8)-*TZX2*\C-[I]C)\1'M=-NT2^O"MW8QV]RKSO*)!*%=?P4_X*%?
ML-?M,_L"?L&_M%?M+?$?]K6ZB_;A_;E_X*)_L8>,?B]\7?V7-/\ %'P>\+^#
M[#2=4G\%Z'X4\ Z1:ZDVMZ[!H]UXB\4^(KV_UE-/3Q3.VCI?>'XKK399=2]
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M8_\ @@Q_P2OBE,T?[--U'+DGS$^,_P =UD^;[WS#XF _/T;/+#(8GD"E;_\
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M?^"HW[3?[+O[<'[%G[7GC;X5_L7?L7?#SXRV'A/X;Z]\._"?B?1-%^ FF?\
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MF_MB?\%_KCXW^/O .H7?AJVN?C)KEK\9OC[\.M#^$.I>)]?@O]%\(:!+\/\
MP1IG@O2[?QX=2T;P[X9O)]/EMK+1+A(B ?WM?"']H7X!_M!:9?ZU\!?C?\(?
MC;HVES);ZGJWPC^)/@WXD:;IUQ(TBI!?7W@[6M9M;29FAE58IY8Y&:*50NZ-
MP/7\X'/\NGUY[=SD5_%WX(_92_:N_9Q^*_[?'_!4;X>_L'?##_@C-X5^&?\
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M=1U>VO)-,TO3=/L_V>_#_ABZN4O+A;_5;&RTV/\ X2"*%HUM-.F*7L-77_\
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M^S?IT>G:/XBU6 ZGK.E:<MG%JNHQ:=>ZQ+JESIT4DF=_P13_ &G_ (2^-?\
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M]M);6OVB&4P2_P FG['?[-/[(/P3_P""2G_!6C_@K)I?A;6_V3O W[87P?\
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MQ=\??#GP?KFH?$S]HOQ_XP*Z9_PJCX2>&?#7A'6+#2;:&\UK6];N[G^RX?T
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M[7X;IMOP^^(]S^S)XAU71=-D=[22UN]$U^[LUM;)[33H+.&Z5K3ZD^+?A_\
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M)+\X:O\ \$H?V -8M/VN-.?]G?0-)TW]NM?#P_:HTWPOXC\;^$K#XI/X8O\
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M56_Q"U70O',US-<^*SJ?B2YUC4+R:XOX-7M+Z[O+FX_5RB@#\>]*_P""%O\
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MHFH>.OC;XLU\:CJGQ)OIM#$6APIJ,EJFGZ1!#8Z9]B@5E;]7J* /Y[_VF/\
M@C/IGB"W\$_L\_L\VFI6'[+G[0O_  4$\/?MK_MR6'Q!^(G]L^&?#&F?#W5M
M1^)E[X&^!7PNGTIM+\/R_'7XB2>'M)\3#2[9=&TS1/#QNM4@N9I8Y#_0<JJH
M"J J@ !0  H X 48  ';'Z8IU(!C_'_/^>_4F@!:*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@#X4_P""B/@/]J/XD?LV^+?"O[+?Q\T7]FO6KNPU^Y^(WQ5/A"Z\
M6_$72?AI8>$_$%WK%C\&7&M:3I'A7XD:MJ$.E6.G>,]<BU2/PUILVIZEI%G#
MXAATF_LL3_@D[K-YXA_X)C?L :]J7BK5_&^K:U^R#^S_ *MK7BWQ!J%YJNMZ
M_KNH?#/P[=ZYJ&JZGJ'_ !,-0OI=5EO!<7E^9+V>16ENY)9V>5_M;X@>&]-\
M9> _&G@W5[\Z9I/B_P *^(?"NHZBKQ))96?B/2KO1KBYB><K$)H8[UGA$C!&
ME"JQYKY$^&/[*_A7X2? #]B?]GGX7_M*?%CPMX$_99M?A=!X?O\ 0O$G@)]6
M_: \!?"/P/>>';+P1\4-1E\)7D6J^!-;LQ9:]XC@\#)X4N;F70["&/58=,6Z
MMYP#X'_X+S>#/B%\3/ G_!/7X7_"_P",_B7X"^,OB-_P4G^"7AG0?B/X5NY;
M?4-%U\?#;XSZUX3N;RWBN;8:OHD'C'2/#\^L:),9(=5LDDM-@FDA=?DC1?VX
M/BI^T?\ MS?\$G&\6^$_$'@KX^_ _6O^"E_P0_;A^!'@OQ*=%\->'?C9\+?V
M?_!6L:!J6KW.NZ[HUC=?"CXDA;'XF?!#5?%MI<H?"WB1+[=<SZ?KLMO^Z/[3
MW[.?P<_:JUK]FF?QE\0-0\-Z[^S7^TI\-OVG/AW+X0U_0K'4M9\7^$+#QIX<
MTKPYJ,M[;7T]QX6\56FL^(M)UFTT8V.JZC%97-E::E;>7<@^*?'#_@F1^R3\
M>?VOO"/[<7BD:EI7Q1TGX$?%+]GKQW;^%M:T_0O#7QD^$OQ7\%:OX9U"Q^(D
M^F6MOXCO=7T#PEJFO6_A7Q+I/B'3-3T[2K@*9;A- \.S:( ?F5^RK_P6P^-O
MQ&_:G\*_ GXKO^QQX[T_X^?"CXY^.OA1:?LF>*_BA\3E^ GBOX!?#C3?BSK'
M@+XV?&[7-,T3X,?'R3Q+X0\0Z?9?\)?^SK=VNDZ'XJTRZ@_L6[\.:QI6O55^
M$W_!5+_@J5\9-;_X)_Z5HG[.O[$GAE/^"FGP$\1_%_X ZIK?Q,^-M]I7PGD^
M&/@[PU\0_'T?QG%GX+AU#Q8WB?P/JLNK_#WPWX 72'T;6M3M=!\5^+]0L-$N
M?$FM?37PB_X)$_#?X?>/O@1\3?''[?7[1'QCF_98^''Q8^!W[*_A7QGJ'P(T
M#X;_  E^"?Q*^"ES\+;GPI%X?\)?#70;CQOXKT#P5/X5U.[^(FOZW<ZQKG_"
M'^'I=>LY;;[>+SZ8^$'_  3:^"_P9OO^";OB;3?BMXUU2X_X)X? KQ7^SS\+
M9]0U'PW#I/Q/TSQU\.= ^'.H:GXOC2R=VU=+3PX=6TO3_#U_:VL-[(($AFM+
M%(G /S+\7_\ !>3Q_I/[,'["7B*Y\,_L\_!;]HG]K%OVB)_B#XJ^/=_\6%_9
MC^#VB?LG_$Z^^$7Q4U=(?A_I>N?%3Q%J7C7QM'I6G_#3P^!9:?96M]JFJ>+?
M%UM9Z-9MXA_6#_@GK^W?#^V9^RWJ/QI\2>'--T#QI\./&GQ&^%OQ4@\"?\)'
MJOPO\0>*OA;=7 O_ ![\%O%/BO2= O\ Q3\(_B!X>73?&7@36M6M;&ZM;;6E
M\*:[,OB/1]0+^!:3_P $G/!/@;X1? /X>?LZ?M;_ !O^"?Q?_9=\8?M(:A\)
M/CMH<GPO\:^+K/PW^T[\1M1^*WQ:^$WCWP-XH\)7_@+Q[X*GO-7\.3Z?8:[H
M(UK2;SPIX-\3)JOV^VD:]^W_ -E;X >$OV>O@W_PJ&\^,GC?]HG6_%7B/QQX
ML^(OQ)^-?BS3?&7B_P")_C;QO>RZKXWO+W2[2&S\+Z#H!%TEAIOP^\(:#H_A
M+PSX?AM--M=*^:[O+X _(KX(?\%:/VOO%V@?L<?M2_%#X#_L]^'_ -AC_@H#
M\;]$^!7P,N/#/C_XBW_[27PI\3_%G7_&GA[]G_6?C#HNI>#]/^'WB7P]XXUK
MPYI-EXJ'@F^TZY\"VFOVM\MUXN6UN9)<S_@@M\&/B;JGB[]O?]L?]HVP^&.K
M?M"?$7]KO]I3X):]\0_A_P"+?CG?W&K6'PH^.WC'2?$'A)_!_P 1]:/@KPO\
M-O!VNZ3I^F?!FR\.>'5\367A6+4/^$IUV:[U*33;3Z0^$_\ P1K^$'PQ\:_!
MW3C^TY\?O'/[)7[-7Q>N?V@OV:?V*?%6M^ I?A'\'_C%9:_?:EX?U6#Q;I'A
M33OBEXR\$?"SQ!J&HWGPK^&OC#Q9JGA[P#KMP\T;:AY%O91?='[)?[,?PH_8
MU\(_%WPIX&\;ZGKFF_%W]IGXW?M'>(+OQAJ^A2W.F>./C]\0[W7=;\-Z?+I]
MKIT8TC3?$#R:!H4%\MUJTLUL]M=W=U?!T0 _/[X5?MX?\%%_VC+^U^/?[/'[
M+7[-OC+]C#4/VCO%GP2\.>'_ !)\:O%?A+]JCQIX#^&_Q@UCX-_$/XY:+<7_
M (9/P&T[3M/O_#?B;QIX7^'U[XON]6\7^$M!DAL/$D.N:GI]BWD_A3_@K/\
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MOSM\H# YY I@U336>&-;^R:2X56MT%U 7G5W>-&A42;I TD;HI0$,Z,BY92
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M9D>"=5GA92#%,!(A5P#5D9[^@_/O2T 5TL[2-0D=M;H@E$X1((E43KC;,%5
M!*-HQ)]\8&&&!47]FZ?M1/L%ELB+-&GV6#9&S[-[(OEX0MY:;BH!;8N<[5Q=
MHH KK:6J.TB6UNDC2F=G6&-7:=D>-IBP4$RM'+)&TA.\I(Z%BK,"Z6VM[CR_
MM$$,_DRQS0F:))3%-$RO'-'O5O+EC=5=)$PRNH92" :FHH 3'^?\_EZXICQ1
MR;3)&C['$B;U5MDB@A70L#L=03AEPPYP>34E% #)(TE79(BNNY'"NH8!XG62
M-P&!&Z.1%D1L95U5A@@&AXXY %D17"NDBAU5@KQL'C< @@-&ZJZ-C*NJL"&
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MLKNW2T4 <<WP]\"&ZM[X>#O#,5[:W-A>07D&B:=;W27&ERW4^FR&>"WCE?\
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MN=0M/%&L_%+2_%.K>*U\1Z;"+.SMO#;IX9MOOC_/^?Y?2C'X?3]?_P!?7TH
M3O\ G_3\/Z]1VR5HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXT+POHWA6UU/3[7ZX_X)/>/?VGM$_;!^.7[/_P 0/&'VGX*VW[/W@'XO:?\
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M$\0G4KUY8C=:?#  ?OQX"_:M_9W^*?BGX?\ @[X:_%3P]X\U?XJ_"/4?CO\
M#>Z\(KJ?B#POXU^$FE>(-+\+:AXUT#QMIEA<^#-0TZVU[6](L#:Q:_\ VG+_
M &C:W,-A)92"X'3_ !W^.WPJ_9H^%7BKXV_&WQ4G@KX8^"_[%_X27Q*^E:WK
M@T[_ (2'Q#I7A72!_97AO3=8UN]:\U[7-,L%CL-.NFC:Y$TJI;QS2Q_Q ?LE
M_M(_M$?LF_L3_ )O@%\9_B+J%GH'_!O+\?\ ]IS0_!_B7Q%>?$'P]H_QCM/V
ME_"/AB/QSH'ABZ-PWV+X$^&=<\4W5GX=@,6B>&]&LK6PU.WGT^VF%M]8?\%
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M!^O/Z_3OTZ>E?Q8? KXK_ML^,_#_ /P64_9Q^%OQC^,WAWXJ_LD_#_\ 9?\
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MJ ?MOC'3U_4D^G;G)_/KDE >G!YXYS[^N!D9R<=L@9P*_B1_93_:B_:4T_\
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MW:R7\]NEQ&S_ %%'*LL:2QY*2(DB$JR$JZAE+(X5T)!&5=593D, 0<?S^?\
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MX?:;J%C:>)[CPIKFDK8Z?+J !_69S^70\_J#_/G/)&,BCG)X';\^_ID#.?\
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MX6LK/PYXST'X-:/IO@3X:Z;>Z78I:VMC'\,]&\,Z-H?@N32$T^X\+QZ!I/\
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MBLEL26_=*\8B8+S@Y0!26W''>K% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(Z#X=TRQ@EL]$T+PE;VNIZU<:OXC\1'6M:US4[RY /S+_9B_X+/^+OC?XD^
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M[JYT\"R0 \=^&7_!7!_'<OP(\=W_ .S?XHT[X ?ME_$SXG_!S]C/X@:/\2/
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M'(=9M;+6AXE70]+FM_D7]HW]A3XS?!;P5_P1>_9A^!7C'XX>.K?]E3]K&_\
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MNU@T!-#]E?\ X)JS_LJ?%:RUSPM^US^TGXA_9S^'][\3KWX!?L>:IKNB:?\
M!OX1#XN:C<ZEXCTK4]5TO2X?'WQ@\.>$WO+RV^$'A[XI>)?$&E_"ZWU'4)-&
M@N;]=)OM( /IO]M#]H2__9@_9M^)7Q:\-^&QXZ^)%GI]AX4^"_PVCN=-@O?B
MA\</'NJV?@OX0?#O3TU36O#T-U-XJ\?:YH6GW<$&JVUY%I3ZE>6Q=[3;7R;X
M._X*_?LER_LT?L>_'_XF^(O$7A'4/VQ? WB?6/ /P]\'> OB)\9_$;^/OA=X
M*O\ Q3\:?AG#%\)_!_BF2X\3_#F^T'Q)X>O+2>VT^?4M7T:XM+&U:Z6:W@^C
M?VF_V.?"W[57Q)_9H\2?$O6M-U[X6?L^^-?%WQ%U7X#>*?!.B>,/ 7Q4\<ZK
MX4F\+^!/%'B4ZI<Q3V.K?"9M2U_7_!AAM[ZR3Q!JZZK>V4UWI.DSVOY_^%?^
M"*NC^#OB=H_BS1/VD/$%A\-/ ?[5O[4'[4GP<^!]C\,M#M?!?PMNOVL/@UXO
M^$/Q"^'&BW/_  D\]X_@_3#XTUCQKX7@L(M%@T3Q'>ZJNG:?:6.I-%;@'U+X
M!_X*U_L)_$W3O%&I>$?BOKLL?AWPO\(O&VE6GB/X5_%/P)J/Q*\)?'N>]LO@
MYXA^#MAX]\'^&;CXLZ1\1-5TK6=&\-7_ (#76[:\U31-:M6>/^R;^2#PWQY_
MP7 _8#N/ 6KZC\-OVB[K3]4N?@M9_&S3?B)JW[+7[4/Q'^%?@+P+JVL>)O#>
ME^,OBG<>"? FDP:!H/\ PE?@KQ9X,O[;5O%OAFZLO%^B7_AR[N;36;9K)_'K
MS_@A;I^H>%OAKIS_ +6/C#2/&GP._9/_ &*OV=/@M\0/#?PG\&VNH>#/%W["
M_B[QUXK^%_Q:U30O$VL>+]!\5V_BA?'NL^'_ (A?#K4+2WTG6M$EF2PUS2[Q
M[>[M/3_'?_!(35?B%I/[2EIXE_:O\2ZSJO[2_P"QM\)?V2O%&KZM\(?!YM]*
M?X8_$GXA?$]OB!IWAKP]K?AGPS96-]JGQ/\ %&@:#\,?#>E>%_!_A3PN-+L2
M=<U*UO-7U  ^I;W_ (*B?L1Z;X@\=>&)?C+)J=W\._#'BCQ+JFMZ'X"^(6O^
M$_$\?@'QCX6^'7Q T7X=>+-"\+:AX:^)'C#P-X_\<>#?!OC'P9X%U/7O$?AS
MQ-XFTW1=2TZ"]2^BL^(U'_@L1_P3^TCP?X>\;ZG\8?$5KHWB+P9X^^(:1)\&
MOC1J&IZ#X)^$GQB;X"?&#Q'XQL-*\ WTG@_3/A)\45;0?B/<>(VTX>%K/R_$
M%^%\.W%KJL_D,7_!)?Q;X6\&_M+_  I^$/[<'QF^$?P3^.?B7Q7\1_ WPG\.
M>!_ -_HGP4^)?Q5\;:+X_P#C;<Z+KVJPS>+O%/PN^(^O6?B58?A%J.O:;HGA
M2S^(7C&33M6NM9/AO6?#GAT?_!"*&S^%GC_X2V/[5^IMX?\ &7[+_P"W'^RY
MIUW=_ GP9:WVB^&/VZ_C[X8_:!\>>(KJV\)>*/">@:GJ_@_Q+X>GT_PK;V&B
M^'K-K#562^#6VG:?8Q 'V)^W_P#M8_&G]FKXG?L9Z%\.O&W[.?@[X>_M1?%/
MQC\%/$GC/X[Z%XDO]-\ >(].^#/Q)^,/A'QO;:KHWQ,\ :1JGA_4A\.KGPGJ
MGAV_O]*O)[O6=(U#2O$"LMQ8/P/[._\ P5Y^"/BKP!X8O_C]K>G^&/%GC?\
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M_@L!\:;_ /9Q_9-\=:=)^Q[KGQ__ &BOV_=*_8^\0?!V#Q5XSTB]\#^$]?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^>WUZ\T8_ID]SC_/X=L4M% !1110 F,=/\_X_CFEHHH 3 _S_GMV].U+110
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MLM'\$Z[^SEXR_P""G/A7_@H#!^V+<?%+^R/BAX8\#+\:M#_:0\6?#6W^$_\
MPC6H:PWQGTWQGX2/PS\)^.K#Q;:>$+SPCXJLO%>H/H]]H>I>%M0 /V/^&/\
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M^'7PB^)WPB^"7PW\,?#;_@B;^T+_ ,$N8->\,?M%0?$+_A*_B+XM\"^"M!\
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MU^*EKXE\'^'/B3X.^''@/QKJ6B:S?>%;3QCX_2X6SDL+9KF1[RR\_P"F[/\
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M\/?BAX0\47FL>'_[;U"XN?!OC'3I]&UBW\0PZC)JL1 /T@^&?[;OPRN?@O\
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M.?!CQ!\2?B1I7Q@/QF\'Z<]@_B'X>SW&H^%(/$UCX+EU3X:_:#_X)T_M )X
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MS=>'OB=\49-5\):3\5/!7BCX:^"OAGI2^'-?U^T\0^(=3?P]8W !]Z_MC_\
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MBTG,?XO?\$^O@]^T[8_MH?!?XI>./V&?$_[(7PB^$W_!+7P]^Q9XCL]3\>?
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M!'[ /QO^%OQ5^+_[(MU^SA9>*_V)/V'/BO\ M!_MH_L,P0:[9^ ].^,7BO\
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MNE^#_"]KK?C36="\.Z+:2&VU#5-8U:_O96T_1M+O[FTT[5+Q+?3[GY*\/_\
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M(T/Q!X0&N:D^FV@!_4O^S_X_^)?Q-^&&C^,/BY\)+?X)^-;[4?$-K<^"=/\
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MO_H+QMX"\.^";3]I[X$>&?V6OC7JW[&^C?\ !7[X=:C\'_[8_9;_ &H?C)\
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MN0_P6U_QE>_&"_\ BY#X52S\'7HC36+Z>XMO[)MM9]$^'WA/XMZE\)OCO?\
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MO^+OC-\</#GQNL_V-OV2/BA_P1,TWX4^*_BGH'A[XH_$*Z^%VEZUXSU#X/\
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M\'OA)/\ %#Q%X?\ $VK^*WTOXZ'PK;_$2Y'BBT\,PLGG/P8\5>,_VF_VB_\
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MX!_"?QKX,^&W[4/BWQ3XUCD^&'BWX*^)] ^(]_X.TW54L_#WA?P//)9>(+,
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MLH8 ,%8\KN  .#R  >U?RE?MD_$CX@W_ (__ &J+OX1_\%7OCI\,OA#\)_\
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MPHTG1=4TGQ!I$/P7TZQCE\,)\/[EY]*CU+2O%&HT ?M9\,OV1?A1:_$KQ_\
ML\_'?]H?]KO]K[XE7/P"TF]U/7/CUJT_AO0-(^"WQ \9S>']:\*^#=<^!7PX
M^"GPQ^W>.=0^%\&C_%*U@N-5^(NO^$H8-'\5W3^#?$]S8ZG^J6F:;IVC:=8:
M1I%A9Z5I.EV=KIVEZ9IUK!9:?IVG6,$=K96-A96J16UG96=M%%;VMK;Q1PV\
M$<<44:(BJ/YD/^"F?[3/[0?PM_:3_P""G?A?X;?MD>)?A9I_PB_X(VV'[6?P
MJ\)Z"WPOM[OP!\;_  I\2_B#8^99VFK:'>2ZY%\0-)\(^'M$U=_%5GJ_B.TM
M_$MG;>%-8TRVFT>QC^I_V!OBY\8M+_X*#?%?]G?QA^U!\0OVBOAW\0/^"??[
M*G[:V@VOQ7OOAMJFN>!OB!\3O&OQ'\"^--.^'-Y\/?!G@:*S^%U]H?AGP;JD
M&@WFGZO'IVK:A%J4&JB77[J740#]U:*** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BB@\^WTH Y;Q5XU\(>!K/3]0\:>)]!\*V&K:[
MHGA;3+[Q!JUGI%I?^(_$VI6^C>'="MKF_FMX9=6UW5[JUTO2+)7\_4=1N;>R
MM4DN+B*-O@WPF/V7_P#@H/\ %NS^*]M!\7+3XB_\$W?VI?B1\+;'3+[7?$'P
M_LO#7QRTGP!I>G^*-2N=$\-ZY+I/CW0K_P"'WQ-;2-/EUN6_T:^TGQ#K-I-I
M(%Q+O\'_ ."V_P ,/"GQ#_9N^ VI>-_ ^K>-?!G@#]N7]D'Q'X[B\/Z+XQ\2
MZYI7PZU3XR>'O!WCV\MO#W@:QU/7=8TVZ\/>);K3?$-M#97+0Z%>7][;Q?VA
M:63I^0>@Z7#X;_:M^+OQ^\)_\+V\*^.=*_X.#?@E\&_#FF^&O%/QFT?X=:S^
MS/XG^!_PN^'OCJ_M?A[9:C;?#/QEX1\1VGAC7-=^('C;5?#U[):Q>%[:YG\3
MAK*R34 #^PP,#N (+#A@""PZD9 S@XP0">GKW=].N<\\]_3(Z9'Z=<"OY2/^
M">]I\0_%_P"W9X/UKXZ_M%_M6P?MJ> OC?\ M>:3^TS^SGX;^"OCWPW\-]1^
M'FI:QX\M/A%XJ^.WQ:UR]C^$?BOX#Z=X#TCX::A^S9>^ M+6_BUG7=-\)>"0
MNG6GC6?3_I/]HSPE9?'3_@L9\5/@Y9_$#XHZ]/X:_P"":'@_XP?#?X2V_P ?
M?CKX!^#UC^UOX#^/'B^Z^'6KZKX?\#^*-%\$3ZC%H)\.7?BGPWJRW^DZWH$Z
MW?B?PCXBMY97MP#^B"2:.**6:1E6.%6>5R<K&B)YCLQ."%5?FSC[I!X'23N0
M<=,X]>WMQQWSR>O S_$[\)=1TOXC?LA?M0^.[W_@H/\ M5_#_P")&L_ 'P!X
M+_;/T3XJ?!#X[^"/AM\%_P!J;1/C+\,=&U?7?VF->B\=>*/$&C^*?B)K)N/A
MIX\D_9KUSPQIP_9EN]:\376CZ-X0\*^&9M.[SX6>./ OC&T_9I\"?M9Z-\6/
M@5_P3FUQ/V\/#O\ PF?AK]ISX_ZA\"O%7[5UCXY\*77@?5_ /[1-F?!_Q+\0
M?L\:Q\-]1^)NK?LO0_$[Q'H&CV_B_1]7T[1AKFM> _#,6D ']1WBC]K#X5^#
M/VG/AI^R;XDM_&^E_$_XO^ _B)\0_A]J4_@W5O\ A7OB#1?A7#X?N/'%C;>.
M0AT<>(-$M/$FEWEQHI;[2MM,)9 GFVWVCZ UG7]!\/Z!JOB?Q!K&E:)X8T31
M[[7M<\0:U?VFFZ)I&@Z;92ZAJ>L:KJ=]+!8Z?I5AI\,U[?W]Y/#9VEG%+<W$
MJ0H[C^2;P=JWQV^,$/\ P2'^%7[2\OQ/UW]I[QQ^PY_P59LH]2\8?VGX(^(F
MJZ#KNC>'/#'[->H^,_%&D)X;N-!^)_C#X>^&/#.N7>J3R:=XEN_%(U'6KQ+;
M5?.:/YETKXOZO^TE\"/!?PQN/''QA^-WQ0\??\&WG[4WPI^,NEZK>_&7QC;>
M*OVQ_A@GP\UY/#?CF:\L[[2]8^.FD@_$JVU!K^ZC\>SZ-JXT#6)[NTU[P_I-
MZ ?V0Z;\<_#6L_%7PU\+/#_A?XAZ_;>*/A5+\6].^+&B>#=0OO@;#H9U32M.
MTGP[>?%"%O[!B\<>(K358O$/A_PI";B_O?#%M=:VYM[4VQNO:A]._.._09__
M %],>@S7\=$/QQ\?Z#H_A'0?^">'CGXZ:KXYUW_@W/\ B7XL^$OP:TOQ#\73
MX)MOC[X3\:^ M)\%^+_ 7PM^(FF:YHS_ !WMH6^*VH^$]+L=%3Q'XSL?#]M:
M7+OHVHZ/?77#?$[XCZ59_L^?M.ZG^R-^U3^U=I_[/FM?\$H+'XL?'OXUZ-\:
M?CSXW\6_#7_@H;H?CWX5:?\ !@Z/XCUW7?$GQ \*_&[XN:/I7Q"T'X]_#OPO
MJ5E+>>'="TC5/$>E^&B;35=: /[4/R(Z'OUZ'ZGJ> .?:CU)Z=NN>.H _#/'
M7/3CG^>K]@WQ%X;^&'_!6?\ :"_9Q^&7[07Q*^)/PO\ %?["'[/_ ,>?$'@K
MXH_&[QI\9;O2?CWJ7B_5;/Q1XETF]^(>NZWJV@^(?&?@G6-"\6^-O#V@/I^C
MK)K&DZDF@:-:R6-K'\J_MQ_&OQ?I_P"TU_P4XAU;XP^//AS^W=\"_#W[.^M?
M\$A/A3HWQ+\6^%6^+.AZY\/]'UJ31?A;\'X-1T#P+^U(?BK\>K/QMX&^-'A7
M6O!OQ.OM(TBSM?#FI:EI6E:-HMSI(!_5]Z$=.PR,=>W&,],<_ES3-\3R-#NC
M:6)8I7BW*TD:2&18I&3.]%D:*98W8 .8Y54G:V/P6_X)GI??$C_@H#_P5-\6
M^,OCU\<?%_BKX(_M _#_ ,):-\%]1_:*^('C'X,?"JR^+7[,WP;\9?$/P[I/
MPT_X2:]^')AT'XS6?Q'\+^&9$TZZG\%/X6UC1M)GLI9]:EU/XL^-'CGXUZ]^
MU_\ \%Q?'/P%^,WQV^(/Q9_8B^&/P(\<?LA?!/X??&CX@^-O!&D_$SQW\!/'
MFA?%?3K_ /9VTKQQ_P (_P"/WTKQ?-:ZJ?"6L^&Y/#WA7QII>G364FEZV=5A
M(!_0A^R_^R!X"_92U7]HC6O!/C#XF>*]0_:;^//BO]HWXCM\0_$.F:[;VGQ'
M\8V.E:3J[^$8-.T#1?[!T$Z)X>\-Z1:Z*TE]!;66@Z<(620W+W'U?TSCI[=B
M/S[^@.,#CBOXW8?$>F^+OV1/B5J_PB_X+(2>.?"'Q'^*'[*C:SI/Q2TO]JWX
M)_![P7\6+76M3N?'OP(^.W[26L?&[XL_M&_LMZU^TH^BSZ;\4= T?X@>%[3X
M)ZSINA-IO@KPEI?C6TLO$O.>%?VC/#7Q:T#X*6_[27[2W[6O[''[(EW_ ,$Y
MOC%K'[)7C[QQ^U!XZTWQ'XE_;6\!?'KQWX>^)NO6?[2>A>+_  CK'[6^J?#[
MP7I7PXU?]E71O'%I>Z9\9_A-K\OB#3_ FL:Q<ZN" ?U9Z;^U;\)=2_:Q\0_L
M6QR^+;;XY>'/@GIW[0MS8ZAX/URQ\)ZC\+=3\60>![?6]!\9W%LF@ZY/%XIF
MDT>\T[3;F>[L;JRO%O$B:(;_ '/Q3XK\,>!_#NM^+_&GB'1/"?A3PWI]SJ_B
M'Q-XEU2QT/0-"TJRC:6ZU/5M7U*>VL=.LK:)2\UU=3Q0QJ-SLH.:_B_^+_B[
M]HGXO:UJE]\;-1\7>"/^"@_C/_@V%\:>-;73?AMJ7B?X:_&N?]HKPG\7;SXJ
MZ!I_A:Q^%=UI^O:)XU^T:39^)O$/PUT8V<U[)>3:4?#5SI6GW]EIWC/[;7QE
M\$?M1?LZ_P#!1%/ 7QI^*OQL^&7CO_@D+_P3>_:,U3P]%\2?B=X\\(:/\;/!
M7QXOO#7Q9U:QL+'7KSP;H7BC2/!ME\/7^+>A>&+E[>#Q!;W^L>(]*N/$NC:N
M+( _M[M/B?IM]\4]1^%5OX7^()O-.\ :#\0)/'$G@K6HOA;=6GB#7=7T.S\-
M:=X^DA71-0\;VAT>76-6\,6DCWVEZ#?:7J=X8X[Z%5]+]\>H]_7'&>N,_@*_
MD&_;:_:<^)WPS^*O_!0J3_@G[\=_C5\3K?QM_P $O?V&_C;\/?!?A?X@^+_B
M;;_";P)=?'_7_AM\;?BU\"_!VN1>([SP[JNA_LL:IX3^)=[>:+I6I>,[JX\4
MZ3\1K<7OG:9-!X#^WQ\9]-^$/[+W[;,O[(_[<_QYU/\ 8DTA_P#@F[\0O@[^
MT+X,_:J\=?%;Q-HW[2/C_P".^M^$OCS\%_ ?[0&M^.?$?Q#\1>#I?@#X9T#X
MM>//AI?>(?'<?P_\3W,^IC3M*M-3O/"4@!_2+X@_X)0_LS^(?BGXO^(<GC']
MJ#2?!WQ(\?:O\5?BA^S?H'[3_P 8='_9C^)GQ(\1:FNM>)/%7C;X0VOB5=-U
M5?$FKP:??^(?"D%_9^ M9?2[6UU#PI<V$VHVE]^F)^AY/7T]_P#Z_IQT %?Q
MY?'#XK6.@W'_  40_9"^'?[?]YX<^&O@+X^?\$\_B!\$-0_:@_:?^,UOX;^(
M^N_M!> O'GQ,^*/[-'BO]K/PWKT7QK^%GP:^,3^ ;'4-'\:Z7XZM=,\%>,]=
MC\*6FM6/ASQ ?"K?:]KX_F^(/_!M?\8_B?\ #;Q'^U=\)[_3?V,OVC/B#X*\
M3?$+XU>)M9_:,\->)/AQ/X^\6V%W:_'[3;FQ\1^/?!EQXK\-RP^ /'<)TZ;Q
MW\$KKPY'=1&'5+B68 _HRDEA0()WB3S)$BB69E7S)F^:.)=YPTIP2JKEB5RH
MR.)?7K[#..OI@@]>.?H.*_AA^-?[17B+P?\ L_?MF^(O@9^WO^T3XR^ K_\
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M_'OQ#X?L_AM\ XM&_:$'BS6Y?@+XFU&'PS^SKX6_9MLX?A-XP^%GQ"\&^#/
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MDZOJIM+;YC\1?M#R>'O^"HT\FJ_M9^-OB!\/_'_Q7T[0OA7/\"OVJ=1O-:^
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M<^'>MZA\&].A\(ZK:/X>\/Z1K>E^$O&FG)XNGU&Y>.['N7PR_:=_:O\ C_\
MMJ_$NYU/]O/X&?!'P;\/?VROVFOV1?$7[$=]K'AJ\^,GB3X6>&;YO!?PXUWX
M:>$X?A_H_P 1?"?Q=UO3=$D^-?A?XKS>/O&_@C5[3Q1:VUQH&E>&?#E]I]V
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M@T7[=X3TS3)V:;3[#09["TL927MX8G+&OYU/%'[<_P"TI\-/%/[7W[/OB?\
M;*UC7O$VI:E_P3$^(G[./BL_##X*Z%\:Q-^V]\1O'<?Q _9M^&VB:CHVB_"^
MR6]T+P!8>%/AIXT^,EG=1_#"V\97WB7XA>+M=;3-/N1XCK/[57Q>_:,\&_\
M!/C1O$/[4/C/1KWP!_P7:^,'[,_COXA_#?XN?"_3_P#A)?A/\$_"/QH^)W@C
M2OB3XU\+VVI?#KQI=Z+X&L/!NG^(KJ^\+Z3%X_>VO9GT5[G7=)\3W(!_3?\
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M 4444 %%%% !1110 4444 %%%% !1110 4444 &.W/\ 7_(_/U.>::JJ@"J
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M2=M2OKZ[N.KLOV</@%IGC;P/\2-,^#?PVTSQ[\,O!T?P\^''BW3O!^AV&N^
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M^TRQOM&\,:N;O1M'O83=Z996EQ-<2R_1E% 'R9XE_8-_8L\9V_CJU\7?LK_
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M.UL8;7PWJ?BK4YYK_P 47^F16]WXCNY9+C6YKZ5BU?40/Y_E_/Z_ATI?U/\
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M<S3IHS7ZI'?Z:L$NJ*IQH23S7$4HG=QM6_EM8].",':=6S&-@#^G7KW^N.X
MS^I-+C_/]/?/?_&@"A:7-].\8N=.-G&UA:W#L]U!-)%>S-+]ITYXX-Z$V:I$
M6NHII()WE98LB(LVA28YS_G_ #T_+ZTM !1110 4444 %%%% !1110 4444
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M[>>'X??L@1:R/V?3X:UO3M;L?$/A/Q3\/[S6GUG3O&/AW5M.\2'7]-T;73J
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MM^#_ ,'_  %\.?A%)XB^*VN_$[Q%XBT^2V\8^//%GB?PAX(T.RA@U#PSX?\
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MPZE=:6;358M.$[G3F_FG_80^('_!0KXH_%__ ()2?$#PUXD^"7Q>_:3\9_\
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M6=5T74O!5C%X3O-1U[Q%X-U30]-UV5_'G@_1Y+O5?!GGP1:1J'B/3;%=0O\
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M!7PP^#_CRV_:!^%G[/OAVW\-?#76M8\+_$SP]XCT;P'\4?"NFS>(K;P]X_\
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M;X*^#.F67AWPUXL^%?[17P,UKPMX!NU_:"^"?C'2?&'ABS\86\4'@KQY\/\
M5M9$5UX?U1='UZ/38_'W_!;OQ=X$^'_[-\WCOX'?!C]FCXL_MF7'Q<^(_P
M-)_;._:=T;X#_"[P=^RW\/8=-O\ PK\4OVC_ ![;^#/%^I> /B?\1]/UWPXV
M@? WPCX9\=:O%<:\+>]\1VUSH'B:UTKZ=N_^"3.E^.O#7A3P)\?/VG?B]\>?
MAU??%O6/CG^T;\._%>@^!=$\#_M1^.H++2M.^&'@[Q_X7\+Z1I>A>%_V=_A+
M:Z-IUQI'P%\!Z=H7AOQCK&F:3K7Q#U3Q1?64ANN4_P"'/@\&>&?@G/\ !/\
M:F^(/A#XN_LMZM\9O#7[-/Q)^)_A#2OCKI?@?]F#XT36UUJ?[(WCOP5XOUW3
MQ\6OA9X3N--T"/P+XI\2^([;XJ^%]+\+>&M%T[QM'IFFRVUX >"?#K_@MW\2
M?VA_ ?[-VE?LN_LS?#/XN_M"?'KXS?M5_LVZCHL?[2-I'^SWX4^*?[*&A>'?
M&?BCQSX<^._ASX>>*(/B;\"?%G@'5W\5>#_%.@>&K#Q%JYU+PYI-MH$SW&LW
MVC^W_!?_ (*3_MC_ ![\;Z]XQ^%_[!.C^-/V0?!O[34_[*_BGXF:!^T!;/\
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MIU+QA8_#_5KOPG%::=XOO/#^L:[K;#Q>^E:#-J-K=VMK_8EC'8)YWYI^,/\
M@B#XBU_7/CAX>\/?MN>-_!/[//QN_:9T?]K'Q)\)M&^!GPID^(WB#XC:?\7M
M,^-USX4^)7[2EP#\3OB'\)8_'FE6E]X6\)SQZ%XA\)V-KIVAIXUU;0=+MM+
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MLY> ?'.E:CXDU;XAZY\&=/\ '6I)<:!X+2XOH9IX?DOX_?\ !1;]IV+XP?\
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M[/OP!T>?X-^&O@Y'X2^&7QCTCP[X<^(6M_$*^\,^(O$$GQ)^+?BSPSX1\/\
MA_6/&FFP?#W0([-M<DTGP3IDNLE+7XO\$_\ !NS\/-"^&G[)?PZ\7_M&^,_'
M2_L\?M7^+_V@_'^M:CH>IPWGQN^&FLK\,]-\-?LXZY))XVO-6TOP3X>\.? 3
M]G[0;O5'UO5X]9B^&(NSX<L[C6X&T, [#]H3_@N];?!'QA\5_#ME\!_AGK$?
M[)W@WPAK7[8FB>/?VR?@C\&?B=X=\9^)/AEX5^*>N_#?]FSX<>- =5_:#UWP
M%X?\3&WU?4]3N/A9X>\2>)-*U+P;X.U36/$ENUG7UA\&/^"E7Q"_:1_;)\4_
ML]? G]DW5O%WP)^&'ACX"^+_ (N_M0:Y\8_"'A:U\,Z)^TO\"=*^./PI?PK\
M+I=%U/5/'NH?8M1.C>+['2O%%K%H,,FGZY:WVJQW\6FCS_XY_P#!)_QYXQ^.
M_P >?B=\!_VH/#7P3\%?M::]X6\5_M!^%/%7[*?P7^./C?2/&'AOPQX2\!WO
MC']G3XE^,X;(_##7_%G@?PCINFZQ#\0O"WQH\.Z9XCC/C7PWH&E:Q<ZC'>^[
M^&_V/?'G[->K_P#!1?X[?![XG:GXL^*7[47@+X6'X0:!J7@_0[FX^'?C?X _
MLR6/P0^'4#OJ7B+3_#'C6;Q1XKTBQ\6WUK?6G@#PM;7FI7.EW*V6EO<ZH@!^
MB'BCQ)I'@WPQXB\7^(+H66@^%="U?Q)KEZ5:06FD:%87&IZG<E$R[_9[*UGE
MV*"Q*;1D]?Q=^ G_  6+\4_%"Y_9*\??%']BOX@_ C]EO]O'XA)\./V6/CIK
M'Q0\+>-O$6LZWXBT76];^$\_Q@^$?AOP_%??"73_ (S0Z'+:^ [ZW\8>.;07
M>I:)_P )#/HEGJ27<7Z:_!;PE\6/%'[*GPT\"?M<R>&M>^-/B+X%^&O"7[1;
M^#&-IX7UCQYJ_@FUT?XF/H+VB6Z6UA?ZM<:LUNVG1P6D/G9TU(K1;94_+KX'
M_P#!(CXL>"M;_9,^'_QC_;(O_BQ^R#_P3Y\>6GCS]D+X(:5\)-%\">/+[4O"
M&EZEHGP6C_:3^+&E^(;JS^)UI\!]$U%K#P;9^#O 'PW/B:_L=)\1>.[G7-4T
M^1+X ^B/^";7_!0;XM_\%#/#%_\ &-OV/]4^!7[-FIQ^,;'X8_%?Q-\</!GC
M/Q+\0_$_@+XE>(/AMXETF3X7>'/#UMJ7A72[>^\-:I=V7B'4O$%U#J#6LUM!
M8B VFH7G@?Q<_P""PGC/PG^VC\;_ -D#X3?L>W_QEU?]G+4_A1!\2;.V_:/^
M$/@3]H/QGHOQ1\,:%XR3Q;^SA^S+XM2UUCXY>%?"^B:[;#Q%J2_$#P5<0W<-
MW:V-AJ%VEM:WOZ"?L(_LI?\ #%'[,O@[]G>3XAW/Q5N?#/BKXN^+M0\=W?AN
M#PC)K>I?%SXP>._B[J2KX>@UGQ#'IT&EWOCB?1X!_;-Z]U%8)>N;=KDVL'YV
M_MR_\$C/BK^V-XU^(>ES?M/^#+?X&?&#6_#7BK5;?XK?LZ^$?BO^TA^S5X@\
M,W6EWUQ_PQ#^T"NM>%-3^"VG^+Y= T9KEO%VA?$C4? 6I17NN^ +S39KW^S8
M0#VGX@?\%6O"O@?X4_\ !4+XL3?!?QE)HW_!,;QQ)X)\5VUWXA\.VMS\7[S3
MOASX(^)6L2^$U5ISX=B73?&ME8:<^M)<_;5DL[] )I[O2K"CXB_X*9_%>]^*
M'Q,\+_ /]A;XM?M)?#/]GKQ!X"\%?M%_$GP9X]\"^'_%7A?Q]X[\*^ _B!>^
M!OA-\&M4-_XE^-FO_"[P)\1/#_B'XHQV&M^$X=.CF73O"!\9ZT]SI=E\U_M.
M?\$=_P!I#XEP?MV_"[]G3]LSP9\"/V=/^"C.IV7CW]H/P[XL^ MW\6OBKX>^
M)3?#C2OAYXV'PQ\='XF>"M!L_!GQ;L/"7@Z3QQ#XF\(:UXMTZ1/$-SX2\2:1
M<:E:_8O8_$7_  3;_:R\-^/?V@V_9E_;=T3]GOX5?MCZCX!\7?M&+8? ^7Q/
M\</#/Q,\.?#/P;\)_'_Q!_9H^);?$?1/#WPSUSXK>#_!.A07DGC'P#\21X#\
M0:?_ ,)9X2VZA>-:68!\L_#3_@IK^T%^S]\1?^"AWB'XI? [Q]\9?V3/@W_P
M4MUKX;>*OVBM<^-O@_0KCX'> O'6@_ #PUH_@[X:_!CQ%#=^*/&'A/X4Z[XP
MM_%OCJ,:MX%TW2=$\8:AJOA<>*M;L=:T2W_;W]KO]J7X9?L4_LW_ !7_ &H?
MC$GB2Y^'GPCT&TUG6M.\'Z2NO>+-=O-8US2_"WAKPSX8T>2ZT^VO]?\ $_BG
M7=$\.Z/#>ZAIUA]OU."34-1L;)+F[B^!_%/_  2UUOQA^R]_P45_9UOOC'I&
MF7?[=/[5&O?M :?XTL_!.HW[> M OH_@;9:9X;UK2+WQ;%+XM\2+I_P;D_MO
MQ+#JVB0:MJOB*74QIT'D/;S?3O\ P4R^#VG?'K]@_P#:6^%6J?#SXK_%2W\2
M^ HKJ+P1\"M9\,:!\9M1U/PQXAT/Q;HVI_"Z]\9W-IX5N/'7A;5]!L?%?AO1
M-;F:Q\2ZIHEMX<>WO#JL=I, ?!>H_P#!9/XO?!ZR^,J?MC_\$Y/BW^S#K_PD
M_8[^)7[:]O92?&_X1?%3P]X[^&?PU\=_#OP5K'A7PYXO\+-I]C:?$^V;XCZ3
M<:QX.URTTZ?1M0^RZ9%=:G9ZUI&M7>[KO_!8/QQX6TGX7>'/&W[%>H?"[]H7
MXS^'/'WQ?\!_!'XP_M8_LT?#S3X/V:_!<7@X6'Q>\;?%F_\ %%_X*\,:]XUU
MCQG8>$O#WPCL1XC\7V7B:QU:3Q--H/@_3KSQC!^8_P .OV:/VQ/^"HOQ$_:>
ML_BM\:/BOK'@/6/^"7WC#]BC1/CK\9_^"?WC']COP_I'QD\>?'3P1XZFFLO@
MO\5/'5WXH^*?C)-'^&-O=?'CQ5X4T?PE\*+?78_#OA[P1' MD+2V_6G]LK_@
MF1XM^-_C_P#9W^/?PJUG]F7Q#\8?@?\ !+6/V>];\"?MB_L[:9\?OV<_B%\/
M=>?1=:.KP^$K+4O#7BWX?>/_  UXT\/:9KV@^)/"/B6"WOM(;4?".M:;/I=Y
MYL0!EP_\%A1\3?@S\$_BQ^RU^R)\5_CN?BI;^/!XUG\0?$3X2_!#X1? +Q!\
M)O'47P[^)?P^^*O[07COQ)-\-#\2+#Q+#K%OX'\,>#+OQ3#\2=.TL>*/#^JI
MX)O8_%$7DUE_P5;^+?[0/Q?_ .".?B?]F/X4WP_9O_;>F_:CUKXV0^*_%/PL
MT_Q#H6G? _PYK7A;7-+?59O$.I&;2_A;XMM]1\>ZGK?@&+6M/^(5EH>AZ7X>
MU];/5FBU7FO$G_!$_P"*>EC]E#6O OQR_9G^)?B#]G[X=?&3P+K'@O\ :?\
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MG[#7Q:_X*U_M2^)?BK_;_@'XC6/[4D/@GP)^T]H?Q&UOPU\/+DK8_"_7=/\
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M'<:5XEUGQ9X1>+Q-X7\)^(-(\/6GBOPW_P )E/X=O-2%G#V/_!83]N+XK?L
M_LBVGQJ^"WPPUSXG>/=;^.GP&^%NFVFG>%[+Q7HNB6/Q"^*'AS0]:N?$UA<^
M,_!$EJOB/1I+_P ">#KV#5)(U^)/BSP9;:BMIIUU<W]IX7XO_P""9?QJ\2_L
MA_M[? "'Q7\+K3Q9^U5_P4;U?]KWP1JDNI>)Y-!TCX>7?[1?P0^+-GI?C&=_
M"LU_:^-8?#GPOU6(67A[3[W1XM6GT.W&N30OJ=^GV'_P4]_99^*?[8?['_B[
MX/? _P 1>"/#'Q@L?B'\"OB[\-]0^)+ZW#X$N?%GP(^-W@'XR:7H?B:^\.6&
ML:SI6E^()/!!T6;5K'0M>DTQ[Y+LZ-J$<+0D _([X>_\%J/B1\'?VL?^"J/A
M3]I/X1_M.?$[X _LM_%?X0:CIFL_"KX+>!M=T7]D?X,>*OA%I?BSQEJ?QM\7
M:3XKTFYUI+'7M1FU*^TW0F^(GB#0-#T+Q7KD4S^%='\^#]+/VC?^"K_P8^ O
MQ&N?AKX3^#7[3'[4NJ>$/ _A/XL_&W5_V6?A6WQ5\.? /X/>-]-O]9\)_$/X
MCZM#K.F0NGB71=*U?7_#O@SPF/$GQ"UWPYHVI:_IGA:XTM+.YO?FG2?^":W[
M1$?@G_@N ^NS_ K5O%__  4]TZ]3X3^$+KQ1XNU7P7X/U#4/V8(_@_+#\2/$
MEY\-;:_.G6'C:_O[NQDT+PEK%Q/X>TG3]1>#3]3U*32=*^8OBU_P1.^*DGQG
MU3XO^%_A)^QK^T[J_P 0?V<O@#X%\0W/[2?Q:_:-^%&I?#+XX? ;X+:/\$X/
M$VDW?P@\'>*[3XS_  H\9Z'HFBZUJ_A/Q?HW@OQ)I^LZ5>RZ/KEB/$EZ]F ?
MO1XQ_:\_9Q\#?LLZE^VKKWQ4T!OV8M-^%UI\9V^+&DK?ZWHE_P##K4=,M=6T
MK7='M-(L[S5]7DUBVO;.+2=*L-/GUB^U"\MM,@LCJ$BVX^&- _X+0?LW2>!O
MBAXO^)WP7_;'^ 6M?#GPSX&\;Z/\+?C'^S=XMT;XI?&7P5\4/'>F_##X:^(_
M@GX6\.7'BA/&R^,OB#K.C^$;;09[_1O%>@ZMJED_C#0?#NER'45Z7XW_ /!-
MF#XQ_P#!([7/^"9L/BOPKX$U"_\ V<?"7PGT[QA\/_#&J>&_A]I/CKP2N@:_
MI&J:3X,U+7?%FM:5\/;SQQX<M'U'PN_B35-4C\)7=]I%IJZW?DW,7AGQZ_9S
M_P""OG[3?P7^+/A/Q/\ $S]E?X%O=^%O@AI'@+X1?!3XD?'46?Q#U3P#\8--
M\8_&27X@_M+:=X"^'7Q8^%7AGXS_  WT-_AKIGA[X9>&-;U;PUI_B:ZU*_\
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MEY8VUK>>!_M+_P#!5;X%?LT_%CQI\'I_A%^U=\=O$/P@\+>&?'G[1.K?LW?
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MQ _@3Q#)X&N;/Q593VRZM?:/K%\8@#F_A[_P5@7PO\2_^"A6K?&'_A(_B?\
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M%ZEH>G>$/ Z:_I=QKECZS\4M+_:R_;&_;2\!? #XZ_LI:)^QGXQ^)'_!&/\
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M\/=,\(>-M>\5:KI7B;1Q)#<MK?ASPWK&D7%CJ_\ PD&G:7YFG1:D ?MY<?\
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M_2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/AG1[BXTS4-8T_PUJVL^'?!OBBYT.2]T+1QSG[)_PZ^'WPT^"/[-G[,^J_\
M!-/XV:S_ ,%(/A-XG_:<3XV?'<? GXA?"OPOX6\5Z]X#^+N@_%']IG6/VHM)
M\&6G@;]H+P1\=M+\3:;8_#SX:6'B?Q4?'\^O^$M,U#PQX:N_ ^EKHX!_0?\
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MO%NM30V^CZ#H6H:G87.I:SJ6G:<A26\BKX?_ ."A_P ,?V@_CK_P1X\5^ /
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M6@@_X171M9U>RU'Q#Y\RO##_ &1;78EE5HT)<,!_,I?_  ZT7PA^TC/\9/\
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M_9@_93^ _P#P1J\4Z+\"O'OQ:U2ST+X4_L]Z?\+_  %X%^$GQE\$>#=5TO\
M9X^)'@;]IE+GXE?$K6;SQ7\/=4NO^$FLO'C:AJNFQQ?9^*_:)_9&_:2\,?$+
M_@I+X3\*?"C6]9_X*+?M _\ !*7]@6[^&GQ?\)_#[4AXF^*?C/X5Z?>^%O\
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M=@ QDH Q_GU)/]:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%5KI44'C_P 6Z/J5_8Z;X9M=2L[&S_/K]E__ ()]:1\3?BE]M\5V?[4FJ?\
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M]XKL].\'Z'XG@U&PTJ;PGKE[?FVET?Q<E_J=A!_PBVI6]KX@8744Z::UONE
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M.?6K>Q@U2XT=+VV?58--N9Y;:VU";3UE^UQ6-Q<6\\$%V\(MYIX9HDD+Q.M
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MOQ6?$]CX1T&;[;IMK'KMH_C-+.W7X@^&O[/?_!0'Q-K'_!/KPQXS_9Y_;?\
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M=3N9+6'^M^C&/Y4 ?PX?MJ_LN?&#PM:?&?\ 97O/V=OBGJ'BCX5_\$^_V?\
M]FSX3_&+X2_L)V7[7/Q6_;WE\%_LRW?A/67_ .&D_'>E>,?AU^R-X"^'/CE=
M6T5['PQX-^&OQ4U6_E3X@'6M1UC_ (1W2(/J+X]_LY_M$>+S\<X?AK\$OB?H
M/QN_:3_X(,?LL_#;X9>.+;P1J2ZMX@^,_P */$_Q)U7]H#X1>+/CKHMWIVG>
M"_CAK7P^\8^&/ UEHWC[7O#UE\29KJUTB;4]0TG0+[3'_KL/&3GM]<?U],C/
M;USE, Y[?D?4<9!QC/3H#QC&<@'\AO[%'P+\':!^TAXH^*=CX<_:C^-_P)\
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MXCZ)X8NOB/XCTSP[JNO>&K;6[>^\.GPYXE?7=&T:33[GO_&/[4?[2?P*T/\
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M3-+CFM=+T;3K(7T>KZFU_JE^ ?5U%8$,7B<,AN-2T%U_M3S76'1-0B9M&*7
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M?ZUJ^AZ*NN:M<W%\XO/["O;';US],COQ]0<$9X%!X]/Q^G^'_P"L4 ?Q>_\
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M;P%%^T#X)E^+UG;^/6^*UEX&TV'7/AL/%FF6]KKOPIUR&'>(IKJ62_2ZTO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3Q;X+^(?[%VN_ _39+7X8:[X0^)3>$_BK\,/$TGQ1CT+2OB#X6@U31_$NO\
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M:=<?$.[UB_F^&GP+\2>.?$W@R&UU?7;'5+T:Y)<?$/Q'I^KZY>->7E[I=Q'
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MBZ?\9/C+X>T&3QMX<NO%_CCX1^!_&&B>%=+URPDU)C=Q7]M:_4\/_!1/Q/\
M$3]D']L?]J3X,?LP_%3[%^SSH'[0T?P?@^*5]X!\.Z;^T+XN_9\N/B;X8\5M
MX>M?#?C7Q/XB\,^$].\>_#+5M&EU#QKIOA>^URPGLKGPS:ZE<W8MX.,\&?\
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M]?ME_L^N(\&?\$C/A'HG@GX7^!?'/Q]_:;^,NE_ _P".G[-?QN^#<WQ#\7>
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M3]A?X]?L??"W0/\ @GK>_ ;Q3XE_:%^'G@[X5:SK?Q'T[X\>$?&5CX(TW2M
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M=O\ ]5)C_)QU_P _EVQ2T4 %&/\ /^?\_D*** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M19O$.LZ!J'BN35VO/&VI^*/B+XWN]8NM,T9=.?1-/L$L)/IZ@ HHHH ****
M"BBB@ HI,^WO_GOFLC7?$.@>%M*O=>\3ZYI'AS0]-MY+O4=9U[4K/1])L+6)
M2\MS>ZCJ,UM9VL$2@M)-/-&D:C<Y4<D V**_/?Q?_P %5/V!O"NM7?AC2_VA
M-&^+OBVQN18WOA#]FOPC\1/VI?%-AJ3QW$D&F:KH?[.?A'XGWVBW]VMI<&TM
M];BTYIQ#*Z$QQNZY4_[=/Q:\:V5S>?L]_P#!/?\ ;,^)B6]O'/9ZG\3?#_PO
M_92\,:PUS9RND(C_ &COB3X$^*EBUG>M90WLA^$5S%);3W-WI3:F+)H9@#]'
M"<>_M]?Q^OIGI]3/7V'^/Y__ *QD]OR\LO'/_!8/XCLS:;\ OV%_V7]+N;*W
MFMKSXF_&_P"+7[2WC+3KF2"!;FQU+P7\,_AW\&?"4D\%T+J=+C3_ (MWUH]L
M+6+,DKSO%T4G[.O_  4)\=KH5S\3/^"A^A?#)X;")=?\-_LJ?LJ^ /">GWMR
M+C=>RP>)_P!H;Q/^TAKV%MI?LUK<VEEHL4,@M[N?3I9(V24 _2'./K_GOCV/
MX<U#/.MO!-.X.V&-I&4;0Q"*6(4LRH68<+EU4L0I89X_#'XY>"OV,/@SJVFZ
M#^UC_P %2?VT_B#\3C-IMI;?"_PY^UEXT\)_%KQ6HU4WUOINE_LX_L&>'?A?
MXRUZ"ZN;BVL+F[T?X=W>IFP%I87NL"&XE-SXJO[,GP&^-FH:K+\*O^"4/[5G
MQTCO7GL;OX@?\%$/VCOC1\-OAEJ\&JZ)+,U_JO@_]H[XM_%CXYZG(FH&;1+^
M*3]G,S6;V\-REX(6LGH _H0USQ_X*\-16LWB#Q7X;T6.\G2WMVU;7]'TT22O
M@LJ&^O;=9#$F9)A&SLD8+!6 KYUU_P#;^_83\*2WD'B?]M+]D_P]+IUL]Y?1
M:U^T/\(],DM+6.U-])<7*7OB^%H8DL0;QVD4*MH/M);R2'/Y7_#G_@CCXCU:
MQT^X\9^#/^"<_P"R5;SRVTFM^"_V._V%_@_\3?$<FGK'I\S:)>?&W]K/PCX^
MTW59+2XN/$*6.J:5\ O"@AN&T>]EM;VWM[O2KC]"_@[_ ,$Q/V+/@[)IVJP_
M!3PE\2_&.DW[:MIOCKXO>'_#7COQ!H>K366DV5[>^"["\T*U\(?#*+4$T/2[
MBZT?X6^%_!7A_P"V6L5Q!I%NZ*5 /N7PYXC\/^,/#^A^+/">N:1XF\+>)](T
MWQ!X;\2:!J-GK&A:_H.LV<.HZ1K6BZMI\UQ8:II6J6%Q;WNGZA93SVEY:3Q7
M%O+)%(K'9KYH\"?M4? ?Q;\:/%_[,^B:[J7AGXP> +?4+C_A7OC'P+XQ^',_
MBKPQH?\ 9%OJWC'X1W'C#P]H&B?%KP#H-_K6FZ+K7BWX8WWB;P_H.L7$6DZO
M=V-Y+;Q2?2P/^?S]>>W7'/4>P M%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !03BBC_/YT )G_/\ ^O\ STHS_G&>!_(^
MW)]NN/YN_P#@X2_9E_:YM_AIX/\ ^"D7[!'QD^(/PY_:%_8DM7\9^.? GAKQ
M7XMM?#'Q>^!/AFXO/%/B73-8\#VNK/X&\5WOA.9KW7]4TSQ5X6U"+Q3X-76=
M'GOXGTO2+"^_(CPC^VI\:_\ @Y>_;V_9-^%?[/WBG]H?]F3]B']F/X/^'OC)
M^VUJOPZ\6^(/AGJVK_&#Q;ILMOXE^%FG>,/"FL07FJZ/JEU#_P *U\"7VHW,
M%_/X;?XI>-;+1HOL\0E /[NU((R"#Z$=".F1['!_ID8)6L[2=+L=#TO3=%TN
M#[-IFD:?9Z7IUMYL]P;>QL+>.TLX&GN9)KB8Q6\4:&6XFEGDQOED=RSMHT %
M%%1/-'&\222(CSLR0JS -*ZQO*R1J3N9ECCDD8#)"(3T!P 2TF?\Y_#^?'UK
M\_?B-_P4F_9_\/:_?^ /@CIOQ&_;0^+NFWMEI^I_"S]C_P -6'Q<U'PU/?W>
MOZ9'-\0OB%+KGA[X*?"JQM-9\.7^BZK<?$SXG^$Y=-U)H+>>VWNP7EH/AW_P
M4"_:;MY;CXQ?$[0?V$_AEJMMIDUO\+/V9M1T_P")_P"TH)++5+35?^*N_:3\
M=>%U^'/A%=4M[=M$\1>#_AK\&?$=W:VCW9T'XV7#727-N ?0W[1W[:/[-W[*
MEMIR?&/XE:9IGBG7?-7PI\+?#-EK'C_XT>.YX[>65+3P!\'/ FG>(_B1XSN9
M9E@M-VA^&[FSM9;NW?4+RSAD60^!6/Q4_P""@W[0VMW5K\,/@;X1_8P^#ZW>
MGM:_%K]IZYM/B=\=O%FB3VD5W=W'A#]F?X9^*+/PWX GN?.^RZ?JOQ>^,G_"
M0Z'/'(WB+X,37"2:7'],_!3]D[]GK]GN]U77?A=\--)TSQQXAMX[7Q9\5/$=
MYK'C_P",_C2WA$2V]OXW^,OC[4?$OQ0\86MFEO!#IUGXB\6:E9:5:P6]EI=O
M9V5O;V\?T50!\(?"G_@GM\$O!/C?0/C'\5M9^(7[67[0/AF?[=X:^.'[3_B"
MS^(WB7P)J$MJ;>]N?A!X0M=)T/X5? Z.^+W$ES%\(/ /@R6Z^T/'?W-\L<13
M[NQ_GCW_ )9I:* #_/\ G_/]:*#_ )_K^5)G_P"OCG'IGOS]* %HHHH *\I^
M-'QE\'_ 7P'>?$?QU8^/M0\.:?JF@Z3=0?#7X6_$CXQ^*4G\1:O::)97,7@;
MX3^%?&?C2[TVVN[V*;5]2LM!N+/1M.2XU+4YK:RMYIT]6HH _.R;]NWXB^*S
M?P? _P#X)^_MK_$J2SOYM*_M?Q[X)\!_LP>&/M7V3[397CM^TG\0?AMXZN]!
MNWVP2:QX=^'WB%;&0NMS;+*@A>W>>)/^"G/Q&:S3PQ\,?V2?V8M#N;R.+4-7
M^)GQ!^(?[27Q#L=*FT^3[1<VO@#X>^'?@YX"@UFTU"2'[)'+\9/$&F3K!<"[
MC\HPM/\ H-DC_P"OQ[<\9Z#CCD\<<4V.6*5=T4B2(6D7=&X<;HI#%*N5R-T<
MJLDJD[DD#(PW @ 'YLVO[&'[5WCNW6+]H7_@I;\==5A$4._0/V6_AE\(_P!E
M3PY-<I-;R2SS:JVC_&/XO*D\4=U9?9;/XN65NEM=^8B?VA;6]\FOH?\ P2B_
M8)LO$47C/QI\![+X\>-HS?L_C#]I_P 8^/\ ]IS7)IM2N--GN;ES\=O%'CW3
MH;P+H^DVD%W::?;7%M8Z?;V<,B0>:DOZ)G_/^?Z=,XKY1_:^_:U\%_LB?#?2
MO%NNZ%JGCWQWX]\4VWPX^"GP?\.ZSX4\/^*/B_\ %'4=*U?7+#P?I'B'QUK?
MAOP1X8M+70M U[Q-XF\6>+_$.C^'O#'A;0=8U6[NI[F"STS4 #Z-\-^%O"_@
MK1[?0?"7AW0?">@6";;31O#FD:=H6CV40R2MOI^F6]I96Z EF(BA1>I(!)S\
MG_%O_@H%^RW\(_%ES\,W\=ZA\5OC5"NLI#\!/V?/"7BCX]?&B2]T/2;C6;JQ
MU/P+\+M*\27W@P36MO)#:ZQ\0I?"/AJ2_P 6$FMPW68Q\2^.-$UGXR:#XE\8
M?\%%/V[_ (<? [X.0:3J=YX@_90_9<^-%M\+/!OAWPKJ4$-G_9_QW_:;CUC1
M?C3\5+A+*Z*:T/ J? ?X=R7&JOI%SX<\7:?;6NLZIWOPF_;W_P""8/PMT#Q%
MX/\ V0;*'QS%IEW%+J/@O]C#]F3XI_$NY\5ZTD,%L;U-2^$WPSO_  ]XNUJ6
MTS-=>(=1\1W=Q>I;W<MSJUQ<1S9 /2C\2/\ @HO^T T,?PJ^"OP]_8C\#OJ]
MW'-\0/VJ;VQ^-GQGO]&T^^\N&?0OV=/@GXWL? ^C1^);$_:+#5?&7[1\&M^'
MW4KJ_P .+MBD+,F_X)S67Q9TZX@_;1_:8_:&_:X75-+GTK7/ E[XL7]G[X!W
M5I<SP336:_!C]GE/A];>(=,D:QTZ8VGQ7\5?%*>.]M&NH;^!9GMUI:!^W1^T
MM\3-2.G_  C_ ."8'[6=M8)>7%A<>,_VC?%'P#_9S\)6D\=K?36]X^EZE\4/
M&_Q8U#2)[BWM+5K[0_A9JDD+7Z2FT:.";'FOQQ^-O_!0GP)X,C\=?&?XM?\
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M-I96.DPV-M:01I^EL444$4<4,:10Q(L<442A(XHXU"I'&B *B(H"HB@*H&%
M'% &5?>'/#VIZOHFOZEH6C:AKOADZBWAO6K[3+*[U;P^VL6HL=7;0]2G@DO=
M);5;$+9ZB;":W-[:*MO<^;" E;./\_I2$D=,?B<?Y]_3K@]*7_/Z_A_GIF@
MHI,_A]>/K^G/\\4O^>F* "BDR<GT'L1_^L=?\\E: "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MNL^"?!6MS_%+XT:+'/96T$UA\=/BMXV\*ZK%'<2+X$T>'4KW3S+XC_X+1?\
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M+U)M \:>*?VI_P!G/]GOX)VWB*RU37=&32/%'B/XH^/[?XO"P^V^'KR2;7?
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M[;4)O"/Q.\%^'/'GAF2_LV+V=\^A>*--U33&O+5B6M[DVOGPDL8W7)S\K_\
M#TK_ ()H8)_X>#?L5C'!)_:>^"X ]/\ F=!UXQSSD8YIH_X*F?\ !,\AB/\
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MQ+\3?BE\5+Q_A7HS_"N#POJ'AJ__ &>O#.I_$+XK0 > /'/Q'\,^%;)/#%N
M?V&?#WX7?\$_?C#_ ,)G;?#KX-?LM^-5^$WQ'\2_!+QG%I7P@^'-Q'X.^)O@
MF&Q?Q3\/[D3>%HXX-;\/P7EB=1T^T\Q;:.2(9.TA/7(OV:/V889KB]@_9_\
M@/%/=6,NB75W#\*?A]'-<Z9<BXTZ;1[B=-!$DUA<K<W=A)82,]O,MQ<VK1,)
M9$;^9CP+^PG\??V8?B[\0OBKX$_80\?^*D^%7_!<WXD?MC+'\+/%WPSTG6?C
M[^R]\:?@5\6?ASX.UKX>1>+_ (FZ5;ZIX@^!^O?$AYO$?@SQHWPVT6;3+V_;
M0-6UC5M3\17]MC?L[_\ !)3]K?Q!X9^"EM\7_AIJWPR\>?#3]C;_ (*%:M\,
M]0U#XVS^*_!WP;_;5^*_[:GC#XI_LJ>(M7DTGQ7?:WK?B/X8>"/%;>+?!^OZ
M;#K>B>#=96\UN/4[SQ*ZV[ '].=S^R7^REJ4C7-]^S-^SWJ$S/*SW%U\&?AO
M=2222RM).S2R^&W=I))VD>8D[GF9V<%FR:C_ +'_ .R%&,R?LN?LWH%5GS)\
M$OAB-J1[=SY;PR,)&-I9NBY!)'4_A3_P0:_8N_:K_9D^)OQN\2_&'X4?$_\
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M0^,/#?C%/B'I]\/B#+XX\=1'X96OC[0OVAO[5LO#'CEH]-@O!* ?T:+^R?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?@YX+^$GCGQ%X)\#_"_X?^/?$.M?&+Q':7WC'Q1HDO@?5=/\->"?$MVMTED
M?N]17X21_P#!7_XS:[\/="U3P=^Q!K+?$C0OA9^T7\9_C7X<^)OQ,USX.>$_
M#/PV_95USX:67Q"\7_"76/&OP?@\;?&#P]\2]-^(UJWP-UJ;X=^!M/UK6+&^
ML?&TW@VWTW4;N'VB]_X*;^.[B'XT_&7P=^RGJOBG]B_X"66KM\1/CM<_%_P7
MX9^(%D?#/[/MI^T'XF\4:7\%-5L6FU;P'IEAKGACX>+<+XWM/'5WXWU*[N;'
MP%>^$K"3Q P!^N=%?F_^PK^WOXB_:^USQWX8\6_L]>./@[J/A;POX.\=Z#XH
M6P^(OB'X3>+O#OC.XU>V/AO3/B9XO^%'PKTNZ^*7@>;2[5?'_A31;+7- @@U
M[1]3\%>,O&^B_;]3LO(XO^"I6NO\9==T=OV<+C_AFRU_:N^*'[#?ASXY+\5-
M)B\8ZW^TK\*?!/BWQ'K-EJ'P=U#POI[:3\,=;\6^!_$/PM\+>,].\=^)-=O_
M !9%:ZIJ?@O1?"=S%K<@!^OE%?&'[(?[4GCO]HO]E+1/VI_B1\"KGX%Z=XU\
M-7_Q-\!?#^Y^)/A/QGXFU+X0WNB0^)_ OB+Q1J_E^%?!W@WQ9XFT"=+G4O"U
M[XAO-'\+R- =5\9*DEZ-,_,;P3_P7,O_ !-\/?'6LS?LQZ7KWQ$MM;_96T;X
M3>'?A-\?-$^(_P -?'MW^V/\5M8^#7PKTC5_C5/X%\*^$K/5_"'C/2X4^,.L
M?#6#XN?##PQ:7\=OX9^)7C/7+>?1P ?T$45^+-]_P66\(> O#7Q-3XU_ 'QI
MX)^*?PGT;]H?2-9^'GA7QMX*\=6?C?XY?L[:]\)-.U3X(?";Q'/<^%;WQGKO
MQ!T#X\_";QG\/M5O?#'AX76BZ]K-EK^EZ#K_ (7U'29/L[]L/]L.\_9'_9Y\
M)_&>[^"WBSXB^-?'?Q%^!GP>\*_!?1?$OA+0O$%W\4?C]XU\/?#SPCX8U#Q7
MK-]_PB>FVVG^+?$ME8Z[KAO+C3K6UANM0@:YMXE+@'VQ_G_/_P!;\*/7]/\
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MBW5\ ?:0.?Z=CT'4=>_?!]O4R1_GO_GZ^V2<#\!/&/\ P6CF\-:IHWQ7\6?
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MK;5'@U3B/BY^Q)^U#XI_9F^'NI:;\#/VMO&$;?&C]J#Q]\.?@=XJ\"_#C1O
MFAW_ ,6/AYX"T+X8V7B#]G'P'^U5X'\;?LR>#;SQKIWQ(\1?"#QCX6^.5]XL
M_9,\2^/O$'C/Q1X6T"TU^30]( /Z>V_8Q_97E\(:CX"F^!7@";PEJVF?'K1M
M3TB?26F2_P!-_:BUQ_$O[0EK<W<LS7\R_%S7RNK^-)&NS+J=_!:7'F1M969A
M^9="^$7_  2\^*W[9'AGXA:#\//@EXQ_:\T?X5ZWXH\*>*--TV35]0;P%\)?
M%Z?L]:SXQMGL9+CP1<>+_AAXMMF^#,7BO4H#\3_",%G/X0TK4+/P[;O;K[U^
MR?\ &6Y\=:5XK^"OB3X?^.O _P 2/V9=#^"?P[^*TNNZO?\ C?P7J?CGQ5\#
M_ OQ#U/3_AY\8-4UO6=?^*D/A-/$D6@>)O%'BAM/\77&N0'4==MII-5MM1O?
MYGOA9_P2F^(?BO3_ !SX0\;_ +(OB/PYHOP4_9!_X*@>!?AF3XAUCPW)J?[5
MGC3]M'4?BC^S9XV\&^(;/QO8:]XS7Q9\']0\(>)_"/B_5[N[TK0?%UCXABOY
M-!\96>J>< ?TX^*_V&OV0O''P^T/X5^+/V>OAEKOP_\ #/P@M_@'X=\,WWA^
M)[+0O@_::WX*\36'@;298W2\L-*T[Q+\./ OB/3)K:YBU'3=?\*Z/K5C>V^I
MVBW1QO ?_!/S]BOX9Z!H?AGP'^S?\,O#>D>';;XMV^FQ6.CR/>F3X]:'HOAG
MXT:KJ>K75U<:OKOB'XH:!X=T/2O&OB?7+_4?$6OV>G6T=]JDN&+?SQ_";]E/
M_@H[-^W%\+?BK^T98?M%:[\3=8^)_P"S_P#$+2?B/X \/>&)_"7@W]F[PY^S
M3X<\,?$?X.>.OC9=?'KPSX8^'5A;_$W5OB+I?Q0^#FA?!WQ5XP^)_C/5+;XH
M^ -2UE3)XP\/?97_  36_87^-_[)'QP_9:\1V/@3XI^$/#?C[]ASXEZ;^VSK
M/Q*^)W_"Q]2\3_M(Z7\6_A[K/PM_X2J]/Q3\8Q:GX_TCP]J_Q#T[0M>TW2;_
M $'3_AX;OPYIWB:TFCCTH 'WS\2/@U_P3'N%A^ WCKP7\ ;>Y\:W'P-_8\/@
MS3(;2PUP:E\,O!OB3XP_LY_!>]U#PI+!KG@_7_ W@S3]<^(/PCMKK4M"UW0-
M.%MK'A6]MC>Z:]Q[C\,?V'?V1?@UX;\.^$_AE\ /ASX3T+PO\-_B)\(M%@L]
M'^V74?PY^+VOZ5XL^*OAJ_U75)K_ %;7(/B1XGT+2?$OCJ^UR]U+5/%>NV4>
MKZ[?WU\TUP_XA?&K_@FG<_%?]O?XL2^+/V:-:\7?"7XR?\%*OV5OVD_B-XXA
MU36=,\(^(?@9X%_X)X?&3X7M'?:U!XMT?4&U7PK^TC 8?$OA?0;57DTGQQX8
M:\_M7P_JMY8:9\D_'/\ 8(_;WU/1=/\ #'BKP3\>O$/PU\#^"/CK\*_V(K3X
M27$?Q/\ B]^S3XHTC]KOXMM\'O%MOK_B']J/X.6'P_U[7/V9U^!%OX"^,'C;
M6?BAX=\)>%_ >J>&?&&D>#]6FMM.\;@']4?PH_9>^ GP-\6^)/''PE^&VB^
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M4NO&[WOB;QWXC\3_ !:/ABY\(ZSK6M>);S5_ _CNTUKPYJ/A+6?#>K3Z'?\
M]IR2O)!JIUMU /U6^%W_  3Z_8A^'/AZ*U^%?P.\(Z-X:UCX<?%3X>P-I&N>
M*=0L=1^&W[0NH:#XE^*^BPW-WXDO1<Z5\1]8\/Z+XDU>\25[FZUI;G7+2[AU
M+5=4N[WX'?\ X(M>';G]LCX1?M KXJ^"GA7X5_ GXU^%/C-\/?!/PV^ VN>
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M2\2:G;PW$EK;W^J7$5KBV2)5_ RW^"/[;2>$?%'Q]_:-3]L;6O'+?M;?LY>
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M-K\+6\5V7P_TSQYX_L_&VIPRZBEAMN?&^OS>)M-L$\9:G+J=QX;XO_X);?\
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MGA?]O.Y_:3\8^!+[]LS]O_P]\*O 7_!27X?_ +%7PVU":R^&U]%XF_9BU?\
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MX.TWX[?$KPI\=_BOX"L[/3OAQX)_8O\ B]XM_:,^)-_\.]$TW5_BQX E\4?
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M?V2/@9\*-4\'_"GQ9<:?\1;WP_X+_9Z_9L^#7PQL?"/Q+\<^)-=\+:QX]M?
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MHYGT+PEXJU_Q5<:5HE_VO[*/_!,[X7?LE_%?PI\8/"/Q%^(_BSQ5H7[-VO\
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MA?J'AWPKI&C>(?#_ (O\+MH&H:-+>7&J70\._$--<TCQAH-A:^!]874?I/\
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M\8QRW4,VDZQ\!_B1XE\0?$'P1JVEQ/<S:EK-]8WO[EK:>U^+9_\ @BQ<^)?
MNL?#'XD?M5:QXR\"^ ?V,?CE^PY^R'ID7P=\,:-?_ +X5_':XT"VUKQ)XZU
M^)]27X]>/_#GA/P#\+O!7AS4-6M?!/AN'3?!<^MW?ABX\7^(K[Q#  ?3$O\
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MGOV1?@-\;?'/P0\7W^LV>J_![]H7X&_ 'XV^+-5-CH?@SX<2_M ?![QC\6_
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M[1\/7>G7%I)9W.AZAD_;=)FA>PNO^6]O)0!^*?PC_P""B/Q4NO\ @DO^TO\
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MZ+XO\10W4-[#KWBC2VT@V.OZU%>6\%W'JNJP7=\EU#%<+<":-' !_+-\0/\
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M 3 ]Q^/^<9[XP3WI:** $Q[G]/?V_P#UXY[Y7'^?\_RZ9YHHH ,#_/\ G_\
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M\(ZEX3O+TVOGSVZ@']9N?\X/<D#^7]>E&?3GIG!]^3W''7&<X]\9_C5^&/\
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MR]TSQ5X=TVZOM(O;D03I%UUA_P %$/V.M7^'WCKXH:1\9M.U3P;\./ OP_\
MB3XKOK/PSXVDU"U\%?%'6]7\*^!M;T_0&\-IK^O1ZQXR\.^)? MQ::%IFHW^
MA^/?#'B;P/X@M=*\5^'M8TBS /M6BOE'X]_MN?LS_LR:]'X9^,_Q!O\ PWK*
M^"KSXEZQ;:-\/?B;X^@\&?#+3KV[TW4/B7\1]0^'G@[Q7IOPS^'-EJ%A?V=S
MXZ\?W?AOPM%<6-]$VJAK*Y\KQ3X(_MRZI\=_VT?VK/@/X3\(Z&GP,_97^'WP
MOO=1^*@A^)E_XF^(_P 0_B?X6TGXC6B^"K6/X>VWP^U#X=Z5X"U>QFMM7T/Q
MQXH\0>+=1O\ 3]1\,Z/=^')Y-0B /T9HK\6?A[_P7-_9)\21?##Q#\0[+QQ\
M%_AU\6/V=++]H70?&OC7PAXZO9=$TK_A>OB[X$:[:^/?#'A[P1J6L?#SP9X?
MU[P[H^J77QC\;?V#\,9++Q=HT$NNV<LD+W7WIX7_ &X/V9?&7QNN/V>O#OC_
M %2\^)L/BCQSX%@@N?AO\4M)\#ZOX^^&5F=2^(?P^\-_%K5_!5C\)_%7C_P7
MIJRZGXC\$^&_&VJ^*-+TVWO;^YTI+2PO9H #ZRHKY6\9_MJ?LX^ ?C7H_P"S
MUXE\:ZW%\4=8UGP+X;DL-'^&7Q5\4>%/#7B/XGO=1_#;P_X_^)GA?P3K'PS^
M&VM^/Y;.XC\&:5\0/%WAF^\2R(B:1#=O- LOQE^R3_P6>_9 _:.^ ^N?%OQO
MXTT_X&>)_A]\/_%GQ/\ BQ\/_%UCX[V^%/!7A+XE:Q\,+_7_  EXKU?P'X:T
MGXQ:?!XELM(T+4YOA/%XM;1O&'B70_!-\B^)-4TNQOP#]=J*^0?A!^WK^R5\
M=I? ]G\,_C!I^JZS\0]1\>Z)X:\+ZYX9\<>!?&J>)/ACX:\/>-/''A'Q+X(\
M>>&?#/B[P/XTT3P5XJT'QJ/!GC71?#_BG4_!M^OBS1])U#P];W>HP9?AS_@H
MA^QCXN\2?"SPIX:^._AW6M8^-&A^#O$7P^:QT;QA+H]_I_Q%C\WX=P:_XE_X
M1P>&_ FM?$!2@\#>&O'FK>&O$?B^26"'P]I6HS7$$<@!]I45\7_&K]MSX0?L
MX?%+Q/X9^.OCGX7?#7X<^&?@UX)^)MWXNUWQ[*?'7]L>./BMJGPKT/08_A59
M^'+K5=0T37=;ATG2_#/B+1]7U&_UKQ;>W'A2'PTMREI=W?R7\1_^"R'[/ND_
M&/\ 9.^&'PEGT'X@>'OVAC\=?$WQ"^*'C;6/&GP;\)_ +X7_ +->E:?J_P 8
M=>\9KXK^&-U<6WC7P[:7=W,W@'Q<_@*XL(=+:Y\2ZOH%IK'AZYU0 _82BOSW
M7_@JQ_P3T/PRUWXP2_M2_#^T\ >&=?\ "7AC6]3U"U\5:;JUGK?Q!TG7]<^'
M5L/!^H>'K;QE=0?$G2?"OB*]^&^H6>@7&F_$"/1[U?!UWKDD80TO&G_!6K_@
MG-\.]:UCPYXQ_:N^'>CZ_H4^H65_HPMO%>H:D^KZ''Y_BSP[IEGI?AV]GUWQ
M7X M0U[\3?">B)J/B7X86"2:A\0M*\,V<;S* ?HK17QKXF_X*%?L5>$/B/\
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MKK7@/7;2YB-C^A^/\_7_ #^':EQGKS_G_/7_  H ^"_V4_V0/B'\'_B3X_\
MV@?VB_CW8?M*?M(>/OAS\.O@K??$?P[\*(_@5X7M?A+\*]:\:^*/">B1_#:R
M\?\ Q$TZ3Q7<^*OB-XPU?Q/XOBUNUBU=;G2-/T[P_H-II+QWWS/:?\$C]+T[
MX<?M-_#^Q^/_ (B1_P!HK]C+2OV18->N/!<5Q=_#_P#LWXC?M(_$F3XCZ5;_
M /"8(=1N-3UC]H>Z&I>$X[K2-.OIO"=I=7>HSKJ1MM._8S'^??\ S_CUS10!
M^,L__!*?XBV?A+]H/X)^%/VQ]9\*?LR_'?7OVA/']]\);+X*^'KKQ%_PLC]I
M5]>N_']QXV^)<OC5+SQC\.H=;\2ZKXKTCP-H7AGX?Z]'XEFMY;[X@7VB6JZ&
M_.:W_P $;AXUUZ[\%_$']HF?Q+^RE9_%S]L/XU^&/@K;?#.[T;XB1>*OVV_A
MQ\9?A[\5/#GB[XVV_P 3KB/7/ GAQOCEXXUWP%I_AGX<>!O$>FRWEII>K^*=
M8MM,M[F3]O/4'^G3L3[<$>_<<T9]CT_PY]?Z^HR10!^%?CC_ ((Y^.?CCH'B
MY?VD?VK/#'Q;\87WPL_9-^&G@[R?V:H/#GPDL$_9$^*7C?XH^%-1^(WPDO\
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M2?M':U9_$O1-4>#P?X%\'^#M,U>PTS5=6UCQC/X>TC^@#'^?\_R_'K1C_/\
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M[Q#H?P_UC1-#T^^OM0O--U[Q)=/]MM-,N]5:_P#WMHQ0!^4'P\_8%^)VB?\
M!/OX[?L9>+O&GP]O?$NN_%']I7Q[\!?'VGP>+KS1_#4WC[]H+Q?^TI\ =;\>
M:,\NAZ@^K_"WX@>(-"BUO0/#FHR:'?:3X0L+:PO98+R>UC^ 8O\ @@QX_C\#
M_MF6.I?M%Z/XN\9?M-?L>_$#X5^%8_$>C:LGA#P!^UC^U!X-\)Z5^VW^T;90
MV,8O+33/CQXI^''@#68]!DL_$.OZ/:6WB.W@\16D7B'4[2\_I=HQ_3]/;I^/
M^ H _%WX)_\ !.+XL^!?VLK/XN^,]7^#^J_"WP+^U9^V=\?/ ]OIY\73>-=:
M\/?M@_"#P)X6N]*UW1)K"Q\-:/XD\$>+M%\5:.]Q_:WB72/$?@/5K&[CLM%\
M11O%!/J'_!.[XZZ7_P $T_V1/V3O"'C+X*7WQV_9 ^(O[+7Q.\,ZMXDT[QCI
M_P $?&6I_LR?%[0?'VG^'=7BL;/5_&FC:-XC\/Z&-'FU"PL;V]T[5)5O(;22
MR46Y_9NDQ_+'M^7^'^% '\ZWQB_X(K?$WXS_ +/7A#X-ZK\8?!/A;Q+IGQ3_
M ."J/C[6O'>@Z?K%_<"S_;[NOCCJ/@FRBCN-*TJ\UB^\(W7Q'\'Z?X[O[VXL
M;G4=(\-ZI;Z)<_:+K3+S3OM;]A[]C3XI_ Z']ISQC\:[3P+I/CCXW^'OASX)
MC_X0KXY?M#_M"ZG)X9^%?@KQ'H&GZGX@^(?Q]N]&B!GU+Q=K8\)>$/"OPS\+
M1^"_#-O8Z+KWBOXB71AU+2_U4I,#TX   [<=/R[>G;O0!_*Q^SI_P2Z_:G_:
M)^ '[+/C/XQ>%?@/^S<?A5^SI^Q]\)?!OP-TG3/%AO/&'@[X0?MC?!C]J7QE
MJO[2^C:AX'T:_P!$\<7?A[X.6.D>%?A]H/B7QAX>TGQYXY^(7BO6/$VWQ.UC
MIOWCXB_X)Y?'&X^-?B-Y+OX#:-^S4O[=VF_\%%HO''@9?'VG?M8:GX\\(^#=
M(M-*^$DNC1Z(G@4:?J6N:1_PCNI?$B/QM=WUU\&7F^%L'PVAO=5_X3#3?VWI
M,=/;_/\ G\NF10!_*Y9?\$K?VPOVJ_V6?V<M3^("?!/]FKQU\"/V5/V>/"WP
M>^'O@#4?BYHVI?$;7/ GQ)^'WQMU[P)^TUJG]@?#;Q'\)=&U.\^&_ACPL/#7
MP^T_X@R^"/&>I>(_B19>(=571](\'7_VU^Q__P $M/'7P@^/_P %/VAOBM;_
M  9?5O!=]^V1X[\4^'--\9?&+XZ>*[7XK_M&7'[.>A^#_&5K\9?C;%'K'C/Q
M?I?P_P#@SX@TGQ]XYM/"'PI6_N=>TG3]!\&I;6^MZQK/[DX'_P!;M_GM[C@Y
MHQUY(S_/&,__ *\CCI0!^,W[<G_!-KXE?M/_ !!_:<\<^%O%'PZT^U^+'P0_
M8?\ "_@?1]:N?$?AO63\1_V0OVK/B!^T5J=MXF\8^'-$U/4/#_A#Q]I&N^&O
M"MEKVDV?BC5="U:P_MR[\*ZK9:#9Z1K7Q-\3/^",O[0WB"ST'XF^%Y?AE!\7
M-<\1_M>)\1?AM;?M6_M+:!X8;2OVJO#_ ,&_!UOXQU3X^ZI\/O&WC#XB^)/#
MGASX&^&-$^)/AG3_ (-_"/PM\0/"OB3Q-9^'8O"OBC1[/Q)XH_IS_P _Y_.D
M. ...G3OT'ZC SV_"@#\!?@M_P $SOVE_@A^UG\'/&/@)?V>_ WP3\+GX":Y
M\4=5\+^+?B5XGL?&%O\ !/\ 9EN_V?H?!&E?LZ?&?PS\3Y_#WQ)26[MH/"7[
M5/A+]I?P?XR@^%NB:'X/\=^"/&E[I^I/XG[[_@H-_P $S?'O[7?Q'_:"\;>'
M-,^"4[?$OX%_L7?"7PG<?$W39=7N;>X^ O[:1_:(^+"ZN3X<UD6?ACQ9\/)+
M3PWIVBV<5['XD\0:8]OKTVAZ:8+Z7]<?$_QB^&'@OXA?#;X4>*O&N@Z'\2/C
M#:^-[SX7^"[Z\6+7_'</PXTW3=9\=?\ ",Z< UQJ\OAG1]8L-5U:"T26:WTV
M22_:/[+;7,L4O@/XN_##XH>&/#7C7X=>/?"OC7PCXQTZZU?POXA\-ZS9ZKI.
MN:78W%[:WNH:?>6LDL,UG:7>GWUK/<AA%%=6D]LS+-"Z$ _ +XG_ /!*S]JK
M3]2^(:_!ZV^!-SX&\<?M0?MS_%#0_ EIXE\.?";4/!G@;]J[X=_![P;H4%E\
M1-2_9=^.?B;P?HTNM>"_B=JWQD^'WP=M_ MYXZLOB%H]Y/X[U*\TW4="3COV
M9/V /%GA[]N3]C[X:>*[#3KWPC^RK^RG^S?\8_VQ[+PKX>^(T_PHUO\ X* ?
ML]?!^3]FG]F'X@>$_BMX^TO1W\?ZKK7P6\7^-]8US2M%-SJ>C+\(?AKJGQ,C
MAU;4/#B7']-<][9VKV\=U=VMO)>2BWM(YYXH7NIR,B"W61U:>4@Y$<89R#D+
MWKSY?C#\+S\1]=^$7_";Z OQ(\->!=$^)>O^%'NQ%J&D>!/$GB+7_">B>)+V
M215LH;#4?$GA;7](A#77VA;S39EE@1'A>0 _,7X_?L>?M&2?M7_%;XX_!SX8
M?LB_'/3_ -I/X>?LM_#KQ;K7[6,VN2Q_ -/V;OB/XI\;C4O"GPW\*?#O5I?B
MSH&OR>)!XRT70+KXG?#?5_#'Q@T3P]X@&OWVB6-G!HOYWW__  2#_;D^(]WK
MK_$+Q#^SGI&H:?\ LU_M'?!#3M7T[6DD\$^-O$7Q _:,^#?[3GP_OM%^"G@7
MX ?#3PA\'?A3=>,/AK?>'?%GA::^^*?C%;;7;[Q9KGB3Q[XC6276OW[_ &E/
MVQ?V;OV0_#^@^)/VA?B7:^!K'Q5=W5GX8L+'PUXS\=^*/$?]FV\=YK5YH7@G
MX=>'/%OC+5M&\,Z?-%JGB[7;'0I]$\(Z1+'J_B:_TK3)%NC[EX/\;>#OB!X:
M\.^,O GBKP]XR\)>+?#^D>*_"WB?POK.GZ]H/B/PQKULM[HGB'1-6TVXN;+5
M-%U:S=+K3M4LYYK.]A82V\TBG- '\Z'Q0_X)T_ML_%OXB_M'_M.>)O@]\#?#
M?Q>^,/QR^#'Q%\ >%/AC^U9XMTWQG\*]+^'/[(/BG]G37M2M?B[XJ_9MU/X=
M^+IO%6I7Z>&O&7PT\>? KQ7\-_'_ ,'O%&J6^I66C^+/#MD^L\5K/_!&K]I'
M5OBU%J?Q"\.?L_\ QBT'XD:I^P=XL^('C'PK\8_BY^S/X(^&_BW]D[X<^ _
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M[37BGQ+X!E\3:?H6H>!/%?QZG_9_N]-\+7'BS1-0TS59O#7A/3_ZB?B3\1/
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M3\3?#'XK?#SQ-)Y]KH.I> -3^%5^NJV<MI);>*M&UV[\*ZY#JGAC5M:TN?\
M*/X4?\$'/'OAOXR?#WQ7\9?BOX,^-W@^+X(^"/A%XXU*ZU;QUX/\0_#[P_8_
M /XN_"'XK?#C]G[PC9:9JUAX9^%_Q4\7_$^X^+EUH\OCW0]"L/$&I>*[74_
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MXYUGQ%XO\2Z@8U N-6\0ZYJFIW3 /<WDK<UV5 !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 ?Y_S_6@ #I_GO_,D
M_4T44 )CZ_\ ZO\ /U_$9I?U^OM110 F/\_Y_+V'3%+110 F!T[>G^?Y=J,=
M??C_ #GC_'O2T4 '^?\ /_U^:*** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
:**** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>ex3-4_pg3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex3-4_pg3.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" 0A R<# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH **** "BBB@ HHHH ****  C/^?\ /Z8/O28SW_0=/3\N"?3.,$YI:* #
M'^>E&/YY_P _Y_7FBB@ _P _Y_6@<444 %%%% !1110 4?Y_S_GU]:** $Q_
M3Z\?2C _S_3TZ#@4M% !1110 4444 %%%% !1110 4444 %%%% !C/\ G_/Y
M]?UHQT]OY?Y_E110 8HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J*::*W
MBDGGD2*&)'EEE=@J)&@W,['H%"@DG/ J6C&?YT %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 ?Y_P _Y[T444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%(3C_\ 7_G\/UQ0 M%&?P_ST^O^1FC/\\?Y
M_KZ<^E !129]N/7C_./?\LCFE_SS0 44F?\ /\^V./J?SXHS[8_S_3J>WH30
M M%%% !1110 44?Y_P _Y_I29^O^?\._Y=>* %HH_P \_P"?\_2B@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ,_P"?\\^F?K7X+_\
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MQ \6:?XCT+6(X)KCXCZW=:O;R>']9M[#3H)&@?33%J#W=]KDEY9SZ9ZY?_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ (_SZC_/^>H)C_//^/_ZZ** $Q_7H/_U^^?7-*>?IW_S_
M #ZYHHH 3 [\^G'0>GTZ_GCIQ1C_ .MCC'^>,@\<=*6B@! /\]/R]![?GGFE
MQU]_3(_KP?<444 )@<>WZ]>OYFC X[XZ9I:* $QGKS_^O/\ ACOQG.:,?Y_S
M_G'%+10 F/\ Z_ YSU_$\Y^I_!<?3\O\^U%% "$9[^OTY&.>Y_/KSZ86BB@
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MI>*;%H-#@O[JTN],U_Q-'X?TK6]%N[?7-)N;O2Y!=5_,/^SM\4K[X??M-_\
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M76[+7(8M=U1;?3]7U6#55>YN9K?4 /G/Q=X0\:_M(?\ !PO_ ,%3_AE^S?\
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M[_2[\>(++1OAI\/M.\36\&G/++_:UKI<UU'8:[%'#/#8R7$=IJ B>=$/]75
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MXDD?=%%-N!5'Q_%S^P#\%?A1K/[0'_!VMX?UCX5_##4_"-AXK\2^'K+P_>^
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MZ2X9KB21_P"8G]DBUL/V[/\ @X*_X*8>'_VN_"NE>-_"'[ /@CX9_#S]C_\
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MXWCM+W7O &LZ+<^'?"^F:CXTN=.B\5Z=HVC>)/&=G::C->);8O\ P4=\ ?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M):3X@\37UMH:^'O#UO:#[+I%I!'^:_\ P39T"']K[36^(_@G]HO]O;P]X/\
MAS\']._9M^-.A?%_XY?M+I?_ !M\4_&/]F']GKXR6?[0/@31?C%JEAXJ^$/C
M;P5KWCG5AX#^(_@>QTO2_%.E:C=:QX?A;1)](NF_/7]@[]IS]H;P;\)_^"IO
M_!+#]H3]H3XV_%#_ (*._#?]IVV^#?[./CWXB?'3XD:5\1?''@OX\66DZ#\
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MN>+O 6L^'#HEG+<^-EAUZXDC /ZQ? __  2N_9<\*^(/@)K'BBY^,/QNTO\
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M&'AK3?#F@V_AGQ9HNM: ND:>VG-:Q_8= !1110 4444 %%%% !1110 4444
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M>%]'\>?#37]'^*'A&X\0^&=7\*^(]+\0:=I&M6IGO(VMKA=?ABNS##^PUO\
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M9>#O&W@KPMXFU6S\!^// U[K%I9:W>6/Q'\*6NF>)-*T^\M8[R)M42T*,X%
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M!T[PEX9\.?$;X;Z7\1M#O/#WB&/P[HNE0G78?$/B&.POK30[W3;&&3P3X/\
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MPQ^T-^TO\1OV>O!\'@?]I'PG\2[W]E/X7>(YOV<?%[VFH^/_ (>Z]KNE:O\
M#C2_&GQ=NO%?Q#^+?B<VVK>(?B%9'Q)JBZR?&4HT*/5M=_2_QQ^PKX=_;Y\5
M?\%4?V?OVM/V<?B/X4^!O[1_C/X->+O@[\5O$/\ PK66:+Q%\._@#X+^#_\
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M)U?Q]X*U3X&S:]\8_P!GW0_&?B'QSX7\%^/],\1_!+7/"EGJ_@75O%OBFV\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MTS\5;%;WQ !IG@[P6-)TW0?$>DQ>*_ ?XS^']4_X*%_\%./V[_B;X9^--O\
M#WX*> _V7_V+_@%#IW[/?QQU[Q3XI^&%MJ^J>-?B9XZ\ >#-#\ :GXJ^(7AW
MQ3^T)\1)/#S:YX*T?5K&PT+X<#Q+KTUMX<CM]4A /WUHHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&7B7Q'X_U+1+#3-&^&OA631KK4_$&K>)M3'A&  _=+/7V^GY]?Y^AHS['O\
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M#O#7B>UFT/3;P^)M2\*7>I>.O#VC:3\29-)TCPMJ_BV:]\-^'CKO]F:CJ5L
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M>M:RGCZP\"Z_:2Z5I_I'P)_X*S:!X8\(_L0>&+GX8?M2_&/QE_P4)^$_Q_\
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M-=\0W&A:1K(!^S%&><?Y_P _Y'0X_*+XB_\ !6/X:^$M3\/W?@OX(?&;XO\
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ML2_#WQCIOBC5]=;0/B%X/O\ P_KEC;>)=32XNVOK/POK7A;[NHQ_G_/^>QH
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M \+Z+XK\9R^&?%?C7QKKWPPTWXD>*?%ND_#>^\4ZA=>'K%-0L?#]_HOZ;44
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MO=%OM!TW1_%.@6WB.7R+QO\ \$<O@IXMM_VCO"6E?$;QSX$^#OQS_8$^%_\
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M/)=:@ ?H9GG'^>/\\>N#Z4O^?\G K\=?A!_P4[^*/Q>_9SU/XOZ)^S1X)O\
MXD^,/VNOB/\ LG_LU_!OPW^T->:__P +QO?A+\3=>^&?Q$^)%[XU/P3L(_ ?
M@GPJ/ WQ(^(>HWL_AOQ#!#\-O!W]LWEW8:IK>EZ++^N^BRZQ-H^E2^(;/3M/
MU^73;&37+#1M2NM8T>QUB2UB?4[/2M7OM*T&]U73;:]::"QU*[T/1KJ^MDBN
M;C2M.ED>SA -.BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/XH6D?A'Q!:^(_"EA-\+]"M]<O?$GC"/PQ^I..?PQ_GU_'/MCG*^G^?\CVH
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MTZ2QMY 4EG4C%=KGV)STQ],\],=Q^62,XH 6BC_/^?\ /8YHS_GT]S[?Y]:
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M_P"O''?_ #Q]: %HIN[&,X!8X49^\<%L#C^Z"W&> 3QBG4 %%'^?\\?KWHH
M**/\_P"?UJ-Y8X_+\R1$\UQ%'O=5\R0ABL:9/SNP5B$7+$*Q ^4T 24444 %
M% I,CI_3UZ<].<8ZXSQUH 6BC^??_/'\J* "BC\OS]^?\^OI1_GC_//\_:@
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MW@J^CU7P/XZ>'P3XBT*UU[6O!FKQ)J_AN#Q1;ZYHMAJ<:7ITF:>-'0 _ O\
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M?&[P1X)_:C_:&^%_PO\ AM>_L[_LC?M'?#_]E)],\7/XHU'XJ_M;_'*?XR>
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M_@I9^T5X*^#?[,/Q#TOP?^S3XLT?]K;XE^,_#'P6_:!TWQ=\0(?V:]?T'4O
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M:K?32-HZ:IJ,NG0V\K6367BOA;_@EU^R/\/_ -GSX-_LX?#3PIXC^&W@_P"
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M,_!_PITOX?\ B7XH>)=-GNO'7B:[.O?M2Z;U9=S(64C<APZY&,J>0&'8X(!
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MXM^(/C/0;VY\"3^+?'T<J?#Y8?'WQ4TOX56;:KIF@?8>H_\ !+G]F37OA?\
M%/X;>*6^('B^_P#VA/BS\)/C#^TU\4?%7B/3]<^*?[1^M_!KQEX3\8>%?"7Q
M3\07N@RZ6?A28O!FE>#C\*O!6@^#O NA>!+G6O#G@O1?"T>M:C<W&'\7?^"4
MG[._QG\4?M.^.O$WC'XU:?XX_:>^*G[,/QKU#Q/HWB[PXUW\(?B5^R'8>&[3
MX*^(O@YI>N^#-=\.:2VD7/AJ+4M6L/&FC>.M.U>?5_$-E):Q:/K%UIC 'IO[
M%G[5?Q,_:=N/C"WC/X.Z'X,\*_#[7?"FD^"OBMX \=ZC\0OA+\6;S7-$NM5\
M8:)\/O%6M^"_ 5YXQ_X5+J,=CX6\3_$+PQHNI?"_Q9KM_-;^!_$VI76@>)]/
MT;6^/7[6>J^ OCM\*OV4_@Q\-XOC!^T-\4?!7C/XM7ND:MXJ?P1X!^$WP4\"
M75AH6J?%#XF>*;3P]XOUF&'7O&VMZ'X%^'?A/0/"NJ:MXV\37&J+)>^&]!\.
M:_XBTWW_ .$GPNE^%GARZTG4?B1\3/BUX@U74#JWB'QY\5==TS5?$FMZC]BL
M]/5HM*\+Z'X2\!>$]-CM+&!8?#O@'P9X3\-1W+7>I#1SJFI:G?7GS-\8_P!@
M[PQ\4/VG-,_:R\*_&KXV? OXKW'P)N?V9OB%??";4/ ,-M\2?@D?%^H>/]*\
M,ZA/XV\ ^,]5\&^(O#GC#5=4U+0/B!\.=1\)>,=/M-8U:R356=]*O-' /S4^
M/7QY\*^*/VT_V2_VAOVG_ 5[^SMH?_!.[]@_XG_MR_M*>']5OM/\:Z]\.?B3
M^TLUA\#/@O\  ^Z\3^"GDL/&7B".'PW\?M0T;PQIIG/BSQ5IW@N;2M&.JS6<
M4/T3XG_X*D_%CP%\0/B3X!\:?L1^+H]<\ ?L#_$+_@H!<>#_  ?\6='\9?%3
M2/!/AW7IO#G@/X1?$#P#:>"+*T\-_&?X@ZEI^OJ=$\)>+?B+X>T<>&M?@T?Q
M%XQN],GA/HOQK_X),_ SXXWW[8&J^(/BE\?]%U7]L+2_V6+'7[S0O&N@2-\+
M[_\ 8YU/1/$?P4USX<_V]X0UN6]U&P\7Z'#XI\0I\2Y_B#9:YJ6I^((VM;2U
MU[4X;BOX<_X)6>%/ WQD^)O[27@C]J_]KG3/VA/B\_P5NO'OQ+UOQI\//$J^
M*KKX'6GC*TT/3M<\)7/PPM/#9\!^*8?&EXGBWX8>'K3PUX"LUTO1IOAUH?P_
MU"VN;Z\ ."OO^"J^N:+\$/@K\:-<^"GPYC\,?M,?'SPO\%?V?/B5X?\ VA[S
MQ/\ L[>.--\=_!I?B3\/?B!XE^+UI\$K77_AIIOQ!^("7?[/7AG1/%WPOMM0
MMOBW#'9^+)O"^E7$=[7ZJ_"[Q+XK\9?#/X>>+_'G@2Y^%WCCQ5X'\)^(_&/P
MSO=;LO$MY\//%.N:#8:GK_@:[\1Z=;V>G:]=>$]5NKK0;C6;"UMK+4YK![RU
M@B@F1%_,"\_X(Y_!:3X$V/[+EA\9?C;8_LX:MX2U'P=\5O@Y(?A?=>%/B;;:
M[\>/&O[2'B7Q/"R?#BUU/X9^/-:^)?CG5$C\2?#&_P##$'AKPG9Z'HW@[2/#
MNJ>'] \0Z7^NX4(JJN[:H4#)9FPH !+LQ9B .2Y8MWR3R ?CM\1O^"M%GX8M
M/$7Q8\'? V^\8?LK> ?VS/ 7[#_BGXQWWC=/#WBSQK\5/%7Q3TSX(>+?$'P(
M^&\?A36;7XA?#WX4_%/7+'PGXE\1>(?&W@2?Q)?Z'X_7P7INKV_A.RO/$GF/
MP$\,^(O^"A/[?/[;/Q"_:2\'^"O$'[/G[$/Q8^&'[,W[+7AGPY\4O&NM:=X9
M_:#^$DOA/]H#XM_&F+3X_"G@6&W^(\VK^+OA3X'N_$=O=K=^%+;P#XJ^%MD/
M$?AC7?%NL^)O3_%?[#'@K]FJS^&FN^&_!7[27[6_PZ^%7[2OCGXY?L_?LG^'
MM1^$%KX,^$/QS^,7B?XC_$RZ^+OBG5O$D_P^U?QGX=\#?$OQKX@/@*_\:^)_
M&\_P>F\;Q>+++PWX@U#POI/B7PO]@_L$?LU:U^RI^S+X/^&WC;5]-\3?%KQ!
MXB^(?QE^.WBW2D<V/BGX[?'3Q[XB^+/Q7U2RN9H+:YOM*MO&'B[4M"\.W]U:
M6=U/X9T?1?/LK)U-G" ><_MT?MSZU^R#XH_9U\ ^&/@[9?%'QG^TSK7Q9\'_
M  Y;Q1\2/^%2>![SXG?#WX:7_P 0O!7P>F\=/X'\>65E\2_CO=V%WX0^%&F:
MO8:5I.K:U9:FEQK4=W!8Z;JOR;\2_P#@J-\1/A'^TW^T:?B3\/O#N@_LL_L@
M?LU_L_77Q1\-^$-5U+QY^T1X\_;/_;!UO0O^%)_L]>!]''AW2?">I>)M-M+-
MO#C:+8>)X;&_E^*O@7QSKGBK3-$>ZTC0/LO]H+]@7P=^TQXT\1ZE\4OBM\5-
M9^%7C75?@'K_ (G^ TMQX4G\ 1Z_^S;X['Q*^'6N>"=5N/#,OCGX=:KJ?BQ8
MI/B#?>%O%%I/XMTBUL-+@?1)(KF]O/)?$W_!)GX*>+6_:MO]=^)_QFU'Q#^U
M'^U%\(?VOX]:O-5\(3)\&_C+\!;GP->_"J^^'>E)X/AT_4-$T*7X>^&],U'2
MO'\?C!M8\+6B^'#=V4 ^TD PM?\ ^"H]U\)?&?Q6^$?Q_P#@#+X7^.?@KX:_
MLM^-/ /PH^$?Q5TGXPZE\4?''[77CWXB?"WX7? >SUC4/"GPUTSP]\58?'GP
MZU&#7GN3J/@2Q\%S77Q'_P"$Q/A'0]8OK7X9_P""P?[4>JW'[)FF_!']M/X7
M:-^RIH'Q9_;N_9A^#,_Q&L/C!+XX\-:[\%/#$'A+]J#XZ_%?X9^*-%\%>#?B
M)IMUX9\$^"/'?P;C@F\!:3X@U/QU*EMX*;7QJVFF7]!O'/\ P2D^%7CG3_%?
MBJX^+_QATG]IOQC^T1\&/VI]4_:JLI/ 5[\1(?BS^SYH=]X6^#VGV7@_6_!6
MJ?"J'X4>!?">L^(_#&C?"V3P7-HIT_Q+XBU74+O4/&6M:EXKNNV^*O\ P31^
M#WQ\M="3X^_$;XS_ !FU'1?@I^U9\%FU'QKKO@UX[^#]L31="\*_%'QTNC:-
MX$TG0]!\9:'X*T+_ (0;X:Q^$]/T#PEX+\*:SXBLX?"U]?ZYJ.J3@'U)^SQX
MV^-WQ!^&^G>*_CW\%O#?P"\9ZK<3SVOPWT#XL/\ &"ZTC0&6(Z7)XG\2)\/O
MA[IEAXFN5,CZAH&C6_B+3M+4P1+XEU"Y:YBM?E?QI^WAXGTS]N1_V*/ ?P&7
MQCKF@^&?@?X_\9:[X@^*>F?#_P 37/PM^+_BOQEX7\2_%GX2> -2\)ZK%\6_
MA]\"KCPI96GQ?O[7QAX:UK1O$7B_PQH&G:#J(O1J1^N?@#\)9O@5\'_ ?PHN
MOB3\1?B]=^"]#M](N_B3\5M6T[6/'?BVXBR7U/6IM%TK0M!M."MO9:7X?T/2
M-'TVQAMK2TL5$;2R_'6E?\$YK _&[PS\=_&W[1OQD^(OB_X57'[5=U\ K_Q+
M9?#M=?\ @W_PUS>7=UXYT>R\8:?X0MO$GC'PCX(M[J/3/A5X0\7WNHZ)X9T^
MPT9=5M_$<_A[PU<:* ?DS^P+^WCX<\-_M/\ QY\>Z+\(_%'B7P#_ ,%!/^"G
MO[1?PAT'XK+X[L?#_@;X>_#?]D?X*>(+"#QMH'A+Q1)=:MXH\-B7X.?$/XE_
M&7QGILOASP)X0?XL>$[&R\0:_P"*(-9\%^'OT;\/_P#!5,>+OBU^R-X>\,_L
M[>([KX&?MQ>)_B)I?[//QJU?QYI>@:_K_@;X3?#W6OB7XU^.GB+X17_AL:EX
M4^"VH>&M)AO/AYXCU/Q;_P ))XLMM9T'4-8\(>#['7_#]QJ\3_\ !&O]GA/!
MW[-/PVTWXC_&[P[\-?V9/V.OC]^QOX;\&>%O$7AS1+;Q5X;_ &E?!^B>$OBK
M\4/$^K1>%9M>C^*VNOHR>*)M=T'4=(L)_%,S7=WI<^FR7^E:AR?A_P#X(M^
MK#Q!\-?&?BC]K?\ :O\ ''C+X1_L6?%?]A[X?ZSJ>M?"_1-/\(_#7XG^"M,^
M'T7B3PQX4\*_#+1?"_ASQUX0\-Z1ILNF^(M(TJVU/Q+K]C8:KX\O/%-OIFFZ
M99@'Y:>#_"FE?M)? G]FWPY%=:QIU[_P6+_X*_>/?VM=#L;+Q7XT\/:WX?\
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M,/C;XBO4TQ;O6==\,_#[X>^%-%ATNU>U@TKX??##X7>&/"W@[P1H4C33W=S
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M?A#XKZY\:O OPPNOB'_PM77?#6B^!_#OC75;/3+[6M#^'-GXVU[X?:2G@_\
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M&C^"[[Q7KNB6-HGA,Z!IEG6UW_@EL^H^%-9\<1_$W3]4_:T\5_MR_"3_ (*
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M$VF_&+2?%VE:+\4OBU;:[XB?0]+\>>&1XOO]:\3Z?X)O;I/B%XP23Q1=>*-
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M/I3:Q=Z1X7\*6)UWQ%XLO #[M\/_ /!5K]EGQ%\-=;^+EO:_%W3_  !;Z3\
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MVZ/^"6_QR_;\/@_Q'\7/B]\,]$\<_!K]G#XTI\!+CP+I/C?P_P"'?A_^VO\
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M\(?&+QG\'+GXE:AXM\.W[VNJ+HFBZS>W]IWEE_P2#^-_PXTO]@*T\$7WPO\
MC%X=_9V_8A^(O[+7QF^%OQ2^.'QV^!GA_5/B7\:?$/@#Q[\7?COH7B;X&^&/
M$>I_$9?B+XLT+Q-IOQ&^&'CJST71/&GAV]TX7/B*.\DO6(!]^:Q_P6-_X)V>
M'?"WA'QGXA^/ESHN@>._@IKW[07A&ZOOA/\ &@/XA^&?A;QE9?#SQ+>Z/#!\
M/)I-4\3:!XWU"W\-ZOX#TX77CBQOO-FG\/KI\,EZOI'A'_@II^Q+XY^+&G_
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M;_P4[^"/PG_9W^)OCNR_9S\!_LC_ !"^/O[37@KQA\$M0\#VOB74?'7BC1/
MO[+PTN_^*?PT\)_%#2!XJ,OQ-\=V^IZ%JTOACQ#H_P --/@MK5#+K$M_\W^)
MO^"<'[2WB?\ 9T\*6VA? []DKX??%:R_:#_8[^(GQ(^#^M_'_P".OQHTCX[_
M  ?_ &7/%,^O1?!KXL_M5_$/X9W_ (\N/!%OJ%MX1\1?##X967PAU;X?_#N;
MP=/HTT7BG3O&.J6^G?9G["'[(G[2GP5_:5_;\_:3_:F^(7PM^)7C3]JWQO\
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M#E^(/[9F@^%OB3X<\!^!?!GQ.^&7PBT?P%^QU?P2_%"\A\0>._@;^SKK6O\
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MOV>/7=4LKO3=(-Y>VMQ!'^$WQ-_X)C_M!_%/Q?\ &SXJ>*/A=HNO^-?VS_\
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MBG@<:%I?BO1M#T=]!\ _9U^#_P"U1\ ?VH_'_P"UK^US^SIKGQ9^$G[3FO\
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M'>/?!?BR34="C\4Z?%X9\4Z'KTE]X9EU"XTJ'Q%9II5_=M=:%+JEI=Z9'JT
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M -I7]AO]K+1O GBK]I#Q+H_C6ZMH]$\!?$7]GGQ!\.?#FM^'M5L=:TWQG?\
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M;K0=1\#^%4\)7/@:Z\=Z-X,U.TL=:\8V5UXEL/$,$&K+%I<3W?X$_P#!/O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&(>&?@K\,+E_B!\3-*U7QW!-\1;N?2=9\6^+!\'Y/&2:W+^P_HC_ !N^(?\
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M;?$*6[\3? /X)R!M)^)'CCPSXV3X+WWBW[/-X*UC2O"$T=Y[EXZT/2M6T_\
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MYX?EM-:TWP0R^$-:N/"UO:6-D ?T)  ?Y_SQ[=**0?3_ #_GTR/>EH ****
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M!^)?PA^ GB;]G/\ 84^&G[</[<WQ<?PC!XEL_ NN_M'>'/'/Q#_9X_9J\#>
M-3U=+8ZTO@[PW]M^)7B^ZFUR\OHK;PWX4\#:*?%7Q%&O>"@#](OVA? 'P)TG
M]J3X1?$O5?VH?'O[-7[0_P 9_!L_[-O@S3?"^L?#>^T_XY^'M#U37/B/IG@?
M_A"OC'\-/BGX5G\0>&+[5/%OB32]0\)V'AKQ->6-]K*:Y>:_HNDVUKI'K/P5
MT7]E;]D']FF/0?AGXK\#^$_@#\)+_P ;IKGB@^*](U#2+/QEJ'C_ %W4/B9=
M>)-<LIS8'QMK/Q6UKQ%_PD6C6L5I/#XTU.X\.:9H>GRK9:)!^+?P?^/'Q?\
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MZ<<YR?< \;>'=/P%?F/_ ,%7OVE_CM^S)^SM\.M7_9??0[_]HGXN?M0_L\?
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M+J\M\:B)[*<3W,'^E;Y8Q7Y8?M,_MN_&?X:_ME_M6)'XF^'%K^QS_P $\_\
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M-&/Q N+^WTJ*[F\;-I&HZAI3>*I9FUTZ=?7EB;\VES/&_P G_L3?M%?M&?M
MZU\8KOXK_"SPAX9^%GA8_#^S^%7Q1\(V'Q,\.:5\2_%&JZ;K=]\5M!\-:%\6
M?#_AKQ9XL\#?#*]7PMH?AWXY6^@>&/"/Q=N]2UN_\(^'K73-$EF;Q7]J;]M[
M]J+P'^VUX<_8I_96^!OPN^.'CSQA^QYX^_:,MV\<^-?$_P /M-^'NL^'OB1H
MG@'PG??$SQ18:'XAT^R^'WC&XNO$&GZ1;Z)I-[XNU#Q3X?&G+%8:+=WWB#1
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MI\)?AFD^D_$&_P#BUI4R^ _"JS:9\5=5@NK;4_B9I\BZ6'L_B#J-O?WUM?\
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MM? 6TC\66.C:1J^I>*+;]I?XV?LP_#'2-;\0>#?!.B?%;7OV;?">C>(OC_\
M%.Q\;^)]<L_"_A7X%_!O4[S7_"7CWXB>(+U!8^)O"MUX?TC1];\3Z]X5\/:V
M ?0GCK]@?]C[XF>*/VA/&GC[X#^#?%7BK]JKP1X-^'/QZUW5SK%QJ/COP?\
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MP!H/@FPU;4B6U?Q)>Z?;"37O%^N.99O-\0>,O$,^J^*M?F65UFUK6+Z5#M8
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MP+H_PX\9-X,U:3PGXNUBTN]!NM: ([+_ ()J? 73(9+_ $OQA\?=.^(3Z_\
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M:IX34>/?$=C8V7CKPU%X%TK3H_'?Z!?'+]KKX;_ WQ7IWPXDT/QS\4_BK>>
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M,='T#P_XB^'UF;"^L?$7BKP[J>JZ1X1UBSNM"\576C:S!+8( >"_%G_@EO\
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M?4-/T[X=>(/&'C'Q]=>$?!VB-JNM:MX1\.1S:W!XO@MO$NI^!=%\1>Z_!?\
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M_#+XS:E\./$WCSQCXR;3O'EMH,7BP^);1H_#+V'BG1+.R"3PS2W !^AWP[\
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M:UCAM=5&E7LDUC_:-M%#!>_9Q<11QQ2JJZ"ZAI[&]"7UFQTYF34=MS QT]Q
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MA>#-#^(.LF#2=#7X=_""#POJ6JWMG)80'Q#K?B72KB]FTJ#3X;7PW1?V/?\
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MEK[]JCQ[\5/@M^SK%^ROX?U+]G#XD^#]5^'?Q3G^&'BGX1>$OVH/V=O#^H_
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M1/$DM_\ VR=%\)>(/CK_ &AXLUNW%M!IG@OX&3V%Y/<7MU;Z)%_2KCCMDCG
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M_"/]HK_@J[\:T\0_LY:_^TKK_P"Q[^PMX>^#OPU^%=A\*O&'BKX<?%C]J/\
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M-(D^'O@6;X0&Q@U[X9>!/BS<1ZG;P?%K5-:\&^#_ !'\5- \'^'K3^N$'/\
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M8=9TCX6>"?$=DG@NUN_$L9\(>)?%^F^+))],A::.'1)"%D+".3].0.G/'/\
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M"/AFYLI] M[_ %KPQK.@\/\ "W_@I!^W%\7;?]AV6'X@V'PYTSQ-^S!^W?\
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M&G]FW2/VIK7P--\:_P#@JW\/O^";/P#^)GP7\"?#WP#>^$OA9\//ASX>U/\
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MIWAACVO<2NID;^;C]F>YUS2O!/\ P2O\$>/_  #\%/$6O?MR_%K]J3_@KO\
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MGAO_ ()R_L:>#]3N-7\+_!JUT2]E_9:\._L70?8?&/Q CM=)_9O\)V?BC3]
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M\*:=XUTGPY\(_"UCX>U73+7X?>$])L?B'XMAM+;P!%X:G#:E!,]P\VD:-)8
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M]*\7^$?$F@>(?#FH:3XB\.>)/"WBC1-(\0>']?T'5=/U72M4TZVN;2Y1D92
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M_@WI_B[X)?'SX72W]G)X!\:^ _C)\7H_$_P=N-$L+U-7^%NI:%#<^,=1FO\
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M^U_P[XA_X3:SN?#%_>:39IJFHRZ_^VK\2O%_Q@^/GPP_97^ 5M\?+#]EC5O
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M@^+V\,6)M;:?5M:U_P 4^-=2MK35O%=]96H!G_M/_M\:I\!_VD_AG^RSX'^
M^M?&#XG?$OX/^*?C5X?TL^.-.^'4GC+0O!WQ"\%^!O%'A+X0RZYH&J:5\3/B
M;X/TSQ=-\4O'7@HZSX7N?#7PIT'4/%4=YJMS/8Z3-Q^G_P#!43P)XU_:*\._
M!/X.?#K4/B]X=U+X[>(/V>-6\:>$_&.AW'B>V\6^!8/$$7Q3^(VB?#&TLM0O
M;[]G?X*^)]#_ .$ ^*7QE\6>)? =C;^/;H^&?ASH'Q+U"*);GTKQQ^PFWQ9^
M/W@OXP_%WXV^+/'_ (4^$G[1.B?M-_ [X:WGACPWH]W\'_'>B?"B\^%*^%_"
MWQ'T46GBR;X6ZW!J-]XR\4^!]3%U_P )#XONIOMVK'PQ+)X:D\@_9V_X):P_
MLRZ'\5?AY\-_VJ/C)IGP9\;ZY\<?$W@[X=V/A+X.Z3JO@W7OCO-X^U+6;OQ9
M\5=/\!)\3OC-!X&\1?$?7M>^'%K\0O$EV-)NK705\1R^+!H&ER6P!Z7_ ,$R
M_P!JWXQ_ML? ;Q;^T?\ %#X<>%OACX.\;_&[XH:5^SOH7ACQ4_C&74O@7\/M
M:C^&VC>*_$&NMI.BQZAJGC/QIX0\<^+M-O+.QATRZ\'ZYX7?3O/M52^O/RLT
M;]JS5OC9^UI\=OBU^T)\-/%7BN/X3_MI>!OV(_\ @F'^SY\&_C=K:ZEXM_:5
M^!^C^)O&?[37CW5[KPO+X%T2#PY##<[?C5XO^)L.K^"/!OPI^&OBSP&NF^)9
M+R]TSX@?K!X)\.+_ ,$U/V-_V?/V>OAI\/\ X^_M3?\ "K_!6G_!+X>CP?X2
M\-ZEXCU+4O"_@;Q#J7@R3XBW&B1^&O#?P_\ "6N7WAZQ\"CQU=Z>OAKPSJ>M
M^'I_&>J6UG<:EXC'R_\ !+_@E#J_P\^#W[!&N1_%\>#?VOOV2O$WQT^,GBGX
MF#PO%\2_!'CWXN_ME:9XENOVL;?Q#X7U?6/#6HZWI^M^(_&>HMX"\3VGB/0=
M>\/1>']"\R.[T2YUKPSJ !?\>_\ !8_P5\,H_"^E>)?@%\0M<\?77_!02Z_X
M)Q>,_ ?PT\0:'X\U32OC8OPSTWXN:1K7@)HK72+OXC^"]>\%Z[H%Q%>RZ7X.
MU7PWJ6KQ:=X]TKPB;'5Y].K:S_P4@^-L?QY?P/\ $']F)_@5\&_@U^PU\1_V
MT/VR)/B!\4_ 7B'XE_#/1I=2^*/A3X5_#6:S^'6I>(O!]EJOB5?A1XO\:7.M
MZ-XYUV&;1$LXHI-.;3[TZE[?\'O^"6OP-^$'Q2_9]^+-KXG\<^,_$OP#U?\
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M6.UT&[^"^J2WNM:5H]CK[2_3\'_!6CX!7?PA\)?%.#P!\9H;SQ9_P3V\9_\
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M:I\0;X _5Z__ ."BW[,5E\2_A[\+K;6O'FNZI\6_B?XM^"_PM\5>&?A9X_\
M$/PV^(?Q4^'^A^*/$?Q#\%^$OB+I.@W7A/5;[P+I?@WQ,/$>I1ZFGAZ/5]!U
M[PUIVL:AXF\.>(]&TCB_@[_P5:_8Q^.VN? ;1/AUXU\8WH_:.B^,C?#;7-;^
M%_C[PKX6^V? BS\1ZQ\0-$\6>)?$F@Z9H_@SQ)9^&/"NL>,;7PSXCN[#Q _A
M%=,U^]TVPL-?T"34_P ^_!'_  3-_P""A.E6_P"Q]>ZE\</V5?!C_L3?L/\
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ML]9U[^S=*;4KVWN;_4(4O9YB_4>/O^"G_P"R=X$^!W[2/QTG\0^.[W2/V6_
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MPYJWB^[\1>)-)\0>(6U., _62S_X*%_LN^&/B!IO[/'Q7^.'@C1/VG=+\7?
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MNOWT-CJ&N-HFFZY<?"8_X)>_M,>(O^"?7C#X(V?P.^!WPK^.NC?!/]F7X!:
MOB/]J#XI?&V+XL?"/X'?%GX?^-OBK\"Q\0+OX=>&H/@%^S_\<?"7@:^\,R^"
M? ?A*[D\17_BHZA\1HK1-#@^T@'ZB_$K_@JI^Q9\-_@E\</CJWQ(UGQ=X<^
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MS^*D?@/XN7/C*Y^&WPF&OZ=IO@GX=>/K'PY8_$2];PX\# 'ZTT4"B@ HHHH
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MX(=10 ?Y_P _E_D48_\ U]Z** $(R<_3WZ'/'H<XR?8>@(,=NW3'T_SS2T4
M)C_Z_P#GMGO^/<YI?TZ_K^E%% "8_P _CG\?QSWSG)R8^G;MC^OUQZ?A2T4
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M.^@:/J^FIJWBR>R /ZP,^W^?\X__ % D+G_/^?6OY$_VG/V\_P!H'X!>-/\
M@I1X.\#_ +3GC?Q_\0_AE\&?V#?V"/AA9W.IV%Y9>%/VN?CC9>'-*^(_[7]S
MX)6U"?#'P_X4_P"%Y_#*&Q&I1ZSJ/Q!^)UAKWAHW>KIX:G_X1[,_:?\ B-^W
MGXN^-G[1>@?LL_MC?&[1H/$/[8G[%O\ P39_8S\.MK-E>Z+K/[0GP+\*Z#\6
M?VV/VA_B)'>65YJU[\+? 7@O2OB9H?Q6\.>&;C2=-^(GB70-<L/$)N7T31=&
MU( _J+_:8_:$\!_LH? 3XJ_M'?%"W\17'P[^#?A#4?'/C1/">F0:UXAB\.:0
M$?4[K3-)GOM-74IK.W=KIK2*[2YFBBD2VCGN#'!)Z[X?UJW\1Z#HGB&TMM0L
M[37M(TW6;:TU:RFTW5;6#5+.&]AMM3TZX N-/U"WCG6*]LIP)K6Y66"4!XV%
M?R%^)OB;XH_:W^"'Q?\ V7_&W[57CSQ=\./VPO\ @LY>_LK?\)[\2/$>@Z/=
M>!/V=_V,_ _ACXH_M2ZOX1U8^%]+\*> +3XM>-?@%X]_X5_\.H[6?0?"VA_$
M_P *Z=:PWD<VK?;/0++]LO\ :&^%C?#GX17OQH\42?LN?ME?MS_M7M^SK^T?
M^T;^T.GPH\1K^R'^S]\(?A_/X?\ !VE_M/>*]%\2>(-&L_VD/C_<>-]5^$GC
M"[TW6/B7=?L\Z)KFJ?#":ZF\1>"_$/A( _K*S_/ _P _6@G'^?R[=SQQDYQQ
MS7\U'@O0/VM_BG^T[^QU^RIX)_;?^+&H^'?#O[,/[6W[3_[67QM^'WB;Q4VG
M1^ /VG?B+JGP]_90^&GPLF^)*^)]5\4ZO\-Y;+XCI\%?BO\ &:V\7:]J?A3X
M?R_$Z5KZ_/AG2K'[I_;T^*/Q3_9L^%G["G[-G@+XQ^+/!\_[0OQ^^%O[*WQ*
M_;#\<S:!JWC/P)\/-"^%WC'QAXU\<7?B?Q)IDG@NU^.GQA@^&P\$>$O$WB+1
M9]+L_&GC>^\46.C7NKZ5I>E7(!^JGB;Q+X?\&>&_$'C#Q;K.F^'/"OA/1-6\
M2^)O$.LWD&GZ/H/A_0K"XU36=9U6_N7CMK'3=+TZUN;Z^O+B1(+:U@EFE=8T
M9AX;^SI^TQX5_:8T37O$O@[P'\8_!_A_2I?#=QHFL?%?X:ZU\/[#X@^&?&7A
M72_&GA7QM\/;C52Z>(O#&KZ!K%E+,Q-EKGA[4S<>'_%FAZ!X@L[O3(/YM?CU
MKGCC]JGX._$G]E[2?B!\;_$G[,?[9W_!57X#_LE_L>^+-9^+GQ+N_%GCW]FC
MP;\-/"WBO]OGQ5#XWN_$=OXL^*_[/^MV/PH_:7TKP7?^+-:\4^&M8FOH[KPQ
M,_AQO!]Q'^N/_!4[XUW7[._[+$?A'X/_ !AT;X<_&;PMX9C^.G@3X=^(_B#J
M'@77_P!H+X'_ +('B7X:^.OVC/@EX?\ BO>/=ZYX5\4>/_A/=-X,L_&%KJ(\
M4V^I>)8=0CU"WACUC6=- /MOXT?M-^ O@5\1/V<?AGXPT?QMJ&O?M1?$_4?A
M#\-KKPMH,&MZ3:>,=+\$>)?B-=1^*YAJ5K?:+I*>#O!WBC6'U>'3M0L[:'1+
MI;Y[1Y+07/T7G_/^?T]>U?R-_M'?%WQ)I_C?PK\7=)^,GQIO/@-_P39_X)<_
M&;]KWXG?%WXKWEI;?M/1_%/]O66_UGX"_ ^TU?4M&NK'P9\:Q\*O >K?#2X\
M17FCZAK'@KP'X]FM-&_L3QUKV@^,-)S?B5_P4=\6_#;]GKXU^$?VB_VPO'?A
M7QE_P3\_X)X?LYZS>Z9X"U2XT']H/]K;]M7XZ_ "T\?Z-\6=1&B:?8^*]7^
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MP^+CP>!]%\9>/?$GC_P[-KOB:VL?%GBKP/\ #/PYXXUOPKX'U#Q#<Z/KGAP
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M-S90Z5#JNKZ;:WM]:M>0%_=<^W'KZ=>WMC'&>3TZD?SU_M+:QI6E_$;]@_\
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MP>3XL^%/!_B27QQ\0;_0/"OP_P#AE\&] TNPM[#Q!K'Q/\5Z])+HFAS7]](
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC[P_X\TWQE:>&?'GAG7-5\+^)/AU9:Y;_#[4/#M[+I+^&1;;57]#** /FO\
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M,7>DZUX-\2>"?$>AZ-JWA?6/#E_IU[I%U80+;2BW\V"3VN@C/J/I_G_/T)R
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M_MO4IO",OBO7KC4;NYF\0VXL?#D&@_JP!CC_ #_GWHH _-#QM_P2O_9[\?\
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M'XAWO@Z#XB6W@M_#\MBGB*3Q))\/[F+QV=)@TJ6[C\&>;XIDB30K>>_C^CO
M?COP;\4/!/A+XD?#OQ+HWC/P%X\\.:-XN\&>+O#M]!J>@^)O#'B&P@U71-=T
M?4+9W@O=-U33KJWO+.YB=DE@F1P>: .LHHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **0_P"?_K9XSG&,_7M7X3_'[_@J9^TQ\(_B
M?_P4<7P=^SA\"OB!^S]_P3.\'_#WX@?&+Q]K'Q\\:> O&OC.Q\:?#"7XP:O\
M.?A]H/\ PI;Q7X3N/BKX0\!)8:E>:?K'C#3=!U"^\6>"]%BU2RO-8O6TD _=
MFBO!/"G[2WP>U_X;?!'XE>(?&.B_"VS_ &@/ _AWQU\.O#'Q:UK0_A_XUU*U
M\0>#K'QU)H3>'=>U*UNY?$_AW0+];CQ1HMA]MN-$-M>-=E8;=YJ[B/XN_"B;
M4+G28?B=\/9M5LO$VC^"[S3(O&GAN34+3QCXAMIKW0/"=S9IJ37$'B;7+.WG
MN]'T&6--5U.VAEGLK2>.-F !Z'_GZ?7_ #_6DSZ\?U]/S]/7/6OSE_X*'_M@
M?&/]D9?V2(OA#\*OAW\4]0_:@_:Y^&?[),L'C_Q[XH\"0>#M:^+&G^)-1\/^
M-TF\->!/',NL:'H4'A#79?$NFFWL+TPRV#V-PX%WY7I/PT_:*^)?Q%^/_P ?
M=,C\'?#32_V0_@=;+X1?]H2]\?ZK:^(_%7QKT.&"7XH^#],\'7GA:'PW!X*^
M$4Z7NB>-/B%<>.!:1>,EN?!NGZ;>:MX5\</X= /M'/J/_P!?8>GYX&< $YI0
M<_Y/]0*_/;]M[]M6]^ O[,5A\:_V;[7X8?'[QEXN^,?P"^"OPU\+#QK/<Z!X
MW\5?'SXF>"_AYH=EHNL>!K7Q'-J&H65EXUMO&JV,(@BO/#.EWUX;^T@:"X;[
MKA\4^&)HKB>'Q%H,T-IKB^&+N:'5]/DBMO$SW-O9KX>N9([AD@UQ[RZM;5=)
ME*W[7-S;P"W,LT:L ;U%<]_PEOA7_A(CX0'B;P\?%HLQJ+>%_P"VM._X2(:>
M5+"^.B?:?[2%F0"PN3;"$J"P<XKH: "BBB@ HHHH **** "BBB@ HHKXG^//
M[=?PC^!'[3_[(?[(.HQ:AXH^-W[8'BSQAI?A/PSHD]K$W@[P1X$^'/CGX@>(
MOB7XPGNRL%EH3/X*G\-^'].,L6K>*=6FU5M @OH/"GB/[" ?;%(3_GG^@/Y=
MZK_;+3#,+F K'.MK(WG1[8[IG2-;9VW86X9Y$00'$I9U7;N90?SS_:Z_X*'^
M!?@#\$/CS\2?@Q8>$/VEOB3^SW\4/A#\%_%_P5T3XAS>%-9O/BU\:_$W@3PQ
MX%^%5AXDT_P7X]LX_B/K5U\2/"$]GX=ETITMXM4C.NWVAHKRH ?HK16=_:=I
M%I\VH7UU86=O90R2:G</?0FQTY[92;Y9[V001QQV;+()99U@**A::.'E0^VU
M33;R&PN+34;&ZM]5@6ZTN>WN[>>'4K9XDG2YL)8I&2\@>"1)DEMVDC:%TD#;
M&!H O45Y#K?Q3U'2/BUX(^&]M\,_'&N^&?%OA'QCXGUGXRZ1-X0;X:_#R\\,
MRZ$ND>&?&K7OBFS\76^K>.8-5OY_"MQH_A;6-)E&@ZE'J.H6#>63Z@FJ:;);
MSW::A8M:VV?M-RMW;M!;;5#MY\RR&*+:C*S;W7"D-T(- %ZBJC7UBL$%T]Y:
MK;7+6Z6URUQ$()WNY$BM%AF+^7*UU)+%';+&S-.\B)$'9U!^&/V*OVU;K]JO
MX&?%WX\>+_AE;?"/PC\,OCM^T9\)='U'2_&US\2]%^(G@_\ 9S\9ZQX UWXO
M>'-1C\$^#-2BT'Q#XF\+>+[;2]"?0;G4(H-"$PN[M[Z.&$ ^\J*_)/X,?\%.
MO&GQF\(? WXL:=^R'XST'X&_M-_#/XH?%OX-_%N^^*O@;5M T3P;X \ ^(/B
M'H5Q^T%:^';/5;CX-ZA\0-&TO28=(LM)D^)8T/4-7NM)\23Z;KVAWFCS?9'[
M%'[2-]^U]^RC\!/VGM0^'%_\(I/CQ\-M!^*>F_#K5?$-KXIU/0/"_B]9]3\'
M7%WK=GIFBPWK>(/"[:7XACV:7:?9EU(V+K)+:22N ?4E%-5U;.T@X)4X(.&4
MX93CH0000<$$$$ @@+GV/^?\_P"01D 6BDSU]NF3@$^G<^G;N,9I0<_Y_EZB
M@ HHHH **** "BBB@ HHHH **** "BBB@!"/K^''Z\?SZ$T48SC//U_SC/\
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MBZBG:"19H1;_ !KDEDN+>,E+B%) UFAN#>6Z-%NC /G7QC^P_P#M[Z]^R/\
M!;X!7?A^76/VDOA%K]K\9_@'^V[8_$GX?Z5\3/A;\<?!'Q'\2_#OX,O^U%>O
M?65]\9M+?]B:+PC\)/VE/$/@[P[XVO/B9:SZYX(L-#UW3WLO%VG?T8Z)H^E^
M'=&TCP_HFFZ9HNC:'IEAI&D:/HFGV^DZ-I6F:;:Q6=AIFD:7:*EIINF6-I#%
M:V%A:JMO9VL,5O"JQQJ*_&"]_P"";W[*,S:D(O"GQ.M[F"6WN8-/C_:7_:U3
M,$-Z=)FA62'XUJ',=[=1QM%!'-#JPM[B8/'=0PVTO;O_ ,$P/V7KFWOY-.\
M_$"[GLC8R):#]J#]J.T)CM9XIM2DFDMOCB?MZRJ\42112Z,9M.,A:R%TYLB
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MNC>)(IG6^BL0UF+"ZY7X@Z9>?$_P9XO^'WB#Q'\1O"EA>6$+:EXI^#^H>*O
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MS?L.0VUJ]O)>1W)TZ[B@U.*WADTRZC@U.XMWD /RN\7?L_\ PJ^'W[2'[?\
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M3]@9-Y='^^D@60,)%#4 >,V>EV-[K3V\.M2(-2=;O4I[NRLH(X6DU>'^SI;
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M'9WNIP?V5<7%[8>8NE7446H7+*7OY;>XTMX;N[18X(X9;I)?(2VM_)"-$K4
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M?#/PX_9-^(_@'P1\9?A+\=?#GC>R^%WP7?X!^+O#'CKP]XG\4K\2-=\+QMX
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M3;B6T0Z=\.;?1/V?KZ[TY;+7K33AJ'AF\NK#2=,U(:A^IW[ \-SX_P#V[O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[\0>5/%%#+"(P#\_?&OQ2^-/[:W[6?\ P31_9M^-=G\,/"6G^*M6UK_@IO\
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M6\5:C9W=M$;JVNH@#XL_X)PII/A;]M+_ (*B?!+X2G7[;]FO]G[Q#^QU\,_
M^C7.JZEK7A;2OC/'\ +GQ'\=AHNIZM?ZC?WWBB^TW7?A'<_$J_N;DW>J>+_M
M.K:L;G7-0U;4=0_,OXF?&3Q[\??AAX__ &XQXL\96_Q>^(G_  6-^ W[%/\
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M= X_=76 ?*:8QLWD86=8T<O;L5FC*.LB*ZE: .WQU^F/4#\/Z=#2XY_S^?\
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M4^-_"RI!*VLVJ07*3R0W,BSQVC1VT0FN)3=O"MND<,;(SR/(J+YD8+!I8U8
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MS.8HX:=S9S1EYH[5DMTEDME\N0W49>WAC\XQODRRPR;Q-',T9@?>$A9Q"Z
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MUNO)O@RV?![X[:Q?C'/&(K7 YP>._!/KR":]9H **** "BBB@ HHHH ****
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MG/7KS1C_ #_C^//&*6B@!,'U_P ?;/7\?7Z9!7\?\_Y_SWHHH *3&1@G_/\
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MG_/Z44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 44?Y_S^5% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 (><>GU_S_ #!ZCUR4
MA]\X_+GZY&/3MU[YHH =1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (<=\>N3CZ?U_7W
MHH/OP/7./SZ'Z8S[]J* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $/IC]2/U'^?R-
M%!QWQ^/_ -?Z44 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 (1GN1[C']0>O\ 2BEH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HI#Z^G^?;_#VSC!0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 44=\?Y_ST_/Z9* "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ,
M<Y_S_G_'ZY*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **/UHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@!,_B.O<_R'O^6?2B@C/^?\>/SHH 6BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **3/L1^7]"?\YHH 6BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH /\_Y_P ]
MZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **"0.I ^M% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 (?\\D?RHH/L"?Q(_P]/Y=CFB@!:*** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
@B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>tex23-1logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tex23-1logo.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 20"! P$1  (1 0,1 ?_$ /T   $#!0$! 0
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MNZM_ZR]R?*"2# \E+9^D<]F8IYW;T?ZIR_+Y QVX7<ZK3B.V[NK?+H#J7N4
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MZJ/L6K_:-0&_3_L@I_K_  GKHTPU>V_6E+\H1V8G S1]V;E]GU7\.Y'3VC%
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MX;'WPO\  JH7PM0='A_XK68^6&"#6_[K,^ZCU(5+T;7]_-1]BU?[1J WZ?\
M9!3_ %_A/71IAJ]M^M*7Y0CLQ-_FC[LW+[/JOX=R.GM&?2V.'9F$>PRS\-JE
MYF)!:83I&D\!;3ZD>46J^$.G@"B2..15 8??"""0ZVJ.,<A#B:PE)#F8A1$/
MX4UCL 1 1RPU?7%*3FAOOA)G@41Q<43@^C4;2G16Y"23*^.#$ GVI!]6(*?0
MZ'G*7T,G[G"*[B>-SV9B13=3Q)]B(J"" ;>HI>!_@R=$/[W 2EI$W@%[Z"/7
MJQ!X#&1O?2YW"MU/)JF !CATHZ#?*>'/EUZ4ON<*^V:>##Y=.]U.3J(-B2$L
MF0G/:I1VQYJN=D5JYQ.:5.**E_2"<3M]H9[ PB1 -P>('E8[6<\8;R=L07\[
MG6ZUT_V#7L31<P5"[U^HM[$"#%?)[2-M#'!M4U0N!3'C;.9TG%&L<\A,*BRA
M1_>APE&K6;TY?L2[?1J2;A4]S*>(2<#UX>US&- *S5G4U&;+HU_V#85)6ZI7
M>K>VMI$^^(5)1 X )[8"I(0>D23()C&$J::9 $3&,(@4B9"@ F,8QA    $1
MSRPS=MM;:ELMI)?<7O2&.,]D3^..H/C%PJ2AMM(;;WR9 (:X>(3 QXH_2F(:
M5I^5D8*>C'\-,Q+M9A*1,FU592,>\;FX%VCUFN4B[9RD;88A@ P#C=J*1]BH
M72OH*2E 5C@9QH6:[T=_M]->+$\AZBJ65/M+2006VU[AQ&$RH2Z4%2\A'7.P
ME*;=Z,;DS2+>H*:]4:ALB\D5P($U32YU'M0T,U64'(7]/N3G>,T<\SLU5"DV
M(@&'-:+9R8KK=Y/U;G[X@DIF=H'!$-_I"M :NQ9D.M>6J=7D[<0GZ1*$C=9J
M#W*%F6.ZN4E'@5+C@FI)8BOR(ANS#(0'9L'/(!S^6#"\J2I"]T[)1&&TZAU(
M6G *$Q/A'XPZ$:6U+?!YOK]QFZ7M'F\%=Y^J*KW!?8CKLA??ZP_;-'^W1 '^
M&J1/G#'JB]D4[UXE/3[C"2U?PM7Y)[!AT]L^I*/I+@[ODN?JW]/OS%???"JD
M</2TK^XU+TNU'GGY[W^9O,?RAC^&;AL??"_P*J$_2"H_VK5E@@UO^ZS7NH]2
M%1]&U_?U4?8M7^T:@-^G_9!3_7^$]=&F&KVWZTI?E".S$X&:/NS<OL^J_AW(
MZ>\9]+(_K?'^ED\2#4WP9CHMI[ CRBU7MS_3/95 9'?"'PV*,^X%27MIK'#5
MM<#_ -U('ZD=@1.+Z-7^Y6Y?;KG[%N(*<(O$B44'=Y'EABT^U.=-,7M]^?<U
M=@QT$N5"?J?+KTICF'VN%-F_,1J6>W  YYB/@8?/I\-W)M"0DR+$R9C\94>:
M?G9$)YPV:5KF$BX)X)S_ '=G9'CUS<S*PVB6F'S:;F&-<7D<L5#4M:" >)JS
MB[I4ARLWM5+)&5)2D FH'$JLX %E2ADBF<PAE3->>;)E.C+M4XERJ]:A)!/5
MD>",6A?-PU$UYO+2,NTKK&5PX$U%:ZDI;:!VR)EO*D, )]&4 MW]OQ<C4Q=J
MK[T77E_5:L*P?=77*CU0D9#1J'$E%4[!-#F/Z"A(1GPHMT\Q$0 3F$3G,(LT
MOU^KLPW=5ZN!WG3.21@D#@DF9QET=L>@_2G2S+FDN0Z7)F666V;=2DE;AQ<J
M%G%2WU"6_P!UB,!(2$2T\EGE^+:C;K-=15SH0Y[(6@G$%X%J_0_S.X=S(XR;
MN.CTR*D%-[ 4DH!'3X>F(HYZBCYYDJ&C^1W[E<?*"N0?H]"@I 7ZX@S$^.&5
M\_7G(L9!RPG2K++A&;+FR?&5I5,TM.X-V?<RDX^#^;GW@F9$RC?'/@T)/Z6K
M8VLZVD*JXI&L/4V+O:QCFIA^MRJT4R,8>N'"*)!X(JI&B:;9ZK\BB\1(<^75
MLPZ#67)50AWRDM:#N;LG -FT"8 V8GAA/O1W\XBD=I'-#LU/#Z1I@7*!Q2MT
MK0H[RJ?>5A).*@D 3X-D#L4S4M0T944)5U(S4C3E44U*M)JGYZ)<J,I.'EX]
M8J[1^Q=)B4Z2Z"Q,P\ P9@("41 6^T58[:W4W"@*FZQM8)QZX(' >&)2LQV&
MS9KM%5EW,C3;EEJV^1J*=X!;:@X,".*6T&<P<1!BO+KYTMM+Z,8"U6I:4A;7
M7N*DVB6%5O13CK?W*=9)((+H2*IB-Z8J9Z8G$JS<G*V65$104V@D5V62-6K1
M?Z=J@O#J*>[2 F9A"I<4R0#U8@IYRO,ASOI7<JS-61V7+GI\%J4-S\X]1MF1
M"5!(!4T-@(!,Y;QB7_4:X3<:>+[*$5342&RMS5"'(("0Y%*%G#%4*<#&*=-0
MNTHAL$-V>%+O!)M%3A-'BZB% S"IC@Z4,\T_[K/EAFE0/TU2 S$ID/HGA ).
M&K[HB?*'!6;Y->J[4S;N%OE;V>M"TH^X*\[*0C6I*GG&$VBV:5!*12Q7[5I3
M3UJBJ+MBH)0!8^9! 1QBMNC^8\PTE/=V7&6F'4*F)S)V@88\/%'"YSY^>ENE
MV:'=.[Q;+U45MM(#CH#20=Y(5*4QA)0QE!8W+OT]U[I:TBVNL;<=W .ZOHL*
MF"3=4R]7D(54LS5$O-MO0CMVS8N%1(U?E*?B2)D?, V!F+G,FV%S+>7*:SU"
M@M]M/='HSZ'0B(#7_4:UZMZLW34&RI<3;K@XE24N )6F2$H$Y8=R !MQX<8T
MYS6='UTM;&GFFK46BDJ3CZEAKI0%:.5:QDG<7&*Q<9"5!'.$47#&-DUO1?5I
M9,Q2BGPF ILS!@EU"RS5YOL**"B*4/\ *3!.P2/:$H[+FF:UV#0?4MW.&8Z>
MHJ;?X@[3%+.[OE;A2J8WB$X;N/0V0/[%=[^:W64O$/'-3V+(W:2T:Z7.2KZA
M4.5)L]0<*"1/ZT2\9@(F.09AGNS#?A&:'1#,3->P^Z^UR3;J5&6V0/2B1*^^
MDETDN%AKK<Q:[NW55-&ZRVM8:*4K<04 D)5,X$]"#,X]!9NP9(+B45D&C5)7
MA^1%1!!-,W!L#,@G*(@._(<.A6D,,I2C8A( /6$0L5 *JEYU!WJ5:E%/'(SD
M#TI_[8'KYJ?*NU)ZU-1L#=BTLS;-C3,7;"!HU=O6$_*Q<F$I&S$](.#I(,8&
M32.T,E)DX3"H!A-F&60!FB^I&G%US=>D5]N<;;0EL [QVG@EAP2B1#FC\[W)
M6@FGM3E7--#7U-;45QJ 6-R0FD).]OD;9"4HC2^+Y:X_XRV(^S*HO<CA//,9
MF;XPQU_]D.J_U+](OY1>O_I\*/DKWOQK?02555J:Q($23.H8?KSJ(=B91/ED
M%(9[<O"# &AF90E8+S"BH @3_%ZG#&9KTEVCZCR8M%[Y5Q0;!_,]QOF4Y;V.
MW88:BKS.-8E#6,I/2E0%<1]KZ#M?$2%"JR5"QY6M93Y6DQ)F>N'E6O3.7[#J
MSAPH4/0!6@]3 NW//'.5&HV9*"UIRW;W2P*7>;44@&<E&?=$$];HPK=OYGFC
MF=,Z5&LF8:6XW6LNW)5**=\I2T@EM  *$E(5@D3"MX<0B.Z2D9"7?O)>8D)"
M7E9%<[N1E95ZZDI*0<GVJ.GS]ZHLZ=KF$=IU#F,/1PGCSSU94"LJEJ<J-LU$
MG'I3E^"'86ZU6BQ4;=MM=(U;Z%F0#3:4MI$A+NDH 2HX8D@SB1[EX\MRZ>N6
MMF;\[23HRP<#))!7-SG#4Z)7Z:!B*.*7H7JY2)S-1O$^D,J3B;L"FZHJ;B J
M9E%R#I[=,W5O+U3:J>TH4"5D&2P""4CIC#H0T_G2\ZS*NA%B>L="XQ6ZDN#]
MVIV5AQK=6#^=J#,[A;[X(]<1NR(G!VEJ+54+9>W]*6MMM3K*EJ'HJ);0M/PK
M$G D@T0#,RRY]AW3]XL8RSA=03*+K',<PB8</%I;?1T-&F@HD!NC1@$@G"71
MG,]4QY^LRYGO>=<PU69<R/N5-UJG%...+.*E*/ !@E*=B$@!*  $@ 1E-44O
M3]7T]-4O5$.PGZ=J".<Q,W"2S<CZ,EHMZD9N\8/V:P'2<-G*)Q*8I@$-O1QF
M>IV*EA5)4)"Z=:=T@\1_#&C0UM7:ZUFXVYUQBX4[@6VXVHI6E8/<G>!!,CP'
M" N^9ERB:QTR24[>:P$3+UKIY=++24K!M4UI.J+0E6.951L_02*J[F**0SR0
M?E RK0G2.0R %C-<U!TIJ[/5*NEB27Z5<RI,B2CCGT.(Q-ES4N>W9-0+:WD+
M55]NWY]ITI0FH7N\C<$#!))("6W4C8E &_B<92$'69%"AEPG*.0AD("4V0@/
M@"(" #EA$RO=4I)1R;PP/'U.(]$2,2-I0P6TC\T];G$3!GOH7/@4DS2I,N!0
M(B1K3]S1=45@K;U=9Q>HB74M%5-%U-1WUFU^X=/W=+M:@@WT,+JD:GXE)B+(
MQ(\$Z;-0R[(>'($R;P[^PZF9BL]$JT.*-3;W$;H"SW@D9@*VXSQQX(:+J?S+
MM*]0<PT^;K,E&7\VTU8FK+S(/)/%I25[BF9\DDDCN2E*3CP[(^?J43ST_D!Y
MN#7Z1'Q9'LU=N,?B]7^.>L.U!(/+^UO:=;(Z2+1VLNC4]9TI7='LZG95% +6
M=N_(*,'+JM:EDFZ0O(JAG\<X*=B]3/Q)*G^2 ,\+ADJ^VZVY4HJ6J6\ER2MK
M"D[%$[ #*(IN<7I?G3-6M%]S'ERGIG[%5N-EMP5;*DF3:!W*B_CB"##S"\S;
M1N)1_E'J\ #9PC8^]X"/B!V/-N.H\L<O3WN65,_JGO!A%O,=J8HXT3'SECWZ
M+0YF.C7,#!<2K0$-PA8^]P"'@;!"WN*#..70CDP\K<XN2>\& ="]2SMH:?OM
M[X2QWTI3]NVRPBAN9MHVSR&XM8"(#O[!][QV^+V/<!.<,NIQ2\H'W)[P8 T/
MU-0<*)B?RECWZ*AS.-' _P XU8>/8^]P?^O< YPRYN[I>5N^Y/># &ANIAG^
MY,?.6/?HN#F:Z.-N5QJOV;\K(7N\,>U[@*SAEU>UY1E^J>\&*JT-U,)WC14Y
M/RECW^+.Z;Z-S" =D6L=NS;8Z]_X/<6^5N6_TJOZ)[P8L&AVI9_X%CYRQ[]'
MQ=<S'1R=!PF6XE7&%1!5("]A&]P&.H=(Q4P* V\ ,LQWB.6?A8N5F:R.)WJ=
MQPNE"PDAES#CVIGMX.&,K.A>IJ*E"O$6.2P6HBI8F A0[KV_"7">" 39&U%R
M:BK>;!"@ZVCF4S5,ZY;S$Q1%9LXE!H]EGCE!X]<)T^Y61;B@<##DD8X!LX<]
MF&:.6&Z5]T<13(J$4CCRY$4I$YJ,R<..<>A>AU.R#E[3^C=KZZE=KJ*W,)\7
M:J&G%E264[PF'YK),^O*)@-(NBOE]4:ZB:RU;7YJ*Y\PV,B]):ZC[,W\B+?M
MUR@54C>HZA4MXWG:F(0VPR2!63<^6T3E$0PJN7\@Y0H%)K,R51?<2/:&V7AU
M%I Q4.&0E.<,4ULYT/.#S72*L.E%C1:+"K_C%U-([6$<"FIODLH/ CNB!A,2
M@B.F.8-H/HJ B:4I&I9&F*:@F:4?#0$!8*\\7$1;-$O"FV8L65ND6R"10_:E
M#,=HYCMPME+FC*]%3)I*1PM4J1((2RZ !TMV(X;GH[K'>J]ZYW:E\9N%0LJ<
M<=JZ52UJ)G-154$]K9&1=TTT;=L:J_>3OA^#[&?RQR_^G7_1.^#&D="]5#MM
M[?SFD_YB*]TUT;]L>J_>3OC^#[ \LLO_ *=7]$[X,#S%:J?R]OYS2?\ ,1YU
M^97HO<)*(KW!J15%8ADEDEK'WM.DJDH04U$U4SV\,15-0AA Q1 0,&P<6^5U
MAW"AIU12K:"R\01PX;L :&ZJ-J2X+>@.((*2*JD!2H;% ^,3!$0,:XM,W+5O
MN[F[C:<;K3-CKGOC.)![3/8'OCV*:LD% XSB:*96[]%T=(NU-IEV(':B8<S-
ML\S82;-N4<DWQ9K+6^JFJ\24ML+DK#A"A(8\0A_&@VOG.+TO9:RYJ!:DW_)Z
M0E(<774XJV$@C%MQ-1O+ 3@$*Z<YQ 7-V<NE$O)&.+;ZN98C-1PW))PU$5FZ
MBGY4\P*Y8+KP#5=5NL7(2\:29]N1BE',,(349;N[-0MH,/O,I5W*BT6\/_=/
M\'5B4*UZLZ=7NSHJ7+Q0T]*^P5BF=?IP^TL &3Q6XHJ4"9)V2QVQ(?V/K@_Q
M"KG[$:C^IF.O^@[I\4>ZQALOE[E'^;T7SFF\*#SB?(EP\=OO$1 (GO8OQGBL
M+ @0L"!"P($+ @0L"!%/,Q3UT [(1=P8M;[SK]F -G4B@[C?,^;C(.#IP!WW
H6B[%($+ @0L"!"P($4# .T=.+4Q8;?C3J_6=7U(O1WQZD+&.+H__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6784718464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abvc_DocumentAndEntityInformationAbstract', window );"><strong>Document And Entity Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">American BriVision (Holding) Corp<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001173313<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ABVC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2016<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--09-30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Smaller Reporting Company<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvc_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvc_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6790528576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
<th class="th"><div>Sep. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 84,904<span></span>
</td>
<td class="nump">$ 994,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abvc_Prepayment', window );">Prepayment</a></td>
<td class="nump">3,500,000<span></span>
</td>
<td class="nump">3,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">3,584,904<span></span>
</td>
<td class="nump">998,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">Deposit</a></td>
<td class="nump">3,815<span></span>
</td>
<td class="nump">3,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">3,588,719<span></span>
</td>
<td class="nump">1,002,460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Liabilities and Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts Payable</a></td>
<td class="nump">11,446<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other payable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionDueFromToRelatedParty', window );">Due to related party</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">22,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToOfficersOrStockholdersCurrentAndNoncurrent', window );">Due to shareholder</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">46,586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short term loan</a></td>
<td class="nump">2,050,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">2,061,446<span></span>
</td>
<td class="nump">369,103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders'equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock</a></td>
<td class="nump">209,353<span></span>
</td>
<td class="nump">3,114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">1,987,127<span></span>
</td>
<td class="nump">1,295,845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable', window );">Subscription receivable</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(350,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abvc_RetainedEarningsAccumulatedDeficit1', window );">Retained earnings-beginning</a></td>
<td class="num">(315,602)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="num">(353,605)<span></span>
</td>
<td class="num">(315,602)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total equity</a></td>
<td class="nump">1,527,273<span></span>
</td>
<td class="nump">633,357<span></span>
</td>
<td class="nump">$ 31,359<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 3,588,719<span></span>
</td>
<td class="nump">1,002,460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,360<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274<span></span>
</td>
<td class="nump">795<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,634<span></span>
</td>
<td class="nump">795<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,594<span></span>
</td>
<td class="nump">64,594<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,228<span></span>
</td>
<td class="nump">65,389<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Liabilities and Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,150<span></span>
</td>
<td class="nump">18,030<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Note payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000<span></span>
</td>
<td class="nump">7,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent', window );">Related party note payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,150<span></span>
</td>
<td class="nump">34,030<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders'equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,011<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,582<span></span>
</td>
<td class="nump">54,582<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55,516)<span></span>
</td>
<td class="num">(23,235)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,078<span></span>
</td>
<td class="nump">31,359<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,228<span></span>
</td>
<td class="nump">65,389<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member] | Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders'equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvc_Prepayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information pertaining to prepayment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvc_Prepayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvc_RetainedEarningsAccumulatedDeficit1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvc_RetainedEarningsAccumulatedDeficit1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of subscription receivable from investors who have been allocated common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToOfficersOrStockholdersCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amounts due to recorded owners or owners with a beneficial interest of more than 10 percent of the voting interests or officers of the company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04.12(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6488278&amp;loc=d3e603758-122996<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToOfficersOrStockholdersCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount for notes payable (written promise to pay), due to related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e7018-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Liabilities<br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionDueFromToRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Receivables to be collected from (obligations owed to) related parties, net as of the balance sheet date where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionDueFromToRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_MetuBrandsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6787695024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Mar. 21, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
<th class="th"><div>Sep. 30, 2014</div></th>
<th class="th"><div>Sep. 18, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, authorized</a></td>
<td class="nump">360,000,000<span></span>
</td>
<td class="nump">360,000,000<span></span>
</td>
<td class="nump">360,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, issued</a></td>
<td class="nump">209,352,897<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,113,856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, outstanding</a></td>
<td class="nump">209,352,897<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,113,856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000,000<span></span>
</td>
<td class="nump">90,000,000<span></span>
</td>
<td class="nump">90,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,011,144<span></span>
</td>
<td class="nump">11,144<span></span>
</td>
<td class="nump">54,593,032<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,011,144<span></span>
</td>
<td class="nump">11,144<span></span>
</td>
<td class="nump">54,593,032<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member] | Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_MetuBrandsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6790168752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2014</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
<th class="th"><div>Sep. 18, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">315,602<span></span>
</td>
<td class="nump">289,098<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Net income (loss) from operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(315,602)<span></span>
</td>
<td class="num">(289,098)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Bank Interest Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Gain on exchange differences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Sundry income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(3,753)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total Other Income (Expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(3,303)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) from continuing operations before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(315,602)<span></span>
</td>
<td class="num">(292,401)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(836)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (315,602)<span></span>
</td>
<td class="num">$ (293,237)<span></span>
</td>
<td class="num">$ (32,281)<span></span>
</td>
<td class="num">$ (70)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Basic and Diluted loss per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and Diluted income (loss) per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.1)<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average number of shares outstanding basic and diluted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,113,856<span></span>
</td>
<td class="nump">208,779,424<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Revenues</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,360<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">521<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,839<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="nump">23,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,120<span></span>
</td>
<td class="nump">70<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Net income (loss) from operations</a></td>
<td class="num">(23,235)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32,281)<span></span>
</td>
<td class="num">(70)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest Expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total Other Income (Expense)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) from continuing operations before income taxes</a></td>
<td class="num">(23,235)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32,281)<span></span>
</td>
<td class="num">(70)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (23,235)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (32,281)<span></span>
</td>
<td class="num">$ (70)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Basic and Diluted loss per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and Diluted income (loss) per share (in dollars per share)</a></td>
<td class="num">$ (2.08)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average number of shares outstanding basic and diluted (in shares)</a></td>
<td class="nump">11,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,929<span></span>
</td>
<td class="nump">11,144<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64836518&amp;loc=d3e30700-110894<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64836518&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Income Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68048583&amp;loc=d3e3636-108311<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_MetuBrandsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6787983056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIENCY) - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Preferred Stock [Member]</div></th>
<th class="th"><div>Additional Paid-In Capital [Member]</div></th>
<th class="th"><div>Accumulated Deficit [Member]</div></th>
<th class="th"><div>Metu Brands, Inc [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning at Sep. 30, 2013</a></td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 28,670,072<span></span>
</td>
<td class="num">$ (30,550,258)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,880,174)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at beginning (in shares) at Sep. 30, 2013</a></td>
<td class="nump">11,144<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abvc_AdjustmentsToAdditionalPaidInCapitalFreshStartAdjustments', window );">Fresh start adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30,495,734)<span></span>
</td>
<td class="nump">30,550,328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,594<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abvc_AdjustmentsToAdditionalPaidInCapitalReorganizationAdjustments', window );">Reorganization adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,880,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,880,244)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(70)<span></span>
</td>
<td class="num">$ (70)<span></span>
</td>
<td class="num">(70)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at ending at Sep. 18, 2014</a></td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">54,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,594<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at ending (in shares) at Sep. 18, 2014</a></td>
<td class="nump">11,144<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning at Sep. 30, 2013</a></td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">28,670,072<span></span>
</td>
<td class="num">(30,550,258)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,880,174)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at beginning (in shares) at Sep. 30, 2013</a></td>
<td class="nump">11,144<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,235)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at ending at Sep. 30, 2014</a></td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">54,582<span></span>
</td>
<td class="num">(23,235)<span></span>
</td>
<td class="nump">31,359<span></span>
</td>
<td class="nump">31,359<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at ending (in shares) at Sep. 30, 2014</a></td>
<td class="nump">11,144<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning at Sep. 18, 2014</a></td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">54,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,594<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at beginning (in shares) at Sep. 18, 2014</a></td>
<td class="nump">11,144<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,235)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,235)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at ending at Sep. 30, 2014</a></td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">54,582<span></span>
</td>
<td class="num">(23,235)<span></span>
</td>
<td class="nump">31,359<span></span>
</td>
<td class="nump">31,359<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at ending (in shares) at Sep. 30, 2014</a></td>
<td class="nump">11,144<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock issued as compensation</a></td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock issued as compensation (in shares)</a></td>
<td class="nump">30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abvc_BankruptcySharesIssuedValue', window );">Bankruptcy shares issued</a></td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abvc_BankruptcySharesIssuedShares', window );">Bankruptcy shares issued (in shares)</a></td>
<td class="nump">30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32,281)<span></span>
</td>
<td class="num">(32,281)<span></span>
</td>
<td class="num">(32,281)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at ending at Sep. 30, 2015</a></td>
<td class="nump">$ 60,011<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 24,582<span></span>
</td>
<td class="num">$ (55,516)<span></span>
</td>
<td class="nump">$ 29,078<span></span>
</td>
<td class="nump">633,357<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at ending (in shares) at Sep. 30, 2015</a></td>
<td class="nump">60,011,144<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(353,605)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at ending at Jun. 30, 2016</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,527,273<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvc_AdjustmentsToAdditionalPaidInCapitalFreshStartAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase decrease in additional paid in capital (APIC) resulting from adjustments to additional paid in capital fresh start adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvc_AdjustmentsToAdditionalPaidInCapitalFreshStartAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvc_AdjustmentsToAdditionalPaidInCapitalReorganizationAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase decrease in additional paid in capital (APIC) resulting from adjustments to additional paid in capital reorganization adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvc_AdjustmentsToAdditionalPaidInCapitalReorganizationAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvc_BankruptcySharesIssuedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of bankruptcy shares issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvc_BankruptcySharesIssuedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvc_BankruptcySharesIssuedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of bankruptcy shares issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvc_BankruptcySharesIssuedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of any shares forfeited. Shares issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of stock value of such awards forfeited. Stock issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_MetuBrandsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6791339104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2014</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
<th class="th"><div>Sep. 18, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (315,602)<span></span>
</td>
<td class="num">$ (353,605)<span></span>
</td>
<td class="num">$ (32,281)<span></span>
</td>
<td class="num">$ (70)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDepositOtherAssets', window );">(Increase) decrease in deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,815)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abvc_IncreaseDecreaseInPrepayment', window );">(Increase) decrease in prepayment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,815)<span></span>
</td>
<td class="num">(3,496,185)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent', window );">(Increase) decrease in due from related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities', window );">Increase (decrease) in other payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="num">(300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent', window );">Increase (decrease) in due to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,517<span></span>
</td>
<td class="num">(22,517)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueToOfficersAndStockholdersCurrent', window );">Increase (decrease) in due to shareholder</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,586<span></span>
</td>
<td class="num">(46,586)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties', window );">Increase (decrease) in accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">11,446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations', window );">Net cash used in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,871<span></span>
</td>
<td class="num">(3,857,447)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations', window );">Net cash provided (used) by investing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from short term loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">948,959<span></span>
</td>
<td class="nump">897,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations', window );">Net cash provided(used) by financing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">948,959<span></span>
</td>
<td class="nump">2,947,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect Of Exchange Rates On Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net increase(decrease) in cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">994,830<span></span>
</td>
<td class="num">(909,926)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">994,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">994,830<span></span>
</td>
<td class="nump">84,904<span></span>
</td>
<td class="nump">994,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosure of non-cash activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Interest paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) from continuing operations</a></td>
<td class="num">$ (23,235)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32,281)<span></span>
</td>
<td class="num">(70)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock issued as compensation</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">(Increase) decrease in accounts receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,238<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">(Increase) decrease in inventory</a></td>
<td class="num">(795)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">521<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Increase (decrease) in accrued expenses</a></td>
<td class="nump">17,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,120<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations', window );">Net cash used in operating activities</a></td>
<td class="num">(6,795)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,360<span></span>
</td>
<td class="nump">1,168<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Acquisition of intangible assets</a></td>
<td class="num">(64,594)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations', window );">Net cash provided (used) by investing activities</a></td>
<td class="num">(64,594)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abvc_ProceedsFromFreshStartAdjustments', window );">Fresh start adjustment</a></td>
<td class="nump">30,389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abvc_ProceedsFromCapitalInjectionToBankruptcyTrustee', window );">Capital injection to bankruptcy trustee</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from related party</a></td>
<td class="nump">9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from note payable</a></td>
<td class="nump">7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations', window );">Net cash provided(used) by financing activities</a></td>
<td class="nump">71,389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net increase(decrease) in cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,360<span></span>
</td>
<td class="nump">1,168<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,360<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">618<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash, end of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 3,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,360<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosure of non-cash activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Interest paid</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abvc_NonCashFreshStartAdjustment', window );">Fresh start adjustment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">30,550,328<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReorganizationItems', window );">Bankruptcy reorganization</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,880,244<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvc_IncreaseDecreaseInPrepayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information pertaining to increase decrease in prepayment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvc_IncreaseDecreaseInPrepayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvc_NonCashFreshStartAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from debt non cash fresh start adjustment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvc_NonCashFreshStartAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvc_ProceedsFromCapitalInjectionToBankruptcyTrustee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from capital injection to bankruptcy trustee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvc_ProceedsFromCapitalInjectionToBankruptcyTrustee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvc_ProceedsFromFreshStartAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from fresh start adjustment..</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvc_ProceedsFromFreshStartAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDepositOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in moneys or securities given as security including, but not limited to, contract, escrow, or earnest money deposits, retainage (if applicable), deposits with clearing organizations and others, collateral, or margin deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDepositOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate increase (decrease) during the reporting period in the amount due from the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDueToOfficersAndStockholdersCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in current obligations (due within one year or one operating cycle) owed to reporting entity's executives and owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDueToOfficersAndStockholdersCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for interest during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReorganizationItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total amount of reorganization items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=34712771&amp;loc=d3e56145-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=64805424&amp;loc=d3e55730-112764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReorganizationItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_MetuBrandsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6779709792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND DESCRIPTION OF BUSINESS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">ORGANIZATION AND DESCRIPTION OF BUSINESS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>1.
ORGANIZATION AND DESCRIPTION OF BUSINESS</b>&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">American
BriVision (Holding) Corporation (the &#147;Company&#148; or &#147;Holding entity&#148;), a Nevada corporation, thru the Company&#146;s
operating entity, American BriVision Corporation (&#147;BriVision&#148;), which was incorporated in July 2015 in the State of
Delaware, engages in biotechnology and focuses on the development of new drugs and innovative medical devices to fulfill unmet
medical needs. &#160;The business model of the Company is to integrate research achievements from world-famous institutions (such
as Memorial Sloan Kettering Cancer Center (&#147;MSKCC&#148;) and MD Anderson Cancer Center), conduct clinical trials of translational
medicine for Proof of Concept (&#147;POC&#148;), out-license to international pharmaceutical companies, and exploit global markets.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><font style="font: 10pt Times New Roman, Times, Serif">REVERSE
MERGER</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
February 8, 2016, a Share Exchange Agreement (&#147;Share Exchange Agreement&#148;) was entered into by and among American BriVision
(Holding) Corporation (the&#160;&#147;Company&#148;), American BriVision Corporation&#160;(&#147;BriVision&#148;), Euro-Asia
Investment &#38; Finance Corp. Limited, a company incorporated under the laws of Hong Kong Special Administrative Region of Taiwan
(&#147;Euro-Asia&#148;), being the owners of record of 52,336,000 shares of common stock of the Company, and the owners of record
of all of the issued share capital of BriVision (the&#160;&#147;BriVision Stock&#148;). Pursuant to the Share Exchange Agreement,
upon surrender by the BriVision Shareholders and the cancellation by BriVision of the certificates evidencing the BriVision Stock
as registered in the name of each BriVision Shareholder, and pursuant to the registration of the Company in the register of members
maintained by BriVision as the new holder of the BriVision Stock and the issuance of the certificates evidencing the aforementioned
registration of the BriVision Stock in the name of the Company, the Company should issue 52,936,583 shares (the&#160;&#147;Acquisition
Stock&#148;) (subject to adjustment for fractionalized shares as set forth below) of the Company&#146;s common stock to the
BriVision Shareholders (or their designees), and 51,945,225 shares of the Company&#146;s common stock owned by Euro-Asia should
be cancelled and retired to treasury. The Acquisition Stock collectively should represent 79.70% of the issued and outstanding
common stock of the Company immediately after the Closing, in exchange for the BriVision Stock, representing 100% of the issued
share capital of BriVision.&#160;&#160;Because of the exchange of the BriVision Stock for the Acquisition Stock (the&#160;&#147;Share
Exchange&#148;), BriVision became a wholly owned subsidiary (the &#147;Subsidiary&#148;) of the Company and there was a change
of control of the Company following the closing.&#160;&#160;There were no warrants, options or other equity instruments issued
in connection with the share exchange agreement.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Because&#160;of
the consummation of the Share Exchange,&#160;BriVision&#160;is now our wholly owned subsidiary and its shareholders own approximately&#160;79.70%
of our issued and outstanding common stock.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.2pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Following
the Share Exchange, we have abandoned our prior business plan and we are now pursuing&#160;BriVision&#146;s&#160;historical businesses
and proposed businesses, which focus on the development of new drugs and innovative medical devices to fulfill unmet medical needs.&#160;&#160;The
business model of the Company is to integrate research achievements from world-famous institutions, conduct clinical trials of
translational medicine for Proof of Concept (&#147;POC&#148;), out-license to international pharmaceutical companies, and exploit
global markets.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.2pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">Accounting
Treatment of the Reverse Merger</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">For
financial reporting purposes, the Share Exchange represents a&#160;&#147;reverse merger&#148;&#160;rather than a business combination
and&#160;BriVision&#160;is deemed the accounting acquirer in the transaction. The&#160;Share Exchange is being accounted for as
a reverse-merger and recapitalization. BriVision&#160;is the acquirer for financial reporting purposes and the&#160;Company&#160;is
the acquired company. Consequently, the assets and liabilities and the operations reflected in the historical financial statements
prior to the Share Exchange will be those of&#160;BriVision&#160;and recorded at the historical cost basis of&#160;BriVision.
In addition, the consolidated financial statements after completion of the Share Exchange will include the assets and liabilities
of the Company and BriVision, and the historical operations of&#160;BriVision&#160;and operations of the Combined Company from
the closing date of the Share Exchange.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=35735333&amp;loc=d3e288-107754<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 272<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6373374&amp;loc=d3e70478-108055<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=d3e5614-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6778367520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><u>Basis
of Presentation</u></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
accompanying audited financial statements and related notes have been prepared in accordance with generally accepted accounting
principles in the United States of America (U.S. GAAP). This basis of accounting involves the application of accrual accounting.
Consequently, revenues and gains are recognized when earned, and expenses and losses are recognized when incurred. The Company&#146;s
financial statements are expressed in U.S. dollars. The condensed financial statements include all adjustments that, in the opinion
of management, are necessary in order not to make the financial statements misleading.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Certain
information and footnote disclosure normally included in financial statements prepared in accordance with US GAAP have been condensed
or omitted. The results of operations for the periods ended June 30, 2016 are not necessarily indicative of the operating results
for the full year.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><u>Use
of Estimates</u></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of
the consolidated financial statements and the amount of revenues and expenses during the reporting periods. Actual results could
differ materially from those results.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><u>Forward
Stock split</u></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
March 21, 2016, the Board of Directors of the Company approved an amendment to Articles of Incorporation to effect a forward split
at a ratio of 1 to 3:141 and increase the number of our authorized shares of common stock, par value $0.001 per share, to 360,000,000,
which was effective on April 8, 2016. The majority of the shareholders of the Company approved the amendment to Articles of Incorporation.
See Note 4 for more details.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><u>Fair
Value Measurements</u></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company applies the provisions of ASC Subtopic 820-10,&#160;&#147;Fair Value Measurements&#148;,&#160;for fair value measurements
of financial assets and financial liabilities and for fair value measurements of nonfinancial items that are recognized or disclosed
at fair value in the financial statements.&#160;&#160;ASC 820 also establishes a framework for measuring fair value and expands
disclosures about fair value measurements.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Fair
value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction
between market participants at the measurement date.&#160;&#160;When determining the fair value measurements for assets and liabilities,
the Company considers the principal or most advantageous market in which it would transact and it considers assumptions that market
participants would use when pricing the asset or liability.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">ASC
820 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of
unobservable inputs when measuring fair value. ASC 820 establishes three levels of inputs to measure fair value. The hierarchy
gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements)
and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements). The three levels of
the fair value hierarchy are as follows:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#149;<font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></b><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#149;</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs
that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial
instruments.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#149;</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Level 3 inputs to the valuation methodology are unobservable and significant to the fair value.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">There
were no assets or liabilities measured at fair value on a recurring basis subject to the disclosure requirements of ASC 820 as
of&#160;September 30, 2015.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><u>Cash
and Cash Equivalents</u></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company considers highly liquid investments with maturities of three months or less, when purchased, to be cash equivalents. As
of June 30, 2016, the Company&#146;s cash and cash equivalents amounted $84,904. As of September 30, 2015, the Company&#146;s
cash and cash equivalents amounted $994,830. All&#160;of the Company&#146;s cash deposits are held in a financial institution
located in PRC where there is currently regulation mandated on obligatory insurance of bank accounts. The Company believes this
financial institution is of high credit quality.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><u>Income
Taxes</u></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.2pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company accounts for income taxes using the asset and liability approach which allows the recognition and measurement of deferred
tax assets to be based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach,
deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities
for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred
tax assets if it is more likely than not these items will expire before the Company is able to realize their benefits, or future
deductibility is uncertain.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.2pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Under
ASC 740, a tax position is recognized as a benefit only if it is&#160;&#147;more likely than not&#148;&#160;that the tax position
would be sustained in a tax examination, with a tax examination being presumed to occur. The evaluation of a tax position is a
two-step process. The first step is to determine whether it is more-likely-than-not that a tax position will be sustained upon
examination, including the resolution of any related appeals or litigations based on the technical merits of that position. The
second step is to measure a tax position that meets the more-likely-than-not threshold to determine the amount of benefits recognized
in the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50 percent likely
of being realized upon ultimate settlement. Tax positions that previously failed to meet the more-likely-than-not recognition
threshold should be recognized in the first subsequent period in which the threshold is met. Previously recognized tax positions
that no longer meet the more-likely-than-not criteria should be de-recognized in the first subsequent financial reporting period
in which the threshold is no longer satisfied. Penalties and interest incurred related to underpayment of income tax are classified
as income tax expense in the year incurred. No significant penalty or interest relating to income taxes has been incurred during
the period from July 21, 2015 (inception) to September 30, 2015. GAAP also provides guidance on de-recognition, classification,
interest and penalties, accounting in interim periods, disclosures and transition.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">As
of June 30, 2016 and September 30, 2015, the Company&#146;s income tax expense amounted $836 and $0, respectively.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><u>Recent
Accounting Pronouncements</u></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">From
time to time, new accounting standards issued by the Financial Accounting Standards Board (&#147;FASB&#148;) or other standard
setting bodies are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes
that the impact of recently issued standards that are not yet effective will not have a material impact on its financial position
or results of operations upon adoption. The recent accounting standards are not expected to have a material impact on the consolidated
financial statements upon adoption.</font></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Note
1 &#151; Summary of Significant Accounting Policies</b></font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif"><b><i>Description
of the Company.&#160;&#160; </i></b>We were originally incorporated on March 12, 1990 in California (&#147;Ecology-CA&#148;).&#160;&#160;Our
current entity was incorporated in Nevada on February&#160;6, 2002 as OCIS Corp. (&#147;OCIS&#148;).&#160;&#160;OCIS completed
a merger with Ecology-CA on July&#160;26, 2007 (the &#147;Merger&#148;). In the Merger, OCIS changed its name from OCIS Corporation
to Ecology Coatings, Inc.&#160;&#160;The Company filed for Chapter 7 bankruptcy protection on May 15, 2013 and subsequently the
corporate shell emerged as its only unencumbered asset on September 19, 2014 using "fresh start" accounting under section 852-10-45-17
as of date of sale corporate shell to reflect intangible assets sale through section 363. On April 28, 2015 the Company amended
its articles of incorporation to change its name to Metu Brands, Inc. Any business description below and all reporting results
of the operating results reported in this filing for the fiscal period ending September 30, 2014 are post "fresh start" activity
and not comparable to prior results. Post bankruptcy the company has been operating a web site for the sale of women's apparel.</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif"><b><i>Reclassifications.
</i></b>&#160;&#160;Reclassifications have been made to the prior year financial statements to conform with the current year presentation.</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif"><b><i>Basis
of Preparation.</i></b> The financial statements of the Company have been prepared in accordance with generally accepted accounting
principles in the United States of America and are presented in US dollars.</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif"><b><i>Principles
of Consolidation.&#160;&#160; </i></b>The consolidated financial statements include all of our accounts and the accounts of our
wholly owned subsidiary Ecology-CA.&#160;&#160;All significant intercompany transactions have been eliminated in consolidation.</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif"><b><i><u>Use
of Estimates.</u>&#160;&#160; </i></b>The preparation of financial statements in conformity with accounting principles generally
accepted in the United States of America requires management to make estimates and assumptions that affect the amounts of assets
and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting
period. Actual results could differ from those estimates.</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif"><b><i><u>Revenue
Recognition.&#160;</u>&#160; </i></b>The Company applies paragraph 605-10-S99-1 of the FASB Accounting Standards Codification
for revenue recognition. The Company recognizes revenue when it is realized or realizable and earned. The Company considers revenue
realized or realizable and earned when all of the following criteria are met: (i) persuasive evidence of an arrangement exists,
(ii) the sales price is fixed or determinable, (iii) collectability is reasonably assured and (iv) goods have been shipped and/or
services rendered.</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif"><b><i>Loss
Per Share.</i></b> Basic loss per share is computed by dividing the net loss available to common shareholders by the weighted
average number of shares of common stock outstanding during the period.&#160;&#160;Diluted loss per share is computed by dividing
the net loss available to common shareholders by the weighted average number of shares of common stock and potentially dilutive
securities outstanding during the period.&#160;&#160;Potentially dilutive shares consist of the incremental common shares issuable
upon the exercise of stock options and warrants and the conversion of convertible debt and convertible preferred stock. Potentially
dilutive shares are excluded from the weighted average number of shares if their effect is anti-dilutive.&#160;&#160;None of the
stock options or warrants outstanding or stock associated with the convertible debt or with the convertible preferred shares during
each of the periods presented was included in the computation of diluted loss per share as they were anti-dilutive.&#160;&#160;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif"><b><i>Property
and Equipment.&#160;&#160; </i></b>Property and equipment is stated at cost less accumulated depreciation.&#160;&#160;Depreciation
is recorded using the straight-line method over the following useful lives:</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; width: 90%; margin-left: 0.5in; border-collapse: collapse; font-size-adjust: none; font-stretch: normal">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 70%; text-align: center; font: bold 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif"><b>Computer
    equipment</b></font></td>
    <td style="width: 30%; text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">3-10
    years</font></td></tr>
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: center; font: bold 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif"><b>Furniture
    and fixtures</b></font></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">3-7
    years</font></td></tr>
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: center; font: bold 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif"><b>Test
    equipment</b></font></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">5-7
    years</font></td></tr>
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: center; font: bold 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif"><b>Signs</b></font></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">7
    years</font></td></tr>
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: center; font: bold 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif"><b>Software</b></font></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">3
    years</font></td></tr>
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: center; font: bold 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif"><b>Marketing
    and Promotional Video</b></font></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">3
    years</font></td></tr>
</table>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif">Repairs
and maintenance costs are charged to operations as incurred. Betterments or renewals are capitalized as incurred.</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif"><b><i>Patents.&#160;&#160;
</i></b>It is our policy to capitalize costs associated with securing a patent.&#160;&#160;Costs consist of legal and filing fees.&#160;&#160;Once
a patent is issued, it will be amortized on a straight-line basis over its estimated useful life.&#160;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif"><b><i>Long-Lived
Assets.</i></b> We review long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying
amount of an asset may not be recoverable.&#160;&#160;Recoverability of assets to be held and used is measured by a comparison
of the carrying amount of an asset to the undiscounted future net cash flows expected to be generated by the asset.&#160;&#160;If
such assets are considered to be impaired, the impairment recognized is measured by the amount by which the carrying amount of
the assets exceeds the fair value of the assets.</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif"><b><i>Stock-Based
Compensation.&#160;&#160; </i></b>Employee and director stock-based compensation expense is measured utilizing the fair-value
method with expense charged to earnings over the vesting period on a straight-line basis.</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif">We
account for stock options granted to non-employees under the fair-value method with stock-based compensation expense being charged
to earnings on the earlier of the date services are performed or a performance commitment exists.</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b><i>Recent
Accounting Pronouncements</i></b></font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif">We
have reviewed all Accounting Standards Updates issued by the Financial Accounting Standards Board since we last issued financial
statements and have determined none of them would have a material effect on the consolidated financial statements upon adoption.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and accounting policies concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_MetuBrandsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6780253136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COLLAOBRATIVE AGREEMENT<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abvc_CollaobrativeAgreementAbstract', window );"><strong>Collaobrative Agreement</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abvc_CallaobrativeAgreementDisclosureTextBlock', window );">COLLAOBRATIVE AGREEMENT</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>3.
COLLAOBRATIVE AGREEMENT</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">On
December 29, 2015, American BriVision Corporation entered into a Collaborative Agreement with BioLite Inc., a related party, pursuant
to which BioLite granted the Company sole licensing rights for drug and therapeutic use of five products: BLI-1005 CNS-Major Depressive
Disorder; BLI-1008 CNS-Attention Deficit Hyperactivity Disorder; BLI-1401-1 Anti-Tumor Combination Therapy-Solid Tumor with Anti-PD-1;
BLI-1401-2 Anti-Tumor Combination Therapy-Triple Negative Breast Cancer; and BLI-1501 Hematology-Chronic Lymphocytic Leukemia,
in USA and Canada. The total consideration of obtaining such grant would be $100,000,000.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">Pursuant
to the Collaborative Agreement, an upfront payment of $3,500,000 (the &#147;Milestone Payment&#148;), which is 3.5% of total
payments due under the Collaborative Agreement, was to be paid by the Company upon signing of that agreement. On May 6 , 2016,
we and Biolite agreed to amend the Collaborative Agreement, through entry into the Milestone Payment Agreement, whereby we have
agreed to pay the Milestone Payment to BioLite $2,600,000 in cash and $900,000 in newly issued shares of our common stock, at
the price of $1.60 per share, for an aggregate number of 562,500 shares. The cash payment and shares issuance were completed in
June 2016.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">This
Collaborative Agreement shall, once signed by both Parties, remain in effect for fifteen years as of the first commercial sales
of the Product in the Territory and automatically renew for five more years unless either party gives the other party six month
written notice of termination prior to the expiration date of the term.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The
Company determined to record the intangible assets and begin to amortize once the first commercial sales was consummated.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The
process related to first commercial sales has not begun as of June 30, 2016.&#160;The Company cannot&#160;make a reasonably reliable&#160;estimate&#160;of
when the first commercial sales would take place.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvc_CallaobrativeAgreementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure pertaining to the information about callaobrative agreement with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvc_CallaobrativeAgreementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvc_CollaobrativeAgreementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvc_CollaobrativeAgreementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6771483392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fresh Start Accounting<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2015</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abvc_FreshStartAdjustmentTextBlock', window );">Fresh Start Accounting</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Note
2 &#151; "Fresh Start" Accounting</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><font style="font: 10pt Times New Roman, Times, Serif">METU
BRANDS, INC.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><font style="font: 10pt Times New Roman, Times, Serif">(Formerly
Ecology Coatings, Inc.)</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><font style="font: 10pt Times New Roman, Times, Serif">FRESH
START ADJUSTMENTS</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"></font></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td nowrap="nowrap" style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" nowrap="nowrap" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">9/19/2014</font></td>
    <td nowrap="nowrap" style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td nowrap="nowrap" style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" nowrap="nowrap" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Dr(CR)<br />Reorganization<br />Adjustments</font></td>
    <td nowrap="nowrap" style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td nowrap="nowrap" style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" nowrap="nowrap" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Dr(CR)
    Fresh Start<br />Adjustments</font></td>
    <td nowrap="nowrap" style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td nowrap="nowrap" style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" nowrap="nowrap" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">9/19/2014</font></td>
    <td nowrap="nowrap" style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Assets</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Current assets</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="width: 40%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;Cash</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right; width: 11%"><font style="font: 10pt Times New Roman, Times, Serif">548</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; width: 11%"><font style="font: 10pt Times New Roman, Times, Serif">(548</font></td>
    <td style="text-align: left; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">) (1)</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; width: 11%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right; width: 11%"><font style="font: 10pt Times New Roman, Times, Serif">0</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;Accounts
    receivable</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,238</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">(1,238</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">)
    (1)</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;Total
    Current Assets</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,786</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;Property,
    plant and equipment, net</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">37,249</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(37,249</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">) (1)</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;Intangible
    assets, net</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">192,864</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">(192,864</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">)
    (1)</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">54,594</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">(2)</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">54,594</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;Total
    Assets</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">231,899</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">54,594</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Liabilities and Equity
    (Deficit)</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total liabilities subject
    to compromise</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,112,143</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,112,143 </font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">(1)</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Commitments and Contingencies
    (Note 5)</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Metu Brands, Inc. ("MTOO")
    shareholders' deficit</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;Predecessor
    Preferred Stock 10,000,000 authorized at $0.001 par value shares issued and outstanding 271 at September 19, 2014</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1 </font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">(3)</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;Successor
    Preferred Stock 10,000,000 authorized at $0.001 par value; shares issued and outstanding 54,593,032 at September 19, 2014</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1 </font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">(2)</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;Predecessor/Successor
    Common Stock 90,000,000 authorized at $0.001 par value; shares issued and outstanding 54,593,032 at September 19, 2014</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">54,593</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">54,593</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;Additional
    paid-in capital</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">28,615,490</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1,880,244</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">) (1)</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">30,495,734</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">(3)</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;Retained
    earnings</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(30,550,328</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">(30,550,328)</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">(4)</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;Total
    equity (deficit)</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1,880,244</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">54,594</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;Total
    liabilities and equity (deficit)</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">231,899</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">54,594</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif">(1)
Reorganization adjustments reflect the transfer of $2,112,143 of liabilities subject to compromise and assets to the bankruptcy
trustee in accordance with the plan of bankruptcy provisions.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif">(2)
Fresh-start adjustments under section 852-10-45-17 as of the date of sale of the corporate shell to reflect intangible assets
sale through section 363 of the bankruptcy code.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif">(3)
Fresh-start adjustments under ASC 852-10-45-17 to predecessor preferred stock and APIC reflect the cancellation of the predecessor&#146;s
preferred stock.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif">(4)
Fresh-start adjustment to retained earnings (accumulated deficit) resets accumulated deficit to zero.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif">(5)
$20,000 was paid to the trustee by Shulamit Lazar for the subsequent issue of 30,000,000 common shares and $5,000 was paid to
the trustee by Innovation Consulting LLC for the purchase of 271 preferred shares.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvc_FreshStartAdjustmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure about fresh start adjustment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvc_FreshStartAdjustmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_MetuBrandsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6633948256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTIES TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTIES TRANSACTIONS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>4.
RELATED PARTIES TRANSACTIONS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">As
of June 30, 2016 and September 30, 2015, the amount due to a related party, BioLite, Inc (&#147;Biolite&#148;) was $0
and $22,517 respectively.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">As
of June 30, 2016 and September 30, 2015, the amount due to shareholder, YuanGene Corporation, was $0 and $46,586 respectively.</font></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTIES TRANSACTIONS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Note
3 &#151; Related Party Transactions</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">We
have borrowed funds for our operations from certain major stockholders, directors and officers as disclosed below.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">We
have an unsecured demand note payable due of $9,000 to Shulamit Lazar, our sole officer and director for funds advanced the Company
through the bankruptcy process. This is unsecured with a zero percent interest rate and is payable on demand.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">As
part of the bankruptcy sale Shulamit Lazar was awarded all 271 of the convertible preferred shares.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">Shulamit
Lazar received compensation of 30,000,000 shares valued at $30,000 during the year ended September 30, 2015.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39678-107864<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_MetuBrandsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6729766096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS PAYABLE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">ACCOUNTS PAYABLE</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>5.
ACCOUNTS PAYABLE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">As
of June 30, 2016 and September 30, 2015, the amount Accounts Payable to LiteArt, Inc. was $11,446 and $0 respectively.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6758675952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2015</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTextBlock', window );">Notes Payable</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Note
4 &#151; Notes Payable</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">We
have the following notes as of September 30, 2015 and 2014:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">Post
bankruptcy the Company acquired the assets of Metu Brands Inc. (a ready to operate web site business). &#160;In addition to a
$3,000 deposit the Company signed a note payable for $7,000. This note was due September 24, 2014 and carries a zero percent interest
rate. This note is note in default.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for short-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_MetuBrandsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6619740832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUTIY<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">EQUTIY</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>6.
EQUTIY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">During
October 2015, $350,000 of subscription receivable was fully collected from the shareholders.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
March 21, 2016, the Board of Directors of the Company approved an amendment to Articles of Incorporation to effect a forward split
at a ratio of 1 to 3:141 (the &#147;Forward&#160;Stock&#160;Split&#148;) and increase the number of our authorized shares of
common stock, par value $0.001 per share, to 360,000,000, which was effective on April 8, 2016.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
majority of the shareholders of the Company approved the amendment to Articles of Incorporation.</font></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">EQUTIY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Note
6 &#151; Equity</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">Common
Stock</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2014 the Company had 11,144 common shares issued and outstanding and 90,000,000 shares of Common Stock authorized
par value $0.001 and the holders of the Company's common stock are entitled to one vote per each share of common stock held. Additionally
as part of the bankruptcy sale the Company has had a reverse stock split of &#160;5,000 for 1 on August 13, 2014 which has been
reflected retroactively in these financial statements. 30,000,000 shares of common stock was issued to Shulamit Lazar for her
initial $20,000 deposit to purchase the company. The Company also issued 30,000,000 shares of common stock in the year ended September
30, 2015 to a related party (Shulamit Lazar) for services valued at $30,000. As of September 30, 2015 the company had 60,011,144
common shares outstanding.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">Preferred
Stock</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2015 the Company had 10,000,000 shares of Preferred Stock authorized par value $.001 and the holders of the Company's
Preferred Stock can convert each share into 100,000 shares of voting Common Stock. Additionally each Preferred Share is entitled
to the voting rights 100,000 common stock shares. Subsequent to the date of these financial statements but prior to issuance the
preferred shares have been amended to carry voting and conversion rights equal to 20,000 common shares each. The Company had 271
shares issued during bankruptcy to Innovation Consulting LLC for $5,000 and 271 shares were issued and outstanding as of September
30, 2015.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74567-122707<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21484-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21488-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Preferred Stock<br> -URI http://asc.fasb.org/extlink&amp;oid=6521494<br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_MetuBrandsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6760801328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>7.
COMMITMENTS AND CONTINGENCIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Capital
Commitment</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
December 29, 2015, the Company entered into the agreement with Biolite, a related party, that Biolite would grant the Company
sole licensing rights of a series of technology for 10 years. The total consideration of obtaining such grant would be $100,000,000.</font></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Note
5 &#151; Commitments and Contingencies</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">Contingencies.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">All
contingencies have been settled through our bankruptcy petition in September 2014 subsequent to this financial reporting period.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">Lease
Commitments.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">None.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6449706&amp;loc=d3e16207-108621<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14435-108349<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=73718637&amp;loc=d3e25287-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_MetuBrandsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6593462560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Options<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2015</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock Options</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Note
7 &#151; Stock Options</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">There
were no stock options issued during the fiscal years ended September 30 2015 and 2014. &#160;As part of our bankruptcy agreement
approved on September 19, 2014 all common conversion rights of any kind including the equity compensation plan without limitation
, warrants, options and convertible notes were cancelled and extinguished for the current and prior fiscal years.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65895303&amp;loc=d3e17540-113929<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68057994&amp;loc=d3e25284-112666<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5444-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_MetuBrandsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6787738960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2015</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Note
8 &#151; Income Taxes</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2015, the Company had approximately $85,516 in post bankruptcy net operating loss carry forwards for federal
income tax purposes which expire between 2015 and 2033. &#160;Generally, these can be carried forward and applied against future
taxable income at the tax rate applicable at that time. We are currently using a 15% effective tax rate for our projected available
net operating loss carry-forward. However, as a result of potential stock offerings and stock issuance in connection with potential
acquisitions, as well as the possibility of the Company not realizing its business plan objectives and having future taxable income
to offset, the Company&#146;s use of these NOLs may be limited under the provisions of Section 382 of the Internal Revenue Code
of 1986, as amended. &#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">Components
of deferred tax assets and (liabilities) are as follows:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellspacing="0" cellpadding="0" style="width: 85%; border-collapse: collapse; font-size: 10pt; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2015</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2014</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left; width: 72%"><font style="font: 10pt Times New Roman, Times, Serif">Net operating
    loss carry forwards valuation available</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right; width: 11%"><font style="font: 10pt Times New Roman, Times, Serif">85,516</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right; width: 11%"><font style="font: 10pt Times New Roman, Times, Serif">23,235</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Valuation Allowances</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(29,075</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(3,485</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">Deferred
    Tax Asset</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">29,075</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,485</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">Net
    Deferred Tax Asset</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-0-</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-0-</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">In
accordance with FASB ASC 740 &#147;Income Taxes&#148;, valuation allowances are provided against deferred tax assets, if based
on the weight of available evidence, some or all of the deferred tax assets may or will not be realized. The Company has evaluated
its ability to realize some or all of the deferred tax assets on its balance sheet for the coming year and has established a valuation
allowance in the amount of $29,075 at September 30, 2015 During the period ended September 30, 2015 the company did not utilize
any of its NOL.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32718-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_MetuBrandsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6780308512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Going Concern<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2015</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock', window );">Going Concern</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Note
9 &#150; Going Concern</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern. Currently, the
Company has limited post bankruptcy operations and a working capital deficit as of September 30, 2015. These factors raise substantial
doubt about the Company&#146;s ability to continue as a going concern. Management believes that the Company&#146;s capital requirements
will depend on many factors including the success of the Company&#146;s development efforts and its efforts to raise capital.
Management also believes the Company needs to raise additional capital for working capital purposes. There is no assurance that
such financing will be available in the future. &#160;&#160;The conditions described above raise substantial doubt about our ability
to continue as a going concern. The financial statements of the Company do not include any adjustments relating to the recoverability
and classification of recorded assets, or the amounts and classifications of liabilities that might be necessary should the Company
be unable to continue as a going concern.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 40<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=64819266&amp;loc=SL51888449-203568<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 40<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=64819266&amp;loc=SL51888443-203568<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubstantialDoubtAboutGoingConcernTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_MetuBrandsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6758675952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2015</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Note
10 - Acquisitions</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">On
September 25, 2014 the company entered into an agreement to buy the ready to operate business assets of Metu Brands Inc. The cost
of this acquisition was $10,000 which was allocated $795 to inventory and $9,205 to the intangible assets of the "MeTu" trade
name and web site MeTuBoutique.com.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1497-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1490-128463<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1392-128463<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7008-128479<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1486-128463<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1524-128463<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7000-128479<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4922-128472<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4934-128472<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4926-128472<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=SL65897772-128472<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1383-128463<br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6996-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_MetuBrandsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6780245632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2015</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income (Loss) Per Share</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Note
11 - Net Income (Loss) Per Share</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The
Company reports basic and diluted earnings per share (EPS) according to the provisions of ASC Topic 260, which requires the presentation
of basic EPS and, for companies with complex capital structures, diluted EPS. Basic EPS excludes dilution and is computed by dividing
net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period.
Diluted EPS is computed by dividing net income (loss) available to common stockholders, adjusted by other changes in income or
loss that would result from the assumed conversion of those potential common shares, by the weighted number of common shares and
common share equivalents (unless their effect is anti-dilutive) outstanding. Common stock equivalents are not included in the
computation of diluted earnings per share when the Company reports a loss because to do so would be anti-dilutive. Thus, these
equivalents are not included in the calculation of diluted loss per share, resulting in basic and diluted loss per share being
equal. The following is a reconciliation of the computation for basic and diluted EPS for the years ended September 30, 2015 and
2014:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellspacing="0" cellpadding="0" style="width: 85%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: bottom">
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2015</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2014</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt; width: 72%"><font style="font: 10pt Times New Roman, Times, Serif">Net
    (Loss)</font></td>
    <td style="padding-bottom: 1pt; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right; width: 11%"><font style="font: 10pt Times New Roman, Times, Serif">(32,281</font></td>
    <td style="text-align: left; padding-bottom: 1pt; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td style="padding-bottom: 1pt; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right; width: 11%"><font style="font: 10pt Times New Roman, Times, Serif">(23,235</font></td>
    <td style="text-align: left; padding-bottom: 1pt; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td colspan="9"><font style="font: 10pt Times New Roman, Times, Serif">Weighted-average common shares outstanding
    basic</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Weighted-average common
    stock equivalents</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,000,929</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">11,144</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;Stock options</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;Warrants</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;Preferred
    stock</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">27,100,000</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">27,100,000</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">Weighted-average
    common shares outstanding - basic and diluted</font></td>
    <td style="padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,303,773</font></td>
    <td style="text-align: left; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">10,000</font></td>
    <td style="text-align: left; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=65016374&amp;loc=d3e4984-109258<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_MetuBrandsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6758675952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2015</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Note
11 - Subsequent Events</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">We
have evaluated subsequent events and transactions that occurred through the date and time our financial statements were issued
for potential recognition or disclosure in the accompanying financial statements. Other than the change in preferred shares rights
itemized in note 6 above, we did not identify any events or transactions that should be recognized or disclosed in the accompanying
financial statements.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_MetuBrandsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6769404576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><u>Basis
of Presentation</u></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
accompanying audited financial statements and related notes have been prepared in accordance with generally accepted accounting
principles in the United States of America (U.S. GAAP). This basis of accounting involves the application of accrual accounting.
Consequently, revenues and gains are recognized when earned, and expenses and losses are recognized when incurred. The Company&#146;s
financial statements are expressed in U.S. dollars. The condensed financial statements include all adjustments that, in the opinion
of management, are necessary in order not to make the financial statements misleading.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Certain
information and footnote disclosure normally included in financial statements prepared in accordance with US GAAP have been condensed
or omitted. The results of operations for the periods ended June 30, 2016 are not necessarily indicative of the operating results
for the full year.</font></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><u>Use
of Estimates</u></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of
the consolidated financial statements and the amount of revenues and expenses during the reporting periods. Actual results could
differ materially from those results.</font></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abvc_ForwardStockSplitPolicyTextBlock', window );">Forward Stock split</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><u>Forward
Stock split</u></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
March 21, 2016, the Board of Directors of the Company approved an amendment to Articles of Incorporation to effect a forward split
at a ratio of 1 to 3:141 and increase the number of our authorized shares of common stock, par value $0.001 per share, to 360,000,000,
which was effective on April 8, 2016. The majority of the shareholders of the Company approved the amendment to Articles of Incorporation.
See Note 4 for more details.</font></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><u>Fair
Value Measurements</u></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company applies the provisions of ASC Subtopic 820-10,&#160;&#147;Fair Value Measurements&#148;,&#160;for fair value measurements
of financial assets and financial liabilities and for fair value measurements of nonfinancial items that are recognized or disclosed
at fair value in the financial statements.&#160;&#160;ASC 820 also establishes a framework for measuring fair value and expands
disclosures about fair value measurements.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Fair
value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction
between market participants at the measurement date.&#160;&#160;When determining the fair value measurements for assets and liabilities,
the Company considers the principal or most advantageous market in which it would transact and it considers assumptions that market
participants would use when pricing the asset or liability.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">ASC
820 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of
unobservable inputs when measuring fair value. ASC 820 establishes three levels of inputs to measure fair value. The hierarchy
gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements)
and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements). The three levels of
the fair value hierarchy are as follows:&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#149;</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#149;</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs
that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial
instruments.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#149;</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Level 3 inputs to the valuation methodology are unobservable and significant to the fair value.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">There
were no assets or liabilities measured at fair value on a recurring basis subject to the disclosure requirements of ASC 820 as
of&#160;September 30, 2015.</font></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><u>Cash
and Cash Equivalents</u></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company considers highly liquid investments with maturities of three months or less, when purchased, to be cash equivalents. As
of June 30, 2016, the Company&#146;s cash and cash equivalents amounted $84,904. As of September 30, 2015, the Company&#146;s
cash and cash equivalents amounted $994,830. All&#160;of the Company&#146;s cash deposits are held in a financial institution
located in PRC where there is currently regulation mandated on obligatory insurance of bank accounts. The Company believes this
financial institution is of high credit quality.</font></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><u>Income
Taxes</u></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.2pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company accounts for income taxes using the asset and liability approach which allows the recognition and measurement of deferred
tax assets to be based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach,
deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities
for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred
tax assets if it is more likely than not these items will expire before the Company is able to realize their benefits, or future
deductibility is uncertain.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.2pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Under
ASC 740, a tax position is recognized as a benefit only if it is&#160;&#147;more likely than not&#148;&#160;that the tax position
would be sustained in a tax examination, with a tax examination being presumed to occur. The evaluation of a tax position is a
two-step process. The first step is to determine whether it is more-likely-than-not that a tax position will be sustained upon
examination, including the resolution of any related appeals or litigations based on the technical merits of that position. The
second step is to measure a tax position that meets the more-likely-than-not threshold to determine the amount of benefits recognized
in the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50 percent likely
of being realized upon ultimate settlement. Tax positions that previously failed to meet the more-likely-than-not recognition
threshold should be recognized in the first subsequent period in which the threshold is met. Previously recognized tax positions
that no longer meet the more-likely-than-not criteria should be de-recognized in the first subsequent financial reporting period
in which the threshold is no longer satisfied. Penalties and interest incurred related to underpayment of income tax are classified
as income tax expense in the year incurred. No significant penalty or interest relating to income taxes has been incurred during
the period from July 21, 2015 (inception) to September 30, 2015. GAAP also provides guidance on de-recognition, classification,
interest and penalties, accounting in interim periods, disclosures and transition.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">As
of June 30, 2016 and September 30, 2015, the Company&#146;s income tax expense amounted $836 and $0, respectively.</font></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><u>Recent
Accounting Pronouncements</u></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">From
time to time, new accounting standards issued by the Financial Accounting Standards Board (&#147;FASB&#148;) or other standard
setting bodies are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes
that the impact of recently issued standards that are not yet effective will not have a material impact on its financial position
or results of operations upon adoption. The recent accounting standards are not expected to have a material impact on the consolidated
financial statements upon adoption.</font></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Description of the Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b><i>Description
of the Company</i></b>. &#160;&#160;We were originally incorporated on March 12, 1990 in California (&#147;Ecology-CA&#148;).
&#160;Our current entity was incorporated in Nevada on February 6, 2002 as OCIS Corp. (&#147;OCIS&#148;). &#160;OCIS completed
a merger with Ecology-CA on July 26, 2007 (the &#147;Merger&#148;). In the Merger, OCIS changed its name from OCIS Corporation
to Ecology Coatings, Inc. The Company filed for Chapter 7 bankruptcy protection on May 15, 2013 and subsequently the corporate
shell emerged as its only unencumbered asset on September 19, 2014 using "fresh start" accounting under section 852-10-45-17 as
of date of sale corporate shell to reflect intangible assets sale through section 363. On that same day the Company acquired the
assets of Metu Brands, Inc including the trade name "Metu" in exchange for cash and a note. On April 28, 2015 the Company amended
its articles of incorporation to change its name to Metu Brands, Inc. Any business description below and all reporting results
of the operating results reported in this filing for the fiscal period ending September 30, 2014 are post "fresh start" activity
and not comparable to prior results. Post bankruptcy the company has been operating a web site for the sale of women's apparel.</font></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b><i>Reclassifications</i></b>.
Reclassifications have been made to the prior year financial statements to conform with the current year
presentation.</font></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b><i>Basis
of Preparation</i></b>. The financial statements of the Company have been prepared in accordance with generally accepted accounting
principles in the United States of America and are presented in US dollars.</font></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b><i>Principles
of Consolidation</i></b>. The consolidated financial statements include all of our accounts and the accounts of our wholly
owned subsidiary Ecology-CA. All significant intercompany transactions have been eliminated in consolidation.</font></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b><u>Use
of Estimates</u></b>. The preparation of financial statements in conformity with accounting principles generally accepted
in the United States of America requires management to make estimates and assumptions that affect the amounts of assets and liabilities
at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual
results could differ from those estimates.</font></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p><font style="font: 10pt Times New Roman, Times, Serif"><b><u>Revenue Recognition</u></b>. The
Company applies paragraph 605-10-S99-1 of the FASB Accounting Standards Codification for revenue recognition. The Company recognizes
revenue when it is realized or realizable and earned. The Company considers revenue realized or realizable and earned when all
of the following criteria are met: (i) persuasive evidence of an arrangement exists, (ii) the sales price is fixed or determinable,
(iii) collectability is reasonably assured and (iv) goods have been shipped and/or services rendered.</font></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Loss Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p><font style="font: 10pt Times New Roman, Times, Serif"><b><i>Loss Per Share</i></b>. Basic loss per share
is computed by dividing the net loss available to common shareholders by the weighted average number of shares of common stock
outstanding during the period. &#160;Diluted loss per share is computed by dividing the net loss available to common shareholders
by the weighted average number of shares of common stock and potentially dilutive securities outstanding during the period. Potentially
dilutive shares consist of the incremental common shares issuable upon the exercise of stock options and warrants and the conversion
of convertible debt and convertible preferred stock. Potentially dilutive shares are excluded from the weighted average number
of shares if their effect is anti-dilutive. None of the stock options or warrants outstanding or stock associated with the
convertible debt or with the convertible preferred shares during each of the periods presented was included in the computation
of diluted loss per share as they were anti-dilutive.</font></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b><i>Property
and Equipment</i></b>. Property and equipment is stated at cost less accumulated depreciation. sDepreciation
is recorded using the straight-line method over the following useful lives:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellspacing="0" cellpadding="0" style="width: 65%; border-collapse: collapse; font-size: 10pt; margin-left: 0.15in">
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left; width: 68%"><font style="font: 10pt Times New Roman, Times, Serif">Computer
    equipment</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: center; width: 31%"><font style="font: 10pt Times New Roman, Times, Serif">3-10
    years</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Furniture and fixtures</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">3-7 years</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Test equipment</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">5-7 years</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Signs</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">7 years</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Software</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">3 years</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Marketing and Promotional
    Video</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">3 years</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">Repairs
and maintenance costs are charged to operations as incurred. Betterments or renewals are capitalized as incurred.</font></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p><font style="font: 10pt Times New Roman, Times, Serif"><b><i>Patents</i>.</b> It is our policy to capitalize
costs associated with securing a patent. Costs consist of legal and filing fees. Once a patent is issued, it will be amortized
on a straight-line basis over its estimated useful life.</font></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Long-Lived Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b><i>Long-Lived
Assets</i></b>. We review long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying
amount of an asset may not be recoverable. &#160;Recoverability of assets to be held and used is measured by a comparison of the
carrying amount of an asset to the undiscounted future net cash flows expected to be generated by the asset. If such assets
are considered to be impaired, the impairment recognized is measured by the amount by which the carrying amount of the assets
exceeds the fair value of the assets.</font></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b><i>Stock-Based
Compensation</i></b>. Employee and director stock-based compensation expense is measured utilizing the fair-value
method with expense charged to earnings over the vesting period on a straight-line basis.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">We
account for stock options granted to non-employees under the fair-value method with stock-based compensation expense being charged
to earnings on the earlier of the date services are performed or a performance commitment exists.</font></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b><i>Recent
Accounting Pronouncements</i></b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">We
have reviewed all Accounting Standards Updates issued by the Financial Accounting Standards Board since we last issued financial
statements and have determined none of them would have a material effect on the consolidated financial statements upon adoption.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvc_ForwardStockSplitPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information pertaining to forward stock split policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvc_ForwardStockSplitPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 305<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6375392&amp;loc=d3e26790-107797<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4273-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=d3e5614-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.3A-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355100-122828<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.3A-02)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355033-122828<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=64802544&amp;loc=d3e202-110218<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32840-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65884525&amp;loc=d3e40913-109327<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32809-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e32247-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e32280-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6003-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=SL51803626-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.B.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6061-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6143-108592<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6132-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_MetuBrandsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6771707776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2015</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of equipment useful life</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">Depreciation
is recorded using the straight-line method over the following useful lives:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellspacing="0" cellpadding="0" style="width: 65%; border-collapse: collapse; font-size: 10pt; margin-left: 0.15in">
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left; width: 68%"><font style="font: 10pt Times New Roman, Times, Serif">Computer
    equipment</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: center; width: 31%"><font style="font: 10pt Times New Roman, Times, Serif">3-10
    years</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Furniture and fixtures</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">3-7 years</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Test equipment</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">5-7 years</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Signs</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">7 years</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Software</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">3 years</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Marketing and Promotional
    Video</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">3 years</font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_MetuBrandsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6726622992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fresh Start Accounting (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2015</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFreshStartAdjustmentsTextBlock', window );">Schedule of Fresh-Start Adjustments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td nowrap="nowrap" style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" nowrap="nowrap" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">9/19/2014</font></td>
    <td nowrap="nowrap" style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td nowrap="nowrap" style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" nowrap="nowrap" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Dr(CR)<br />Reorganization<br />Adjustments</font></td>
    <td nowrap="nowrap" style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td nowrap="nowrap" style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" nowrap="nowrap" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Dr(CR)
    Fresh Start<br />Adjustments</font></td>
    <td nowrap="nowrap" style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td nowrap="nowrap" style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" nowrap="nowrap" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">9/19/2014</font></td>
    <td nowrap="nowrap" style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Assets</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Current assets</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="width: 40%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;Cash</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right; width: 11%"><font style="font: 10pt Times New Roman, Times, Serif">548</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; width: 11%"><font style="font: 10pt Times New Roman, Times, Serif">(548)</font></td>
    <td style="text-align: left; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif"> (1)</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; width: 11%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right; width: 11%"><font style="font: 10pt Times New Roman, Times, Serif">0</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;Accounts
    receivable</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,238</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">(1,238</font>)</td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">
    (1)</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;Total
    Current Assets</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,786</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;Property,
    plant and equipment, net</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">37,249</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(37,249)</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"> (1)</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;Intangible
    assets, net</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">192,864</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">(192,864)</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">
    (1)</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">54,594</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">(2)</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">54,594</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;Total
    Assets</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">231,899</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">54,594</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Liabilities and Equity
    (Deficit)</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total liabilities subject
    to compromise</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,112,143</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,112,143 </font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">(1)</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Commitments and Contingencies
    (Note 5)</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Metu Brands, Inc. ("MTOO")
    shareholders' deficit</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;Predecessor
    Preferred Stock 10,000,000 authorized at $0.001 par value shares issued and outstanding 271 at September 19, 2014</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1 </font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">(3)</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;Successor
    Preferred Stock 10,000,000 authorized at $0.001 par value; shares issued and outstanding 54,593,032 at September 19, 2014</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1 </font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">(2)</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;Predecessor/Successor
    Common Stock 90,000,000 authorized at $0.001 par value; shares issued and outstanding 54,593,032 at September 19, 2014</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">54,593</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">54,593</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;Additional
    paid-in capital</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">28,615,490</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1,880,244)</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"> (1)</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">30,495,734</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">(3)</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;Retained
    earnings</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(30,550,328</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">(30,550,328)</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">(4)</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;Total
    equity (deficit)</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1,880,244</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">54,594</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;Total
    liabilities and equity (deficit)</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">231,899</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">54,594</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif">(1)
Reorganization adjustments reflect the transfer of $2,112,143 of liabilities subject to compromise and assets to the bankruptcy
trustee in accordance with the plan of bankruptcy provisions.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif">(2)
Fresh-start adjustments under section 852-10-45-17 as of the date of sale of the corporate shell to reflect intangible assets
sale through section 363 of the bankruptcy code.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif">(3)
Fresh-start adjustments under ASC 852-10-45-17 to predecessor preferred stock and APIC reflect the cancellation of the predecessor&#146;s
preferred stock.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif">(4)
Fresh-start adjustment to retained earnings (accumulated deficit) resets accumulated deficit to zero.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif">(5)
$20,000 was paid to the trustee by Shulamit Lazar for the subsequent issue of 30,000,000 common shares and $5,000 was paid to
the trustee by Innovation Consulting LLC for the purchase of 271 preferred shares.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFreshStartAdjustmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of description and amounts of adjustments to historical balance sheet to arrive at fresh-start amounts following bankruptcy and reorganization with a different owner.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=34712771&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)-(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6918054&amp;loc=SL2890621-112765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFreshStartAdjustmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_MetuBrandsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6771697280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2015</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of deferred tax assets and liabilities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">Components
of deferred tax assets and (liabilities) are as follows:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellspacing="0" cellpadding="0" style="width: 85%; border-collapse: collapse; font-size: 10pt; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2015</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2014</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left; width: 72%"><font style="font: 10pt Times New Roman, Times, Serif">Net operating
    loss carry forwards valuation available</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right; width: 11%"><font style="font: 10pt Times New Roman, Times, Serif">85,516</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right; width: 11%"><font style="font: 10pt Times New Roman, Times, Serif">23,235</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Valuation Allowances</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(29,075</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(3,485</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">Deferred
    Tax Asset</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">29,075</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,485</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">Net
    Deferred Tax Asset</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-0-</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-0-</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_MetuBrandsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6756989232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2015</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of reconciliation for basic and diluted EPS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The
following is a reconciliation of the computation for basic and diluted EPS for the years ended September 30, 2015 and 2014:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellspacing="0" cellpadding="0" style="width: 85%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: bottom">
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2015</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2014</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt; width: 72%"><font style="font: 10pt Times New Roman, Times, Serif">Net
    (Loss)</font></td>
    <td style="padding-bottom: 1pt; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right; width: 11%"><font style="font: 10pt Times New Roman, Times, Serif">(32,281</font></td>
    <td style="text-align: left; padding-bottom: 1pt; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td style="padding-bottom: 1pt; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right; width: 11%"><font style="font: 10pt Times New Roman, Times, Serif">(23,235</font></td>
    <td style="text-align: left; padding-bottom: 1pt; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td colspan="9"><font style="font: 10pt Times New Roman, Times, Serif">Weighted-average common shares outstanding
    basic</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Weighted-average common
    stock equivalents</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,000,929</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">11,144</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;Stock options</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;Warrants</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;Preferred
    stock</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">27,100,000</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">27,100,000</font></td>
    <td style="text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">Weighted-average
    common shares outstanding - basic and diluted</font></td>
    <td style="padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,303,773</font></td>
    <td style="text-align: left; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">10,000</font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_MetuBrandsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6778625792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Narrative) - shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Feb. 08, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued</a></td>
<td class="nump">209,352,897<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,113,856<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=abvc_ShareExchangeAgreementMember', window );">Share Exchange Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Percentage of common shares issued and outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=abvc_ShareExchangeAgreementMember', window );">Share Exchange Agreement [Member] | American BriVision (Holding) Corporation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,936,583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Percentage of common shares issued and outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=abvc_ShareExchangeAgreementMember', window );">Share Exchange Agreement [Member] | Euro-Asia Investment &amp; Finance Corp. Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,945,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=abvc_ShareExchangeAgreementMember', window );">Share Exchange Agreement [Member] | American BriVision Corporation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,336,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66011266&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=abvc_ShareExchangeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=abvc_ShareExchangeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_AmericanBriVisionHoldingCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_AmericanBriVisionHoldingCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_EuroAsiaInvestmentAndFinanceCorpLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_EuroAsiaInvestmentAndFinanceCorpLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_AmericanBriVisionCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_AmericanBriVisionCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6787294384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Metu Brands, Inc [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2015</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Computer Equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property and equipment, useful lives</a></td>
<td class="text">P3Y<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Computer Equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property and equipment, useful lives</a></td>
<td class="text">P10Y<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Furniture and Fixtures [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property and equipment, useful lives</a></td>
<td class="text">P3Y<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Furniture and Fixtures [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property and equipment, useful lives</a></td>
<td class="text">P7Y<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Test Equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property and equipment, useful lives</a></td>
<td class="text">P5Y<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Test Equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property and equipment, useful lives</a></td>
<td class="text">P7Y<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Signs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property and equipment, useful lives</a></td>
<td class="text">P7Y<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property and equipment, useful lives</a></td>
<td class="text">P3Y<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Marketing And Promotional Video [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property and equipment, useful lives</a></td>
<td class="text">P3Y<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68071081&amp;loc=d3e1205-110223<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_MetuBrandsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=abvc_SignsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=abvc_SignsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=abvc_MarketingAndPromotionalVideoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=abvc_MarketingAndPromotionalVideoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6769582016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 21, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Description of forward split</a></td>
<td class="text"><p><font style="font: 10pt Times New Roman, Times, Serif">1 to 3:141</font></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized</a></td>
<td class="nump">360,000,000<span></span>
</td>
<td class="nump">360,000,000<span></span>
</td>
<td class="nump">360,000,000<span></span>
</td>
<td class="nump">360,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 994,830<span></span>
</td>
<td class="nump">$ 84,904<span></span>
</td>
<td class="nump">$ 84,904<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 836<span></span>
</td>
<td class="nump">$ 836<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Income Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6778770048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COLLAOBRATIVE AGREEMENT (Details Narrative) - Collaborative Agreement [Member] - BioLite Inc., [Member] - Licensing Rights For Drug And Therapeutic Use of Five Products [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 06, 2016</div></th>
<th class="th"><div>Dec. 29, 2015</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Total consideration</a></td>
<td class="nump">$ 2,600,000<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abvc_UpfrontPayment', window );">Upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Value of shares issued for aquisition</a></td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Number of shares issued for aquisition</a></td>
<td class="nump">562,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share)</a></td>
<td class="nump">$ 1.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abvc_DescriptionOfAgreementTerms', window );">Description of agreement terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><font style="font: 10pt Times New Roman, Times, Serif"><a name="a_DV_C39"></a>This
Collaborative Agreement shall, once signed by both Parties, remain in effect for fifteen years as of the first commercial sales
of the Product in the Territory and automatically renew for five more years unless either party gives the other party six month
written notice of termination prior to the expiration date of the term.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvc_DescriptionOfAgreementTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of agreement terms.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvc_DescriptionOfAgreementTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvc_UpfrontPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of partial payment made.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvc_UpfrontPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=abvc_CollaborativeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=abvc_CollaborativeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvc_BioLiteIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvc_BioLiteIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=abvc_LicensingRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=abvc_LicensingRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6795200112">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Fresh Start Accounting (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 18, 2014</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Mar. 21, 2016</div></th>
<th class="th"><div>Jul. 20, 2015</div></th>
<th class="th"><div>Sep. 30, 2014</div></th>
<th class="th"><div>Sep. 30, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 994,830<span></span>
</td>
<td class="nump">$ 84,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">998,645<span></span>
</td>
<td class="nump">3,584,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,002,460<span></span>
</td>
<td class="nump">3,588,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Liabilities and Equity (Deficit)</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities subject to compromise</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">369,103<span></span>
</td>
<td class="nump">2,061,446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (Note 5)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Metu Brands, Inc. (""MTOO"") shareholders' deficit</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Predecessor/Successor Common Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,114<span></span>
</td>
<td class="nump">209,353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,295,845<span></span>
</td>
<td class="nump">1,987,127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(315,602)<span></span>
</td>
<td class="num">(353,605)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total equity (deficit)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 54,594<span></span>
</td>
<td class="nump">633,357<span></span>
</td>
<td class="nump">1,527,273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,359<span></span>
</td>
<td class="num">$ (1,880,174)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity (deficit)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,002,460<span></span>
</td>
<td class="nump">$ 3,588,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Predecessor/Successor Common Stock, authorized</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">360,000,000<span></span>
</td>
<td class="nump">360,000,000<span></span>
</td>
<td class="nump">360,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Predecessor/Successor Common Stock, par value (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Predecessor/Successor Common Stock, issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,113,856<span></span>
</td>
<td class="nump">209,352,897<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Predecessor/Successor Common Stock, outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,113,856<span></span>
</td>
<td class="nump">209,352,897<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 618<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Liabilities and Equity (Deficit)</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities subject to compromise</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (Note 5)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Metu Brands, Inc. (""MTOO"") shareholders' deficit</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Predecessor/Successor Common Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55,516)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,235)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total equity (deficit)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity (deficit)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 68,228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65,389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Predecessor Preferred Stock, authorized</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Predecessor Preferred Stock, par value (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Predecessor Preferred Stock, issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Predecessor Preferred Stock, outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abvc_PreferredStockSharesAuthorizedOne', window );">Successor Preferred Stock, authorized</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abvc_PreferredStockParOrStatedValuePerShareOne', window );">Successor Preferred Stock, par value (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abvc_PreferredStockSharesIssuedOne', window );">Successor Preferred Stock, issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">54,593,032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abvc_PreferredStockSharesOutstandingOne', window );">Successor Preferred Stock, outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">54,593,032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Predecessor/Successor Common Stock, authorized</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">90,000,000<span></span>
</td>
<td class="nump">90,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Predecessor/Successor Common Stock, par value (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Predecessor/Successor Common Stock, issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">54,593,032<span></span>
</td>
<td class="nump">60,011,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Predecessor/Successor Common Stock, outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">54,593,032<span></span>
</td>
<td class="nump">60,011,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member] | Convertible Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Metu Brands, Inc. (""MTOO"") shareholders' deficit</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Predecessor Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Predecessor Preferred Stock, authorized</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Predecessor Preferred Stock, par value (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Predecessor Preferred Stock, issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Predecessor Preferred Stock, outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member] | Mr.Shulamit Lazar [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Metu Brands, Inc. (""MTOO"") shareholders' deficit</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Amount paid to trustee</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Number of shares issued upon bankruptcy</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member] | Innovation Consulting LLC [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Metu Brands, Inc. (""MTOO"") shareholders' deficit</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Amount paid to trustee</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member] | Innovation Consulting LLC [Member] | Convertible Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Metu Brands, Inc. (""MTOO"") shareholders' deficit</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Number of shares issued upon bankruptcy</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">271<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementScenarioAxis=abvc_RestatementAdjustmentOneMember', window );">Prior Bankruptcy [Member] | Metu Brands, Inc [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 548<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,786<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">37,249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">192,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">231,899<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Liabilities and Equity (Deficit)</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities subject to compromise</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,112,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (Note 5)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Metu Brands, Inc. (""MTOO"") shareholders' deficit</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Predecessor Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abvc_PreferredStockValueOne', window );">Successor Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Predecessor/Successor Common Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">54,593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">28,615,490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(30,550,328)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total equity (deficit)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,880,244)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity (deficit)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">231,899<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementScenarioAxis=us-gaap_RestatementAdjustmentMember', window );">Post Bankruptcy [Member] | Metu Brands, Inc [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">54,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">54,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Liabilities and Equity (Deficit)</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities subject to compromise</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (Note 5)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Metu Brands, Inc. (""MTOO"") shareholders' deficit</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Predecessor Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abvc_PreferredStockValueOne', window );">Successor Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Predecessor/Successor Common Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">54,593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total equity (deficit)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">54,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity (deficit)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">54,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementScenarioAxis=us-gaap_ScenarioAdjustmentMember', window );">Dr(CR) Reorganization Adjustments [Member] | Metu Brands, Inc [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Metu Brands, Inc. (""MTOO"") shareholders' deficit</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReorganizationValueCashInExcessOfNormalOperatingNeeds', window );">Cash - reorganization adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(548)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abvc_ReorganizationValueNetRealizableValueOfAccountsReceivableDispositions', window );">Accounts receivable - reorganization adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(1,238)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abvc_ReorganizationValueNetRealizableValueOfPropertyPlantAndEquipmentDispositions', window );">Property, plant and equipment, net - reorganization adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(37,249)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abvc_ReorganizationValueNetRealizableValueOfIntangibleAssetDispositions', window );">Intangible assets, net - reorganization adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(192,864)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abvc_ReorganizationValueNetRealizableValueOfTotalliabilitiestDispositions', window );">Total liabilities subject to compromise - reorganization adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,112,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abvc_ReorganizationValueNetRealizableValueOfAdditionalPaidInCapitalDispositions', window );">Additional paid-in capital - reorganization adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(1,880,244)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abvc_ReorganizationValueNetRealizableValueOfLiabilitiesAndStockholdersEquityDispositions', window );">Total liabilities and equity (deficit) - reorganization adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementScenarioAxis=abvc_FreshStartAdustmentsMember', window );">Dr(CR) Fresh Start Adustments [Member] | Metu Brands, Inc [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Metu Brands, Inc. (""MTOO"") shareholders' deficit</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FreshStartAdjustmentIncreaseDecreaseAmortizableIntangibleAssets', window );">Intangible assets, net - fresh start adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">54,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FreshStartAdjustmentIncreaseDecreasePreferredStock', window );">Predecessor Preferred Stock - fresh start adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abvc_FreshStartAdjustmentIncreaseDecreasePreferredStock1', window );">Successor Preferred Stock - fresh start adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FreshStartAdjustmentIncreaseDecreaseAdditionalPaidInCapital', window );">Additional paid-in capital - fresh start adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">30,495,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FreshStartAdjustmentIncreaseDecreaseRetainedEarningsDeficit', window );">Retained earnings - fresh start adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="num">(30,550,328)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FreshStartAdjustmentIncreaseDecreaseLiabilitiesAndStockholdersEquity', window );">Total liabilities and equity (deficit) - fresh start adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="9"></td></tr>
<tr><td colspan="9"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Reorganization adjustments reflect the transfer of $2,112,143 of liabilities subject to compromise and assets to the bankruptcy trustee in accordance with the plan of bankruptcy provisions.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Fresh-start adjustments under section 852-10-45-17 as of the date of sale of the corporate shell to reflect intangible assets sale through section 363 of the bankruptcy code.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Fresh-start adjustments under ASC 852-10-45-17 to predecessor preferred stock and APIC reflect the cancellation of the predecessor's preferred stock.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Fresh-start adjustment to retained earnings (accumulated deficit) resets accumulated deficit to zero.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvc_FreshStartAdjustmentIncreaseDecreasePreferredStock1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of fresh-start adjustment to preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvc_FreshStartAdjustmentIncreaseDecreasePreferredStock1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvc_PreferredStockParOrStatedValuePerShareOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvc_PreferredStockParOrStatedValuePerShareOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvc_PreferredStockSharesAuthorizedOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvc_PreferredStockSharesAuthorizedOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvc_PreferredStockSharesIssuedOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvc_PreferredStockSharesIssuedOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvc_PreferredStockSharesOutstandingOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvc_PreferredStockSharesOutstandingOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvc_PreferredStockValueOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvc_PreferredStockValueOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvc_ReorganizationValueNetRealizableValueOfAccountsReceivableDispositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of fresh-start adjustment to receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvc_ReorganizationValueNetRealizableValueOfAccountsReceivableDispositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvc_ReorganizationValueNetRealizableValueOfAdditionalPaidInCapitalDispositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total fresh-start adjustment additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvc_ReorganizationValueNetRealizableValueOfAdditionalPaidInCapitalDispositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvc_ReorganizationValueNetRealizableValueOfIntangibleAssetDispositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total fresh-start adjustment to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvc_ReorganizationValueNetRealizableValueOfIntangibleAssetDispositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvc_ReorganizationValueNetRealizableValueOfLiabilitiesAndStockholdersEquityDispositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total fresh-start adjustment to liabilities and stockholders equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvc_ReorganizationValueNetRealizableValueOfLiabilitiesAndStockholdersEquityDispositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvc_ReorganizationValueNetRealizableValueOfPropertyPlantAndEquipmentDispositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total fresh-start adjustment to property and equipment, net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvc_ReorganizationValueNetRealizableValueOfPropertyPlantAndEquipmentDispositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvc_ReorganizationValueNetRealizableValueOfTotalliabilitiestDispositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total fresh-start adjustment to total liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvc_ReorganizationValueNetRealizableValueOfTotalliabilitiestDispositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FreshStartAdjustmentIncreaseDecreaseAdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of fresh-start adjustment to additional paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=34712771&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FreshStartAdjustmentIncreaseDecreaseAdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FreshStartAdjustmentIncreaseDecreaseAmortizableIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of fresh-start adjustment to amortizable intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=34712771&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6918054&amp;loc=SL2890621-112765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FreshStartAdjustmentIncreaseDecreaseAmortizableIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FreshStartAdjustmentIncreaseDecreaseLiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total fresh-start adjustment to liabilities and stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6918054&amp;loc=SL2890621-112765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=34712771&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FreshStartAdjustmentIncreaseDecreaseLiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FreshStartAdjustmentIncreaseDecreasePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of fresh-start adjustment to preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=34712771&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FreshStartAdjustmentIncreaseDecreasePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FreshStartAdjustmentIncreaseDecreaseRetainedEarningsDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of fresh-start adjustment to retained earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=34712771&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=64805424&amp;loc=d3e55811-112764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FreshStartAdjustmentIncreaseDecreaseRetainedEarningsDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReorganizationValueCashInExcessOfNormalOperatingNeeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of reorganization value related to cash in excess of normal operating requirements generated by operations. Reorganization value is the amount attributed to the reconstituted entity, as well as the expected net realizable value of those assets that will be disposed before reconstitution occurs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=34712771&amp;loc=d3e56239-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 05<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=49179835&amp;loc=d3e54813-112758<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReorganizationValueCashInExcessOfNormalOperatingNeeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_MetuBrandsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvc_InnovationConsultingLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvc_InnovationConsultingLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=abvc_RestatementAdjustmentOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=abvc_RestatementAdjustmentOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=us-gaap_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=us-gaap_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=us-gaap_ScenarioAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=us-gaap_ScenarioAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=abvc_FreshStartAdustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=abvc_FreshStartAdustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6777938688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTIES TRANSACTIONS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 18, 2014</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Dec. 02, 2015</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member] | 0% Unsecured Note Due On Demand [Member] | Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Number of shares issued upon bankruptcy sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvc_BioLiteIncMember', window );">BioLite, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent', window );">Notes payable due</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,517<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvc_YuanGeneCorporationMember', window );">YuanGene Corporation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent', window );">Notes payable due</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46,586<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ChiefExecutiveOfficerMember', window );">Mr.Shulamit Lazar [Member] | Metu Brands, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Number of shares issued upon bankruptcy sale</a></td>
<td class="nump">30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Number of shares issued upon services rendered</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Value of shares issued upon services rendered</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ChiefExecutiveOfficerMember', window );">Mr.Shulamit Lazar [Member] | Metu Brands, Inc [Member] | 0% Unsecured Note Due On Demand [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent', window );">Notes payable due</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abvc_DebtInstrumentCancelledAmount', window );">Notes payable cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvc_DebtInstrumentCancelledAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refer the amount of the debt instrument that was cancelled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvc_DebtInstrumentCancelledAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableRelatedPartiesClassifiedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_MetuBrandsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvc_BioLiteIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvc_BioLiteIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvc_YuanGeneCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvc_YuanGeneCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6771630768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCOUNTS PAYABLE (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">$ 11,446<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_LiteArtIncMember', window );">LiteArt, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">$ 11,446<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_LiteArtIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_LiteArtIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6772654784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable (Details Narrative) - Metu Brands, Inc [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2015 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherPaymentsToAcquireBusinesses', window );">Deposit</a></td>
<td class="nump">$ 3,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">0% Notes Payable Due September 24, 2014 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="nump">$ 7,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=64930739&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28551-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPaymentsToAcquireBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with other payments to acquire businesses including deposit on pending acquisitions and preacquisition costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPaymentsToAcquireBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_MetuBrandsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6778823248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUTIY (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 21, 2016</div></th>
<th class="th"><div>Sep. 18, 2014</div></th>
<th class="th"><div>Aug. 13, 2014</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
<th class="th"><div>Sep. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Oct. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,113,856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">209,352,897<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,113,856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">209,352,897<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized</a></td>
<td class="nump">360,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">360,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">360,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Description of forward split</a></td>
<td class="text"><p><font style="font: 10pt Times New Roman, Times, Serif">1 to 3:141</font></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable', window );">Subscription receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 350,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,593,032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,011,144<span></span>
</td>
<td class="nump">11,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,593,032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,011,144<span></span>
</td>
<td class="nump">11,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000,000<span></span>
</td>
<td class="nump">90,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Description common sharesholders voting rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p><font style="font: 10pt Times New Roman, Times, Serif">Entitled to one vote per each share of common stock
held.</font></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Description of forward split</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p><font style="font: 10pt Times New Roman, Times, Serif">5,000 for 1</font></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member] | Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Each preferred shares converted into voting common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockVotingRights', window );">Description preferred sharesholders voting rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p><font style="font: 10pt Times New Roman, Times, Serif">Each Preferred Share is entitled to the voting rights
100,000 common stock shares.</font></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member] | Convertible Preferred Stock [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Each preferred shares converted into voting common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member] | Mr.Shulamit Lazar [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued upon initial deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositAssets', window );">Intial deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Number of shares issued upon services rendered</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Value of shares issued upon services rendered</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Number of shares issued upon bankruptcy sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member] | Innovation Consulting LLC [Member] | Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Number of shares issued upon bankruptcy sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Number of shares issued upon conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of subscription receivable from investors who have been allocated common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockVotingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockVotingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8,17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockVotingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of voting rights of nonredeemable preferred stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockVotingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_MetuBrandsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvc_InnovationConsultingLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvc_InnovationConsultingLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6615966192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details Narrative) - BioLite, Inc [Member]<br></strong></div></th>
<th class="th">
<div>Dec. 29, 2015 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abvc_AgreementPeriod', window );">Agreement period</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvc_AgreementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Agreement period in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvc_AgreementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6578-128477<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvc_BioLiteIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvc_BioLiteIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6772653136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details Narrative) - Metu Brands, Inc [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2015 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Post bankruptcy operating loss carryforward</a></td>
<td class="nump">$ 85,516<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_abvc_OperatingLossCarryforwardsExpirationPeriodDescription', window );">Description of operating loss expiration period</a></td>
<td class="text"><p><font style="font: 10pt Times New Roman, Times, Serif">Expire between 2015 and 2033</font></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Current effective tax rate</a></td>
<td class="nump">15.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abvc_OperatingLossCarryforwardsExpirationPeriodDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to description of expiration period for operatin loss carryforward between periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abvc_OperatingLossCarryforwardsExpirationPeriodDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abvc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_MetuBrandsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6616463584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes (Details) - Metu Brands, Inc [Member] - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
<th class="th"><div>Sep. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carry forwards valuation available</a></td>
<td class="nump">$ 85,516<span></span>
</td>
<td class="nump">$ 23,235<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation Allowances</a></td>
<td class="num">(29,075)<span></span>
</td>
<td class="num">(3,485)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred Tax Asset</a></td>
<td class="nump">29,075<span></span>
</td>
<td class="nump">3,485<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net Deferred Tax Asset</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Asset<br> -URI http://asc.fasb.org/extlink&amp;oid=6510090<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68052875&amp;loc=d3e28680-109314<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32621-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_MetuBrandsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6611933456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions (Details Narrative) - Metu Brands, Inc [Member]<br></strong></div></th>
<th class="th">
<div>Sep. 25, 2014 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Purchase price</a></td>
<td class="nump">$ 10,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Purchase price allocated to inventory</a></td>
<td class="nump">795<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Purchase price allocated to intangible assets ("MeTu" trade name and web site MeTuBoutique.com)</a></td>
<td class="nump">$ 9,205<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=73531372&amp;loc=d3e2207-128464<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=73531372&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_MetuBrandsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6778889264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2014</div></th>
<th class="th"><div>Sep. 30, 2014</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
<th class="th"><div>Sep. 30, 2014</div></th>
<th class="th"><div>Sep. 18, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (23,235)<span></span>
</td>
<td class="num">$ (315,602)<span></span>
</td>
<td class="num">$ (293,237)<span></span>
</td>
<td class="num">$ (353,605)<span></span>
</td>
<td class="num">$ (32,281)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (70)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract', window );"><strong>Weighted-average common shares outstanding basic</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted-average common shares outstanding- basic and diluted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,113,856<span></span>
</td>
<td class="nump">208,779,424<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember', window );">Metu Brands, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (loss)</a></td>
<td class="num">$ (23,235)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (32,281)<span></span>
</td>
<td class="num">$ (23,235)<span></span>
</td>
<td class="num">$ (70)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract', window );"><strong>Weighted-average common shares outstanding basic</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,929<span></span>
</td>
<td class="nump">11,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,100,000<span></span>
</td>
<td class="nump">$ 27,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted-average common shares outstanding- basic and diluted (in shares)</a></td>
<td class="nump">11,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,929<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">11,144<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of preferred stock and warrants for common stock issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Weighted-Average Number of Common Shares Outstanding<br> -URI http://asc.fasb.org/extlink&amp;oid=6528421<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abvc_MetuBrandsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abvc_MetuBrandsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>54
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M^GH A3&^.R6:E((C-Z."N[_8_ )02P,$%     @ !(PM21.#K'*E 0  ]1@
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M%H[: M@6CML"X!:.W +H%H[= O 6CMX*]%:.W@KT5M*[-GK9YNBM0&_EZ*U
M;^7HK4!OY>BM0&_EZ*U ;^7HK4!OY>BM0&_EZ&U ;^/H;4!OX^AM0&\C?2M!
M'TLX>AO0VSAZ&]#;.'H;T-LX>AO0VSAZ&]#;.'H;T-LX>A= [X*C=W&C=ZC*
MWN^>8W]L#N'>-=^&PZ(;O$.\G/W]4ZY38<.-UG'8R;OK\>Y/L^O4SQ#WZP_'
M^@-02P,$%     @ !(PM23O?C+@- P  N@H  !    !D;V-0<F]P<R]A<' N
M>&ULO59=;]HP%/TK%D_T80UC5;<A&LE- HT4$I:$3MV;&PQ83>S4-@CVZ^<D
MP$(Q&? P'N#ZYIS[?4WZ5'1Z8\YRS"7! JRSE(J>4CZT%E+F/<,0R0)G2-PJ
M"%5/9XQG2*HCGQML-B,)MEFRS#"51K?3N3?P6F(ZQ=-/^=YHR^P77F">IR1!
MDC!JCDC"F6 S"9QU@M.^\1%0,I3E""=+3N3&[%28NJK$1 E*L:5\F3.4"ERA
M_BI+C,6R'-&-49T\0M_$)(^9C22NLPX?5-87B..I<GI@?:\L,4\;E6=:<*T%
MHG,\K6./'^YJ\8RY*#+]W+WMJ,^^!#M]91NC*:'S,2)<F/V5[*UP(AG?MFDE
MK^W2E"5%T\5SK.(3+?"*!"[$A]8*<8*H; %!?JMCMU6YK;2EG.9"<O,GXV]B
M@;$4?6.O+,4ZMBZ3._.N4R*4=(@T]IF9V[(=Y%UH8B)3+(+9&''YGTI1YK0K
MQ%VG5<M^9P(@.@4.E6H<@4LK5ZIY]9+L)2OP;<>/'!LH*0H\UX:Q.CQ"#_J6
M Z[@?+F$$\7J9^3XISC'R#@"P0!83_ DI\'/O983A$/HN[]@[ 8^@+X-;">R
M0G=<GH.!EA--1B,8OA2Q1.[0=P>N!?T80,L*)G[LGHC-\V#P&"I'SPZ P] I
M$])B!QR+!8BD&BP DX0M53OI7 L-':_,<0S#V'4B$(?0CZ!51!]I"=L@(\5X
M@8^>HP7Y3*J;=XPVZ#7%6H3S8Q*[+R<R'8W<N.I645#5B]CUAXYOJ0#U]90L
M>0-!7@RJT")<FK ,@QBML1XP9*I"P&(TP5P_[#!Y7Q)!3OOPL01;/VV/"7$#
MQIB#\FK51[U\%?A]6>R<LU+?>JN-L]+MGK"<98AO )N!B,PI45>$NI2VH]#5
M[YA^9D [+EHH;OY9U69D0VT*XN6;U?UZ1;6^7<'Y?LDV@K:-)2+I116N*/KN
M-ZVG8IZUH7L/P$><ZVM]L+ ?")*L&E;X&(SU(]"XUJ!]QH =.3J?HP^IOM+G
MFF^<9/N <_0.\.$?WSA\4S7_ %!+ P04    "  $C"U)?-)L>SX!  !I P
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MKK5>ACK=KS$ZO)RXLK7UW3'U(_KVJNI/4$L#!!0    (  2,+4F97)PC$ 8
M )PG   3    >&PO=&AE;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&
M-H&VM!-S:7;;M)F$[4X?A1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'
MY^@X>?/N+F+HAHB4\GA@V2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X
M?<D3$L/<@HL(2W@4R]9<X%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A T%116F]?
M(+3E'S/X%<M4C66C 1-702:YB+3R^6S%_-K>/F7/Z3H=,H%N,!M8('_.;Z?D
M3EJ(X53"Q,!J9S]6:\?1TDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*
MVG0T;1K@X_%X.+;+THMP' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3
M]WW?ZYMHG J-6T_3:W?=TXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H
M0D;CZWH2%;7E0-,@ %AP=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9I
MTAF6-$9RG9 %#@ WQ-%,4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]
M]9>[R:0S>IU].LYKE']IJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88<G
M;CL3<CH<9T)\S_;VD:4E,L_O^0KK3CQG'U:6L%W/S^2>C'(CN]WV6'WV3T=N
M(]>IP+,BUY1&)$6?R"VZY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3
M?;>^",C?C8CWJV^:/5>A6$G:A/@01AKBG'/F<]%L^P>E1M'V5;S<HY=8%0&7
M&-\TJC4LQ=9XE<#QK9P\'1,2S90+!D&&ER0F$JDY?DU($_XKI=K^G-- \)0O
M)/I*D8]ILR.G=";-Z#,:P4:O&W6':-(\>OX%^9PU"AR1&QT"9QNS1B&$:;OP
M'J\DCIJMPA$K0CYB&38:<K46@;9QJ81@6A+&T7A.TK01_%FL-9,^8,CLS9%U
MSM:1#A&27C="/F+.BY 1OQZ&.$J:[:)Q6 3]GE[#2<'H@LMF_;A^AM4S;"R.
M]T?4%TKD#R:G/^DR- >CFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0
MKH)[ ?_1VC?"J_B"P#E_+GW/I>^Y]#VATK<W(WUGP=.+6]Y&;EO$^ZXQVM<T
M+BAC5W+-R,=4KY,IV#F?P.S]:#Z>\>WZV22$KYI9+2,6D$N!LT$DN/R+RO J
MQ GH9%LE"<M4TV4WBA*>0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-
M"S-#MW)+ZK:4OK4F.$KTL<QP3A[+##MG/)(=MG>@'37[]EUVY".E,%.70[@:
M0KX#;;J=W#HXGIB1N0K34I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\
MEAW'B/*B(>ZAAIC/PT.'>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#
MKU$"\E)58#%;Q@,KD*)\3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@3
M9ZO*WF6QP54=SU5;\K"^:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON<K
M2<15.+]%,[82EQB\X^;'<4Y3N!)VM@\",KF[.:EZ93%GIO+?+0P)+%N(61+B
M35WMU>>;G*YZ(G;ZEW?!8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!
M=$4"(Y4<!A87,N10[I*0!A,!S93)1/ "@F2F'("8^@N]\@RY*17.K3XY?T4L
M@X9.7M(E$A2*L P%(1=RX^_ODVIWC-?Z+(%MA%0R9-47RD.)P3TS<D/85"7S
MKMHF"X7;XE3-NQJ^)F!+PWING2TG_]M>U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_
M6-8>^3+?.7#;.MX#7N83+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND
M]MW@#'S4JUJE9"L1/TL'?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?
MAT6:&C/5BZPYC0IO0=5 Y3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.
MX>V+OP%02P,$%     @ !(PM2> ^S\]. @  U H   T   !X;"]S='EL97,N
M>&ULS59=:]LP%/TK0BFCA1';V9IVJVT8A<!@*X7F86]%MF5'H ]/EC.GOW[Z
M<&S'D#;INBUYT=71O><>Z<JY"BNUH?AAA;$"#:.\BN!*J?*SYU7I"C-4346)
MN5[)A61(Z:DLO*J4&&65"6+4F_G^W&.(<!B'O&8+IBJ0BIJK"'[L(.#B;T6&
M(_AX_NYG+=3-&7#CY/UDXC]>W(SQ<[MP 8'C^)I%,)A?0N]PTJGO[R<VBR/R
M^7'DSU"/B*^.5/V<Z!'UM:'VVI./PUSPO@ SZ( XK)[ &E'M'QCW5% A@=(5
MUAHLPA'#SN,649)(8L <,4(W#IX9P%Z*UH\1+J3-[3*,\TS]/I,LD@CZ[>_P
M=$G/;@>S/4+I[O8T$(<E4@I+OM 3T-K+3:DWQP7'3J3U>\&[D&@3S"X' 7;0
M>1,A,RR[S '<0G%(<:YT@"3%RHQ*E$:Z4$HP;60$%8(C:BBW$:VA:5-,Z8/Y
M!'_D.]Q-#IR/J;$/@5&Q-?5!M&9_#>RA>D,VQSVD?1TO:/(N@8Y&94DW7R@I
M.,-.K(,6HIV]1!_LH8]#M&4%*R')D_8W%R'5 )80K+%4)!TBOR0JE[A1[0WV
MFGR?PM=N^6]J>OM3Z]7H*_BOC^>_)A_6QGZ&<*3G@%+<U2S!<F'_FX\7]N'J
M5)69CGFRTN:G*^V$"WK]A]*\MC,,VL].\^E0D-2$*L*W&I!Y+MP9W72G+_2-
M1W-F3=]S[*I"B7YB[F319!G.44W5/5D+91<CV-O?C/Q@WGDM.XH(]O9WG)&:
M?;(*^G=L_!M02P,$%     @ !(PM2:BY*R@%!   6@T   \   !X;"]W;W)K
M8F]O:RYX;6R5EUUSHCP4@/]*AJONS2I!;>NL.T.1NLPH^ KM.]V[B+%F"L1-
M0C_VUV\"NGNL6;O>: +DX21Y.!R^R.$+%T]+SI_0:UE4<BA&SD:I[;#3D?F&
MED1^YEM:Z7-K+DJB=%<\=OAZS7(ZYGE=TDIU<+<[Z A:$,5X)3=L*YT=3?X+
M36X%)2NYH52510LK":N<KU_D<,T*>D^%U&!$MMN8E'3DO!8.*HA4X8HINAHY
M/=WE+_3@@*BW-S4K3*??[3L= ]M/=2Y0SE>TA64;)O_?G7#0BJY)7:A,![N_
M[\AQ<0_C0<LPE]TS^B(AT!Q )%?LF69D.7*Z#B*UXK>L4%2,B:(3P>LMJQXU
MRT%K)J1*S72;*TM6L9+]-''KGMSPEV]<L)^\4J1(<\&+HAEE3C2#]!WD[R,Z
M1L7R@PL562[,3HR<05<#GYED2U8P]39RFG9!S4PZ[Z;2+/^?%JJ:Q=EO,2+5
M"H65TA045>WFZ:4Q,>B+HU5S8S%DNB&BE=LN%00%23P.XS0<(]U*DVDT]C/=
MN?&G?AR$"( P .%S01X >0#D_3,HS?3?+(P!J = /2OH>'B6HN06!=]\".H#
M4/_<B 8 - "@P3$H64S\./KN9U$2(S\>HW&8!HMHWO236P"Z!*#+8U!Z-YOY
MBP<SE32:Q-%M%/AQAOP@2.[B+ *@*P"ZLDUM.O63FX4.Z3Y$_F01-HL$ -<
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M%"!-5Q%[Y&+'T\CQ+)<+FKHH$3.MI"S_52$%D&]_/=,Z&-=UR 5KN3.1O!,
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M^O"RJ?\-HH<@);L[4-*%_[,8"AH?CY_"V4XC-1D>^]L'67YI^1=02P,$%
M  @ !(PM26H5$/:] 0  C00  !@   !X;"]W;W)K<VAE971S+W-H965T."YX
M;6R%5-MNG# 0_16+#XA9+DVZ8I&R5%7R4"G*0_KLA0&L^$)MLZ1_']NPA&ZL
M] 7/C,^9.6-[*":I7G4/8- ;9T(?HMZ888^QKGO@1-_( 83=::7BQ%A7=5@/
M"DCC29SA)(Z_84ZHB,K"QYY46<C1,"K@22$]<D[4WR,P.1VB770)/-.N-RZ
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MK_YLII&:#(?]]8,LO[3\#5!+ P04    "  $C"U)*3E3IY\!  "S P  &0
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M/'X(9SN-U&1X[.\?9/FEY1]02P,$%     @ !(PM24&W"ZN@ 0  LP,  !D
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MZ/QLXP0J1 =>2G*WHZ3Q/VAV)%0NF+^\;<9'-3H.N^L7F?]I_@]02P,$%
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M.:/SLXT3J!$=>"GIW38AK?]!LR.A=L'<>]N,CVIT'';7+S+_T^(_4$L#!!0
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MO&W&1S4Z#KO+%YG_:?$%4$L#!!0    (  2,+4DODQ\9H $  +,#   9
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M6Q(&&['EQUJ_R-,/<9Y#:@G7LE;N&:R/2LOF$A(&#?_HWU7KWJ?^2YJ<PW
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M":9'[B^B#,'8=SSS0JV/7@N>'G)V#8EFS'G"\!4FS1X6#//YER)\J\B9?TO
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M-G:@1G3@I20W.TI:_X,61T+M@OG#VV8:JLEQV%^_R/)/BT]02P,$%     @
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M7MONPO3E</\. RVZ\W,RO6G%7U!+ P04    "  $C"U)B@0Z5D "   !"0
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M<#:NN[)]-5;H<6!D=W]P3*^>\B]02P,$%     @ !(PM24U#W<4< @  5 <
M !D   !X;"]W;W)K<VAE971S+W-H965T,CDN>&ULC97=CJ(P&(9OA7 !T_*O
M!DE69;-[L,ED#G:/JU8A4RC;5IF]^^T/.E ;!P^D+<_[?>]+2<E[RMYYA;'P
M/AK2\K5?"=&M ."'"C>(O] .M_+.B;(&"3EE9\ [AM%1BQH"0@A3T*"Z]8M<
MK[VR(J<70>H6OS*/7YH&L7\;3&B_]@/_MO!6GRNA%D"1@[ON6#>XY35M/89/
M:_];L"HS16C@=XU[/AI[RON>TG<U^7E<^U!9P 0?A*J Y.6*MY@054@V_CO4
M_&RIA./QK?IWG5:ZWR..MY3\J8^BDF:A[QWQ"5V(>*/]#SQ$2%3! R5<_WN'
M"Q>TN4E\KT$?YEJW^MJ;.UDTR-R"<!"$=T$0/Q5$@R":*X@'03Q7D R"Q!(
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M1Z-A3(*J%ZS4TEMU><X= HW4S5RUN;U/;$>RX7P[SE=T^1]02P,$%     @
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MSMT!+YDQ?S.X F6#-IJ_&?,W _ZR-<3Y*S4BY HB[E*]RY\BKU924B%RP53
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MH'.AW/C:I*\H39P>+F]B?ICU)U!+ P04    "  $C"U)!-D"R[P!  ! !
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MG=<%@\:XZ:V=J[G"YX61PZ5?UY]&^0U02P,$%     @ !(PM27GC*\+5 0
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M6G^GQD1 XT*X\K%)OUE*G.Y.EV:\N>4/4$L#!!0    (  2,+4G[AO$'I@(
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MX-QR+IF21'?JJ]^K"^6E4[*MU,U4M9OVBM5V)#^<;XR7:^O\'U!+ P04
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MF/V[,;+)'OYK6\/2MX;%W]X:7F6RBHK)*O^.)JNHFZRZ<@>)XAJD:&ZPC>C
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MB <YZ+WINPEM2L"!2+P#&.]0YY3I\MTWVWCJ>GY=E$.W:#7,")5S]9^K5#
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MEB:%<PNDS?6(9:TJ7X?NV57118\SK+$B9L"JFDI3&,(.2M9]HE/,3%4HOT-
M4E!'KZ<KVAD2=G1H0U15.:U&@X013S5YY.3JPXRK& R,NDH F=5F><ND'(I&
MRAG:SE><&<-]$8$@F34(0)*5-9ZFB[M8):[CF<A:5@Z7?8L];K/S")['%M-6
M8KE5P: E AD/;%'P0[<:GW*4?,.B(3OH]2?BJTUCX-J?1^].C[P^0(P>)I41
M7_99U0UGMR?J4WXNP]5[J2-5(=./TEQ;L<1H@T%G9\?D 9]FM+;6[,R%.\B%
ME6&6!<C;L[>O^;I6T%(N1]"@A?:UO$RR7+BMF=STGKGF:&NF:#['7-?6.CFD
ML\<RGX%!CPDX^'G9SV8+R\WL14*2FF)CR-3!17;5 "N'.X(J&R,?;KSE^!TQ
M%3U%/".#EQO=WM$6*)< IBE9;\WL)E+*4Y;3V7^1Y6X#4%7>21W]V\WUR<_U
MO[[I"7X@#SE7?@'"@\ AVMD8[C(WH#G4W F>MH)7A1Y-+P0U,[=0JO<C>O_L
METYT4%1?E]&NQQC?,6V$GGDE14P_]TJ*7/M*BOA;7TEIY.HWR-6Z6RU[:OIV
MT:BYYG>G L8\F$D0,@-P7ZJ&68O7AK_O>S*;DK:.DUB>@/ P;2_<-N+EJUJK
M$+K7B+7[NN((0[SWQ-38[P&+1;F'0^W2$57;@K*S#F/T*,B\;-=\5:QDA!E[
M1US/RA>V,)1+NT>!,B!:*.[ 5I6#H<8PDXRI@A'E'6VPTK%.5#<IX5!IUE84
MYNO&^BZI71D?E&>5$'1SE8H0,^0PM;'HK<!,2JN9%;I.V[N10RJUT4L\#8];
M2533TL*J#]_DE9M5T+G<WB9K/8N@O93;W0B=(#(RT[>HTK=#U+WRNPNK66?7
M9YTFE-1C.8X\<KAA+6;PXD*8S=26ETO^E$<9>)  I^BOXUC>K#(%S^$LPK-E
MEN=,?DO/I%.5@YHOQ\QA3+_2_S,7%,I8>PNQ@Z+/RU"]37[D?+>U8ELZ5W5)
M;#+M4W6T@9+T-B&)<KX::(65ZSAVN\D1141421_/%^Q=416(VAAUC9[D"?]4
M^[=D-H']K.=[X,K^9BE;)6_1:N$>7)R=G7" FWHS'ES03?ZC\Z86 6\Q?[YB
MO.GW[D1>6Q+K+AM4LNBDS+S,>43>K.?G4I[1)!$YJ< Y5]<[:LZ54Z$S" AS
MSZ1LN$@RN6^J]O\ZV=Y&O;N+>G=EC+KZ&]T4$=/*@)*4N?IV9F-5:,>XSJ#*
M=65P[!JJJ&NR&KN%V8HJU)X\1:/)C:UCI6?<T(F">/IBV=@0FQ#PEBK%W&&U
MBT[56J J_W!ZB3X3QID_WZFK.ALD\XW^KF''4IRP5E42-X64T875;._+!UV
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MTLO=,#.^>SEE^XH-9*<GD_9Z;$*+3 %5B?01S6/#M=(OJNRXXZ&H#36 E4K
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MR_+O_AM02P$"% ,4    "  $C"U)*E>.-\4!  #!&0  $P
M@ $     6T-O;G1E;G1?5'EP97-=+GAM;%!+ 0(4 Q0    (  2,+4E(=07N
MQ0   "L"   +              "  ?8!  !?<F5L<R\N<F5L<U!+ 0(4 Q0
M   (  2,+4D3@ZQRI0$  /48   :              "  >0"  !X;"]?<F5L
M<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (  2,+4D[WXRX#0,  +H*
M   0              "  <$$  !D;V-0<F]P<R]A<' N>&UL4$L! A0#%
M  @ !(PM27S2;'L^ 0  :0,  !$              ( !_ <  &1O8U!R;W!S
M+V-O<F4N>&UL4$L! A0#%     @ !(PM29E<G",0!@  G"<  !,
M     ( !:0D  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    "  $C"U)
MX#[/STX"  #4"@  #0              @ &J#P  >&PO<W1Y;&5S+GAM;%!+
M 0(4 Q0    (  2,+4FHN2LH!00  %H-   /              "  2,2  !X
M;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  $C"U)@!]?;0@"  !F!@  &
M            @ %5%@  >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#
M%     @ !(PM26DP6%?)!   M!D  !@              ( !DQ@  'AL+W=O
M<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    (  2,+4EG=SSZ\P(  , -
M   8              "  9(=  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q0
M2P$"% ,4    "  $C"U)2%Y=]3$$  "(%@  &               @ &[(
M>&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ !(PM20?57KU;
M!   !A<  !@              ( !(B4  'AL+W=O<FMS:&5E=',O<VAE970U
M+GAM;%!+ 0(4 Q0    (  2,+4E"=D_ =04   H@   8              "
M ;,I  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    "  $C"U)
MFX:!N)T!  "Q P  &               @ %>+P  >&PO=V]R:W-H965T<R]S
M:&5E=#<N>&UL4$L! A0#%     @ !(PM26H5$/:] 0  C00  !@
M     ( !,3$  'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    (
M  2,+4G8D^W GP$  +$#   8              "  20S  !X;"]W;W)K<VAE
M971S+W-H965T.2YX;6Q02P$"% ,4    "  $C"U)*3E3IY\!  "S P  &0
M            @ 'Y-   >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4
M Q0    (  2,+4F^"D=SO0$  (T$   9              "  <\V  !X;"]W
M;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @ !(PM24U22[B@ 0
ML0,  !D              ( !PS@  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX
M;6Q02P$"% ,4    "  $C"U)0;<+JZ !  "S P  &0              @ &:
M.@  >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    (  2,+4EG
M"LOTO $  (T$   9              "  7$\  !X;"]W;W)K<VAE971S+W-H
M965T,30N>&UL4$L! A0#%     @ !(PM2<<O(@B\ 0  C00  !D
M     ( !9#X  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  2,+4F+5V]KH $  +,#   9              "
M ;)'  !X;"]W;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ !(PM
M22^3'QF@ 0  LP,  !D              ( !B4D  'AL+W=O<FMS:&5E=',O
M<VAE970R,2YX;6Q02P$"% ,4    "  $C"U);,F3J*L"  !I"P  &0
M        @ %@2P  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0
M   (  2,+4DH0L-QH@$  +,#   9              "  4).  !X;"]W;W)K
M<VAE971S+W-H965T,C,N>&UL4$L! A0#%     @ !(PM27TK3=&C 0  LP,
M !D              ( !&U   'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q0
M2P$"% ,4    "  $C"U)3C)F_Z,!  "S P  &0              @ 'U40
M>&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    (  2,+4GJMEL/
MHP$  +,#   9              "  <]3  !X;"]W;W)K<VAE971S+W-H965T
M,C8N>&UL4$L! A0#%     @ !(PM23PEX/X7 @  WP8  !D
M ( !J54  'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    "  $
MC"U)B@0Z5D "   !"0  &0              @ 'W5P  >&PO=V]R:W-H965T
M<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    (  2,+4E-0]W%' (  %0'   9
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M970S,RYX;6Q02P$"% ,4    "  $C"U)M?ZYL+@!   ;!   &0
M    @ $%;0  >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    (
M  2,+4F4KM9"_@,  '05   9              "  ?1N  !X;"]W;W)K<VAE
M971S+W-H965T,S4N>&UL4$L! A0#%     @ !(PM2:_Q>^28 0  I ,  !D
M             ( !*7,  'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"
M% ,4    "  $C"U)!-D"R[P!  ! !   &0              @ 'X=   >&PO
M=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    (  2,+4EYXRO"U0$
M !(%   9              "  >MV  !X;"]W;W)K<VAE971S+W-H965T,S@N
M>&UL4$L! A0#%     @ !(PM24SLRMR< 0  Q0,  !D              ( !
M]W@  'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6Q02P$"% ,4    "  $C"U)
M^X;Q!Z8"  #""@  &0              @ '*>@  >&PO=V]R:W-H965T<R]S
M:&5E=#0P+GAM;%!+ 0(4 Q0    (  2,+4GN;!T^N3   *+8   4
M      "  :=]  !X;"]S:&%R9613=')I;F=S+GAM;%!+!08     ,0 Q $D-
(  "2K@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.5.0.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>88</ContextCount>
  <ElementCount>185</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>32</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/CondensedConsolidatedStatementsOfOperations</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIENCY)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficiency</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIENCY)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/CondensedConsolidatedStatementsOfCashFlow</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/OrganizationAndDescriptionOfBusiness</Role>
      <ShortName>ORGANIZATION AND DESCRIPTION OF BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - COLLAOBRATIVE AGREEMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/CollaobrativeAgreement</Role>
      <ShortName>COLLAOBRATIVE AGREEMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - Fresh Start Accounting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/FreshStartAccounting</Role>
      <ShortName>Fresh Start Accounting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - RELATED PARTIES TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/RelatedPartiesTransactions</Role>
      <ShortName>RELATED PARTIES TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - ACCOUNTS PAYABLE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/AccountsPayable</Role>
      <ShortName>ACCOUNTS PAYABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Notes Payable</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://metuboutique.com/role/NotesPayable</Role>
      <ShortName>Notes Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - EQUTIY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/Equtiy</Role>
      <ShortName>EQUTIY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/CommitmentsAndContingencies</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - Stock Options</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/StockOptions</Role>
      <ShortName>Stock Options</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - Going Concern</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/GoingConcern</Role>
      <ShortName>Going Concern</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/Acquisitions</Role>
      <ShortName>Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - Net Income (Loss) Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/NetIncomeLossPerShare</Role>
      <ShortName>Net Income (Loss) Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://metuboutique.com/role/FreshStartAccounting</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - Fresh Start Accounting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/FreshStartAccountingTables</Role>
      <ShortName>Fresh Start Accounting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://metuboutique.com/role/FreshStartAccounting</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://metuboutique.com/role/IncomeTaxes</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - Net Income (Loss) Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/NetIncomeLossPerShareTables</Role>
      <ShortName>Net Income (Loss) Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://metuboutique.com/role/NetIncomeLossPerShare</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative</Role>
      <ShortName>ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://metuboutique.com/role/OrganizationAndDescriptionOfBusiness</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/SummaryOfSignificantAccountingPoliciesDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://metuboutique.com/role/SummaryOfSignificantAccountingPoliciesPolicies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://metuboutique.com/role/SummaryOfSignificantAccountingPoliciesPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - COLLAOBRATIVE AGREEMENT (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/CollaobrativeAgreementDetailsNarrative</Role>
      <ShortName>COLLAOBRATIVE AGREEMENT (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://metuboutique.com/role/CollaobrativeAgreement</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - Fresh Start Accounting (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/FreshStartAccountingDetails</Role>
      <ShortName>Fresh Start Accounting (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://metuboutique.com/role/FreshStartAccountingTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - RELATED PARTIES TRANSACTIONS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/RelatedPartiesTransactionsDetailsNarrative</Role>
      <ShortName>RELATED PARTIES TRANSACTIONS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://metuboutique.com/role/RelatedPartiesTransactions</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - ACCOUNTS PAYABLE (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/AccountsPayableDetailsNarrative</Role>
      <ShortName>ACCOUNTS PAYABLE (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://metuboutique.com/role/AccountsPayable</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - Notes Payable (Details Narrative)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://metuboutique.com/role/NotesPayableDetailsNarrative</Role>
      <ShortName>Notes Payable (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://metuboutique.com/role/NotesPayable</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - EQUTIY (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/EqutiyDetailsNarrative</Role>
      <ShortName>EQUTIY (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://metuboutique.com/role/Equtiy</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://metuboutique.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - Income Taxes (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>Income Taxes (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://metuboutique.com/role/IncomeTaxesTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://metuboutique.com/role/IncomeTaxesTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - Acquisitions (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/AcquisitionsDetailsNarrative</Role>
      <ShortName>Acquisitions (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://metuboutique.com/role/Acquisitions</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="abvc-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - Net Income (Loss) Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/NetIncomeLossPerShareDetails</Role>
      <ShortName>Net Income (Loss) Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://metuboutique.com/role/NetIncomeLossPerShareTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>abvc-20160630.xml</File>
    <File>abvc-20160630.xsd</File>
    <File>abvc-20160630_cal.xml</File>
    <File>abvc-20160630_def.xml</File>
    <File>abvc-20160630_lab.xml</File>
    <File>abvc-20160630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies/>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>60
<FILENAME>0001615774-16-007154-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001615774-16-007154-xbrl.zip
M4$L#!!0    (  2,+4DX6&TGPGX  - *!@ 1    86)V8RTR,#$V,#8S,"YX
M;6SLO6MSXTBN(/I](_8_<+TUY[@B))>>ME4U/1LJV]7C<UQEK^WJOG._3%!B
M2LIIBM3PX4?_^@60F622HF0]*(F2>>),ERR1F4@D@ 20>/SU_[R,;>.)>3YW
MG5^.ZB>U(X,Y?=?BSO"7HY\/U>[#Q?7UD?%__O8__X<!__?7_U6M&A<>,P-F
M&;U7XZ%A?.,V/.Q7C)N;BZHQ"H+)YT^?GI^?3_S&0/QTTG?'1K4*0_SUI>?9
M_#/^UX")'?_SB\]_.=)>>FZ>N-[P4Z-6JW_Z_[[?//1';&Q6N>,'IM-G1^HM
M&/>/K/?JG4[G$_VJ'IUZ$B=7<S0_X<\]TX]'1@#G/#\%"?QJ!=$+^L/M3^+'
MQ*,\\]%3\2A7CUHL]9S/^B=#]^D3_ #/UUO56KW:K*O'/3:8"?+I)_A5/<A]
MM]6HG\U;GWA"O1#ZU:%I3J(7!J;?HX?E#PC,:1(8^,5S;>9GOD._9+SDN(X3
MCK/AL@+O4_ Z89_@H2H\Q3S>C]Y[^Z7D"V;OJ1^],69!V'/#@/\[9$BD!%CM
MM%D[4N2.Y/'9)R*\9P.#*.OSB/"-(U75"R<OOG4D?\9I?SGR^7AB YE\4D,)
MTN^[3L!> H-;OQQ]\]PQ#-"NUFN C< 5:#FMQO-'KS$GX,%K]&WT/;?PEP%G
MGD%0L@0V%-5<7/_WT=]JP%+ULV:SWOSKI_3+\72?,N>3LTT DZXU#06PA!=<
M@DSX6[P<-5+\V]1KS+'42W+=\?16XA7U?0( ]:5$Z6P\=_W;P=[B5@B<( -)
MZI=<D=2NUCI[C22Y@,T@27(L;$3K@#A6+J= '!M)QMI9M2'PO)^$F9*,M)SE
M\)RBYXU(1@'8ON$VR?2X@(U*1B#X1K5V_L]^Z ?N^)\/(]-C5R_]D>D,67?H
M,4"#$WQGXQ[S=H;(F.[8$,'1?I _60#,R\3F?2YA-2P.3PKU7RIUGQ]!@[D=
M=#T/UX;C=%^X?_0WU'@^SUOW7S]E3J&#]RD;OCS.1MR=HE" >J9+RJ?I?/7X
M;QR1_'?71MOJPO4FKF<&\$U),O-)9A$HP"SZ?,.&IGU%6-/F7G@#2MI-T^Y5
MZ+E=GYO7SA/S ]I3Q_K&'31_$7TW?,P#9I7TNTGZ76H32AI^4_Z6@G=7@O<=
M2MPF:/O[JU3+!6S:DH8Y:LJ2WD.$I2WIIF:'+&Q)ZWC>I.]+B<6OW+V!8^/:
MZ1^&$+QG-MY(W &Z7Q]!$OIF'^6,__55_T633FD$[%86;<NK5VY_\;9_H_[*
M;.[_1V@ZOS*''9PNM#0=S,3$^Y(')4$4F2!V("%0.':]8.\/B-GF27J%[XOA
MR_T],/ZE2_?FOME."231 C9J;,(<C6KC7%XGXN=.J1$71"-.AY#@1BU[44H[
MNN$+Z9D4=.':MMDCG>%IEC<RC>18'/=Q YWA/1^. O\P2'">8W(>LO)Q3&Z1
M$98!Y]JQV( [,,$-K-RZ=D#*#7G/9EW?9P% ]=W\E^M=V*;O)PZS#/HH.72&
M0Q'.V[9R*,+GTY)#2PY]?QPJ&6%I5S1RS*9=T257EESY;K@R:>GK[+4I(R<=
M35ZR6LEJ[X+5"IZ'(#FTI7%HRB_WG07A5R !RX\94.X+<.]X$@;,N_IWR"<:
MXZK?O\.>C</Q?G/F;(=>!FKRI?L[SX5M#5[O;)."K"(\?WU%.2% 40_/V(R<
M!0.%[23F36SR3MFKM0I[;328?</L9;Z4['7P[*5O<LE>.;+7M] #E2+T&(6O
MON GOSS =L=AL_>C/,,.FLG*8^Q],%EYDFV(R4K[JP"<5=I=!\].Y4%UP.Q4
MGDXYLY/*B>-#9\^=\T7G&9%9%^.Y)-\<3X,'=Q \FQZ[9$_,=C615%+S9JA9
M/3P3\25YYR>=OYO>'RS@SA!V W9G[.(]GVG_!F3GEF2^<:']-OI+8E\@>6">
M_/[I .F%'K,N62^MT5^,.!M<O<#O>*5^.QCP/O-*LE^1[!'!UXX?>&$<N*!^
MR]B%W84L1'<ZL[=_AR$Y6TK.:%1KC9)_2OXY0/XAVMYH2-NJ-_HEOY0D>[":
MU@\W8/Z=^6KV;'8;C)@G/Y?>GTV<"&]@^^ 5F+?(LB2W_=_E5KG+.][EUA9J
M5R^G3)4[OH$=+[@N$A$*S%$_(T(I14,1"(7V8SE":6V!4)J:1!% GI>$LD-"
M::XB4>3&;9=02HFRIX2R^:/GO%IO*$*!S\V24'9[].!^+$THN'%%NH:-<WV<
M)^8%F-1XY[$!\SQF/01N_X^2H%;TG3P$L+<(,N6%W@X(F^F<GKE(+Y7P-1V"
M)5&71%TXCU%)G25U;MW3M8+L+*\*<Z3,/;\JW'(SP2P=-@J'#7L^^W<(\%\]
ML72IEG<H;B/9E\1+1CAK%N+RH?)2Y!^<EDVG4:-=^AAVJP\TVAO5!TK?="%V
MN;[9MDO-TK&\XUUN[EAING#'8]<Y)&U''?N8VA"\8G$<UX$__:FB.<EUEX?]
M/ %1DLN.R65;(B-U_)?[7IQ]WX9"T"KYO9C[OB7W7[GOQ=GW;5Q*I,_W@_1_
M+;;U1?  [?B4+W>_*+N_B[.^W/U"[?Z63_QR]XNR^[N^1^M:%A?%'NY,;ET[
M%^:$!Z;]KDAB+@Y*5]$BJF1)1@4CHQTKER4]%)<>=J%NEO10<'K8L@):TD-Q
MZ6'7*ND]"TSN,.O*]!SN#/>\;,.21)&]^%()740)+0EGYX2S"[6SI(""4L N
M%(N2 HI$ =M0)3*2['>VW3F<MH7-4<]0V?89ST77:O8,M[OQ-^TODK;HA-ES
M)&W_^"B]%$7U4NS'23F/I$K]=.?ZZ7X0T6I]%*X=QWTRD5\O7,</;:SI?W-S
M\3YR(/<DL9<@FKM1^<)6YD86@D,79+YY!>]+QBPD\2\#3^[%]=\5YV7GJ]XS
M7^URU_H7?(>?;AWV9E& ?>6G*>)^Z#/'!(1JG#4?*?D0];[D76[-V$XH^AGX
M?Z\4&:M),Y%24F3^=^RI,L5ZBM_LHC('3)U;+[^S]R2;4YWEC=O*TY2^D$%<
MDOHV#=*2THM(Z8?N%7I''%$TP_A=<>@,.R!2A$LC0/T\ R.%9*G]M "R_23?
M/.:/'I!3NI;$O/]>B9$H8C9"2EK<C#7:2;2X*"]%BWDI*O=JA<-U*YV7$D2T
M9]$M!<1SZ'"!Y)\/EU/8'#/3#SWV-^Z[K4;][#,\HP93/R6GP-%FC/\P,D'@
MSIQ"(H$>6GD.@.]NQCP6?X)MG,8MOOLC'#//#-P,";\$#M(P9HVJ37K)''?,
MG;>F?1LOZ7FS!E:_)["P $+O8)HWMFP"'Q??,"7W;KC9XS8/./,-29?W;!#I
M+J?5VBFRMX'OT@](GH;%^GQLVOXO1\#YC=IIO=4Z_>NGC#&7G$Y%M,Z;KGG:
MJ=>:.<XV3^V:"TBGWJ[E <<"O:;FPM&J-?.#(X\+O;G44J\WZJU<]B^GRYYY
MT"Z&UX>1ZP6/S!M_=3W/?4;]875F:L.YITV;,?:*T\]@KA>??W:X_<M1X(7L
MR/B4'OTR9(^N]+C[MQZY'D:N;<%?%Z'G(;(=ZX?K],4?2RQ\"S,O(E!:I^US
M37HM.6L:Z!D.+A@5M:='5_\]1URM.^TBB*HV&FUT]JPR9QI>:E+=[?=A-9;&
M61>Y$]'R$RUT"-627#I_EC1,\* ;@@DBFW0OO^@$+/7DZ9L]^.H@K"@VEEZC
M$M$W/&!=+UA,/F]G[2N!5EL:+-]GP<H'1[-]?GZ&5DQRN,4G683LZ[5:HW5:
M6WN258_CT_-&XWSUV==4M$[;S?,U$+P=]:I9/^_D .0&=:IVJ]UIO07A)9NX
M/@]\\>M*ZD62/<[K;>V,GS'Z.E L=&RL!(7X?<U3 N1#JU.;POM<6;3F(=GI
MG)^VVCG/N+*5=-K,;?%KRI&S3FY(V8I,J9_I^G$^ &_'9LN$E5S_=QZ;F*_C
MM1A*ZH"I\9:89G&1,6..Z([8]$>KKB,E%G"H18=?3 BTSG7WQ)+CGU4;2ZN>
M;X"[L@1IGJZXCC7EQ3JSSN\GM(%9%^AO,U?'JI_GLMK-2,)V:TWHMB/V,B%S
MQV,N+E>[CG4!(')GR)S^<H[?-UEON5E6M"U7FV4)Q.8,P/+\OPD -L <&P(S
M7RZ9!:1,T$C>^X*I'HY#\EM=L@%>^=97/5BKS7K[M-:0A_<"$^4!V!H<)9LP
MT+T=]J?L>[S'K*]A\-/AOA\R2WXYH8"]>]9G_ G=&3F+CSS!6$C!2CG<UX%A
M\^NIUX"L=K:>&64(5O9<=L[/Z@W-HSQC_#7 6,BKU>B <=S> A@K>W5:[?/&
M)N%;4T-M;P6^C?O.SD_K;;"&MK&0+=F_B\&OB8C?3#M<1J*G+B\[S78S4_30
MN*O,NY (K]=;&YEU92L&0Y?RA6A-#MT(.)LWM]J=G,EI2_[M):#6+YA%C.+*
MQVF[<=8XTZ:>'GJUR1?AP=-FL]D^V]C<*\OT3NWL/'^HU@W9J3?;G?RA>KMU
MZ*(B(E<\S6UJN1.("H6CMQL!+G'4;(J4,G/1YF)J\\14&)@*AJ>%^DQM&:;E
M6M6\H:6?U6IGC<W3U^HPINRA31%;X0!<KL'$$A;OILAP1L[+?+=>K=VN-=H;
MU"K6@:[1;#3;F]_954!KM]OUTXWMZ?RYZ^?GM?I9:V-"8YF(EYS)91>:YE;,
M/]JT1FMSF[;%**>W(=?"1KN.E9]5.!48^-9$>0"V4C#A%@'+*0!Q&Q#G&[2X
M-8BW'>BXS85M3VPLNZJW;PU7O\UL-T]KFF;Q]E3Y +=09H*Z:MT1<"N?<"F5
M:%M@KRE3TDKF5L'>N-9!^GU3%_/;7M]V+H>67U7Z*MGOAL'(]?B?S%I,K,B<
M8 VDZQ_?,#:W5JO-O[76IEH3JFEY4@2H %?-:J->,*B6$F\S .YL$=ZEY%I1
MX%TT1'/#\-Z9'F8[(OO3/=4=\^CMA16&NQD UDYJM>S;QUE3Y@1EIN90."BG
M.;^(4"ZKZ!1N <NJ/,5<P!+AW%M9@)CCFF+(UE(!*'2D<=XYFR/&Q#1K0+/X
MT5^O-\_;IYN$!3#3J-:B[:3'KU[Z(],9LN[08VQ:U^N.F<?[IO/5X[]QK'+T
M=S %07.[<+V)ZU&-Q$4/C7:CTSQMGV>'*>QNA5>AYW9];EX[3TQHNV#U?N..
MZ?09KO*&CSE0Y\*KK'=:[4:C7;!53NWC2AO8)$UP"^RREG9"U]/U5G9X5DYP
MYJ'U;0?(-54]BBP"TW1].&_# *O+H?38N-C6YEH7KAP%>/Y0;9I/<H1X&QR3
M-[B;YYTY$#^8-O/OV1-S0O:#)9TWLBH>\$Q+-2):,?UA@5E$2F2R_VO^LRS7
M5&F)K,G4W"N!EJJ]G4M>Y?IP9;4;W#A<%ZX?W Y^=5V+K@>8]\3[S'\ M7!#
M%+K<A#D0ZW(3YDBW[4;"2)H%Q;KP;H*8-P7M9DA\<6A_]5S?O_/< =^4 'YC
MAASH^8T9<B3@QGE3NQ[5YET:I$W0Z.KP;(8*Y\#SP&P;5()?F<,\TP8:[5IC
M[G _0(OM"8R]"7-\MB)%IK:L4^OH<64+S9P?O O0=RJX*'GKNAJ\MQ,LSPKO
MP::Y8W8#&Y$',JMI;&;,LR(HR^)IZGHZ/U!R%!C59J-Q7M\,D+F)D/35<WY
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MX2ARAC[!:3O4JVG-:GNIM7/23BEY+F7I"Y?<)H 76TL4A;+R>HR%UT+Q)6[
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M4SX4;0^IN$B28.C@-;$+O;3K&F=1<MR\-(!RYW(&5FT+@2.V)FKVF_"GP>:
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M$^A4GX<BAV:T/Q5\J%J=AL QZ E8($MYH9,_/WUACRUV_#"W*R/A-U6YX.0
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M'ID".X$N^ !F T+(0J2<K)F<3$:-)K$629I,$I#]F46/6__S_K/ 3JK&;:G
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MU*O[RWPA6F_[OQ@Y0O5A7;Z(H<D#G';KO$C867G/B@!#,3&S80(ZSI&"FCG
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M/\)NH8Q0@M6R"&S7P?:H#G/Z5&9!E=&:T65:]%$]&H#D&2%W>\$1\7_H4,$
MT=33ER">MQO(A*UVM7X&HRH2)B$+__JFK4%H".BH#N? IDH-4S5YZ TEK]4L
MS=,FR$M'"BW<!,M\3=18H&)!0M3+>H!9U89H-U*UYJCLC]C9(WST",F6O4AQ
M3.5'3$"$*-:'(I<@Z4X\;AN-<ZWN9@2*:%(JQ366:@ SW&8$2\P>N"RLSB&E
MOB(N^"H-[XG1A5&C,DI6+#"P=IW[+$"S;5EG M<ERCOXND")6]O*'^7C2L9S
M'PF33BM9C4&VZ(Y+CN*/4V496J) +%8Y3)-,P)_TJFYX,M$IXJG2)*(5N(3G
MQ+A+E4K4:T]A246JW1BOPXS+,RF0B7A@P<\N[,%_^M@\&*"SWSZ8IL^;](ET
MA[#>$2[N6;+47#>J<*<)\T,]K]*+]S./*-KTJ4>U$IQC9+JH:A"2 =71S53%
M1 $^V..QD/%Z1WE\BR;32PF]O=_+[F::&BY@-7A10V_<P:?^ZZ':/M'. \Y@
M:^#DC>1* @O9JHJL4BD?PW,O:X>C>I&B'#-5IQ0GCE3MI0H:RI*3^,#SR 4E
M1X#R[$BK@%L<58Q8"SC!WF0@)$"WQ0UVZ,AAGA(K"94XIDZ&U5L=I</T]66^
M35OS:"--1[+;]7UL3FR*F/(EB%"( M&J6X.>\!%F$ 'M4W1"4C=XW\"C8.B9
MDY%Q6FOCHAXZG6I=U0X2Q<MCQ>,!7<'4U//"M>+JH ,Z0@0DFEF6U+DB\T;0
MKGJ>2C5Q*ABE"HH;-!Q^%CWG'5'C*5UI'&F"4]6O>.XW!A"S 8GKQW)<10E$
M#1 F:.)XGHX9;,PQ_XBGKQ^:/G^*RZ93,748",/K9"%;]L)]K(IZS.$5=1#Z
M*%C[5(5VP%^D80=JLX>D#:!5" YX!=[!BD&@:ZF2P (?OHO/O8H"MJ@T8M-O
M_O31&+JNI;.+/^*3B7C@DXNZH??$L72\AXH0O/DVS[S)!V\52MP/MB'QB-5$
M4@4.I\2FJ%R7+,,E%,H91>!PT[$0'+V26?\-AUB\4IVZ@1DDZL<)RIU;MDXS
MUBZSJXGEL@2"9-5E$"5'SAS[U5 UU]#@@!51O> WEGD7OTZPQ$.(*4E ^($2
M9G#"B5+8Z5IXY&.BA883V3.!O< !A=6;<0%Z!H&H22KC:J.#,2Z\IP2+^"8@
ML\IB6/39L1)?:AXF'#^Q&B.]$BJY]R++S$5E_V8@78&@%C>87YGOQ/CA.DPA
M*;E8++"MUJIO!DH8L8N^[X(F@4 HO9"FGUJ^ZVF*8S8:!+ARGYG9'RF8Q'[[
MJE0ESF7ZTV7WXCIWD0F<3?TFU2I\%<Z:)"[>E))O"+UIDP6-I>#USH9YNHYU
M!28R54Q_-PJK6']D@48(R!:ZZGEQ9JMGD69)5;6P/0=6*3:HXB3HH^$82RW"
M#Q8#\NB+TH<GAG^I_:FD=E3!7+A7!+E[)C)1%<QN.O)'8&=C/?249A#Z;!#:
MA@TTXI=U#ZDNS>ER=0_5\JIX 0=K/*FWN1-'0KP54+&9&F9J*><YU-BY$ >J
M%TW.$J2^^&UE$8I 31?8BY#5S .P)LBV:&JJ.5JXR)OU%_DMA+,"G5HDS<
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MRWR)/<%>8)AX )W+X([MNN -.\XK<2*>D:.[-,E%.-M\0H9)I_;E&BW$+3&
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M3TXKAE='<N?"V^CLEV+$6RKO' CUSDVIUU-7:[UAV!>M^%5PN/P?4$L#!!0
M   (  2,+4EJII5X#0X  "FK   5    86)V8RTR,#$V,#8S,%]C86PN>&UL
M[5W=<]NX$7_O3/\'U/=0WTP5678N=\DDO:$DVN%4$76B?&WZ<D.1D,4+1>@
MTA_]ZPN0DLT/D 0E4H [S4-LR=CE[OX6NXM/?OSY<>.#>XB)AX)/9X,W%V<
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MICPXEU>=9P!(NDE(G B[O> !9?%C='&ZPH$;>(AIUL=+'*,I%Q:E.D[N 9*
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M^M^FT/U^G7V;PNP<U/9M"NUO4P".E$M,^CA&HA>2BL4T/<<I][!!F;)USUQ
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M^"1V0Z\_9_^[=R-$/_E_4$L#!!0    (  2,+4F-,X>-&CX  .M- P 5
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M3+Y#X[ Q$=1@.& 4?"W#WP[CWB%&.P.I3I+\@I%WGD5F"JDRHQ'&!*^A1U\
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M\)#)/&/_M 7C.W0FF1#9X&LG13H%,,3R0:EDNA"B:"L+RB$%K/&F7]CYKN9
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M)Y$U%+0K,E7R7AU)VM^#X84&5)\*(@_]6HK H $C9[[)RAJWTY]HA4=V)A;
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MGF)*7]AX)8@9%-"@Z$X?2F(HCCN4I*<(QON'H#6&DHBWC8E?*,D881CGSSR
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M8-=?-(G:6@>* YW=4T+X09:<(/:*I!<9+=;3 *Z)[NQ]/[G#LH!20AEJ*?[
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M>D5OA4N069BJQ*5N%EDT(;/)#;O/JD\XVD:3]/SG=G[$XQQ[+.H2CZD&T0H
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M4 4IJQ;DB''@IC$_P:49<DR>J=!JBP]LDYB$AQ&JSK2$!*8=18U9>1HQD,D
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MJQ).<.P@@7]/PICG!4WW&;7I*-655A6$0)WVJ2F=)IYH)S?502+ H=BRY"U
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M\(Y'-G8V1&77BREPX":>?5)0\HR@>,7HQF=[1!+R(EJWRH>82QN;-H)4<ZN
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G+3(P,38P-C,P7W!R92YX;6Q02P4&      8 !@"* 0  V3(!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
